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Abstract 
The design of luminescent lanthanide complexes is of great importance in the development 
of biological labelling systems providing effective alternatives to radioisotopes, and for their 
application as light triggered sensors and materials. Our approach involves the controlled 
formation of mixed-ligand Eu(Ill) and Th(III) complexes based on specific molecular 
recognition such that a biological molecular recognition event may be detected. The strategy 
is based on design of lanthanide systems with controlled coordination around the metal ion. 
Enhancement of the emission is based on intramolecular energy transfer, which is much 
more efficient than the FRET mechanism. Our design is based on the arrangement of two 
different ligands around the metal ion. 
A multidentate non-absorbing ligand (NAL) is chosen to form a stable, 
coordinatively unsaturated complex with the metal, allowing one or two water molecules to 
occupy the vacant binding sites. Formation of the luminescent ternary complex is achieved 
by displacement of the remaining inner sphere water molecules upon recognition between 
the LnNAL chelate and a strongly absorbing, strongly binding light harvesting centre (LHC). 
This strategy allows flexibility in choosing the antenna ligand. The chromophore, which 
governs the input energy of light, need not be included in the structure of the encapsulating 
ligand. Complicated syntheses are avoided and the system can be optimised for maximum 
emission output. 
We have chosen diethylenetriaminepentacetic acid bis(amide) (DTPA-AM 2) ligands 
as our NAL ligands and simple aromatic carboxylic acids as LHCs to test the design. The 
DTPA-AM2 chelates the metal in an octandentate manner via the three nitrogen donors of the 
diethylenetriamine backbone, the two amide carbonyls and the three remaining carboxylate 
groups. The amide nitrogen atoms are not involved in coordination and are free to form a 
binding cavity, ideal for LHC recognition. The binding of the LnNAL chelate (Ln = 
lanthanide) by the acid moiety is followed by monitoring the emission of the europium ion, 
triggered by intramolecular energy transfer from the LHC. Electrospray mass spectrometry 
data and NMR spectroscopic studies provide additional evidence of the controlled formation 
of ternary complexes. Selectivity of molecular recognition is observed between EuDTPA-
bis(ethylamide) and picolinic acid, phthalic acid and benzoic acid binding units, forming 
mixed ligand species in 1:1, 1:1 and 1:2 stoichiometries respectively. 
Combinatorial screening strategies are employed in development of the mixed ligand 
system, allowing the interaction between a large library of aryl acid potential LHC units and 
a selection of LnNAL chelates to be evaluated. The DTPA-AM 2 ligands were selected to 
impart a variety of structural and electronic properties on the binding cavity, including 
hydrophobicity, rigidity, stenc interactions, and 7t electronic effects. It is demonstrated that 
the selectivity of molecular recognition is based largely on the aryl-acid binding unit, with 
additional selectivity imparted by the amide arms of the LnNAL chelate. Equilibrium 
constants for ternary complex formation, luminescence lifetimes and quantum yields are 
evaluated for 1:1 mixed ligand species formed upon molecular recognition between 
LnDTPA-AM2 chelates and aryl acid LHCs. 
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I Introduction 
Supramolecular chemistry,' defined as chemistry beyond the molecule, is a growing 
interdisciplinary research area which studies the non-covalent interactions involved in the 
spontaneous assembly of complex molecular architectures. 
Processes of molecular recognition are vital in nature, perhaps the most celebrated 
example being the specific hydrogen bonding between nucleic acid base pairs in spontaneous 
self-assembly of the DNA double helix (Figure 1-1). Accurate transcription and translation 
of genetic material ensures correct expression of the gene, resulting in the synthesis of the 
appropriate amino acid sequence of a protein. Molecular recognition between the amino 
acid side chains in the peptide leads to the secondary structure of the protein, forming (X-
helices and 3-sheets, which in turn influence the ternary structure defining the overall 
function of the protein in the organism. 
Figure 1-1 The DNA double helix 
Much of the inspiration for the supramolecular chemist is found in the natural world. 
Researchers are keen to exploit the concept of molecular complementarity in the design and 
synthesis of novel and elegant molecular frameworks which exhibit intriguing physical or 
chemical properties. Such systems have been developed for application as molecular 
switches, signalling devices and sensors. 2 
Intermolecular forces of recognition such as electrostatic and 7t-stacking effects, 
hydrogen bonding and hydrophobic interactions are fundamental to biological function. 
Enzymatic conversions require specific molecular recognition between the substrate 
molecule and active site. Similarly, an active pharmacophore must recognise and bind the 
target receptor for a drug to have the desired therapeutic effect. Specific interactions 
between antibody and antigen are implicated in immunological responses and can be 
exploited in biological detection methods. Our interests lie in the development of a 
luminescent labelling system based on molecular recognition capable of detecting biological 
macromolecular interactions. Labelling techniques have been widely applied in 
immunoassay systems. A brief account of some of the methods used to date is given below. 
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1.1 Immunoassay Methods 
The qualitative and quantitative analysis of biologically active molecules is of great 
importance in clinical applications. Immunoassays' -' form a class of highly sensitive, 
powerful analytical techniques employing the specific molecular recognition between 
antigen and antibody for the detection of chemically similar species in biological samples. 
Finding application in areas across the spectrum from routing clinical diagnosis to early drug 
discovery and development, immunological assays provide sensitive analyses for species 
such as hormones, proteins, enzymes, drugs and metabolites where traditional chemical or 
biological analysis may prove ambiguous. The immunological detection of such species in 
low concentrations using radio-isotope or fluorescence labelling techniques is now standard 
practice. A typical solid-state immunoassay is schematically represented below in Figure 1-
2. An antibody immobilised on a solid support is reacted with a solution containing the free 
antigen under investigation and a second labelled antibody, forming an immunocomplex on 
the solid support. Detection of the sample signal following separation of unbound labelled 
antibody allows quantitative determination of the antigen present in the sample. Direct 
detection of biological interactions in solution is relatively unusual and somewhat 
underdeveloped in comparison with the now commonplace solid-phase assay techniques. 
Label 
-I ) ( 	1. Molecular Recognition 2. Washing 
Unbound 	 Immobilised Labelled supported 	Antigen 	Labelled Immunocomplex Antibody Antibody 
Figure 1-2 Schematic representation of a typical heterogeneous immunoassay 
1.1.1 Radioimmunoassay (RIA) 
Yalow and Berson first pioneered the use of radioisotopic labelling in the 1960s. 6 
Radioisotopes 125j 3H, 32P, 33P and 35S are frequently employed in immunoassays, providing 
a distinct signal with a low and stable background count, allowing sensitivities of 106 
molecules per assay to be achieved in practical applications. The label is robust and 
unaffected by environmental factors such as temperature, pH and solvent polarity. Its small 
size allows the immunoreaction to proceed unperturbed by label interference. Radiolabelling 
techniques are routinely applied in drug discovery and development, often in a Scintillation 
Proximity Assay (SPA) format, an example of which is given below. 
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1.1.2 Scintillation Proximity Assay (SPA) 
Common in drug discovery and development, the SPA employs the specificity of interaction 
between the tetrameric protein streptavidin and the soluble vitamin, biotin, (Log Kaffinit y 
15) in the formation of a radiolabelled immunocomplex on a solid phase SPA bead. One 
particularly elegant example of SPA application was developed by Glaxo Wellcome 
scientists (California, 1 999),8  where high throughput screening technologies were employed 
in identification of selective enzyme inhibitors in a kinase enzyme cascade. 
The cascade requires three enzymes in order to complete a signalling pathway from 
the cell membrane to the nucleus, regulating gene expression and DNA synthesis. Each 
enzyme is activated by phosphorylation, mediated by the preceding enzyme in the sequence. 
Enzyme activated phosphorylation of the biotinylated product peptide in the presence of 33P 
forms a radiolabelled species in the sample solution. This labelled peptide is recognised by 
the streptavidin labelled SPA bead, forming a supported immunocomplex. Only 
phosphorylation by the third enzyme in the cascade results in the labelled peptide product, 
hence detection of the SPA signal is indicative of the complete cascade. Conversely, the 
absence of an SPA signal signifies inhibition at some point in the pathway. The SPA is 
schematically represented in Figure 1-3. 
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Figure 1-3 Schematic representation of a Scintillation Proximity Assay for a three enzyme cascade 
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The assay was developed to determine the output from each specific kinase cascade 
under investigation. Using this SPA 335 000 compounds were screened for inhibitory action 
against the enzymes, from which 1200 leads were identified. The SPA results allow 
identification of enzyme specific inhibitors, from which potential therapeutic agents may be 
developed. Such kinase enzyme cascades have implications in inflammatory responses and 
in some 30% of human tumours, hence are attractive targets in drug discovery. 
Despite the widespread and successful application of RIA, the significant disadvantages 
associated with the technique have prompted the search for alternative technologies. 
Increasingly strict legislation surrounding the supply, handling and disposal of radioactive 
material, and the short shelf life of reagents (1251  half-life = 6- days) have, together resulted in 
research into alternative labels. In addition, the heterogeneous nature of the assays, involving 
several washing steps, is not readily applicable to today's modern automated and 
miniaturised high throughput screening technologies, now an integral part of the 
pharmaceutical industry. 
In past decades assay methods based on fluorescence technology have emerged as 
attractive and viable alternatives to radioisotopes in immunoassays. 913 The relatively 
inexpensive technology is clean, safe and versatile. Highly sensitive instrumentation for the 
detection of light has been developed in recent years and is now commercially available. 
1.1.3 Fluorescent Labelling Involving Organic Fluorophores 
In 1941 Coons et al reported the first use of an organic compound in biomolecular detection, 
using anthracene isocyanate to label a bacterial protein. 14  Fluoroimmunoassays (FIA) 
involving organic fluorophores (Figure 14) such as dansyl chloride, fluorescein and 
rhodamine derivatives (Figure 1-5) have achieved sensitivities of 1010  M in routine practice. 
The organic fluorophore is covalently coupled to the biomolecule of interest as in RIA, its 
relatively small size not affecting the immunological properties of the antibody. The 
photophysical characteristics of the probe are sensitive to the environment and changes in the 
pH and hydrophobicity of the probe's immediate surroundings upon immunoreaction result 
in changes in the absorption and emission spectra. Such bathochromic or hypsochromic 
shifts and hyper or hypo-chromic effects allow differentiation between free and bound 
labelled antibody. Consequently, separation of the labelled immunocomplex from the 
sample solution is not always necessary reducing the number of steps in the assay. 
Homogeneous assay methods lend themselves to modern analytical techniques including 
4 Biological Labelling 
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high throughput screening of combinatorial libraries, of immense value in the search for 
novel lead compounds in drug discovery. 1518 Such technological innovations are discussed 
further in Chapter 1.3. 
	
hv 	/hV 1 	 hv 
G) —<Ag Molecular Recognition 
by2 
Supported 	 Labelled 	 lmmobiised labelled 
Ab Ab immunocomplex 





d 	 FITCansyl chloride 	 fluorescein isothiocyanate 
	Texas Red (Rhodamine derivative) 
Xex = 340 nm 
X em =480-520 nm 
(Stokes shift - 140-180 nm) 
c = 3400 cm -1 M 1 
t = 14 ns 
4) = 0.3 
ex = 492 nm 
? em = 520 nm 
(Stokes shift - 18 nm) 
c = 72000 cm -1 M-1 
T = 4.5 fls 
4) = 0.85 
Xex 525 n 
X em = 615-620 nm 
(Stokes shift - 80-95 nm) 
= 85 000 cm-1 M -1 
4) = 0.3 
Figure 1-5 Structures and photophysical properties of some organic 
fluorophores commonly applied in FIA 
An example of direct replacement of an isotopic label with an organic fluorophore in 
biological receptor-ligand binding studies is discussed briefly below. 
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Fluorescein isothiocyanate (FITC) has found application in specific labelling of 
chemokines,' 3 offering sensitivity comparable to that achieved by traditional 125!  radio-
labelling. Interleukin-8 (11,8), a pro-inflammatory protein implicated in conditions including 
rheumatoid arthritis, cystic fibrosis, bronchitis, atherosclerosis and a multitude of tumours is 
the most extensively studied chemotractant cytokine. Targeted labelling of the N-terminus 
of the 1L8 protein with FITC was performed and its binding affinity to specific receptors 
assessed by fluorescence techniques. The small molecular size of the F1TC label allows 
biological recognition to occur unperturbed thus offering a viable alternative to isotopic 
detection methods. 
1.1.4 Enzyme Linked Immunosorbant Assay (ELI SA) 
Organic fluorophores are also universally applied in enzymatic immunoassays, an excellent 
example of which is ELISA (Enzyme Linked Immunosorbant Assay) discussed below 
(Figure 1-6). Enzymes were first introduced as biological labels in the early 1970s. 19 As 
with traditional FIA and RIA systems, a supported labelled antibody specifically binds the 
antigen under investigation. A second antibody covalently conjugated (Scheme 1-1) to an 
enzyme recognises the antigen and forms the immunocomplex. The unbound labelled 
antibody is separated and removed from the sample prior to enzymatic reaction, which 
converts a colourless substrate molecule into a coloured (Scheme 1-2) or luminescent 
(Scheme 1-3) product allowing quantitative detection of the antigen. Enzymes routinely 
employed in ELISA include alkaline phosphatase (AP), -galactosidase (GAL) and 





(Ag 1 	 Ag 	




Figure 1-6 Schematic representation of Enzyme Linked Immunosorbant Assay (ELISA) 
The main disadvantage associated with these heterogeneous fluoroimmunoassay systems is 
the laborious multistep nature of the processes involved. Separation of immunocomplex 
from the sample solution and several thorough washings are required to remove the 
remaining free labelled antibody prior to fluorescence measurement. 
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Scheme 1 - 1 Bifunctional coupling reagents used in enzymatic labelling of an antibody 
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Scheme 1-3 Schematic representation of enzymatic conversions resulting in organic fluorogenic 
products commonly applied in ELSIA assay systems 
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The use of organic fluorophores in immunoassays has resulted in a reduction in the number 
of steps in heterogeneous assays and has facilitated development of simple homogeneous 
methods. The latter have been vitally important in the mechanisation, miniaturisation and 
automation of immunological detection methods, offering obvious economic advantages. 
One such example is the Fluorescence Polarisation (FP) assay summarised briefly below. 
1.1.5 Fluorescence Polarisation Assay (FP) 
Fluorescence polarisation 20  was initially introduced as an alternative labelling method in the 
immunoassay field in the early 1960s. 9 An antibody labelled with a fluorescent dye, such as 
fluorescein isothiocyanate (Figure 1-5) will emit polarised light when excited by a plane 
polarised excitation source. The degree of polarisation observed is a function of rotational 
relaxation time and thus related to molecular size. Small molecules, tumbling more rapidly 
than their larger counterparts, have shorter relaxation times hence the light emitted is 
polarised to a lesser extent. Molecular recognition between the labelled antibody and 
antigen under investigation forms the immunocomplex in solution. The greater molecular 
size of the product immunocomplex slows molecular tumbling, in turn increasing the degree 
of polarisation detected. As with FIA, the changes in photophysical properties of the dye 
upon macromolecular recognition render the separation steps associated with traditional 
assays unnecessary, allowing discrimination between free and bound antibody in solution. 
Consequently, the assay can be carried out in a "mix-and read" format and is readily 
applicable to modern automated technologies. The fluorescence polarisation assay is, 
however, restricted to the study of relatively small antigens, since the rotation of large 
molecular weight species in solution is slow and changes very little upon 
immunocomplexation. 
Despite the advantages presented by the homogeneous assay format, the use of organic dyes 
as labels is hindered by the high level of background fluorescence from serum proteins at 
wavelengths comparable to that of the probe employed, causing significant signal overlap. 
Rayleigh and Raman scattering by solvated macromolecules and scattering by colloidal 
particles or solid supports also contribute to high background signals. In addition, the small 
Stokes shifts (20-50 nm) of organic molecules renders distinction between the excitation 
source and emitted light difficult. Problems are also incurred due to overlapping spectral 
bands, which can result in self quenching of the excited state by adjacent fluorophores. 
Consequently fluoroimmunoassays employing organic probes are in general less sensitive 
than the corresponding radioimmunoassay methods and the search for alternatives continues. 
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1.2 Lanthanides as Labels 
The unique photophysical properties of lanthanide trivalent cations" make them ideal 
candidates in the search for efficient non-isotopic alternative labels in biological assays. The 
characteristic emission in the visible region of the electromagnetic spectrum is long-lived, 
providing a clean, safe, readily detectable signal. Currently finding application in structural 
determination and analyses," rare earth cations are routinely utilised as probes in a variety of 
biological23' 24  and chemical systems in addition to their use as components of photoactive 
signalling devices25' 26  and sensors .27' 28 
Perhaps the most common application of lanthanide cations is as luminescent labels 
in immunological detection methods,'-" 9-12,29,30  examples of which are discussed later in 1.3. 
Instrumentation has been developed allowing lanthanide luminescence to be used in flow 
cytometry3 ' and microscopic imaging, 32 capillary electrophoresis 33 and in nucleic acid 
sequencing studies .34  Long-range electron transfer, fundamental to many physiological 
processes, including photosynthesis and respiration, can be studied by isomorphous 
replacement of the spectroscopically silent Ca 2 or Zn2 with redox active rare earth ions. 35 
Similarly, information can be gained regarding the nature of these metal ion binding sites 
employing luminescent lanthanide cations as structural probes in proteins '36-39  as the Ln(llI) 
ions employed are of comparable ionic size. 
In addition to their ubiquitous application in biological assays, rare earth cations 
provide robust, sensitive analytical handles in NMR as chiral shift reagents '40  structural 
probes of crystalline materials 4 ' and in clinical Magnetic Resonance Imaging (MRI) as 
contrast agents. 42 
1.2.1 Lanthanide Luminescence 
Only four trivalent lanthanide ions, europium, terbium, samarium and dysprosium, emit light 
in the visible region of the electromagnetic spectrum, their characteristic luminescence the 
result of radiative decay of the excited state competing efficiently with other non-radiative 
de-excitation pathways. 2 ' In contrast to the lanthanides, most transition metals absorb UV 
light but very few re-emit the energy in the visible region. Strong coupling between the d-
electron excited state and the ligand, field leading to charge transfer processes, provides an 
efficient depopulation pathway. 
Spectroscopic transitions of the lanthanides involve the 4f electrons, shielded from 
the environment by the outer 5s and 5p orbitals. Although formally forbidden by the Laporte 
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selection rule (AL # 0) prohibiting the redistribution of electrons within a single electronic 
subshell, f -), f transitions become allowed due to the large degree of spin-orbit coupling 
present. The degeneracy of the electronic configuration of the spherical Ln(ffl) ion is 
removed by interelectronic repulsions, splitting the energies into spectroscopic terms (S, P, 
D, F ... ), which are then further split by spin orbit interaction into spectroscopic levels. For 
Eu(Ill) and Th(III) ions, (4f 6 and 40 configurations respectively) the ground state term is 
given by 7F3 where J = 0 (Eu(ffl)) and J = 6 (Th(llI)) as determined by application of Hund's 
rules and the Russell-Saunders coupling scheme. 43 The spectroscopic transitions occurring 
in Eu(llI) and Th(Ill) ions are shown below in Figure 1-7. 
Figure 1-7 Partial energy diagram for Eu(III) (4f) and Th(III) (0) ions showing the relative 
magnitude of the interelectronic repulsion, spin-orbit coupling and ligand field effects. Downward 
arrows indicate luminescence. 21 
Emission spectra are narrow and line-like, with long luminescence lifetimes, in the 
order of milliseconds, in contrast to organic molecules whose emission lifetimes are typically 
in the order of nanoseconds. Large Stokes shifts (generally 200-300 nm) prevent 
overlapping absorption and emission spectra thus minimising scattering effects. Molar 
extinction coefficients of the lanthanides are intrinsically weak, typically less than 10 
Mcm' reflecting the forbidden nature of the f-f transitions, presenting significant problems 
in the application of lanthanide ions as spectroscopic probes. A typical Eu(Ill) emission 
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spectrum, showing radiative decay of the 5D0 luminescent level following excitation to the 
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Figure 1-8 Typical Eu(III) emission spectrum showing the electronic transitions resulting in 
characteristic red luminescence of the ion 
A significant disadvantage associated with lanthanide luminescence is the inherently weak 
emission observed from the free ion in aqueous solution. This is due to low absorbance and 
the quenching effect of coordinated water moleculeS, 21,44'45  a phenomenon first investigated 
by Kropp and Windsor in the 1960s. 46 Vibronic coupling with vibrational overtones of high 
energy 0-H oscillators in the primary coordination sphere provides an efficient dc-excitation 
mechanism, depopulating the emissive state via non-radiative energy transfer 47 (Figure 1-9). 
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Figure 1-9 Partial energy diagram illustrating the relative quenching abilities of H 20 and D20 in 
depopulating Eu(III) and Th(HI) excited states 
The luminescence lifetime of a lanthanide excited state is dependent on the efficiency of the 
dc-excitation mechanisms and is therefore proportional to the number of coordinated 0-H 
oscillators. The observed rate of luminescence decay (k obS) comprises several terms 
(Equation 1-1) where k, and k fl0 d are the rate constants for natural photon emission and 
non-radiative de-excitation respectively. EkXH  represents the contribution of non-radiative 
energy transfer to proximal high energy X-FI oscillators (X = 0, C and N: Stretching 
frequencies: VOH 3400 cm'; amide NI-I VNH 3310 cm'; methylene CH VCH-  2950 cm'). 
The lifetime, tobs,  is expressed as the reciprocal rate constant. 
kobs = kna t + knonrad  + kXH 	 Equation 1-1 
An estimate of the hydration state of the metal (q) can be gained from lifetime 
measurements performed on luminescent species in quenching 1120 and non-quenching D 20. 
For the lower energy 0-D oscillator to provide an efficient deactivating pathway, higher 
overtones must become involved, energetically unfavourable due to poor overlap of the 
wavefunctions, as stated by the Franck-Condon principle. The relative quenching power of 
13 Lanthanides as Labels 
Introduction 
an X-D oscillator is approximately 200-fold less than that of the corresponding X-H bond, 
hence the much longer observed luminescence lifetime of Eu(Ill) in non quenching D 20 
relative to that of the free ion in water. This phenomenon can be applied to provide a 
measure of the number of coordinating water molecules in the inner sphere of the metal. 
The rate constant for depopulation of the excited state by non-radiative energy 
transfer to coordinated X-H bonds can be obtained by difference (Equation 1-2). 
k1120 - k020  = EkxH 	 Equation 1-2 
Application of an empirical formula determined by Horrocks (Equation 1-3) allows 
the number of coordinated water molecules (q) to be calculated. 
q = ALfl(IJI)•( t'H20 - 	020) 	 Equation 1-3 
The parameter ALfl(111) is an empirically determined factor, 1.05 for Eu(III) and 4.2 
for Th(III). The 5D0 luminescence excited state of Eu(III), of lower energy (17 250 cm') 
than the corresponding 5134 luminescent level of the Th(III) ion (20 430 cm'), is more 
susceptible to quenching by the solvent environment. t 'io and r 020  are the reciprocal 
luminescence lifetimes (ms) for the species in 1120 and D20 respectively. Values of q can 
be obtained to ± 0.5 water molecules. 
In addition to solvent quenching effects, an important consideration in the design of 
luminescent lanthanide complexes for application as probes in biological or chemical 
systems is the inherently weak absorption coefficient of the metal ions. 48 
Weissman '49  in 1942, observed that a europium (III) 3-diketonate complex emitted 
characteristic red light upon exposure to sunlight. Although initially believed to be the result 
of electron transfer, this was later explained as the "Antenna Effect" (Figure 1-10) whereby 
the diketonate ligand absorbs UV radiation then transfers the energy to the metal ion. 
Excitation to the ligand singlet excited state is followed by intersystem crossing to the longer 
lived, lower energy triplet state facilitated by the heavy atom effect. Intramolecular energy 
transfer to the excited state of the lanthanide populates the emissive level of the metal, from 
which radiative decay to the ground state manifold results in emission of characteristic light 
(Eu(III) = red, Th(ffl) = green). The widely accepted Absorption Energy Transfer Emission 
(AETE) mechanism was established by Balzani et a!50' 51  on studies with the [Eu(bipy)3 ] 3 
cryptate and is represented schematically in Figure 1-11. 









Figure 1-10 Schematic representation of the 'antenna effect" whereby light is absorbed by 
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Figure 1-11 Schematic representation of the Absorption Energy Transfer Emission (AETE) 
"Antenna Effect" mechanism 
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1.2.2 Coordination Properties 
Classified as "hard acid" in character by the Pearson scheme, 52 Ln(Ill) ions will 
preferentially coordinate "hard donor" ligands such as anionic oxygen and nitrogen atoms, 
forming predominantly non-covalent, electrostatic bonds. The metal ions are hydrated in 
aqueous solution, and negatively charged oxygen donor ligands are required to displace 
water molecules from the primary coordination sphere. Neutral 0 and N donor atoms in 
general only bind the metal as components of multidentate ligands. 53 Water molecules can be 
excluded from the primary coordination sphere of the ion by encapsulating it in the cavity of 
a cryptand or macrocyclic ligand, or by using a polydentate aminopolycarboxylate chelator. 
Since the f orbitals are shielded from the environment by the outer s and p electrons and are 
only minimally involved in coordination, complex geometries take on the characteristics of 
the ligand and are not dictated by the electronic configuration of the metal. The coordination 
properties of trivalent lanthanide cations are similar to those exhibited by the alkali and 
alkaline earth metals, with the ions readily forming stable complexes with multidentate and 
macrocyclic ligands. These multidentate chelators will adopt the conformation of lowest 
energy around the spherical cation. Coordination numbers between 6 and 12 have been 
reported with eight and nine most common. 
By careful choice of chromophoric ligand such that excited state energies are suitably 
matched for intramolecular energy transfer to occur, and exclusion of quenching moieties 
from the inner coordination sphere of the metal, highly luminescent chelates can be prepared, 
several of which now find application in biological detection methods. Diketonate 
complexes were initially tried as luminescent labels in biological systems but instability and 
poor solubility in aqueous media have limited their direct application in immunoassays. 14,11  
In order to overcome these problems, polydentate aminopolycarboxylate ligands have been 
exploited in the design of luminescent lanthanide chelates for biological labelling. Chelates 
formed with EDTA (ethylenediamine tetraacetic acid) and DTPA (diethylene triamine 
pentacetic acid) are highly stable (Log K > 20) and water soluble. Such stability prevents 
non-specific ionic exchange with biological cations such as Ca 21,  Mg2 and Zn2 . These 
aminopolycarboxylate ligands have been employed in radiolabelling of biomolecules,56' 57 
magnetic resonance imaging" and luminescent immunoassays involving mixed ligand 
Eu(ffl) 59 " and Th(Ill) chelates. 6569 A few examples of lanthanides in immunoassays are 
briefly discussed here. 
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1.3 Time Resolved Fluoroimmunoassay (TR-FIA) Involving 
Lanthanides 
A highly sensitive fluorescence immunoassay technique was developed based on the 
characteristic long lived luminescence of the europium and terbium cations.59 65  These 
trivalent lanthanides are employed as versatile labels in time resolved immunoassays. Three 
currently available TR-FIA kits are briefly discussed here. Sensitivities comparable to RIA, 
unobtainable with organic fluorophores can be achieved with lanthanide labels in routine 
practice. The sensitivity is based on minimisation of short-lived background signal by 
implementing a fixed time delay between the excitation flash and signal detection. The long 
emission lifetimes of the lanthanide species allow strong signal detection after the delay, 
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Figure 1-12 Schematic representation of the principal of Time-Resolved Fluorescence Detection 
Time resolution, in combination with careful use of filters gives a distinct signal with 
relatively low background noise levels. 
1.3.1 Dissociation Enhanced Lanthanide Fluoroimmunoassay (DELFIA) 
A popular time resolved immunoassay method employing europium (UT) luminescence is the 
Dissociation Enhanced Lanthanide Fluoroimmunoassay or DELFIA system 7072 (Figure 1-
13). An antibody is covalently coupled via a protein to an aminopolycarboxylate (EDTA) 
derivative forming a stable Eu(H1) chelate. Multiple labelling of the antibody, with up to 15 
chelates per molecule is possible increasing the sensitivity of the system. Molecular 
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recognition between the labelled antibody, free antigen and supported antibody in solution 
forms the desired immobilised immunocomplex. Free antigen and unreacted labelled 
antibody are then washed from the sample. The EuEDTA chelate is non-luminescent, and 
treatment of the supported complex with an acidic "enhancing" solution is required. The low 
pH of the enhancing solution facilitates dissociation of the chelate, liberating Eu(I11) into the 
solution, containing an aromatic 13-diketone sensitizer ligand and a hydrophobic tris(octyl) 
phosphate which together form the luminescent species 73 (Figure 1-14). The amount of 
antigen present in the sample is indirectly determined by comparison with a luminescent 
Eu(ffl) standard. Care must be taken to avoid contamination as small europium impurities 
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Figure 1-13 Schematic representation of the Dissociation Enhanced Lanthanide 






Figure 1-14 Structures of the sensitising "fnac" and hydrophobic "topo" ligands present in the 
"enhancement" solution for the DELFIA assay 
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The exact nature of the emissive complex is unknown, but it has been proposed that 
two sensitising ligands chelate the metal, in combination with two tris(octyl)phosphates, 
each of which form a hydrophobic umbrella around the inner coordination sphere, thus 
excluding water molecules and preventing quenching of the luminescence by OH. The 
sensitivity of the assay is improved by employing time resolved techniques. 
Despite its popularity the DELFIA assay system is not without disadvantages. The 
assay is heterogeneous and several washing steps are required to ensure complete removal of 
unbound labelled antibody prior to treatment with the enhancement solution. Excess ligand 
is employed in formation of the luminescent chelate, the presence of which contributes to the 
background fluorescence detected. 
Europium DTPA derivatives have also been employed in luminescence assays as direct 
alternatives to FITC and 1251  for detection of IL-8 receptor-ligand interactions 
.74  The assay 
can be performed in high throughput format, exhibiting enhanced sensitivity over the 
traditional organic or isotopic labelling methods. IL-8 is covalently coupled to the 
[EuDTPA] chelate via a sulphonamide linker and N-terminal cysteine residue forming a 
labelled ligand. A monolayer of cells immobilised on the surface of a microplate is treated 
with the labelled 1L8 ligand solution, upon which molecular recognition occurs. A non 
luminescent labelled monolayer is thus formed on the solid support. Treatment of the 
sample with the DELFIA enhancement solution releases the ion, allowing the highly 
luminescent 13-diketonate chelate to form. Time resolved detection of the luminescence in 
the lanthanide assay offers enhanced sensitivity over the corresponding assay employing the 
FITC probe. 13 
1.3.2 Cyberfluor 
Like the heterogeneous radiolabelled SPA system (1. 1.2) the Cyberfluor method '2' 
65  utilises 
the highly specific molecular recognition between the soluble vitamin, biotin, and the 
tetrameric protein streptavidin, and offers a versatile assay commonly used in DNA 
hybridisation.75  A labelled single strand of DNA can be used as a specific gene probe since 
it will only bind with the corresponding complementary nucleic acid sequence to form the 
double helix. The technique, as commonly used in heterogeneous assay systems is 
schematically represented below (Figure 1-15). For DNA hybridisation the antibody is 
replaced with a specific nucleic acid sequence. 
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Figure 1-15 Schematic representation of the Cyberfluor assay system 
The biotinylated antibody forms an immunocomplex with the supported antibody/antigen. 
Molecular recognition between biotin and streptavidin produces a multiply labelled species. 
The Eu(III) luminescent complex is formed upon addition of the sensitising ligand, BCPDA 
(4,7-bis(chlorosulphophenyl)- 1,1 0-phenanthroline-2,9-dicarboxylic acid (Figure 1-1 5)),55  the 
mechanism of which is not understood. Qualitative analysis of the antigen present is 
achieved indirectly by time resolved detection of the Eu(ffl) sensitised emission and 
comparison with an external Eu(III) standard. The Eu(llI)BCPDA chelate is less 
luminescent than the -diketone employed in the DELFIA system, but background 
fluorescence is reduced since excess ligand is removed from the sample prior to analysis. In 
common with DELFIA, the Cyberfluor method offers indirect, heterogeneous analysis of 
biological species under investigation. 
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1.3.3 Enzyme Amplified Lanthanide Luminescence (EALL) 
Like ELISA (1.1.4), the commercially available Enzyme Amplified Lanthanide 
Luminescence (EALL) assay system 65 utilises the enzymatic conversion of a substrate to its 
corresponding product in analyte detection (Figure 1-16). The enzyme amplified lanthanide 
luminescence assay is based on formation of a mixed ligand luminescent complex between a 
Th(llI) aminopolycarboxylate species and the product of the enzymatic reaction. In this 
case, the enzyme is Alkaline Phosphatase (AP) and the substrate the phosphate ester of 5-
fluorosalicylic acid (5 -FSAP), which prior to enzymatic hydrolysis does not interact with the 
[ThEDTA] - chelate and no luminescence is detected. 
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Figure 1-16 Schematic representation of Enzyme Amplified Lanthanide Luminescence 
(EALL) in immunoassay 
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A solid-supported antibody forms an immobilised immunocomplex with the antigen 
under investigation and a biotinylated detection antibody, which then undergoes specific 
molecular recognition with the streptavidin labelled enzyme (see Cyberfluor, 1.3.2) as shown 
in Figure 1-15. The immobilised enzyme is then treated with the substrate, 5-FSAP, which 
is hydrolysed liberating 5-FSA. The product salicylate then forms an intensely luminescent 
mixed ligand complex with [ThEDTA]' under alkaline conditions. Quantitative analysis of 
the antigen of interest is achieved by comparison of the observed luminescence intensity 
with that of a known standard. This assay has been demonstrated with a number of enzyme 
substrate pairs and can achieve sensitivities comparable to that of traditional RIA by 
employing time resolved detection methods. 
The exact nature of the emissive [ThEDTA.FSA] chelate is unknown, however, the 
high stability of the Th(llI) aminopolycarboxylate chelate prevents release of Th(III) thus 
formation and precipitation of terbium hydroxide species under the alkaline assay conditions 
is avoided. 
An analogous mixed ligand chelate between a Th(llI) aminopolycarboxylate and 4-
aminosalicylic acid (pAS) has been applied to DNA hybridisation allowing development of a 
homogeneous system, discussed below. 
1.3.4 Homogeneous Nucleic Acid Hybridisation Assay 
Oser and Valet 76 employed ThDTPA and pAS in specific labelling of oligonucleotide strands 
such that a nucleic acid could be detected by fluorescence resonance energy transfer (FRET). 
Two nucleic acid probes of known base sequence are employed, one labelled with the 
ThDTPA chelate at the 5' terminus. The other is labelled at the 3'end with a salicylic acid 
derivative. Only upon hybridisation are the two components of the label brought into close 
proximity allowing energy transfer to occur from the pAS donor to the ThDTPA acceptor 
(Figure 1-17). Hybridisation is confirmed by observation of characteristic green Th(ffl) 
emission. The assay can be performed in solution, under time resolved conditions, 
minimising background fluorescence. The homogeneous nature of the assay eliminates the 
need for laborious pre-hybridisation incubation periods (since the hybridisation kinetics are 
more favourable in solution) and washing steps, therefore presents itself as an attractive 
candidate in the development of automated high throughput systems. 
22 Time Resolved Assay Techniques 
Introduction 








Double Strand Formed 





Donor labelled 	 Acceptor labelled 
diga,ededide dignucteide FRET Donor and Acceptor pair 
form Luminescent Tb(II) Species 
CTATGL...G ci 
pAS FRET donor labelled 	 TbDTPA Acceptor  




ç CO2  
Coe .. 
c°2_ 
Characteristic Green Light 
Indicative of Hybridisation 
Event 
Figure 1-17 Schematic representation of lanthanide labelling in nucleic acid hybridisation assay 
The hybridisation assay discussed here demonstrates the applicability of FRET pairs and 
time resolved detection methods to probing nucleic acid sequences, 7783 of great importance 
in detecting mutations and modifications to genetic material. 
1.3.5 Homogeneous Time Resolved Fluorometric Assay (HTRF) 
Much of the effort devoted to the development of biological detection methods has focused 
on the search for highly sensitive homogeneous assay systems that are readily adaptable to 
automation and mechanisation. One success story, termed Homogeneous Time Resolved 
Fluorometric Assay (HTRF) developed by CisBio International 14  is discussed below. The 
system (Figure 1-18) utilises a Fluorescence Resonance Energy Transfer (FRET) pair 
comprising of a europium bipyridine cryptand and an allophycocyanin dye. 54 The donor, a 
[Euc(bipy.bipy.bipy)} 3 chelate (Figure i - i 1), incorporates the selectivity of metal binding 
and complex stability offered by a macrobicyclic polyaza ligand with the chromophoric 
properties of the organic bipyridine unit. The donor is covalently coupled to the biomolecule 
(antibody or antigen) using conventional labelling methodology (see Scheme 1-I), without 
the loss of immunological reactivity or photophysical characteristics of the probe. 
Depopulation of the metal excited state by components of the serum, such as uric acid, is 
prevented by incorporation of excess fluoride ions in the sample media. The fluoride ions 
occupy the remaining vacant coordination sites of the metal preventing association of 
quenching moieties. The acceptor, an allophycocyanin dye, is also coupled to an antibody 
23 Time Resolved Assay Techniques 
Introduction 
such that formation of the immunocomplex brings the FRET pair into close proximity. 
Resonance energy transfer from the donor to the acceptor by the Förster mechanism 84 can be 
observed over distances of 5-10 nm, comparable to those of the immunocomplex. Laser 
excitation at 337 nm populates the singlet excited state of the tris(bipy) ligand, which 
undergoes intersystem crossing to the triplet state, from which intramolecular energy transfer 
populates the metal excited state. Characteristic Eu(llI) emission at 620 nm is observed from 
free labelled antigen in the assay media. Upon immunocomplexation radiationless de-
excitation of the donor excited state populates the emissive state of the allophycocyanin dye, 
from which fluorescence at 665 nm is observed. 
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Figure 1-18 Schematic representation of the HTRF FRET based assay 
Background fluorescence by serum components and free acceptor-labelled 
antibodies is minimised by implementing time resolved detection. Dual wavelength 
detection is performed at 620 nm (donor) and 665 nm (acceptor). The ratio of observed 
intensities is dependent solely on the concentration of the immunocomplex in solution, 
allowing quantitative analysis of the antigen. The assay is completely homogeneous, thus 
negating the tedious washing and separation steps necessary in comparable heterogeneous 
fluoroimmunoassays. 
HTRF systems are now routinely applied in clinical situations, in complex assays involved in 
drug discovery8590 and are continually evolving to meet the demands of the pharmaceutical 
industry. The efficiency of the FRET assay is proportional to the distance between donor 
and acceptor (proportional to l/r 6, where r = distance). Due to the long-lived metal excited 
state which populates the APC emissive level, APC fluorescence, the result of biological 
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molecular recognition, can be detected after a time delay following the excitation pulse. 
Fluorescence from un-complexed APC is short-lived and decays on timescales comparable 
to that of serum proteins. 
Development of such important homogeneous assay methodology has paved the way 
forward for rapid technological evolution in pharmaceutical drug discovery and detection. 
1.4 Combinatorial Technologies - Synthesis and Screening 
Fluorescence based sensing technologies are now routinely employed in identification and 
optimisation of target and lead compounds for potential drug development and 
optimisation .15-90  Cell based fluorescence assays are common in pre-clinical and 
toxicological studies allowing the behaviour of potential therapeutic agents to be monitored 
in a cellular environment. Advances in genomics now provide researchers with an 
abundance of information on disease areas, and supply potential target proteins almost as fast 
as chemists can validate them. Thanks to evolution of new screening technologies it is now 
possible to evaluate the activity of large libraries of potential therapeutic agents against these 
targets quickly and effectively. 
The demand for compound libraries has in turn lead researchers to investigate and 
develop novel synthetic strategies to generate large numbers of small, chemically diverse 
molecules of high purity to supply such screening programmes. 
In the 1960s Merrifield9 ' devised an automated system for generation of peptidic 
molecules employing polymeric supports. This resin based chemistry remained limited to 
peptidic syntheses until the early 1990s when interest turned to widening the applicability of 
the automated system. Synthetic strategies are discussed briefly in Chapter 1.4.2. 
Crucial to effective drug discovery and optimisation is careful library design. 92 Libraries for 
early discovery, designed to identif' potential agonists and antagonists in general are chosen 
to maximise chemical diversity. In contrast, smaller, more focussed libraries of 
chemically/structurally similar compounds are important in lead optimisation in order to 
maximise the potency of the pharmacophore identified by initial diversity screening. 
Advances in computational chemistry 92  enable such libraries to be designed based on 
molecular similarity or diversity. 93 A molecule can be described mathematically as a set of 
vectors in space, representing the 2D structure. 94 A target receptor, such as a protein, can be 
described correspondingly by a 3D descriptor. Computationally, the interaction between the 
two can be predicted or estimated. 95 Chemically similar compounds in general exhibit 
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comparable 2D descriptors, enabling faster and more efficient database searching. Chemical 
diversity can also be represented and searched for in the same way, identifying species with 
differing 2D descriptors. 
1.4.1 Combinatorial Synthesis - an overview 
Despite the rapid evolution of combinatorial chemistry technologies 92 in the field of drug 
discovery limitations still exist. Several semi or automated systems are widely applied 
throughout the pharmaceutical industry but their use is often restricted to well-established 
and reliable chemical conversions. Reaction kinetics often differ unpredictably between 
solid and solution phase syntheses and substantial investment is required at the development 
stage. 
1.4.2 Parallel Synthesis 
Conventionally, solid phase library generation enables the assembly of a product molecule 
on an inert polymeric support by sequential reaction of monomeric units. Excess reagents 
can be employed without the need for laborious purification procedures since their removal 
can be facilitated by careful washing of the resin. The product is obtained in good yield and 
high purity following cleavage from the solid support. Solid phase synthesis can be applied 
to "split-and-mix" chemistry (schematically represented below, Figure 1-19) rapidly 
generating large chemical libraries. 
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Figure 1-19 Schematic representation of parallel "spit and mix" solid phase synthesis 
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Using parallel synthetic strategies a large array of compounds can be generated 
quickly and easily, with control over the monomer sequence in the final product. For 
example, three starting materials, reacted twice, in sequence with three different reagents 
will yield twenty-seven distinct products for testing in a high throughput screen. 
Such syntheses can be followed by a radiofrequency tagging system developed by 
1R0R196 which tracks the inert support as it progresses through many reaction steps. 
Specialised polymeric supports such as MicroKans and Pins are available. The radio-
frequency labelled tag slots directly into the Pin and the molecule is created directly on the 
functionalised polymer support. With the Microkans the resin beads and tag are held within 
a polymeric container. These systems reduce the effort required in the often complicated 
deconvolution of library product mixtures since only one compound per solid support is 
formed, of which the monomer sequence is recorded. 
Where a particular reaction may not be suitable for solid phase synthesis, a modified 
version of the traditional solution phase synthesis may be employed. 97 Scavenger resins and 
solid-phase purification systems are available for facile removals of excess reagents. 
Scavenger resins are employed after the reaction to covalently couple the excess reagent, 
immobilising it on a solid support and allowing filtration of the clean product or intermediate 
solution. Common scavengers include amine based resins and aldehydes. 
In addition to this, solid supported reagents and catalysts may be used with product 
filtration. Not surprisingly, combinatorial chemistry and HTS have also found application in 
catalysis research .98101, 103 Similarly, combinatorial screening methods have been applied in 
development of novel materials 102  exhibiting interesting photophysical and magnetic 
properties. 
1.4.3 Combinatorial Chemistry in Catalysis Research 
Traditionally the development of novel catalytic species was achieved through trial and 
error. Over time, a series of iterative experiments would be performed in order to maximise 
the efficiency of ligand and metal components in facilitation of chemical conversions and to 
optimise reaction conditions. With the introduction of combinatorial technologies 98 ' ° ' it 
became possible to perform experiments in parallel, modifying only one or two variables per 
reaction. Optimum conditions can be established rapidly and the effect of subtle 
ligandlmetal modifications can be evaluated. An excellent example of combinatorial 
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chemistry in catalysis research is given by Hartwig et al. 103 Novel catalysts for palladium 
mediated coupling of aryl and alkyl halides with alkenes (Heck chemistry) were prepared 
and screened for activity. Active species identified on the solid phase were then prepared 
and tested in solution, and found to exhibit retained and improved enantioselectivity. 
1.4.4 Combinatorial Techniques in Materials Research 
Luminescent materials find application in a variety of systems from lamp phosphors and 
light emitting displays to photonic devices and consequently attract much interest. The 
tricolor lamp phosphors, employing lanthanide ions doped into host metal oxide lattices to 
produce a material emitting light at three individual wavelengths, are perhaps the most 
celebrated examples of inorganic luminescent materials.' 04 The trivalent lanthanides are 
attractive dopants since their luminescence properties arise from spectroscopic transitions 
involving the f electrons, shielded from, and thus affected little by, the host lattice 
environment. 
Discovery of novel luminescent materials has traditionally been achieved by trial 
and error making the experimental processes slow and laborious. Developments in 
instrumentation for detection of light, made largely in association with the pharmaceutical 
industry in response to the need for sensitive, automated equipment applicable to high 
throughput screening technologies have enabled such techniques to be applied in materials 
research. The search for novel phosphors can now be undertaken using a combinatorial 
approach, applied to the synthesis and screening of high density compound libraries.' 06 
Aimed at identification of the best lattice-dopant mixtures or optimisation of stoichiometries 
thin film or powder libraries can be quickly and effectively generated and their 
photophysical properties evaluated. 
The importance of fluorescence based sensing technology in combinatorial chemistry, drug, 
materials and catalysis discovery chemistry cannot be underestimated. Without the advances 
in fluorometric and spectroscopic detection technology of recent years high throughput 
screening would be limited to radio-isotopic heterogeneous type assays with long incubation 
periods, complicated and laborious preparation procedures. Improvements can still be made 
and research into luminescent species applicable to screening technologies is very much 
alive. Our approach to the design of luminescent lanthanide chelates is outlined below. 
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1.5 Our Approach 
1.5.1 Strategy 
As outlined previously, several commercial fluoroimmunoassay detection methods 
employing lanthanide chelates are available. These methods, such as DELFIA (1.3.1) and 
EALL (1.3.3) are heterogeneous and formation of the luminescent species is not 
mechanistically understood. With the homogeneous FRET based assay systems (HTRF, 
1.3.5) the transfer of energy is non specific through space. The donor and acceptor need 
only be in close proximity to one another for ET to occur, the efficiency of which is 
dependent on the distance between the two components of the FRET pair. Consequently, a 
drawback of the system is potential interference effects from solvated species in serum 
samples. Furthermore, the synthetic difficulties encountered in preparation of rare earth 
polypyridine cryptand species add interest to the search for novel chelators applicable as 
biological probes. In our approach we aim to develop a system to detect biological molecular 
recognition by means of specific lanthanide molecular recognition. In contrast to the FRET 
system of HTRF the lanthanide chelate will be non-luminescent in the absence of biological 
molecular recognition, only forming a luminescent species upon the macromolecular binding 
event (Figure 1-20). 
Molecular 
recognition 
Figure 1-20 Schematic representation of lanthanide molecular recognition for direct detection of a 
biological event 
The system will comprise two components: a stable, water soluble, non-luminescent 
rare earth chelate (LnNAL) and a separate aromatic moiety. The preformed chelate is 
attached to the biomolecule under investigation. The sensitising aromatic ligand, or light 
harvesting centre (LHC), bearing a binding site that recognises the lanthanide site is attached 
close to the corresponding biological recognition site. No signal is observed prior to 
biological molecular recognition, upon which the LHC and the LnNAL are brought together 
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and intramolecular energy results in lanthanide signalling. The close proximity of the two 
separate components of the luminescent label allows lanthanide molecular recognition to 
occur. Excitation of the LHC with 1JV light triggers the characteristic metal emission. 
Ternary complex formation is achieved by controlling the arrangement of ligands 
around the ion, based on replacement of coordinating water molecules from the inner sphere 
of the metal. Previous studies on mixed ligand lanthanide luminescent assemblies have 
achieved little or no control in their formation. 106, 107 
On a molecular basis, the problem centres on the design of mixed ligand lanthanide 
species. Due to the coordination properties of the lanthanide, the NAL (non absorbing 
ligand) should be polydentate, therefore able to surround the metal displacing most of the 
coordinated quenching solvent water molecules, forming a highly stable, but non 
luminescent chelate. The second component, the LHC (Light Harvesting Centre) should be 
an aromatic strongly absorbing species, with a triplet excited state of appropriate energy for 
efficient intramolecular energy transfer to the emissive state of the metal centre. The LHC 
must bear a coordinating group, capable of displacing coordinated water molecules from the 
inner sphere of the Ln(ffl) cation chelate, (Figure 1-21). 
hv,  
NA 	 NA 
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Figure 1-21 Schematic representation of luminescent ternary complex design 
1.5.2 Choice of Ligands 
Simple, commercially available aminopolycaboxylate' °8 "6 ligands have been chosen in our 
ternary complex design, offering obvious advantages over macrobicyclic cryptand species. 
Syntheses are uncomplicated and inexpensive as the chromophoric unit is not required to be 
incorporated into the NAL structure. Since a wide variety of LHC units are possible, 
molecules that offer potential as DNA intercalators may be considered,' °7 allowing the 
potential to develop methods to detect protein—DNA interactions. In addition to complicated 
syntheses, another disadvantage associated with the bipyridine units of the cryptand 
employed in CisBio's HTRF method is their ability to quench the lanthanide excited state by 
non-radiative energy transfer to thermally populated low lying charge transfer states. We 
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have selected DTPA-AM 2 ligands as our NALs and simple aromatic carboxylic acids as 
LHCs to test the design. 
1.5.2.1 The NAL 
Preliminary investigations undertaken in our research group showed simple 
aminopolycarboxylate ligands to be capable of forming anionic mixed ligand luminescent 
species. Europium EDTA and DTPA chelates were employed in luminescence studies with 
the aromatic -diketone, dibenzoylrnethane (DBM), and with simple aromatic carboxylic 
acids. Assembly of mixed ligand species in 1:1 stoichiometry was observed in aqueous 
solution by emission and excitation spectroscopy. Similarly, cationic ternary complexes 
were successfully formed with macrocyclic lariat crown ether NAIL chelates. Initial studies 
showed the mechanism of formation to differ between positively and negatively charged 
NAIL species. This work centres on molecular recognition employing a series of neutral 
lanthanide chelates prepared from DTPA-bis(amide) ligands (DTPA-AM 2) (Figure 1-22). 
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Figure 1-22 Structures of DTPA-AM 2 ligand and Eu(III) chelate 
The multidentate aminopolycarboxylate DTPA-bis(amide) derivatives form a class 
of well known ligands for lanthanide compJexation, 736 developed for application as 
contrast agents in Magnetic Resonance Imaging (MIRI). Several preparative methods are 
reported, describing formation of the bis(amides) from the cyclic dianhydnde of DTPA upon 
reaction with the relevant amine. Straight chain alkyl, adamantyl, benzyl, aniline and 
boronic acid DTPA-AM 2 derivatives (Figure 1-23) have been prepared targeting different 
relaxation properties of their Gd(llI) complexes, except for a few cases where transition 
metal binding has been reported. A uracil derivative has been prepared 36 for introduction of 
a hydrogen bonding interface to the amide arms. 
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Figure 1-23 DTPA-AM 2 ligands reported in the literature 
To the best of our knowledge, these ligands have not been investigated as 
components of luminescent signalling systems, with the exception of a study into the 
luminescence lifetime and hydration state of the methyl substituted derivative."' 
Macrocyclic DTPA-bis(amide) complexes have been extensively studied. A molecular 
switching system based on photoinduced electron transfer (PET) using DTPA ligands has 
also been reported. 129 
Several reports exist on the non-specific bioconjugation of monosubstituted Ln(III) 
chelates to oligonucleotides and proteins as luminescent probes. The photophysical 
characteristics of these aminopolycarboxylate derivatives have been evaluated as potential 
components of fluorescence resonance energy transfer (FRET) systems.' 37 ' 46 In these 
systems the antenna unit is non-coordinating and energy transfer to the lanthanide is weak 
and non specific. 
The reported crystal structure of [GdDTPA-bis(ethylamide)]" 7 shows octadentate 
coordination of the Gd(Ill) ion, via the three carboxylate anions, the two amide carbonyls 
and the three nitrogen donors of the diethylenetriamine backbone. The amide nitrogen atoms 
are not involved in complexation and leave the ethyl arms of the ligand free to form a 
binding cavity, occupied by one coordinating water molecule. Stability constants for 
lanthanide complexation in the order of LOgKML 15 have been reported for several DTPA-
AM2 derivatives. 
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1.5.2.2 The LHC 
Several features are required for a good choice of antenna ligand. The LHC should bear a 
characteristic binding unit with sufficiently high affinity for the lanthanide cation so as to 
competitively coordinate in aqueous solution. The triplet excited state should lie at an 
energy level appropriate for efficient intramolecular energy transfer to occur such that 
sensitised luminescence of the rare earth ion employed is observed upon molecular 
recognition. A good absorption cross section in the UV region is required for efficient 
excitation to the ligand singlet state such that intersystem crossing can occur prior to the 
intramolecular energy transfer event. Aromatic carboxylic acids have been chosen as 
potential LHCs, offering a variety of simple, model binding units with the potential to vary 
the chromophore as required. 
1.5.3 Studies Undertaken 
The controlled formation of mixed ligand luminescent complexes upon binding of the NAL 
chelate by the acid moiety is followed by monitoring the emission of the europium ion, 
triggered by intramolecular energy transfer from the LHC. Electrospray mass spectrometry 
and NMR provide supporting evidence for controlled assembly of ternary complexes. 
Specific molecular recognition is demonstrated between the model chelate EuBEA and 
simple carboxylic acids. These results, validating our ternary complex design, are reported 
in Chapter 3. Experimental details are given in Chapter 2 and the synthetic methods 
employed discussed in Chapter 4. Combinatorial screening strategies, employed in 
development of the mixed ligand system, allowed the interaction between a large library of 
aryl acid potential LHC units and a selection of LnNAL chelates to be evaluated. Results are 
presented in Chapter • 5. It is demonstrated that the selectivity of molecular recognition is 
based largely on the aryl acid binding unit, with additional selectivity imparted by the amide 
arms of the chelate. Equilibrium constants for ternary complex formation, luminescence 
lifetimes and quantum yields are evaluated for 1:1 mixed ligand species formed upon 
molecular recognition between LnDTPA-AM 2 chelates and aryl acid LHCs. These results of 
the binding studies are discussed in Chapter 6. An unexpected observation, which may 
ultimately lead to luminescent materials with tuneable photophysical properties, ispresented 
in Chapter 7. The crystal structure of a heterobimetallic, one-dimensional coordination 
polymer formed between Eu(III), picolinate antenna ligands and sodium counterions is 
reported. The interesting luminescence behaviour exhibited by the polymer in the solid state 
is discussed. 
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2 Experimental 
2.1 Acronyms and Abbreviations 
Compound 





2.4.2.2 DTPA-BEA 1,11 -(bis(ethylamino)- 1,11 -dioxo-3,6,9-triaza-3,6,9- 
triscarboxymethyl)undecane 
2.4.2.3 DTPA-BUA 1,11 -(bis( I -butylamino)- 1,11 -dioxo-3 ,6,9-triaza-3 ,6,9- 
triscarboxymethyl)undecane 
2.4.2.4 DTPA-BDA 1,11 -(bis( 1 -decylamino)- 1,11 -dioxo-3 ,6,9-triaza-3,6,9- 
triscarboxymethyl)undecane 
2.4.2.5 DTPA-BBZA 
1,11 -(bis(benzylamno)- 1,11 -dioxo-3,6,9-triaza-3,6,9- 
triscarboxymethyl)undecane 
2.4.2.6 DTPA-BTA 1,11 -(bis(4-methybenzylamino)- 1,11 -dioxo-3 ,6,9-triaza- 
3,6,9-triscarboxymethyl)undecane 
2.4.2.7 DTPA-cyHA 1,11 -(bis(cyclohexylamino)- 1,11 -dioxo-3 ,6,9-triaza-3,6,9- 
triscarboxymethyl)undecane 
2.4.2.8 DTPA-mcyHA 
1,11 -(bis(methylenecyclohexylamino)- 1,11 -dioxo-3 ,6,9- 
tnaza-3 ,6,9-triscarboxymethyl)undecane 
2.4.2.9 DTPA-cyOA 1,11 -(bis(cyclooctylamino)- 1,11 -dioxo-3 ,6,9-triaza-3 ,6,9- 
triscarboxymethyl)undecane 
2.4.2.10 DTPA-NBA 1,11 -(bis(2-norbornylamino)- 1,11 -dioxo-3 ,6,9-triaza-3,6,9- 
triscarboxymethyl)undecane dihydrate 
2.4.2.12 DTPA-BAA 1,11 -(bis( I -adamantylamino)- 1,11 -dioxo-3 ,6,9-triaza-3 ,6,9- 
triscarboxymethyl)undecane 
2.5.2.1 EuBEA 11, 11  -(bis(ethylamino)- 1,11 -dioxo-3,6,9-triaza-3 ,6,9- 
triscarboxymethyl)undecane 
} europium(III) dihydrate 
2.5.2.3 EuBUA 








2.5.2.6 EuBTA { 








(1,11 -(bis(methylenecyclohexylamino)- 1,11 -dioxo-3 ,6,9- 














1,11 -(bis(±)2-aminonorbornylamino)- 1,11 -dioxo-3 ,6,9- 
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Compound Name !UPAC Name Reference  
2.5.2.13 EuBDA {  
1,11 -(bis( I -decylamino)- 1,11 -dioxo-3 ,6,9-triaza-3 ,6,9- 
triscarboxymethyl)undecane} europium(Ill) hydrate 
2.5.2.14 EuBAA 





(1, 11  -(bis(ethylamino)- 1,11 -dioxo-3 ,6,9-triaza-3 ,6,9- 
triscarboxymethyl)undecane} terbium(III) trihydrate 
2.5.3.2 ThBUA 
11, 11  -(bis( I -butlylamino)- 1,11 -dioxo-3,6,9-triaza-3,6,9- 
triscarboxymethyl)undecane} terbium(III) trihydrate 
2.5.3.3 ThBBZA 
(1,11 -(bis(benzylamino)- 1,11 -dioxo-3,6,9-triaza-3,6,9- 
triscarboxymethyl)undecane} terbium(III) pentahydrate 
2.5.3.4 ThBTA 
1,11 -(bis(4-methylbenzylamino)- 1,11 -dioxo-3 ,6,9-triaza- 
3 ,6,9-triscarboxymethyl)undecane 
} terbium(III) tetrahydrate 
2.5.3.5 ThcyHA 




(1,11 -(bis(methylenecyclohexylamino)- 1,11 -dioxo-3,6,9- 
2.5.3.6 ThmcyHA triaza-3 ,6,9-triscarboxymethyl)undecane} terbium(III) 
trihydrate 
2.5.3.7 ThNBA 
























2.5.5.1 YBEA { 
1,11 -(bis(ethylamino)- 1,11 -dioxo-3 ,6,9-triaza-3,6,9- 
triscarboxymethyl)undecane } yttrium (III) hydrate 
2.5.5.3 YBUA 
11, 11  -(bis( 1 -butylamino)- 1,11 -dioxo-3 ,6,9-triaza-3,6,9- 
triscarboxymethyl)undecane} yttrium (III) hydrate 
2.5.5.4 YBBZA 
11, 11  -(bis(benzylamino)- 1,11 -dioxo-3,6,9-triaza-3 ,6,9- 
triscarboxymethyl)undecane } yttrium (III) hydrate 
2.5.5.5 YNBA 
1,11 -(bis((±)-2-norbomylamino)- 1,11 -dioxo-3,6,9-triaza- 
3,6,9-triscarboxymethyl)undecane } yttrium (III) hydrate 
{ 
1,11 -(bis(methylenecyclohexylamino)- 1,11 -dioxo-3 ,6,9- 
2.5.5.6 YmcyHA triaza-3 ,6,9-triscarboxymethyl)undecane} yttrium (III) 
hydrate 
2.5.5.7 YcyHA 1,11 -(bis(cyclohexylamino)- 1,11 -dioxo-3 ,6,9-triaza-3 ,6,9- 
triscarboxymethyl)undecane 
} 
yttrium (III) hydrate 
2.5.6.1 GdBUA 1,11 -(bis( 1 -butylamino)- 1,11 -dioxo-3 ,6,9-triaza-3,6,9- 
triscarboxymethylundecane) gadolinium (III) hydrate 
2.5.6.2 GdBBZA 11, 11  -(bis(benzyllamino)- 1,11 -dioxo-3 ,6,9-triaza-3,6,9- 
triscarboxymethyl)undecane 
} 
gadolium (III) tetrahydrate 
2.5.7.1 LuBEA { 
1,11 -(bis(ethylamino)- 1,11 -dioxo-3,6,9-triaza-3,6,9- 
triscarboxymethyl)undecane 
} 
lutetium (III) hydrate 
Table 2-1 Ligands and complexes - Abbreviations used and IIJPAC names 






o-(7-azabenzotriazol- I -yl-N,N,N'N'-tetramethyl 
uronium hexafluorophosphate 
DIPEA NN-diisopropylethylamine 
DMAP NN, -dimethyl-4-aminopyridine 
TNBSA 2,4,6-trinitrobenzene sulfonic acid 
PS-MB-CHO Polystyrene based aldehyde resin 
TBAOH Tetrabutylammonium hydroxide 
TBACI Tetrabutylammonium chloride 
DMSO Dimethylsulfoxide 
Table 2-2 General reagents - abbreviations used 
2.2 Materials 
All chemicals in the solution phase syntheses of the ligands were of reagent grade, purchased 
from commercial suppliers and used as received without further purification. DTPAI-1 5 
(diethylenetriamine pentacetic acid) (97%); benzylamine (99%); cyclohexylamine (98%) 
cyclododecylamine (98%) and tetrahydrofurfurylamine (97%) were obtained from Acros 
Organics. Acetic anhydride (99%); ethylamine (70% wt H 20); 1-butylamine (98%); 1-
decylamine (98%); methylencyclohexylamine (98%); cyclooctylamine (97%); 4-
methylbenzylamine (99%) 4-picolyamine (99%); 1-adamantylamine (97%); +1- 2-exo-
aminonorbomane (99%) and 2-aminobiphenyl (98%) were purchased from Aldrich. All 
solvents were reagent grade and used without degassing or further drying. Deionised water 
was used in all synthetic procedures and spectroscopic studies. Concentrated HCI was 35-
38% (aq) purchased from Fluka and diluted as required. Sodium Hydroxide pellets were 
obtained from BDH. Tetrabutylammonium hydroxide (TBAOH) (40% wt H 20) was 
purchased from Aldrich or Fluka. The Ln(III)Cl 3.6H20 salts were of >99.9% purity, stored 
in a dry atmosphere (dessicator) and used as received from Acros or Aldrich. Eu 203 
(>99.9%) was purchased from Aldrich. 
The aryl acids screened for their interaction with LnNAL chelates, and subsequent binding 
studies were supplied by Compound Control, GlaxoSmithKline Medicines Research Centre, 
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Stevenage, and used as received (>98%). Benzoic, phthalic, picolinic, salicylic, dipicolinic 
and isophthalic acids used in binding studies were purchased from commercial suppliers 
(Aldrich, Acros and Fluka). Prof. Ioanniou and Dr Lianilou, University of Athens provided 
5-fluorosalicylic acid (5-FSA) and 4-aminosalicylic acid (p-NH 2AS). 
2.3 Instrumentation 
Emission and excitation spectra were measured using Photon Technology International 
QM-1 luminescence spectrometer consisting of a 75-watt PowerArc xenon lamp and single 
monochromator (350 nm blaze) excitation source. The sample chamber is equipped with 
focusing lens for detection of emitted light at 900  to the excitation beam by a single emission 
monochromator (500 nm blaze), and Hamamatsu R928 digital photomultiplier tube. The 
instrument is computer controlled, with FeliX 1.41 software installed for data analysis. 
Emission spectra are corrected for monochromator and PMT response. Excitation spectra 
are corrected for the spectral response of the xenon arc lamp and the excitation 
monochromator. Light is directed by a beam splitter to a photodiode giving "real time" 
correction of the excitation part response for each spectrum. Absorption spectra were 
obtained with a Shimadzu UV.3 101-PC spectrometer equipped with a deuterium lamp. 
Luminescence lifetime measurements were made using an "add-on" set-up to the PTI QM-1 
luminescence spectrometer. A Continuum Surelite (II) Nd:YAG pulsed laser with selection 
wavelengths 532, 355 and 266 nm (1st, 2nd and P harmonics of 1064nm) was used as the 
pulsed excitation source. Light at the strongest wavelength emitted by the sample was 
focussed by lenses of the PTI instrument on to the emission monochromator and detected by 
an analogue Hamamatsu R928 PMT tube. A LeCroy oscilloscope then treated the signal 
(external trigger: 50 0; coupling for signal: 50 f). Lifetime decay curves were averaged 
over 500 sweeps. Data fitting was performed using Kaleidagraph software. 
Proton NMR spectra were measured on BrOker spectrometers at 200, 250 360, 400 and 600 
MHz in deuterated solvents purchased from Goss Scientific. Carbon NMR spectra were 
obtained at 62.9 MHz or 100.6 MHz. FAB-MS was performed on a Kratos MS-SO 
spectrometer using an 1-NOBA or thioglycerol matrix. Electrospray MS were recorded at 
the EPSRC MS service centre in Swansea. Flow injection ES-MS was performed at GSK 
Medicines Research Centre, Stevenage using a Micromass LC-TOF instrument. LC-MS 
were run on a Micromass series II platform with HPI 100 LC/Auto injector. Details of the 
LC methods employed are given in Appendix 1. Elemental analyses were carried out by 
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departmental services at Edinburgh University on a Perkin Elmer 2400 CHN analyser and by 
Butterworth Laboratories LTD, Middlesex. 
Combinatorial screening of aromatic acids versus LnNAL chelates was performed in 96 well 
format using black, flat-bottomed NUNC plates. A Tecan Ultra Multifunctional Microplate 
reader consisting of a high energy xenon arc flash lamp, flash lamp monitor, fused silica 
condensing optics, choice of dichroic or 50% mirror, excitation and emission filter slides and 
a red sensitive (R928) PMT for fluorescence-intensity (Fl) and time-resolved fluorescence 
(TRF) measurements was employed. Luminescence was recorded from a fixed position 
above the plate, initially optimised for maximum fluorescence intensity. The PMT gain was 
set for optimal signal to noise ratios. Signal integration time was delayed against the flash 
by a pre-defined lag-time of 20 ts, avoiding detection of short lived organic fluorescence. 
2.4 Synthesis of DTPA -bis(amide) Ligands 
2.4.1 N, N-bis[2-(2,6-dioxomorpholino)-ethyl]g lycine: DTPA-d ia nhyd ride 
DTPA-dianhydride, although commercially available in small quantities, was prepared by a 
modification of the published procedure  146  (Scheme 2-1). Acetic anhydride (65 ml, 0.69 
mol) was added slowly via a dropping funnel to a stirring suspension of DTPAIT 5 (48.0 g, 
0.122 mol) in pyridine at 65°C. Stirring was continued at this temperature for 5 hours after 
which time the new solid that had formed was collected by filtration and washed with acetic 
anhydride (200 ml) and refluxed in acetonitrile for 1 hour. The solid was filtered, washed 
with CH3CN and dried under vacuum to yield the title compound, DTPA-dianhydride (40.7 
g, 94%).'H NMR (200 MHz, DMSO-d6): 6 (PPM)  12.10 (s, CO2fl); 3.71 (8H, s, NCJj2CO); 
2.77-2.75 (4H, broad t, NCjj2CH2N); 2.68-2.63 (4H, broad t, NCH 2CJj2N); 13C NMR (62.9 
MHz, DMSO-d6): 6 (PPM)  172.6 (CO2H); 171.9 (L=O); 54.7 (NCH2CO2H); 52.7 
(NCH 2CO); 51.7, 50.7 (NCH2CH2N). CHN: Calculated for C 14H, 9N308 : 47.04% C; 5.37% 
H; 11.76% N. Found: 46.83% C; 5.39% H; 11.67% N. 
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N 	 0 
65°C, 5 hrs 
Scheme 2-1 DTPA-dianhydride preparation 
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2.4.2 Solution Phase Synthesis of DTPA-bis(amide) Ligands 
2.4.2.1 General DTPA-bis(amide) preparation 
The ligands were prepared according to the literature procedure' 7 118  (Scheme 2-2). DTPA-
dianhydride was added in small portions over 30 minutes to an excess amount of the stirring, 
ice cold amine. The reaction was allowed to warm to room temperature following dilution 
with water and stirring continued overnight. The solvent was then removed by rotary 
evaporation, the oily residue re-diluted with water then acidified to pH - 2 with conc. HCI. 
The colourless solid/crystals that formed were collected by filtration, washed with water, 
ethanol and diethyl ether then dried under vacuum to yield the desired DTPA-bis(amide) 
derivative. Ligands were characterised by 'H and ' 3C NMR FAB-MS and elemental 
analysis. 
~-A/ ---- \F --- \F-~l 
ON 
CO H40 
H02C__\ /_\ /____\ ,,r—0O2H R—NH2 	0 	N 	N 
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Scheme 2-2 DTPA-bis(amide) ligand preparation 
2.4.2.2 1, 11 -(bis(ethylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)u ndecane: DTPA-BEA.21-120 
DTPA-dianhydride (15.0 g, 0.042 mol) was added slowly over 30 minutes to a stirring, ice 
cold solution of ethylamine (30 ml, 0.37 mol, 70% w/w 1120). The mixture was then diluted 
with 30 ml H20, allowed to warm to ambient temperature and stirring continued overnight. 
The yellow solution was filtered and the volume reduced to an oil by rotary evaporation. 
The oil was then diluted with 10 ml H 20 and acidified to around pH 2 with conc. HC1. The 
colourless crystals that formed were collected by filtration, washed with water (100 ml), 
ethanol (50 ml) and diethyl ether (50 in]) then dried under vacuum. The solid was 
recrystallised from 1120 to yield the title compound, DTPA-BEA.2H 20 (4.46 g, 22 %). '11 
NMR (360 MHz, D20) S (ppm): 3.84 (411, s, NCjjCO 2H, terminal); 3.73 (411, s, 
NCJj,CONH), 3.67 (2H, s, NCjCO 2H, central); 3.34-3.38 (411, t, NCthCH 2N); 3.25-3.28 
(411, t, NCH2CthN); 3.19-3.25 (4H, q, NCthCH 3); 1.07-1.11 (6H, t, NCH2Cth). ' 3C NMR 
(62.9 MHz): 172.7 (Q0 2H); 172.4 (02H); 168.2 (çONH); 57.3, 57.1, 55.0 (NcH2co) ; 
52.2, 51.5 (NdH2dH2N), 35.0 (NC171 2CH3); 13.9 (CH 3); FAB-MS [M+1] 448 D; CHN: 
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Calculated for C 18H37N50 10 : 44.70% C; 7.73% H; 14.49% N. Found: 44.60% C; 7.77% II; 
14.49% N. 
2.4.2.3 1, 11 -(bis(1 -butylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9- 
triscarboxymethyl)u ndecane: DTPA-BUA.2H 20 
DTPA-dianhydride (10.0 g, 0.028 mol) was added in small portions over 30 minutes to 
stirring, ice cold neat 1-butylamine (14 ml, 0.14 mol). The mixture was diluted with 10 ml 
1120 and stirred at ambient temperature for 24 hrs. The volume was reduced by rotary 
evaporation and the yellow oil diluted with H 20 (50 ml) before acidification to around pH 2 
with conc. HC1. The colourless crystals that quickly formed were collected by filtration and 
washed with water (20 ml), acetone (100 ml) and ether (100 ml) then dried under vacuum to 
yield the title compound (12.7 g, 84%). 'H NMR (250 MHz, D 20): 6 (ppm) 3.68 (2H, s, 
NCCO2H, central); 3.47 (4H, s, NCthCO 2H, terminal); 3.31, (411, s, NCthCNH); 3.26-
3.29 (4H, br. t, NCHCj2N & 4H, s, NCthCONH); 3.11- 3.21 (4H, br. t, NCthCH2N); 1.50 - 
1.39 (4H, quintet, NCH 2CthCH 2CH3); 1.30 - 1.20 (4H, sextet, NCH2CH2CthCH3); 0.87 - 
0.81 (6H, t, NCH2CH2CH2C!j3). 13C NMR (62.9 MHz, D20): 6 (ppm) 176.9 (ç0 2H 
terminal); 171.7 (CO 2H central); 171.2 (CONH); 58.4, 58.2 (NCH2CONH, NCH2CO2H 
terminal); 54.6 (NCH 2CO2H central); 52.4, 50.7 (NCH2CH2N); 38.9 (NCH 2CH2CH2CH3); 
30.4 (NCH2CH2CH2CH3); 19.4(NCH 2CH2CH2CH3); 12.9 (NCH 2CH2CH2CH3). FAB-MS 
[M+l] 504 D; CHN: Calculated for C 22H45N5010: 48.96% C; 8.42% H; 12.98% N. Found: 
48.91% C; 8.36% H; 12.89% N. 
2.4.2.4 1, 11 -(bis(1 -decylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9- 
triscarboxymethyflundecane: DTPA-BDA.2H 20 
Neat 1-Decylamine (2 ml, 0.Olmol) was added slowly to a stirring suspension of DTPA-
dianhydride (1.05 g, 3.0 mmol) in 5 ml pyridine and the mixture stirred at room temperature 
overnight (18 hrs). The resultant yellow solution was filtered to remove any unreacted DTPA 
prior to reducing the volume by rotary evaporation. The residue was dissolved in water (50 
in]) before acidification to around pH 2 with conc. HCI, upon which a colourless solid 
formed. This was collected by filtration, washed with water (2 x 10 ml), ethanol (2 x 10 ml) 
and diethyl ether (2 x 10 in]) then dried under vacuum to yield the title compound, DTPA-
BDA (1.58 g, 78%). 'H NMR (400 MHz, DMSO-d6): S (ppm) 7.75 (3H, CO2fl); 3.17 (211, 
s, NCthCO2H, central); 3.10 (4H, s, NCthCO 2H, terminal); 2.95 (4H, s, NCthCONH);  2.79 
(411, q, NHCthC9H19); 2.69 (4H, br, t, NCthCH 2N), 2.56 (411, br, t, NCH 2CthN); 2.23 (811, 
br, -NCH2CthCth-);  1.12 (4H, q, -CthCH3);  0.95 (20H, br, -Cth-); 0.59 (6H, t, -CH 2CH3). 
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2.4.2.5 1, 11 -(bis(benzy1amno)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane: DTPA-BBZA.2H 20 
DTPA-dianhydride (10.0 g, 0.028 mol) was added in small portions over 30 minutes to 
stirring, ice cold neat benzylamine (20 ml, 0.18 mol). The mixture was diluted with 10 ml 
H20 and stirred at ambient temperature for 20 hrs. The volume was reduced by rotary 
evaporation and the yellow oil diluted with H 20 (50 ml) before acidification to around pH 2 
with conc. HC1. The colourless crystals that quickly formed were collected by filtration and 
washed with water (2 x 10 ml), acetone (2 x 10 ml) and diethyl ether (50 ml) then dried 
under vacuum to yield the title compound, DTPA-BBZA (12.9 g, 81%). 'H NMR (360 
MHz, D20INaOD): 6 (ppm) 7.2-7.3 (10H, m, Cjj s); 4.25 (4H, s, PhCthN); 3.1 (4H, s, 
NCJJ2CO2H, terminal); 3.0 (4H, s, NCthCONH); 2.85 (2H, s, NCCO 2H, central); 2.4 (8H, 
2 x t. NCft~CthN). ' 3C NMR: (62.9 MHz, D20): 6 (PPM)  177.4 (Q02H, terminal); 172.4 
(02H central); 170.8 (=O amide); 137.9 (aromatic ); 129.2, 128.8, 127.5 (aromatic CH); 
58.33, 58.27 (NcHçH 2N); 54.6, 52.3 50.4, 42.7 (NCH 2CON, NCH2CO2 central, NCH2CO2 
terminal, NCH 2Ph). FAB-MS: [M+l] 572 D; CHN: Calculated for C 28H41 N5010 : 55.36 % C; 
6.82%H; 11.53 %N.Found: 55.69%C; 6.93 %H; 11.44%N. 
2.4.2.6 1, 11 -(bis(4-methybenzylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane: DTPA-BTA.2H 20 
DTPA-dianhydride (5.0 g, 0.014 mol) was added slowly to neat, ice cold, stirring 4-
methylbenylamine (10 ml, 0.078 mol), the reaction diluted with 15 ml water, allowed to 
warm to room temperature and stirring continued overnight (24 hrs). The volume of the 
cloudy solution was reduced by rotary evaporation and the yellow oil diluted with 20 ml 
water. Concentrated HCI was then added dropwise, the solution became clear around pH 5. 
Further acidification to pH - 2 resulted in the formation of colourless crystals, which were 
collected by filtration, washed with water (50 ml), ethanol (50 in]) and diethyl ether (50 ml), 
then dried under vacuum to yield the title compound DTPA-BTA.2H 20 (6.8 g, 79%). LC-
MS: 599 D (retention time 2.63 mins). 'H NMR (400 MHz, D 20/NaOD, pD 6): 6 (ppm) 
6.90 (8H, s C 6H4CH3); 4.02 (4H, s, 2 x NCthPhMe);  3.31 (2H, s, NCthCO 2 central); 3.01 
(4H, s, NCCO2 terminal); 2.85 (4H, s, NCfl 2NCOCH2PhMe, 2H t, NCthCH2N);  2.60 
(4H, t, NCH 2CthN); 2.00 (611, s, PhCth). 13C NMR (100 MHz): S (ppm) 179.0 (Q0 2H 
terminal); 173.8 (çONI-I); 170.9 (CO 2H central); 137.9 (CH 2CC5H4CH3 aromatic); 135.4 
(cH3C); 129.7 (CH 2CCH); 127.9 (CH 3CçH); 59.1, 59.0 (NCH 2CONIH, NCH 2CO2H); 55.0 
(NCH2CO2H); 52.7, 50.4 (NCH 2CH2N); 42.8 (NCH 2Ph); 20.5 (Phd 3). CHN: Calculated 
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for C30H41 N508.2H20: 56.66% C; 7.41% H; 11.01% N. Found: 56.37% C; 7.03% H; 
10.78% N. 
2.4.2.7 1, 11 -(bis(cyclohexylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane: DTPA-cyHA 
DTPA-dianhydride (10.0 g, 0.028 mol) was added in small portions over 30 minutes to neat 
ice cold, stirring cyclohexylamine (16 ml, 0.14 mol). The mixture was diluted with 30 ml 
H20 and stirred at ambient temperature for 20 hrs. The volume was reduced by rotary 
evaporation and the yellow oil diluted with H 20 (50 ml) before acidification to around pH 2 
with conc. HC1. The colourless solid that quickly formed was collected by filtration and 
washed with water (100 ml), ethanol (2 x 50 ml) and diethyl ether (100 ml) then dried under 
vacuum to yield the title compound (13.6 g, 87 %). 'H NMR (250 MHz D20INaOD): 
(ppm) 3.68 (2H, s, NCIj2CO2 central); 3.56 (2H br, m, NCJjC5H,o);  3.40 (411, s, NCthCO2 
); 3.30-3.28 (411, br, t, NCthCH2N); 3.25 (4H, s, NCthCONH);  3.09-3.07 (4H, br, t, 
NCH2CthN); 1.74-1.66 (8H, br, t. cyhex); 1.57 (2H, br, d, cyhex); 1.10-1.30 (IOH,br, 
m, cyhex). ' 3C NMR (62.9 MHz): 177.7 (-CO2 terminal); 171.2 (-çONH); 170.7 (-CO 2 
central); 58.8, 58.5 (NCH 2çH2N); 54.6 (NCH2CO2 central); 52.1 (NCH 2CO2 terminal); 50.7 
(NCH2CON}I); 48.9 (CONHCH-); 31.8, 24.9, 24.4 (cyhex -CH 2-). FAB-MS [M+1] 556 D; 
CHN: Calculated for C 26H45N508 : 56.18% C; 8.17% 11; 12.60% N. Found: 55.98% C; 7.59% 
H; 12.49% N. 
2.4.2.8 1, 11 -(bis(methylenecyclohexylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)u ndecane: DTPA-mcyHA 
DTPA-dianhydride (12.85 g, 0.036 mol) was added in small portions over 30 minutes to neat 
ice cold, stirring cyclohexanemethylamine (23 ml, 0.18 mol). The viscous suspension was 
then diluted with water (20 ml), and allowed to warm to room temperature, at which 
temperature stirring was continued for 24 hours. The volume of the yellow solution was 
reduced by rotary evaporation and the oil diluted with 50 ml H 2O before acidification to 
pH-2 with conc. HC1. The colourless solid which quickly formed was collected by 
filtration, washed with water (500 ml), EtOH (500 in]) and diethyl ether then dried under 
vacuum to yield the title compound, DTPA-mcyHA (12.9 g, 62 %). FAB-MS: [M+1] 584 
D. 'H NMR (360 MHz D 20/NaOD) 6 (ppm): 3.6 (2H, s, NCthCO2  central); 3.3 (411, s, 
NCJJ2CO2 terminal); 3.2 (811, s, NCjjC 6H,,); 3.0-3.1 (2 x broad t, 4H each, NCthCthN); 
2.9-3.0(211, br, CONHCH 2CHC5H,0); 1.6-1.7 (12H, m, cyhex); 1.4-1.5 (2H, m, cyhex); 1.1-
1.3 (611, m, cyhex); 0.7-1.0 (411, quintet, cyhex). CHN: Calculated for C 281149N508 : 57.60% 
C; 8.64% H; 12.00% N. Found: 57.40% C; 8.64% H; 11.30% N. 
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2.4.2.9 1, 11 -(bis(cyclooctylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane: DTPA-cyOA 
DTPA-dianhydride (9.0 g, 0.025 mol) was added slowly to neat, ice cold stirring 
cyclooctylamine (13 ml, 0.095 mol). The mixture was diluted with water (30 ml) and 
allowed to warm to ambient temperature at which stirring was continued overnight (24 hrs). 
The volume of the solution was reduced by rotary evaporation then the yellow oil diluted 
with H20 (50 ml) before acidification to pH 2 with cone. HC1 upon which a colourless 
solid began to form. This solid was collected by filtration, washed with H 20 (200 ml), EtOH 
(100 ml) and diethyl ether (100 ml) then dried under vacuum to yield the title compound, 
DTPA-cyOA (10.9 g, 71%). 'H NMR (200 MHz, D 20INaOD) 8 (ppm): 3.83 (211, broad m, 
NHCIIC7H 14); 3.6 (2H, broad s NC1j2CO2  central); 3.27 (4H, s, NCthCO2  terminal); 3.15 
(4H, s, NCC0NB); 2.93 (8H, broad m, NCthCthN); 1.70-1.58 (2811, m, NCHC 7H,4). 
13C NMR (62.9 MHz): 178.9 (ç02 -), 171.8 (QONH); 58.9 (NC112CO2 , NCH2CONH); 52.7, 
52.1 (NCthCthN);  49.8 (NHCHC 7H, 4); 31.2, 26.6, 25.1, 23.2 (NHCHC7H, 4). FAB-MS 
[M+1] 612 D: CHN: Calculated for C 30H53N50892.511 20 54.59% C; 8.64% H; 10.60% N. 
Found: 54.5 8% C; 8.88% 11; 10.61% N. 
2.4.2.10 1, 11 -(bis(2-norbornylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)u ndecane di hydrate: DTPA-N BA.2H20 
DTPA-dianhydride (2.5 g, 0.007 mol) was suspended in 20 ml chloroform and stirred at 
room temperature. The amine, (±) 2-exo-aminonorbornane (2.1 ml, 0.018 mol), was added 
slowly to this suspension and stirring continued at room temperature for 30 minutes before 
heating the reaction to reflux overnight. The mixture was cooled to room temperature, 
forming an orange oil, which was then diluted with 25 ml of CHC1 3 . The solvent was 
removed by rotary evaporation leaving a yellow powder and viscous orange liquid. This 
mixture was dissolved in 10 ml 1120 before acidification to pH 2 with 2M HC1. No 
precipitate was observed and the solvent was removed by rotary evaporation. The brown oil 
was dissolved in methanol, the volume reduced and a white solid obtained by triturating with 
diethyl ether. This solid was recrystallised from water to yield the title compound, DTPA-
NBA (0.94 g, 23%). 'H NMR (400 MHz, D 20) 8 (ppm): 3.8 (411, s, NCCO 2 , terminal); 
3.7 (4H, s, NCjjCONH); 3.6 (2H, s, NCCO 2 -  central); 3.5 (2H, dt, NHCIIC 6H, 0); 3.35 
(4H, t, NCthCH 2N); 3.15 (411, t, NCH 2CN); 2.22, 2.12 (411, d, NHCHCthCH);  1.7 (211, 
m, Nb); 1.4 (2H, m, Nb); 1.3 (2H, m, Nb); 1.0-1.2 (6H, m, Nb) (Nb = norbornyl). LC-MS: 
(ES+) 580 D, (ES-) 578 D. (Retention time = 2.51-2.57mins). CHN: Calculated for 
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C28H45N508.2H20: 56.25% C; 7.77 % H; 11.71% N. Found: 56.55% C; 8.17% H; 11.70% 
N. 
2.4.2.11 1, 11 -(bis(2-norbornylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)u ndecane: DTPA-N BA 
The amine, (±) 2-exo-aminonorbomane, (5.0 g, 0.045 mol) was added slowly to a stirring 
suspension of DTPA-dianhydride (5.0g. 0.0 l4mol) in ice cold propan-2-ol. The ice bath was 
removed after 30 minutes and the reaction mixture allowed to warm to room temperature 
before heating the mixture at reflux for 1 hr, then stirring at room temperature overnight. The 
solvent was removed by rotary evaporation forming an orange oil and a white solid. 
Addition of water (30 ml) resulted in the formation of an orange solution, which was 
acidified to pH 3 with conc. HC1 and refrigerated overnight. Addition of acetonitrile 
afforded a white solid, which was collected by filtration and recrystallised from water to 
yield the title compound, DTPA-NBA (1.3 g, 17 %). 'H NMR (250 MHz, D20INaOD): 
S (ppm) 3.7 (2H, s, NCfl 2CO2 central); 3.5 (211, dd, NHCffC6H, o); 3.3 (4H, t, NCthCH2N; 
4H, s NCthCO2 ), 3.1 (4H, s, NCthCONH);  3.0 (411, t, NCH2CthN); 2.2 (2H, br, Nb); 2.1 
(2H, br, dd, Nb); 1.6-1.8 (2H, ddd, Nb); 1.2-1.5 (811, m, Nb); 1.0-1.2 (611, m, Nb). FAB-
MS: [M+l] 580 D. 
2.4.2.12 1, 11 -(bis(1 -adamantylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl) u ndecane tn hydrate: DTPA-BAA.3H 20 
A suspension of the amine, l-adamantylamine, (2.34 g, 0.0125 mol) in pyridine was added 
slowly to a stirring suspension of DTPA-dianhydnde (1.00 g, 0.0028 mol) in 5 ml pyridine 
and the mixture stirred at room temperature overnight. The yellow solution was filtered to 
remove any unreacted DTPA before reducing the volume of the filtrate to an oily residue by 
rotary evaporation. The oil was then diluted with 20 ml water forming a cloudy solution. 
Acidification of this solution to pH 3 afforded a colourless precipitate. This solid was 
collected by filtration, washed with ethanol (20 ml) and diethyl ether (20 ml), then dried in 
air to yield the title compound, DTPA-BAA (0.55 g, 30 %). 'H NMR (360 MHz, DMSO-
D6) S (ppm) 3.4 (2H, s, NCCO 2H); 3.3 (411, s, NCjCO 2H); 3.1 (4H, s, NCJLCONHAd, 
Ad = 1-adamantyl), 3.0 (411, br, s NCthCH 2N); 2.8; (4H, br, s NCH 2CthN); 2.55 (8H, in 
1511, adamantyl D. CHN: Calculated for C 34H 59N50 11 : 57.19% C; 8.35% 11; 9.81% N. 
Found: 57.45% C; 8.69% 11; 9.25% N. 
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2.4.2.13 1, 11 -(bis(2-biphenylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane: DTPA-BPA 
The amine, 2-aminobiphenyl, (5.10 g, 0.03 mol) was dissolved in DMF/H 20 (2:1 v/v, 30 ml) 
forming a red solution at 120 °C. A slurry of DTPA-dianhydnde (3.57 g, 0.01 mol) in 20 ml 
DMF was added and the reaction heated at reflux for 21 hrs. The solution was cooled to 
room temperature and the solvent removed by rotary evaporation to yield a red/brown oil. 
Dilution of this oil with 20 ml water afforded a cloudy suspension. The solvent was 
removed after failed extraction attempts using first DCM then with diethyl ether. The oil was 
dissolved in DMF, and the solvent removed again. Acidification was attempted using 1 M 
HCI (20 ml). This resulted in the formation of a red/brown organic phase, and a cloudy 
suspension in the aqueous phase. The aqueous phase was washed with 50 ml DCM and the 
mixture placed in a separating funnel, upon which a viscous pink solid began to form in the 
upper aqueous layer. The organic phase was discarded and the aqueous suspension collected 
then filtered before recrystallisation from methanol. Several crops of product were obtained 
from the crystallisation media, with overall yield of the title compound, DTPA-BPA, of 3.7 g 
(53 %). 'H NMR (DMSO-D 6): 200 MHz S (ppm) 9.59 (311, br. s, CO21j); 8.20-8.24 (2H, br, 
s, NH_); 7.30-7.47, 7.13-7.27 (18H, m, aromatic if); 3.17 (br, 8H, NCifCO 2H, NCjj. CON); 
2.83 (2H, s NCthCO2H, central); 2.39 (4H, br. t, NCthCH 2N), 2.01 (411, broad. t, 
NCH2CIj2N). The ligand could be further purified by suspension in hot chloroform and 
filtration to remove any unreacted amine before preparation of Ln(III) complexes. 
2.4.3 Solid Phase Synthesis 
2.4.3.1 Step 1: Attaching the Linker (Scheme 2-3) 
The resin, ArgoGel-NH 2, (1.0 g, 0.46 mmol, R4273/55) was swollen in DMF for 15 minutes 
then recovered by filtration. The linker, 4-(3,5-dimethoxy-4-formylphenoxy) butyric acid, 
GW428586, (0.37 g, 1.38 mmol) was combined with HATU (o-(7-azabenzotriazol-1-yl-
N,N,N',N'-tetramethyl uronium hexafluorophosphate) (0.525 g, 1.38 mmol) and DIPEA 
(N,N-diisopropylethylamine) (0.48 ml, 2.76 mmol) in 3 ml dry DMF, left for 15 minutes 
before adding to the pre-swollen resin. The mixture was shaken for 3 V2 hours at room 
temperature, then washed with DMF, DCM, MeOH and DCM. 'H NMR (400 MHz, magic 
angle spinning): S (ppm) 10.25 (1H, s, CEO); 6.10 (211, s, aryl Cif); 4.1 (211, t, CifO); 3.88 
(6H, s, OCth); 2.40 (2H, t, NHCOCth); 2.18 (2H, t N}ICOCH 2CkL2 ). 
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Scheme 2-3 Attaching the linker 
2.4.3.2 Step 2: Reductive Amination - I 
4-methyl benzylamine (Scheme 2-4) 
Glacial acetic acid (0.13 ml, 2.3 mmol) was combined with Me4NBI-!(OAc) 3 (0.60 g, 2.3 
mmol) and 4-methylbenzylamine (0.30 ml, 2.3 mmol) in 5 ml DCM then added to the resin. 
This mixture was left for 1 hr to allow evolution of H 2 before shaking the reaction for 14 hrs. 
The resin was then washed with DCM, 1:1 DCM!MeOH and finally MeOH before drying 
under vacuum for 8 hours. 'H NMR (magic angle spinning): 8 (ppm) 7.8 (IH broad, NH); 
7.15 (2H, d, CH 2C6H4CH3); 7.05 (2H, d, CH 2C6FI4CH3); 6.0 (2H, s, aryl CH); 4.1 (6H, broad, 
-NHCO(Cth)30-); 3.68 (61-1, s, OCth); 2.30 (2H, t,); 2.22(3H, s); 2.00 (2H, t). 
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Scheme 24 Reductive Amination: attaching 4-methylbenzylamine (R,) 
and 4-picolylamine (R2) to the solid phase 
2.4.3.3 Step 2: Reductive Amination —2 
4-picolylamine (Scheme 2-4) 
Glacial acetic acid (0.13 ml, 2.3 mmol) was combined with Me 4NBH(OAc)3 (0.614 g, 2.3 
mmol) and 4-picolylamine (0..23 ml, 2.3 mmol) in 5ml DCM then added to the resin. This 
mixture was left for 1 hr to allow evolution of H 2 before shaking the reaction for 16 hrs. The 
resin was then washed with DCM, 1:1 DCM/MeOH and finally MeOH before drying under 
vacuum for 1 hour. 'H NMR (magic angle spinning): 6 (ppm) 8.45 (2H, d 
N(CJ-ICI-I) 2CCH2); 7.2 (2H, broad N(CHCH) 2CCH2); 6.10 (2H, s, aryl CH); 4.00 (2H 
NCPy); 3.68 (6H, s, OCth); 2.40 (2H, t); 2.05 (2H, t). 
2.4.3.4 Step 3: DTPA-bis(amide) Formation - I 
DTPA-bis(4-methylamide) (DTPA-BTA) 
A solution of DTPA-dianhydride (50 mg, 0.14 mmol) and DIPEA (N,N- 
diisopropylethylamine) (24 p.L, 0.14 mmol) was added to the resin (100 mg, 0.046 mmol) 
loaded with 4-methylbenzylamine and the reaction shaken at room temperature for 18 hours. 
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The resin was then washed with DMF before addition of 4-methylbenzylamine (29 JAL, 0.23 
mmol) and a catalytic amount of DMAP in 0.5 ml DMF then shaking continued for 2 hrs. 
The excess reagents were removed by thoroughly washing the beads with DMF, 
AcOH:EtOAc (1:1 v/v), NH 3 :EtOAc (1:1 v/v) and DCM. Cleavage was twice performed 
with 1 ml TFA.1120 (95:5), 1 hour each. The solution and washings (DCM and MeOH) 
were collected and the solvent removed by rotary evaporation. The colourless oily residue 
was dissolved in MeOH and the solvent removed again before drying under vacuum. This 
residue was then dissolved in D20 for 'H NMR analysis: (400 MHz) S (ppm) 7.05 (8H, 2d, 
CH2C6H4CH3); 4.22 (4H, s, NCPhMe); 3.75 (4H, s, NCCO 2 , terminal); 3.65 (4H, s, 
NCthCONH); 3.55 (211, s, NCthCO 2 . terminal); 3.15 (4H, t, NCjCH 2N); 3.05 (411, t, 
NCH2CthN); 2.18 (6H, s, PhC). LC-MS: [M] 599 D. Some DIPEA, DMF, DTPA and 4-
methylbenzylamine peaks are observed in the 'H NMR spectrum. Conventional 
chromatographic methods cannot be used to purify the ligand and no further characterisation 
was attempted from this reaction. 
2.4.3.5 Step 3: Attempted DTPA-bis(amide) Formation 
DTPA-bis(4-picolylamide) (DTPA-PYA) 
Preparation of the DTPA-bis(4-picolylamide) was attempted using the same procedure as for 
DTPA-BTA . The amine was successfully attached to the resin via the aldehyde linker as for 
DTPA-BTA (see Step 2 above) but it was unclear as to whether any product was obtained 
from subsequent reactions. The nature of the problem was not determined, but is likely to be 
due to the cleavage of the ligand from the resin and the difficulties experienced in washing 
the excess amine and DTPA-dianhydride reagents from the reaction. 
In both reactions 2.3.3.4 and 2.3.3.5 a plastic residue and orange gum was observed 
in the crude product following cleavage. We attribute this to decomposition of the rubber 
stopper by the DCM used in the reductive amination steps. The harsh cleavage conditions 
may also have resulted in some decomposition of the  plastic reaction vessel affording the 
insoluble colourless residue upon preparation of the NMR sample. An alternative reductive 
amination procedure was attempted using DMF in place of the DCM. 
2.4.3.6 Step 2 - Modified Reductive Amination in DMF 
The resin, ArgoGel-NH 2, 0.47 mmol/g loading (1.07g, 0.5 mmol) was swollen in DMF and 
the solvent removed by filtration. The linker, 4 (3,5-dimethoxy-4-formylphenoxy) butyric 
acid (0.400 g, 1.5mmol), HATU (hexafluorophosphine azotriazole urea) (0.578 g, 1.5 mmol) 
and DIPEA (0.523 ml, 3 mmol) were combined in 3 ml DMF and left for 30 minutes prior to 
48 Synthesis and Characterisation 
Experimental 
reaction with the resin. This resin mixture was shaken for 3 hours then washed with DMF (6 
x 5 ml). The unreacted ArgoGel-NH 2 resin gave a positive TNBSA (trinitrobenzene sulfonic 
acid) spot test (red beads indicating presence of primary amine). The reacted resin and 
linker gave a negative TNBSA test (indicting no -N -H2). Reductive amination was carried 
out in DMF instead of DCM avoiding the decomposition of the rubber stopper observed 
previously. Five equivalents of the amine, 4-methylbenzylamine, (0.318 ml, 2.5 mmol) were 
added to the resin in a solution of 4 ml 1% Glacial AcOHIDMF and the reaction shaken for 1 
hour. After this time the reducing agent, solid NaBH(OAc) 3 , (0.644 g, 3 mmol) was added 
to the reaction, the mixture diluted with a further 2 ml DMF then shaken overnight (18 hrs). 
The resin was then washed with DMF, MeOH and DCM (4 x 4 ml each), MeOH (1 x 4 in]) 
and Et20 (2 x 4 ml), the beads giving a positive Chloranil spot test (deep blue coloured 
beads) for secondary amine. This aminated resin was used in subsequent attempts to prepare 
asymmetric DTPA-AM 2 ligands. 
2.4.3.7 Alternative Solid Support: Polystyrene Resin - Reductive Amination 
The resin, PS-MB-CHO (160 mg, 0.2 mmol; 100 mg 0.13 mmol) was swollen in DMF prior 
to addition of 1.5 ml 1% AcOH/DMF and 4-methylbenzylamine (5eq, 0.075 ml, 0.65mmol) 
and the reactions shaken for 1 hour. After this time, 6 equivalents of the reducing agent, 
NaBH(OAc) 3 or Me4NBH(OAc)3 were added, the mixtures diluted with 1.5 ml DMF and 
shaken for 18 hours. The resins were then washed with DMF, methanol and diethyl ether. 
Both gave positive chloranil spot tests for secondary amines. JR analysis of the beads 
confirmed that conversion of aldehyde to imine followed by reduction to the secondary 
amine had occurred. The resins were then used without further treatment in subsequent 
attempts to prepare asymmetric DTPA-bis(amide) ligands. 
2.5 Ln(lll) Complex Preparation 
2.5.1 General Ln(l I l)DTPA-AM2 Preparation 
Equimolar amounts of the ligand and metal were combined in aqueous (or H 20IMeOH) 
solution (20-50 ml, pH 1) before addition of TBAOH (40% w/w H 20) until pH 5-6 was 
reached. The volume of the colourless solution was reduced by rotary evaporation (-1 ml) 
and acetonitrile added forming a white precipitate. The solid was collected by filtration, 
washed with CH 3CN and Et20 then dried under vacuum to yield the desired Ln(III)DTPA-
bis(amide) complex as a hydrated species (Figure 2-1). 
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Figure 2-1 General structure of Ln(ffl)DTPA-AM 2 chelate complex 
2.5.2 Europium (Ill) DTPA-bis(amide) Complexes 
2.5.2.1 (1, 11 -(bis(ethylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl )undecane}eu ropi um(lll) di hydrate: 
[EuBEA.H20]H20 
The ligand, DTPA-BEA.2H20, (0.242 g, 0.500 mmol) was combined with 2 ml aqueous 
EuC1 3.6H20 (0.179 g, 0.489 mmol), the mixture diluted to 20 ml with water before 
sonicating and heating gently until all of the powder had dissolved (pH -1). The colourless 
solution was raised to pH 5 by dropwise addition of TBAOH (40% w/w H 20) then the 
volume reduced to -0.5 ml by rotary evaporation. Addition of CH 3CN to the concentrated 
solution instantly afforded a colourless solid which was collected by filtration, washed with 
CH3CN (50 ml) and Et20 (50 ml) then dried under vacuum to yield the title complex, 
[EuBEA.H20] (0.288 g, 96%). ES-MS (+): [M+ 1] + 596/598 D, [TBA] 242 D. The solid was 
dissolved in methanol (5 ml), the volume reduced and the complex re-precipitated with 
acetonitrile to remove the excess TBAC1. CHIN: Calculated for [EuC 18H34N5010]: 34.17% 
C; 5.43% H; 11.07% N. Found: 34.44% C; 5.26% H; 10.92% N. 
2.5.2.2 Alternative preparation of [EuBEA.H 20]H20 
Solid DTPA-BEA.2H20 (0.835 g, 1.73 mmol) was added to a stirring suspension of Eu 203 
(0.302 g, 0.858 mmol) in 50 ml H20. The mixture was heated at reflux and stirring 
continued until all the solid had dissolved then filtered before reducing the volume of the 
colourless solution by rotary evaporation. Addition of 50 ml acetonitrile to the concentrated 
solution afforded a colourless solid, collected by filtration, washed with CH 3CN and Et20, 
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then dried under vacuum to yield the complex, [EuBEA9H 20] (0.983 g, 94%). FAB-MS 
[M±1] 598 D. Cl-IN: Calculated for EuC 18H34N5010: 34.17% C; 5.43% H; 11.07% N. 
Found: 34.10% C; 5.38% H; 11.17% N. 
2.5.2.3 (1, 11 -(bis(1 -butylamino)-1, 11 -dioxo-3,6,94riaza-3,6,9-
triscarboxymethyl)u ndecane}europium(lll) monohydrate: 
(EuBUA.H 201 
An aqueous solution (2 ml) of EuC1 3.6H20 (0.197 g, 0.54 mmol) was combined with DTPA-
BUA.2H20 (0.292 g, 0.54 mmol) and the mixture diluted to 20 ml, then sonificated and 
heated until all the ligand had dissolved (pH 1). Addition of TBAOH (40% w/w H 20) 
raised the colourless solution to pH - 5 before reducing the volume of the solution to 1 ml by 
rotary evaporation. Acetonitrile (50 ml) was added to the concentrated aqueous solution 
instantly affording a colourless precipitate, which was collected by filtration, washed with 
CH3CN and Et20 then dried under vacuum to yield the title compound as a monohydrate, 
[EuBUA.H20] (0.313 g, 87 %). LC-MS (ES+) [M] 652/654; CHN: Calculated for 
[EuC22H40N509]: 39.39% C; 6.02% H; 10.44% N. Found: 39.14% C; 6.20% H; 9.53% N. 
2.5.2.4 Alternative preparation of [EuBUA91-1 20] 
The ligand, DTPA-BUA.2H20, (1.897 g, 3.48 mmol) was added to a stirring suspension of 
Eu203 (0.609 g, 1.73 mmol) in 20 ml water. The mixture was diluted to 50 ml with water 
and stirring continued at reflux for 17 hours. The volume of the colourless solution was 
reduced by rotary evaporation before addition of acetonitrile, instantly affording a colourless 
precipitate. This solid was collected by filtration, washed with CH 3CN and Et20 then dried 
under vacuum to yield the complex, [EuBUA.H 20]0.5H20 (2.203 g, 95%). FAB-MS: 
[M+1] 652 D. CHN: Calculated for EuC 22H41 N5095 : 38.87% C; 6.09% H; 10.38% N. 
Found: 38.89% C; 6.23% H; 10.38% N. 
2.5.2.5 {1, 11 -(bis(benzylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)u ndecane}eu ropium(l II) tetrahydrate: 
[EuBBZA.H20]3H20 
An aqueous solution (2 ml) of EuC1 3 96H20 (0.245 g, 0.67 mmol) was combined with DTPA-
BBZA.2H20 (0.408 g, 0.67 mmol) and the mixture diluted to 20 ml, sonificated and heated 
until all the ligand had dissolved (pH - 1). The colourless solution was raised to pH 5 by 
dropwise addition of TBAOH (40% w/w H 20) before the volume was reduced to —1 ml by 
rotary evaporation. Addition of acetonitrile (50 ml) instantly afforded a colourless 
w 
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precipitate, collected by filtration, washed with CH 3CN (20 ml) and Et20 (20 ml) then dried 
under vacuum to yield the title compound as a tetrahydrate, [EuBBZA.H 20]3H20 (0.436 g, 
90%). LC-MS (ES+) [MJ 719/721. CHN: Calculated for [EuC 28H41 N5012]: 42.42% C; 
5.34% H; 8.84% N. Found: 42.70 % C; 5.23% H; 8.64% N. 
2.5.2.6 (1, 11 -(bis(4-methylbenzylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane}europium(l II) trihydrate: 
[EuBTA.H20]2H20 
An aqueous solution (2 ml) of EuC1 3 .6H20 (0.368 g, 1.0 mmol) was combined with DTPA-
BTA.2H20 (0.639 g, 1.0 mmol). The mixture was sonificated and heated gently until all the 
ligand had dissolved forming a colourless solution (pH 1). Dropwise addition of TBAOH 
(40% w/w H 20) raised the pH of the solution to 5. The volume was reduced to 1 ml by 
rotary evaporation. Addition of acetonitrile to the concentrated solution instantly afforded a 
colourless precipitate which was collected by filtration, washed with CH 3CN, Et20 then 
dried under vacuum to yield the title compound, [EuBTA9H 20]2H20 (0.69g. 87%). 
2.5.2.7 (1, 11 -(bis(cyclohexylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane}europium(l II) tn hydrate: 
[EucyHA.H20]2H20 
Aqueous EuC1 3.6H20 (0.194 g, 0.53 mmol) was combined with DTPA-cyHA (0.296 g, 0.53 
mmol). The mixture was then diluted to 50 ml, sonificated and heated until all the ligand had 
dissolved (pH - 1). The colourless solution was raised to pH 5 by dropwise addition of 
TBAOH (40% w/w H 20). The volume was then reduced to - 1 ml by rotary evaporation. 
Addition of acetonitrile instantly afforded a colourless precipitate, which was collected by 
filtration, washed with CH 3CN (20 ml) and Et20 (20 ml) then dried under vacuum to yield 
the title compound as the trihydrate, [EucyHA.H 20]2H20 (0.381 g, 83%). LC-MS (ES+): 
[M] 704; 2.33 mins. CHIN: Calculated for [Eu(ffl)C 26H48N5011 J: 41.15% C; 6.39% H; 
9.23% N. Found: 40.45% C; 6.16% H; 9.17% N. 
2.5.2.8 Alternative preparation of [EucyHA.H20]1.5H20 
The ligand, DTPA-cyHA (0.513 g, 0.922 mmol) was dissolved in 50 ml water in the 
presence of TBAOH and refluxed for 30 minutes (pH 4). Solid Eu 203 (0.158 g, 0.449 
mmol) was added to the hot ligand solution forming a suspension (pH 10). The pH was 
lowered with HCI (IM aq) and heating continued until the solid had dissolved (pH 1). 
This solution was filtered and TBAOH added until pH 4 was reached and the volume 
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reduced by rotary evaporation. Addition of acetonitrile to the concentrated solution afforded 
a colourless precipitate that was collected by filtration, washed with CH 3CN and Et20 then 
dried under vacuum to yield the complex [EucyHA.H 20]. FAB-MS [M+l] 704/706. 
CHN: Calculated for EuC 26H49N50 115 : 40.66% C; 6.44% H; 9.12% N. Found: 40.72% C; 
6.36% H; 8.99% N. 
2.5.2.9 (1, 11 -(bis(methylenecyclohexylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane}europium(III) hydrate: [EumcyHA.H 20] 
Solid DTPA-mcyHA (0.326 g, 0.55 8 mmol) was added to an aqueous solution (2 ml) of 
EuC1396H20 (0.203 g, 0.554 mmol). The mixture was diluted to 20 ml with water then 
heated and sonificated until all the ligand had dissolved (pH-1). TBAOH (40% w/w H 20) 
was added dropwise raising the colourless solution to pH 5 before reducing the volume by 
rotary evaporation. Addition of CH 3CN (20 ml) instantly afforded a colourless precipitate. 
This was collected by filtration, washed with CH 3CN (50 ml) and Et20 (50 ml) then dried 
under vacuum to yield the title compound, [EumcyHA.H 20]2H20 (0.339 g, 82 %). LC-MS 
(ES+): [M] 731/733 D (2.57 mins). 
2.5.2.10 (1, 11 -(bis(2-biphenylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane}europium(III) trihydrate: 
[EuBPA.H20]2H20 
The metal salt, EuC1 396H20, (0.193 g, 0.527 mmol) was dissolved in lml H 20, combined 
with the ligand, DTPA-BPA, (0.371 g, 0.527 mmol) and the mixture diluted to 50 ml with 
H20IMeOH forming a pale yellow solution (pH —1). Aqueous TBAOH (40% w/w) was 
added dropwise until the pH 5 was reached, then the volume reduced by rotary evaporation. 
The viscous yellow residue was diluted with 1 ml methanol and the complex precipitated 
upon addition of acetonitrile (20 ml) to this solution. The solid was collected by filtration, 
washed with CH ICN (50 ml) and Et,O (20 ml) then dried under vacuum to yield the title 
compound, [EuBPA.H 20]2H20 (0.294 g, 65%). LCMS (ES+): [M] 844, (2.66mins). 
CHN: Calculated for Eu(II1)C 38H38N508.3H20: 50.77% C; 4.94 % H; 7.79 % N. Found: 
49.67% C; 4.90% H; 7.7 1% N 
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2.5.2.11 {1, 11 -(bis(cyclooctylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)u ndecane}eu ropium(i II) trihydrate: 
[EucyOA.H20]2H20 
The ligand and the metal were combined in 1:1 stoichiometry (EuCI 306H20, 0.176 g, 0.480 
mmol; DTPA-cyOA, 0.318 g, 0.482 mmol) in 20 ml water and sonificated and heated until 
all the ligand had dissolved (pH 1). Aqueous TBAOH was added dropwise until pH 5 was 
reached then the volume reduced to an oil by rotary evaporation. This concentrated solution 
was diluted with water (10 ml) and filtered to remove insoluble impurities before removal of 
the solvent, this time forming an off white solid. This solid was dissolved in methanol (5 
ml) and the complex then precipitated as a colourless solid upon addition of acetonitrile (50 
ml), collected by filtration, washed with CH 3CN (50 ml) and Et20 (20 ml) then dried under 
vacuum to yield the title compound [EucyOA.H 20]2H20. CFIN Calculated for Eu(III) 
C50H50N508 .31120: 44.22% C; 6.74% H; 8.60 % N. Found: 44.27% C; 6.74 % H; 8.58% N. 
2.5.2.12 {1, 11 -(bis(±)2-aminonorbornylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane}europium(III) trihydrate: (EuNBA.H 20] 
An aqueous solution (2 ml) of EuCI 3.6H20 (0.160 g, 0.437 mmol) was combined with the 
ligand, DTPA-NBA.2H20 (0.254 g, 0.438 mmol), the mixture diluted to 20 ml with 
MeOH/H20 (1:10 v/v) and heatedlsonificated until all of the solid had dissolved (pH 1). 
Aqueous TBAOH (40% w/w H 20) was added dropwise until the colourless solution reached 
pH 6, then the volume was reduced by rotary evaporation. The complex was precipitated 
from this concentrated solution upon addition of CH 3CN (50 ml), collected by filtration and 
washed with CH3CN (20 ml) and Et20 (20 ml) and dried under vacuum to yield the title 
compound, [EuNBA.H 20] 0.236 g, 72 %). LC-MS (ES+): [M] 727/729 (2.38 mins). 
CI{N: Calculated for EuC 26 450N5012 : 41.99% C; 6.30% H; 8.74% N. Found: 41.99% C; 
6.18% H; 8.65% N. 
2.5.2.13 (1, 11 -(bis(1 -decylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9- 
triscarboxymethyl)u ndecane}europium(III) hydrate: [EuBDA.H20] 
The metal salt, EuC1 3.6H20, (0.081 g, 0.22 mmol) was dissolved in 2 ml H 20 and combined 
with the solid ligand (0.148 g, 0.22 mmol) then the mixture diluted to 20 ml with water. A 
small amount of methanol was added to aid dissolution of the ligand. The colourless solution 
(pH 1) that formed following heating/sonification was treated with TBAOH (40% w/w 
H20) until pH 5 was reached. The volume was reduced by rotary evaporation and the 
complex precipitated from the concentrated solution upon addition of acetonitrile (50 ml). 
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The colourless solid was collected by filtration, washed with CH 3CN (20 ml) and Et20 (20 
ml) and dried under vacuum to yield the title compound [EuBDA.H 20] (0.167 g, 90%). 
2.5.2.14 {1, 11 .(bis(1 -adamantylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl) undecane}europium(l II) hydrate: [Eu BAA.H 20] 
An aqueous solution of the metal salt, EuC1 3.6H20 (0.159 g, 0.434 mmol) was combined 
with the solid ligand, DTPA-BAA.3H20 (0.286 g, 0.434 mmol), the mixture diluted with 
water/methanol (50 ml) and sonificated/heated until all the ligand had dissolved. Any 
insoluble impurities were removed by filtration and the colourless solution (pH 1) was 
treated with aqueous TBAOH until pH - 5 was reached. The solvent was removed by rotary 
evaporation forming a milky white suspension. This solid dissolved upon addition of 
acetonitrile and the solvent was again removed by rotary evaporation. The colourless solid 
that formed was collected by filtration and washed with CH 3CN (20 in]) and Et 20 (20 ml) 
then dried under vacuum to yield the title compound, [EuDTPA-BAA.H 201 (0.292 g, 82%). 
ES-MS (+) [M+l] 808/8 10 D; [M+Na] 830/832 D. 
2.5.3 Terbium (Ill) DTPA-bis(arnide) Complexes 
2.5.3.1 (1, 11 -(bis(ethylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)u ndecane}terbium(III) trihydrate: 
[TbBEA.H20]2H20 
The metal salt, ThC1 3 .61120, (0.219 g, 0.587 mmol) was dissolved in 2 ml H 20 and 
combined with I molar equivalent of the ligand, DTPA-BEA.2H 20, (0.285 g, 0.589 mol). 
The mixture was diluted to 10 ml with water, sonificated and heated until all of the ligand 
had dissolved (pH 1). The base, TBAOH (40% w/w H 20), was added dropwise until the 
colourless solution reached pH 5. The volume was then reduced to about I ml before 
precipitation of the complex as a colourless solid upon addition of acetonitrile (20 ml). The 
solid was collected by filtration, washed with CH 3CN (20 ml) and diethyl ether (20 ml) and 
dried under vacuum to yield the title compound, [ThBEA.H 20]2H20 (0.354 g, 100%). ES-
MS (+): [M] 604 D. CHN: Calculated for ThC 18H36N50 11 : 32.88 % C; 5.52 % H; 10.65 % 
N. Found: 32.28% C; 5.59%H; 10.14%N. 
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2.5.3.2 {1, 11 -(bis(1 -butlylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)u ndecane}terbiu m(UI) trihydrate: 
[TbBUA.H20]2H20 
Solid ligand, DTPA-BUA.2H20, (0.321 g, 0.595 mmol) was added to an aqueous solution (2 
ml) of the metal salt, ThC1 3 961120, (0.222 g, 0.595 mmol), the mixture diluted with water to 
20 ml, then sonificated and heated until a colourless solution was formed. Aqueous TBAOH 
(40% w/w H20) was added dropwise until the solution reached pH 6, after which the 
volume was reduced by rotary evaporation to --imi. Addition of CH 3CN (50 ml) afforded a 
colourless solid, collected by filtration, washed (CH 3CN and Et20, 20 ml each) then dried 
under vacuum to yield the title complex, [ThBUA.H 20]2H20, (0.284 g, 70%). LC-MS: 
[M] 659 D (2.07mins). CFIN: Calculated for ThC 22HN5011 : 37.02% C; 6.2% H; 9.81% N. 
Found: 36.90% C; 6.3 1% H; 9.5 1% N. 
2.5.3.3 (1, 11 -(bis(benzy1amino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)u ndecane}terbiu m(III) pentahydrate: 
[TbBBZA.H20]4H20 
Equimolar amounts of the ligand, DTPA-BBZA.2H 20, (0.368 g, 0.605 mmol) and metal salt, 
ThCl3.6H20, (0.266 g, 0.605 mmol) were combined in water/methanol solution (1:10 v/v, 10 
ml) and the mixture heated/sonificated until all the ligand had dissolved (pH 1). Aqueous 
TBAOH (40% w/w H 20) was added dropwise until the colourless solution reached pH 5, 
the volume reduced by rotary evaporation and the complex precipitated from the 
concentrated solution upon addition of acetonitrile (20 ml). The colourless solid was 
collected by filtration, washed with CH 3CN (20 ml) and Et 20 (20 ml) and dried under 
vacuum to yield the title complex, [ThBBZA.H 20]4H20 (0.348 g, 77%). LC-MS: [M] 727 
D (2.22mins). CHN: Calculated for ThC 28H47N5018 : 40.97% C; 5.78% H; 8.53% N. Found:. 
41.21% C; 5.24% H; 8.24 % N. 
2.5.3.4 {1, 11 -(bis(4-methylbenzylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)u ndecane}terbium(II I) tetrahydrate: 
[TbBTA.H 2013H20 
The ligand, DTPA-BTA.2H 20, (0.350 g, 0.551 mmol) was added to aqueous ThC] 396H20 
(0.208 g, 0. 551 mmol), the mixture diluted with water to 20 ml, sonificated and heated until 
all the solid had dissolved. The colourless solution was raised to pH - 5 by dropwise 
addition of aqueous TBAOH (40% w/w 1120). The volume was reduced by rotary 
evaporation before precipitation of the complex as a colourless solid with acetonitrile (50 
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ml). The complex was collected by filtration, washed with CH 3CN and Et20 (20 ml each) 
and dried under vacuum to yield [ThBTA.H 20]4H20. CHN: Calculated for ThC 301149N5012 : 
43.37% C; 5.95% H; 8.43% N. Found: 43.67% C; 5.47% H; 8.23% N. 
2.5.3.5 {1, 11 -(bis(cyclohexylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)u ndecane}terbium(III) hydrate: [TbcyHA.H 20] 
An aqueous solution (2 ml) of ThCl 3.6H20 (0.203 g, 0.560 mmol) was combined with 
DTPA-cyHA (0.315 g, 0.567 nimol), the mixture diluted to 50 ml with methanol/water (1:5 
v/v) then sonificated and heated until all the ligand had dissolved. TBAOH (40% w/w 1120) 
was added dropwise until the colourless solution reached pH - 5. The solvent was removed 
by rotary evaporation and the pale yellow residue diluted with imI methanol, prior to 
precipitation of the complex upon addition of CH 3CN (50 ml). The solid was collected by 
filtration, washed with CH 3CN and Et20 then dried under vacuum to yield the title complex, 
[ThcyHA.H20] (0.327 g, 80%). LCMS: [M 4] 711 D (2.30 mm). 
2.5.3.6 (1, 11 -(bis(methylenecyclohexylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane}terbium(III) trihydrate: 
[TbmcyHA.H20]2H20 
The ligand, DTPA-mcyllA (0.196 g, 0.525 mmol) was added to an aqueous solution (2 ml) 
of ThC1 3.6H20 (0.306 g, 0.525 mmol), the mixture diluted to 20 ml with MeOHIH 20 (1:10 
v/v) and sonificated/heated until all the ligand had dissolved. The colourless solution was 
treated with TBAOH (40% wt/w 1120) until pH - 5 was reached, then the volume reduced by 
rotary evaporation to - 1 ml. Addition of acetonitrile (50 ml) to the concentrated solution 
afforded a colourless precipitate, which was collected by filtration, washed with CH 3CN (20 
ml) and Et20 (20 ml) and dried under vacuum to yield the title compound, 
[ThmcyHA.H20]2H20 (0.329 g, 83%). LC-MS: [M] 739 D (2.56mins). CHN: Calculated 
for ThC28H52N0 1 : 42.03% C; 6.56% H; 8.75 % N. Found: 42.27% C; 6.78% H; 8.66 % N. 
2.5.3.7 {1, 11 -(bis((±)2-norbornylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)u ndecane}terbium(II I) trihydrate: 
[TbNBA.H20]2H20 
Aqueous ThC1 3 96H20 (0.142 g, 0.380 mmol) was combined with solid DTPA-NBA.2H 20 
(0.222 g, 0.383 mmol), the mixture diluted with methanol/water to 20 ml then 
heatedlsonificated until all the ligand had dissolved. Addition of TBAOH changed the 
solution from pH 1 to pH - 6 before the volume was reduced by rotary evaporation. 
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Acetonitrile (50 ml) was added to the concentrated solution and the precipitate that was 
formed collected by filtration, washed with CH 3CN and Et20 then dried under vacuum to 
yield the title compound, [ThNBA.H 20] (0.245 g, 86%). LCMS: [M 4] 735 D (2.38mins). 
CHN: Calculated for ThC 28H51N5011 : 42.09% C; 6.44% H; 8.76%n. Found: 42.31% C; 
6.25% H; 8.53% N. 
2.5.4 Lanthanum (Ill) DTPA-bis(amide) Complexes 
2.5.4.1 (1, 11 -(bis(ethylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane}Ianthanum(UI) dihydrate: 
[LaBEA.H20]H20 
The ligand, DTPA-BEA.2H 20, (0.350 g, 0.72 mmol) was added to an aqueous solution of 
LaC1 3.6H20 (0.72 M, I ml, 0.72 mmol) and the mixture diluted to 5 ml with water (pH 1). 
Aqueous TBAOH (40% w/w H 20) was added carefully until the colourless solution reached 
pH 5, then the volume reduced by rotary evaporation. Addition of acetonitrile (20 ml) to 
the concentrated solution instantly afforded a colourless precipitate, which was collected by 
filtration, washed with CH 3CN (20 ml) and Et 20 (20 ml) then dried under vacuum. Analysis 
(NMR and LCMS) revealed the presence of excess TBA. The solid was dissolved in 
methanol, the solution concentrated and the precipitate that formed upon addition of 
acetonitrile was collected by filtration, washed (CH 3CN and Et20) and dried under vacuum 
to yield the pure complex, [LaBEA.H 20] (0.231 g, 54%). ES-MS (+): [M+1] 584 D. 'H 
NMR (400 MHz, D20, pD - 6): S (ppm) 1.0(6H, t CH 2Cth); 2.3-3.0 (4H, 2H, 2H, 3m, 
NCthCthNCthCthN); 3.1-3.9 (14H, m, NCthCONCthCH 3, NCthCO2). ' 3C NMR (100 
MHz, D20): 181.0-180.6 180.2 (5 x CO,); 175.0-174.4 (2 x C0); 61.6, 60.8 
(NCH2CONHEt, NCH 2CO2) 58.5, 57.5, 57.0, 55-56 (Nd1129112NC1-I2CH2N), 35.5 
(NCH2CH3), 13.7 (NCH2CH3). CHN: Calculated for LaC 18H22N50 10 : 35.94% C; 5.37% H; 
11.65% N. Found: 36.07 0/,u' 55 H; 11.40% N. .2% 
2.5.4.2 (1, 11 -(bis(1 -butylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9- 
triscarboxymethyl)undecane}terbium(III) hydrate: [LaBUA.H 20] 
Aqueous LaC13.6H20, 0.72 M, (0.431 ml, 0.311 mmol) was added to the ligand, DTPA-
BUA.2H20, (0.168 g, 0.311 mmol) and the mixture diluted with 20 ml water before heating 
and sonification until all remaining solid had dissolved (pH - 1). TBAOH (40% w/w H 20) 
was added dropwise until pH 5 was reached. The volume of the colourless solution was 
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reduced by rotary evaporation before precipitation of the complex from the concentrated 
solution upon addition of acetonitrile (20 ml). The colourless solid was collected by 
filtration, washed with CH 3CN (20 ml) and Et 20 (20 ml) then dried under vacuum to yield 
the title compound, [LaBUA.H 20} (0.204 g, 87%). 'H NMR (400MHz, D 20, pD 6): 
(ppm) 32.90-3.20 (14H, m, NCCONHCthC 3 H7, NCffCO2H (central and terminal)); 
3.10-2.95 (4H, broad m, NCthCthN); 2.85-2.70 (2H, broad, m, NCthCthN); 2.70-2.50 
(IH, broad, in NCH 2CthN); 2.50-2.40 (IH, br, m, NCjCH 2N); 1.55 (4H, quintet, 
NBCH2CCH2CH3); 1.35 (4H, sextet, NHCH 2CH2CthCH3); 0.95 (6H, t, 
NHCH2CH2CH2Cth). ' 3C NMR (100 MHz) ö (ppm) 180.1 (5 ço2 ) ; 175 (2 C=O); 63. 1, 
62.5, 61.5, 60.9 (NCH2CO); 58.5, 58.0, 57.5, 56.1 (NCH2CH2N); 40.1, 39.9 
(NCH 2CH2CH2CH3); 30.6, 30.5 (NCHH 2CH2CH3); 19.8, 19.7, 19.5 (NCH 2CHH2CH3); 
13.3, 13.2 (NCH 2CH2CH2CH3). 
2.5.4.3 (1, 11 -(bis(1 -benzylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane}Ianthanum(IH) hydrate: [LaBBZA.H 20] 
An aqueous solution of LaC1 3.6H20 (0.72 M, 0.457 ml, 0.329 mol) was added to DTPA-
BBZA.2H20 (0.200 g, 0.329 mmol) and the mixture diluted with 20 ml H 20 then 
headed/sonificated until all the ligand had dissolved (pH 1). TBAOII (40% w/w H 20) was 
added dropwise to the colourless solution until pH 5 was reached, prior to reducing the 
volume to -, 1 ml by rotary evaporation. Addition of CH 3CN (50 ml) instantly afforded a 
colourless precipitate, which was collected by filtration, washed with CH 3CN (20 ml) and 
Et20 (20 ml) then dried under vacuum to yield the title compound, [LaBBZA.H 20} (0.189 g, 
79%). 'Fl NMR (400 MHz, D 20, pD 6): 5 (ppm) 7.20 (1 OH, m, benzyl ); 4.34-4.12,4.0- 
4.1 (4H, m, NCthPh); 3.55-3.05 (8H, m, NCthCO2, terminal, NCfl2CON}1); 2.95-1.09 
(1011, m, NCthCO2, NCCNCJjCN). ' 3C NMR (100 MHz): 8 (ppm) 181-180 (4 x 
CO2 ); 175-177 (3 x CONII); 138 (Aromatic ); 129.5, 129.3, 128.2, 128.0, 127.5, 127.1 
(CH); 63.1, 61.2, 61.0 (NCH 2CO); 57.3, 56.3, 55.8 (NCH2CH2NCH2CH2N); 43.8, 43.7, 43.4 
(NçH2Ph). 
2.5.4.4 Attempted synthesis of {1, 11 -(bis(cyclohexylamino)-1, 11 -dioxo-3,6,9-
triaza-3,6,9-triscarboxymethyl)undecane} lanthanum(III) hydrate: 
(LacyHA.H201 
To 1.0 ml of aqueous LaC1 396H20 (0.72 M 0.76 mmol) was added the solid ligand, DTPA- 
cyHA (0.421 g, 0.76 mmol). The suspension was diluted to 30 ml with water, heated and 
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sonificated until most of the solid had dissolved then left to stand for 72 hrs after which time 
a colourless solid had formed. The reaction was then heated at reflux in the presence of 
TBAOH (pH 6). Not all of the solid dissolved and the remaining amount was collected by 
filtration (0.4g) and found to be soluble in concentrated acid, but not in neutral or basic 
solution or DMSO indicating that the solid was indeed a La(III) complex and not recovered 
free ligand (soluble in base and DMSO). No analysis was performed on this compound due 
to the insoluble nature of the species. 
2.5.5 Yttrium (Ill) DTPA-bis(amide) complexes: 
2.5.5.1 (1, 11 -(bis(ethylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9- 
triscarboxymethyl) u ndecane} yttrium (III) hydrate: (YBEA.H 20] 
Anhydrous YC1 3, (0.077 g, 0.39 mmol) was dissolved in 20 ml H 20 and combined with 
DTPA-BEA.2H20 (0.191 g, 0.39 mmol). The suspension was heated/sonificated until all the 
ligand had dissolved (pH - 1) and TBAOH (40% w/w H 20) added dropwise until the 
colourless solution reached pH 5. The volume was reduced by rotary evaporation and 
addition of acetonitrile to the oily residue afforded a colourless solid that was collected by 
filtration, washed with CH3CN (20 ml) and Et 20 (20 ml) and dried under vacuum to yield 
the title compound, [YBEA.H 20] (0.181 g, 84%). 'H NMR (400 MHz, D 20): 6 (ppm) 3.85-
3.05 (14H, m, NCCO2 , NCIj2CONH, NCthCH3); 3.0-2.80 (4H, broad, NCthCthN); 
2.72-2.60 (211, broad, NCthCthN);  2.50-2.38 (2H, broad, NCH CH N) 1.02 (6H, broad, 
NCH2Cfl). 
2.5.5.2 {1, 11 -(bis(ethylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane} yttrium (Ill) hydrate (YBEA.H 20] 
The hydrated metal salt, YCI 3 9611 20, (0.355 g, 1.17 mmol) was dissolved in 2m1 water, solid 
DTPA-BEA.2H 20 (0.5 70 g, 1.18 mmol) added and the mixture sonificated until all the 
ligand had dissolved (pH 1). The colourless solution was treated with TBAOH (0.5 M aq) 
until pH - 5 was reached then the volume reduced to Imi by rotary evaporation. The 
colourless solid which formed upon addition of acetonitrile to the concentrated solution was 
collected by filtration, washed with CH 3CN (50 ml) and Et20 (50 ml) then dried under 
vacuum to yield the title compound, [YBEA9H 20}.2.5H 20 (0.590 g, 91.5%). FAB-MS: 
[M+l] 534 D. CHN: Calculated for YC 18H37N50 115 : 36.24% C; 6.26% II; 11.74% N. 
Found: 36.42% C; 6.16% H; 11.35% N. 'H NMR (360 MHz, D20): 6 (ppm) 3.86-3.13 
(14H, m, NCthCO 2 , NCthCONHCthCH 3); 2.92 (4H, broad s, NCH 2CN) 2.73, 2.71 (211, 
broad d NCfl2CH2N); 2.49 (211, broad s) (NCjCN); 1.06-1.11 (6H, t, NCH 2Cth). 13C 
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NMR (100 MHz): 181.4, 181.1, 180.8, 180.2, 180.0 (Q02); 175.9, 175.8, 174.7 (ONI1); 
66.6, 63.4, 61.4 (NCH 2CO); 58.7, 58.6, 56.5, 56.3 CHH2NCHH2N); 35.8, 35.4 
(NCH2CH3); 13.7, 13.6 (NCHQH 3). 
2.5.5.3 {1, 11 -(bis(1 -butylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane} yttrium (III) monohydrate: [YBUA. H 20] 
The ligand, DTPA-BUA.2H20 (0.430 g, 0.78 mmol) was added to an aqueous solution of the 
metal salt, YC13.6H20, (0.235 g, 0.77 mmol) and the mixture heatedlsonificated until all the 
solid had dissolved. Aqueous TBAOH (0.5 M) was added carefully until the colourless 
solution reached pH 5-6, then the volume reduced by rotary evaporation. Addition of 
acetonitrile to the concentrated solution instantly afforded a colourless precipitate. This was 
collected by filtration, washed with CH 3CN (20 ml) and Et20 and dried under vacuum to 
yield the title complex, [YBUA9H 20] (0.345 g, 74%). FAB-MS [M+1] 590 D, [TBA] 242 
D. Recrystallisation was attempted from H 20/CH3CN but was unsuccessful. The solvent 
was removed by rotary evaporation and the complex precipitated from the oily residue upon 
addition of acetone. FAB-MS [M+1] 590 D. 'H NMR (250MHz, D20, pD - 6): 5 (ppm) 
3.52-3.14 (14H, m, NCJj2CO2 , NCjCONHCthCH 2CH2CH3); 2.91 (4H, broad, s, 
NCthCthN); 2.73, 2.70 (2H, broad, d NCthCR2N);  2.49 (broad, s NCCflN);  1.49-1.40 
(4H, m, NCH 2CthCH2CH3); 1.32-1.23 (NCH 2CH2CCH3); 0.88-0.80 (NCH2CH2CH2Cth). 
13C NMR (63 MHz) 180.9, 180.4, 179.8, 179.6 (Q0 2 ); 175.7, 175.5, 174.5, 174.4 (çONH); 
66.1, 62.9, 61.2 (NCH 2CONH; NCH2CO2 ); 58.1, 55.9 (NCH2CH2NCH2CH2N); 40.0, 39.5, 
39.8 (N9H2CH2CH2CH3); 30.1 (NCH 2CH2CH2CH3); 19.5, 19.3, 19.2 (NCI-I 2CH2CH2CH3); 
12.9 (7cH3 ). CHN: Calculated for YC 22H40N509 : 43.49% C; 6.65% H; 11.53% N. Found: 
43.28% C; 6.32 % H; 11.29% N. 
2.5.5.4 (1, 11 -(bis(benzylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane} yttrium (III) monohydrate: [YBBZA.H 20] 
The metal salt, YC13.6H20, (0.251 g, 0.83 mmol) was dissolved in 5 ml H20 and solid 
DTPA-BBZA.2H 20 (0.5 10 g, 0.84 mmol) added. The mixture was heated and sonificated 
until all of the ligand had dissolved (pH 1) before dropwise addition of aqueous TBAOH 
(0.5M) until pH 5 was reached. The volume of the colourless solution was reduced to 
lml by rotary evaporation. Addition of CH 3CN (50 ml) afforded a colourless solid, which 
was collected by filtration, washed with CH 3CN (50 ml) and diethyl ether (50 ml) and dried 
under vacuum to yield the title compound, [YBBZA.H 201 (0.414 g, 76%). FAB-MS: 
[M+1] 658 D. 'H NMR (250 MHz, D20): 8 (ppm) 7.47-7.25 (IOH, m, aromatic Cki);  4.78- 
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4.01 (4H, m, CONCLI2Ph); 3.63-3.08 (10H, m, NCthCONTI,  NCthCO2 (central and 
terminal)); 2.81-2.43 (8H, m, NCjCj2N). ' 3C NIvIR (63 MHz): 180.7, 180.4, 179.8, 179.6 
(c02); 176.5, 176.0, 175.0, 174.8 (QONH), 137.3, 137.1, 137.0 (aromatic ); 129.2, 128.9, 
128.8, 128.7, 127.8, 127.6, 127.5 (aromatic CH); 126.8 (Aromatic c.);  66.0, 65.7, 63.1, 61.4, 
61.0 (NCH2CON; NCH 2CO2); 58.0, 55.9, 55.8 (NCHH2NCH2CH2N); 43.4, 43.1 
(NCH2Ph). Colourless, monoclinic, single crystals suitable for X-ray diffraction were 
obtained by slow evaporation of the NMR solution (D 20). The crystals were of poor quality 
and the complex was found to be isostructural with a [YBBZA.H 20]3H20 structure 
published by D. Parker 127 . 
2.5.5.5 (1, 11 -(bis((±)-2-norbornylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane} yttrium (III) dihydrate: [YNBA.H 20]H20 
The ligand, DTPA-NBA.2H 20, (0.330 g, 0.56 mrnol) was added to an aqueous solution of 
YCI3.6H20 (0.165 g, 0.54 mmol), the mixture sonificated/heated until all solid had dissolved 
(pH -1) then the pH adjusted (pH 6) by dropwise addition of TBAOH (0.5 M aq) and HC1 
(1 M). The volume of the colourless solution was reduced to -1 ml by rotary evaporation. 
Addition of acetonitrile (20 ml) to the concentrated solution afforded a colourless solid, 
collected by filtration, washed with CH 3CN, (20 ml) Et20, (20m1) and dried under vacuum to 
yield the title compound, {YNBA.H 20] (0.326 g, 83%). FAB-MS: [M+1] 666 D. CHN: 
Calculated for YC 28H46N50 10: 47.92% C; 6.62% H; 9.98% N. Found: 47.76%C; 6.76% H; 
9.61% N. 
2.5.5.6 (1, 11 -(bis(methylenecyclohexylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl) u ndecane} yttrium (III) hydrate: 
[YmcyHA.H20]1 .5H20 
YCI3.6H20 (0.327 g, 1.08 mmol) was dissolved in 2 ml H 20 and solid DTPA-mcyHA 
(0.367 g, 1.09 mmol) added. The mixture was diluted with MeOH/H 20 then 
heatedlsonificated until all of the ligand had dissolved (pH 1) before dropwise addition of 
TBAOH (0.5M H20/MeOH) until pH - 6 was reached. The volume of the colourless 
solution was reduced to lml by rotary evaporation. Addition of CH 3CN (50 ml) afforded a 
colourless solid, which was collected by filtration, washed with CH 3CN (50 ml) and diethyl 
ether (50 ml) and dried under vacuum to yield the title compound, [YmcyHA.H 20] (0.587 g, 
79%). FAB-MS: [M+1] 670 D. 'H NMR (250 MHz, D 20): S (ppm) 3.5-2.46 (22H, m, 
NCJjCNCCN, NCCO2 , NCJjCO, NHCthCH); 1.73-0.86 (22H, m, 
NCH2CHC 5H, 0). ' 3C NMR (63 MHz): 180.8, 180.4, 180.1, 180.0, 179.8 (Q02); 175.9, 
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175.6, 174.6, 174.5 (QONH); 66.1, 62.7, 61.2 (NCH2CON; NCH2CO2 ); 58.1, 55.9 
(NCH2CH2NCH2CH2N); 46.1, 46.0 (NCH 2C6H 11 ); 37.3, 37.0, 36.9 (NCH 2CHC5H 0); 30.2, 
30.0, 25.8, 25.4, 25.3 (NCH2CHC51j10). CHN: Calculated for YC 28F151 N50105 : 47.04% C; 
7.21% H; 9.80% N. Found: 46.82% C; 6.90% H; 9.68% N. 
2.5.5.7 {1, 11 -(bis(cyclohexylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9- 
triscarboxymethyl)u ndecane} yttrium (Ill) hydrate [YcyHA.H 201 
Anhydrous YC13, (0.207 g, 1 .O6mmol) was dissolved in 10 ml H 20 and DTPA-cyHA 
(0.5 90 g, 1.06 mmol) added. The suspension was heatedlsonificated until all the ligand had 
dissolved (pH 1), then filtered before addition of TBAOH (40% w/w H 20) until the 
colourless solution reached pH 5. The solvent was removed by rotary evaporation to a 
final volume of- lml. Addition of acetonitrile to the oily residue afforded a colourless solid 
that was collected by filtration, washed with CH 3CN (20 ml) and Et20 (20 ml) and dried 
under vacuum (0.561 g, 74%). Peaks corresponding to excess TBACI were observed in the 
proton NMR spectrum of the complex. This solid was dissolved in 10 ml methanol and the 
volume reduced to dryness by rotary evaporation. The residue was dissolved in MeOH (1 
ml) and the white solid that formed upon addition of acetonitrile was collected by filtration, 
washed and dried to yield the title complex, [YcyHA.H 20]. 'H NMR (400 MHz, D20): 
6 (ppm) 4.00-3.75 (2H, broad, NCJj); 3.75-3.32 (1011, m, NCthCO);  3.20-2.90 (4H, broad, 
); 2.90-2.80 (2H, broad); 2.7-2.45 (211, broad) (NCthCthNCthCthN);  1.97-1.85, 1.85-1.72, 
171-1.62 (4H, 4H, 2H, broad, cyhex); 1.48-1.18 (1 OH, broad, cyhexjj). 
2.5.6 Gadolinium (Ill) DTPA-bis(amide) Complexes 
2.5.6.1 {1, 11 -(bis(1 -butylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane} gadolinium (Ill) monohydrate: 
[GdBUA.H20] 
The ligand, DTPA-BUA.2H 20 (0.260 g, 0.482 mmol) and the metal salt, GdCI 396H20 
(0.179 g, 0.482 mmol) were combined in aqueous solution, sonificated and heated until the 
solid had dissolved (pH - 1). Aqueous TBAOH (40% w/w H 20) was added dropwise until 
the colourless solution reached pH 5 then the volume reduced to - lml by rotary 
evaporation. The colourless precipitate that formed upon addition of acetonitrile to the 
concentrated solution was collected by filtration, washed with CH 3CN (20 ml) and Et20 (10 
ml) then dried under vacuum to yield the title compound, [GdBUA.11 20] (0.294 g, 90%). 
ES-MS (-): [M] 655.2, 657.2, 659.2 (characteristic Gd(III) isotopic pattern). [M+C]] 693.2. 
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CHN: Calculated for Gd(HI)C 22H40N509: 39.01% C; 5.98% H; 10.36% N. Found: 38.94% 
C; 5.93% H; 10.42% N. 
2.5.6.2 (1, 11 -(bis(benzyllamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9-
triscarboxymethyl)undecane} gadolium (Ill) trihydrate: 
[GdBBZA.H20]2H20 
The ligand, DTPA-BBZA.2H 20, (0.297 g, 0490 mrnol) and the metal salt, GdCl 306H20 
(0.182 g, 0.490 mmol) were combined in aqueous solution, the mixture then diluted with 
water and heated/sonificated until all solid had dissolved (pH 1). Aqueous TBAOH (40% 
w/w H20) was added dropwise until the colourless solution reached pH 
5 before reducing the volume to lml by rotary evaporation. Addition of acetonitrile (20 
ml) to the concentrated solution afforded a colourless precipitate that was collected by 
filtration, washed with CH 3N (20 ml) and Et20 (20 ml) then dried under vacuum to yield the 
title compound, [GdBBZA.H 20] (0.349 g, 96%). ES-MS: (-) [M] 722.1, 723.1, 725.1, 
727.1 (characteristic Gd(III) isotope pattern. CHN: Calculated for Gd(HI)C 28H42N5011 : 
42.15% C; 5.31% H; 8.78% N. Found: 42.03% C; 5.14% H; 8.35% N. 
2.5.7 Lutetium (Ill) DTPA-bis(amide) Complexes 
2.5.7.1 {1, 11 -(bis(ethylamino)-1, 11 -dioxo-3,6,9-triaza-3,6,9- 
triscarboxymethyl) u ndecane} lutetium (Ill) hydrate (LuBEA. H 20] 
The metal, LuC1396H20 (0.069 g, 0.18 mmol) was dissolved in 2 ml water and combined 
with the solid ligand, DTPA-BEA.2H 20 (0.089 g, 0.18 mmol). The mixture was diluted 
with water (20 ml) then heated and sonificated until all the ligand had dissolved. TBAOH 
(40% w/w H 20) was added dropwise until pH 5 was reached. The volume of the 
colourless solution was reduced by rotary evaporation to - lml before addition of 
acetonitrile to the oily residue. The colourless precipitate was collected by filtration, washed 
with CH3CN and Et20 then dried under vacuum to yield the title compound, [LuBEA.H 20]. 
'H NMR (400 MHz, D 20): 6 (ppm) 3.79-3.15 (14H, in NCjCO 2 , NCthCONHCCH3 ); 
2.88, 2.65, 2.44 (4H; 2H; 2H; 3 x broad m, NCjCjj2N); 1.01 (611, m, NCH 2Cth). ' 3C 
NMR (100 MHz, D20): 6 (ppm) 181.6, 181.1, 180.6, 180.4 (ç02); 176.3, 175.0 (QONH); 
66.6, 66.4, 63.2, 61.5, 61.2, 61.0 (NCH 2CO); 58.9, 58.8, 56.3, 56.2 (NCH2CH2NCHH2N); 
35.7, 35.3 (NCH2); 13.6, 13.5 (NCI-1 2CH3 ). 
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2.6 Ternary Complex Formation 
2.6.1 General Procedure 
The mixed ligand [LnNAL.LHC] complexes were formed upon combination of the LnNAL 
chelate and deprotonated aryl acid in aqueous solution. Chelate solutions (0.1 mM aq) were 
prepared by dissolution of the isolated complexes (2.4) in deionised water. The aryl acid 
LHCs (0.01 mmol) were initially dissolved in DMSO (1 ml) forming stock solutions (0.01 
M) which were diluted and deprotonated as required. The acid solution (100 p1, 1 XI O,6 mol) 
was diluted with deionised water (100 p.1) and the pH raised upon addition of NaOH (7.5 p1, 
0.1 M) to pH 7-8. Where the LHC compound was supplied as the HC1 salt, contained a 
phenol OH or more than one carboxylate group additional base was charged accordingly. 
2.6.2 Combinatorial Screening 
Ternary complex formation was performed in black, flat-bottomed NUNC96 microplates. 
Aqueous chelate solution (0.1mM aq) was dispensed in 100p.l aliquots (1 x10 8 mol) into 
each well by auto-pipette. Addition of one molar equivalent of each acid (5mM, 50% v/v 
H20IDMSO pH - 7) resulted in a unique LnNALILHC combination in each well. Resultant 
solutions were mixed by aeration with the pipette. The sample luminescence (612 ± 10 nm) 
following UV excitation (275 ± 10 nm) was detected using a Tecan Ultra Multifunctional 
plate reader, as detailed in section 2.3. A 20 p.s lag time was implemented between the 
excitation flash and detection of the metal emission allowing decay of background organic 
fluorescence. The signal was detected over a 40 p.s integration time and data recorded using 
Xfluor software. The relative emission intensity (Il1 3) was calculated as the ratio of ternary 
complex luminescence (I) to that of the LnNAL complex (1 o). Results from the three 
iterations of the assay were combined in an MS-Excel spreadsheet (Appendix 2) 
incorporating both the raw luminescence data and the calculated relative emission intensities 
for each acidlchelate combination. Analysis of the data following grouping of the acids into 
clusters of related compounds allows electronic and structural similarities to be identified 
and correlated with features common to active or inactive species. Due to the large volume 
of data generated only the more interesting observations are discussed. 
2.6.3 Binding Studies - Steady State Luminescence 
The LnNAL solution (2 ml, 0.1 mM aq) was titrated with LHC solution (5 mM, 1:1 v/v 
DMSOIH20, pH 7-8) in 0.1 molar equivalent aliquots. Emission and excitation spectra were 
measured as detailed in 2.3. The increase in sensitised metal emission upon excitation of the 
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LHC is plotted versus aromatic acid concentration and the data fitted to a 1:1 binding model 
by non-linear least squares analysis using Kaleidagraph software. 
The observed emission intensity, I, is the weighted average of luminescence from 
the emissive EuNAL and ternary complex species in solution (Equation 2-1). 
Jobs = [EuNAL]o— IEUNAL.LHC1'IEUNAL + FEUNAL.LHC1•I EUNALLHC  
[EuNAL] o 	 [EuNAL]o 
Jobs[EUNAL]0 = ([EuNAL]o - [EUNAL.LHC])OIE UNAL + [EUNAL.LHC]eIE UNALLHC 
Jobs[EuNALIO = IEAL•[EuNAL]o - IEUNAL•[EUNAL.LHC] + IEUNALLHCS[EUNAL.LHC] 
10b5[EUNAL]O = IEUNAL•[EUNALIO + [EuNAL.LHC] •(IEUNAL.LHC - 'EUNAL) 
'obs = 'EuNAL + {EUNAL.LHC1•(IEUNALLHC - 'EUNAL) 
[EuNAL]o 
'obs = 'EuNAL + [EuNAL.LHC1.AJo 
[EuNAL] o 	 Equation 2-1 
AI 0 is the maximum change in emission intensity observed at complex saturation 
equilibrium, [EuNAL] o is the total chelate concentration and [EuNAL.LHC] the 
concentration of ternary complex in solution, obtained by solving the mass balance equations 
(Table 2-3) for the equilibrium under investigation (Equation 2-2). 
K 




[EuNAL.LHC] = K[EuNAL][LHC] 	 Equation 2-2 
Species Mass Balance Equation 
EuNAL [EuNAL] = [EuNAL] o -[EuNAL.LHC] 
LHC [LHC] = [LHC] 0 - [EuNAL.LHC] 
EuNAL.LHC [EuNAL.LHC] = [EuNAL.LHC] o + [EuNAL.LHC] 
Table 2-3 Mass balance equations for the formation of the 1: I complex with EuNAL and 
LHC (Equation 2-2) 
66 Synthesis and Characterisation 
Experimental 
Substituting the mass balance equations into Equation 2-2 and solving the quadratic for 
[EuNAL.LHC] we obtain Equation 2-3 which in turn is substituted into Equation 2-1. 
[EuNAL.LHC] = ([EuNAL] 0 + [LHC]0 ± I/K) - {([EuNAL] 0 + [LHC]0 + I/K)2 -4[EuNAL] 0[LHC] 0 12 
2 
Equation 2-3 
For the curve fit, the change in luminescence intensity (Lb, - lo) is plotted versus the total 
LHC concentration and Equation 2-4 employed in the method of non-linear least squares 
analysis. AInx 
I - = 	. [EuNAL.LHC] 	 Equation 2-4 
[EuNAL] 0 
2.6.4 Time Resolved Luminescence Spectroscopy 
The luminescence lifetimes of the chelates and ternary complexes (formed upon combination 
of the aqueous LnNAL solution with the deprotonated LHC solution as 2.5. 1) were measured 
in aqueous or D20 solutions (102 - 10' M) upon excitation at 532, 355 or 266 nm (chapter 
2.2). Luminescence decay was measured at 616 nm (5D0 -+ 7F2 transition) and at 545 nm 
(5D4 -+ F5 transition) for europium and terbium respectively. The luminescence decay 
curves were fitted to mono or biexponential equations (Equations 2.5 and 2.6) using 
Kaleidagraph software. 
I = 	-I0exp(-kt) 
Equation 2-5 Monoexponential decay equation. I = luminescence intensity at time t (secs), I, = 
background correction factor for the oscilloscope, k = decay constant (s'). Lifetime t = 0 (sec) 
I = 	-[I 1)exp(-k(1)t(1) ) + IO(2)exp(-k(2) t(2) )] 
Equation 2-6 Biexponential decay equation 
2.6.5 Ternary Complex NMR Studies 
The mixed ligand species were formed upon combination of the diamagnetic LnNAL 
analogues (Ln = La(III) and Y(III)) with deprotonated picolinic acid in equimolar quantities. 
The isolated chelate (2.4) (= 40 mg) was dissolved in 0.5 ml D20 (pD 6-7) forming a 
colourless solution to which one molar equivalent of PCA (D 20/NaOD, pD 7-8) was added. 
The pD of the resultant solution (pD 4-5) was adjusted to around 7 with D 20/NaOD. 
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2.7 Heterobimetallic Luminescent Polymers 
2.7.1.1 [EuNa(pca) 4(H20)]O.5nH20 
Picolinic acid (0.62 g, 5 mmol) was dissolved in 3 ml H20 and 1M NaOH (aq) added until 
the pH of the solution reached a value of 7-8. Addition of EuC1 306H20 (0.185 g, 0.5 mmol) 
in - 2 ml H20 afforded a colourless solution (pH 2) after mixing. The solution was 
neutralised with NaOH upon which a colourless microcrystalline solid began to form. This 
solid was collected by filtration and washed with water and acetone. A substantial amount 
of the solid dissolved in the water and the filtrate was concentrated under reduced pressure 
inducing precipitation of the polymer. Recrystallisation of the solid by vapour diffusion with 
acetone, acetonitrile or methanol also afforded single crystals suitable for structural analysis. 
Elemental analysis: Calculated for EuNaC 24H23N40115 : 39.67% C; 3.19% N; 7.71% N. 
Found: 39.75% C; 2.63% H; 7.48% N. (crystal - sample losing weight). ES-MS (+): 
[M+Na] 684/686 D; ES-MS (-) [M] - 639/641D. 
The polymer, [EuNa(pca) 4(H20)]0.5nH20, could also obtained from solutions containing 
both EuNAL species and picolinic acid. The NAL was dissolved in H 20fNaOH forming a 
concentrated colourless solution (pH 7-8) before combination with one equivalent of 
EuCI36H20, also dissolved in water, to give a colourless solution at pH 2. Aqueous NaOH 
(IM) was added dropwise until the solution reached pH 7-8 before addition of 10 x excess of 
picolinic acid (pH 7-8, aqfNaOH). Slow evaporation of the solution resulted in the 
formation of hexagonal colourless crystals of suitable quality for X-ray diffraction. The 
crystals exhibited strong red characteristic Eu(III) emission upon exposure to UV light. 
Formula: [EuNa(pca) 4(H20)10.5nH20 	Unit Cell 
FW 	699.39 	 a"12.5718(17)A 	a=90° 
Wavelength 	1.54178A 	 b=12.5718(17)A 
T 	 220(2) K 	 c = 60.364(19) A 
Hexagonal crystal system 	 Y = 120° 
Space group P6(5)22 
Crystal Data: in = 16.999 mm- ' final R = 7.67% [based on Fand 2195 data with F54s(F)], 
wR2 = 16.50 % (based on F2 and all 3726 unique data used in refinement) for 366 
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parameters. The structure was solved by Patterson methods (DIRDIF) and refined by full 
matrix least squares on SHELLXL-97). 157 
2.7.1.2 [TbNà(pca)4(H20)]O.5nH20 
A concentrated aqueous solution of picolinic acid (0.54 g, 4.4 mmol) was neutralised with 
NaOH (1 M aq) before mixing with ThC1 396H20 (0.174 g, 0.47 mmol) in imi water (pH 2). 
Addition of 1M NaOH resulted in the evolution of a fine white precipitate that redissolved 
immediately upon mixing. After. approximately 5 minutes a microcrystalline solid 
precipitated from the solution and was collected by filtration, washed with methanol and 
ether then dried under vacuum to yield the hetrobimetallic luminescent polymer, 
[ThNa(pca)4H20]0.5nH20. Elemental analysis: Calculated for ThNaC 241121 N4010 . 5 
(724.39): 40.29% C; 2.96% H; 7.83% N. Found: 40.18% C; 2.615% H; 7.59% N. ES-MS 
[MH] 648 D. 
2.7.1.3 [GdNa(pca)4(H20)]0.5nH20 
A solution of picolinic acid (0.615 g, 5 mmol) in H 20/NaOH (pH 7-8) was combined with 
GdCl3.6H20 (0.180 g, 0.48 mmol) in 1 ml H 20. The resultant solution, (pH 2) was 
neutralised with 1 M NaOH and refrigerated overnight but no precipitate was observed in the 
flask. Addition of excess base until the pH reached approximately 8 afforded the expected 
microcrystalline solid, which was collected by filtration, washed with water (5 ml), acetone 
(5 ml) and ether (2 x lOmi) then dried under vacuum. A few large, colourless hexagonal 
crystals, suitable for x-ray structural analysis formed in the pasteur pipette used in 
preparation of the solid and were found to be isostructural with the Eu(III) polymer. ES-MS 
643, 644, 645, 646, 648 [M] (characteristic Gd(III) isotope distribution pattern). ES-MS 
(+): 689, 690, 691, 694 [M+Na]. 
X-ray powder diffraction was performed on the bulk microcrystalline samples of the Eu(III), 
Th(III) and Gd(III) polymers. The diffraction pattern obtained was the same for each 
lanthanide, indicating the same unit cell for the three polymers. The pattern also matched 
that generated from the {EuNa(pca) 4(H20)]0.5nH 20 single crystal data, confirmation that 
the bulk samples are isostructural with the single crystals obtained. 
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2.7.1.4 (YNa(pca)4(H20)10.5n H20 
Mixing aqueous solutions of YCI 3.61­120 and picolinic acid at pH 7-8 did not afford a 
microcrystalline solid as observed with Eu(Ill), Th(III) and Gd(III). Instead, large, well 
defined, colourless, hexagonal crystals formed overnight. X-ray analysis revealed the 
compound to be isostructural with the Eu(III) and Gd(III) polymers. Elemental analysis: 
Calculated for Y(IH)NaC 24H21 N40105 : 44.66% C; 3.28% H; 8.68% N. Found: 44.59% C; 
3.28% H; 8.69% N. 
2.7.1.5 (NaLa(pca) 4(H20)]0.5nH20 
The La(III) analogue was prepared in the same way as the other Ln(III) polymers and 
characterised by elemental analysis only as the species was found to be insoluble. 
Calculated for La(III)NaC 24H20N40 10: 42.00% C; 2.94% H; 8.16% N. Found: 41.77% C; 
2.66% H; 8.11% N. 
2.7.1.6 [NH4Eu (PCA)4H201 
Picolinic acid (0.157 g, 1.28 mmol) dissolved in imI H 20 and concentrated NH 3 (38% w/w 
H20) added until pH 7 was reached. This solution was then combined with aqueous 
EuCI 3'6H20 (0.060 g, 0.164 mmol) and the pH adjusted to around 7 with conc. N11 3 . A 
colourless, microcrystalline solid quickly formed and was collected by filtration, washed 
with water (2 ml), ethanol (5 ml) and diethyl ether (5 ml) to yield the title compound, 
[NH4Eu (PCA)4H201 (0.057 g, 52%). Large, colourless, well-defined hexagonal crystals of 
suitable quality for X-ray diffraction were obtained upon slow evaporation of the filtrate. 
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3 The Ternary Complex Model System 
Several DTPA-bis(amide) (DTPA-AM 2) ligands have been prepared from DTPA-
dianhydride and are reported in the literature. 117-121, 130-137 Forming highly stable, water 
soluble, neutral chelates with the lanthanide trivalent cations, these ligands are inexpensive 
and avoid the synthetic complications associated with macrocyclic crown ethers and 
cryptands. Neutral Ln(III) chelates are more "biologically compatible" than charged species 
such as the anionic [LnDTPA] 2 complex which can become implicated in membrane 
transport mechanisms. DTPA-bis(ethylamide) (BEA) was chosen as a ligand on the basis 
of the well documented gadolinium complex formation, studied as a contrast agent for MRI. 
The gadolinium complex, [GdBEA92H 20] was prepared initially by Konings et al' 17 
in 1991. The X-ray crystal structure provides confirmation that octadentate chelation occurs 
via the three nitrogen atoms of the diethylenetriamine backbone, the three carboxylate 
groups and two amide carbonyls of the ligand (Figure 3-1). The amide arms do not 
coordinate the metal and form a binding pocket, occupied by one remaining water molecule, 
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Figure 3-1 Eu(JII)DTPA-AM2 structure 
3.1 LnBEA complex formation 
The formation of the neutral 1:1 complex between Eu(III) and DTPA-BEA in aqueous 
solution was studied by luminescence spectroscopy. The binding curve was obtained by 
integration of the corrected emission spectra (Figure 3-2) for the main Eu(Ill) peaks between 
572 and 640 mm The weak emission from the free Eu(H1) ion in water is increased upon 
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incremental addition of the ligand. Upon ligand binding parity forbidden f—*f electronic 
transitions become more allowed, as the symmetry of the spherical ion is reduced and 
quenching water molecules are excluded from the primary coordination sphere. Plotting the 
relative emission intensity (I/Is) versus the mole ratio of ligand to metal provides a measure 
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Figure 3-2 Corrected Eu(ffl) emission spectra (? ex = 394 mn) for 
titration of the metal (1.5 x lO M aq) with DTPA-BEA (pH 7). 
Titration of an aqueous solution of EuC1 3 (pH 6) with DTPA-BEA (pH - 7) yields 
the 1:1 complex, EuBEA, as illustrated by the plateau observed in the emission plot (Figure 
3-3) above one equivalent of ligand, indicating saturation of the metal coordination sphere. 
The sharp inflection at 1:1 stoichiometry is evidence of the strong binding interaction. 
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Figure 3-3 Eu(1II) emission titration with DTPA-BEA 
The 1:1 complex, EuBEA, is also detected in solution by positive and negative electrospray 
mass spectrometry. Characteristic europium peaks appear in both spectra: ES(+) [MI-I] 
596/598 D; [M+Na] 1 618/610 D. ES(-) [M-H] 594/596 D; [M+C1] 630/632 D. 
Formation of the diamagnetic La(Ill) analogue was studied by 'H NMR spectroscopy in 
accordance with the Eu(III) luminescence studies. The broad, unresolved chelate spectra 
differ considerably from that of the free ligand. The AB system of the diethylenetriamine 
methylene protons in the ligand spectrum is broadened and shifted to lower frequency upon 
chelation to the metal. The quartet signal of the methylene protons of the amide arms is 
unchanged upon complexation. This observation correlates with the crystallographic 
evidence indicating that the amide nitrogen atoms are not involved in coordination. The 
NMR behaviour of LnDTPA-AM 2 complexes has been thoroughly investigated and is well 
documented in the literature'17' 119, 124, 126-128, 130, 134, 136 as the chelates are frequently employed 
as contrast agents in MRI. Our studies are in agreement with the literature spectra and were 
undertaken to investigate the selective molecular recognition involved in ternary complex 
formation. 
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3.2 Ternary Complex Formation - Luminescence Studies 
Several simple aromatic acids were studied with regard to their binding to the neutral 
EuBEA chelate. Benzoic (BZA), phthalic (PTA), isophthalic (IsoPTA), picolinic (PCA) and 
dipicolinic (diPCA) acids (Figure 34) were chosen to represent a variety of mono and 
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Figure 34 Structures of aromatic acid LHCs 
The controlled formation of mixed ligand europium complexes with EuBEA and these aryl 
acid LHCs in aqueous solution was investigated by luminescence spectroscopy. Increasing 
europium luminescence upon incremental addition of the deprotonated acid to the EuNAL 
was monitored upon excitation of the aromatic moiety at 270 am. Emission plots obtained 
upon integration of the Eu(III) spectra (572-640 run) allow the stoichiometry of the mixed 
ligand species to be determined. 
Acid pKa (M'cm') X (nm) 
BZA 4.19 2930 273 
PTA 2.89, 5.51 3200 280 
IsoPTA 3.54, 4.60 - - 
PCA 5.52 3830 264 
diPCA 1.9,5.9 - - 
Table 3-1 Aromatic acid pKa values and molar extinction coefficients 
(Ref: See CRC Handbook of Organic Photochemistry, Scaiano. J. C. 1989) 
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3.2.1 Benzoic Acid Binding 
The emission plot (Figure 3-5) shows that benzoic acid (BZA) binds the EuNAL in a 
monodentate manner. Two equivalents of LHC are required to saturate the metal 
coordination sphere, as shown by the plateau observed in the binding curve. A ten-
coordinate ternary luminescent complex is formed. The 2.5 fold enhancement in emission 
intensity is relatively low due to the poor light harvesting properties of the acid and the weak 
nature of the binding interaction. BZA recognition of the EuBEA binding cavity is not well 
defined, as indicated by the shallow gradient of the binding curve. The characteristic 
absorption of BZA around 270 nm is observed in the excitation spectrum and provides 
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Figure 3-5 Relative emission intensity versus mole ratio for titration of EUBEA (1.5 x10M 
(aq), pH 7) with benzoic acid LHC (2.ex = 270 nm) 
3.2.2 Phthaiic Acid Binding 
The binding interaction between EuBEA and bidentate phthalic acid (PTA) is much stronger 
than the corresponding interaction with monodentate BZA. Phthalate is able to form a seven 
membered chelate ring, whereas benzoate cannot, requiring only one molar equivalent to 
saturate the Eu(III) coordination sphere (Figure 3-6). The eight-fold increase in 
luminescence can be attributed to sensitised emission upon excitation of the acid (X 280 
nm, c = 3200 M 1cm') confirmed by the characteristic absorption of PTA observed in the 
excitation spectrum (Figure 3-7). 
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Figure 3-6 Relative emission intensity versus mole ratio for titration of EuBEA (1.5 x 10 AM) with 
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Figure 3-7 Excitation spectrum of [EuBEA.PTA]. uncorrected for lamp response 
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3.2.3 Picolinic Acid Binding 
Picolinic acid (PCA, pyridine-2-carboxylic acid) was chosen as a light-harvesting centre on 
the basis of its bidentate binding unit, allowing comparison with the dicarboxylate unit of 
PTA. PCA is capable of bidentate coordination with the EuNAL involving the carboxylate 
anion and the heteroatom of the pyridine ring. The acid is observed to recognise the binding 
cavity of EuBEA forming a ternary luminescent complex in 1:1 stoichiometry as expected. 
Molecular recognition was followed by luminescence spectroscopy. Intramolecular energy 
transfer leading to sensitised Eu(III) emission is confirmed by the characteristic PCA 
absorbance around 270 nm observed in the excitation spectrum of the sample (Figure 3-9). 
The bidentate interaction between PCA and EuBEA yields a ten coordinate luminescent 
mixed ligand species. The interaction is strong, reflected by the steep gradient of the 
emission plot (Figure 3-8). The plateau above one equivalent of PCA, indicative of complex 
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Figure 3-8 Relative emission intensity versus mole ratio for titration of EuBEA (1. 5xl0M) 
with picolinic acid LHC (2.ex = 270 mn) 
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Figure 3-9 Excitation spectrum of [EUBEA.PCAF (X em 616 nm), uncorrected for lamp response 
In stark contrast to the well defined stoichiometry of mixed ligand complexes formed upon 
molecular recognition between EuBEA and BZA, PTA and PCA, isophthalic and dipicolinic 
acids exhibit quite different binding characteristics as discussed below. 
3.2.4 lsophthalic Acid Binding 
Isophthalic acid was chosen on the basis of its potential bidentate binding unit and light 
harvesting characteristics. Containing the same chromophore as both phthalate and benzoate 
it allows direct comparison of binding modes. Bidentate chelation of EuBEA by IsoPTA is 
prevented by the steric constraints enforced by the meta positioning of the carboxylate ring 
substituents. Consequently, monodentate binding is expected, as observed with BZA. 
Formation of the ternar complex is followed by luminescence spectroscopy. Emission of 
the solution is monitored upon excitation of the aromatic moiety at 270 rim. Sensitised 
Eu(III) emission is confirmed by the presence of a characteristic aromatic absorbance around 
280 nm in the excitation spectrum (Figure 3-11). 
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Figure 3-10 Relative emission intensity versus mole ratio for titration of EuBEA (1.5x10M) 
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Figure 3-11 Excitation spectra of [EuBEA.Is0PTA] in aqueous solution at 
1:1 and 1:2 stoichiometr (X em = 616 nm). uncorrected for lamp response 
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The binding of EuBEA by isophthalic acid is clearly different from that of PTA, as 
illustrated by the emission plot (Figure 3-10). Stoichiometry of the mixed ligand species is 
not well defined, and saturation of the coordination sphere is not achieved upon titration of 
EuBEA with the acid. The steeper gradient of the binding plot, and the greater relative 
emission intensity observed upon recognition of the acid, suggests that the interaction 
between this LHC and EUNAL is stronger than that of phthalic acid. At experimental pH 
both carboxylate residues are deprotonated but only one can coordinate the metal. 
It has been shown 47 that electronic resonance effects from the meta carboxylate increase the 
stability of the monodentate binding interaction with the metal. This can contribute to the 
strong increase in emission intensity observed. The absence of a plateau in the emission plot 
indicates the likelihood of metal coordination by more than one isophthalic acid LHC unit. 
Multinuclear complex formation may occur in solution, with each isophthalate acting as a 
bridging ligand between discrete EuNAL complexes. 
3.2.5 Dipicolinic Acid Binding 
Dipicolinic acid was selected as a light harvesting centre based on its potential for terdentate 
interaction with the metal. Formation of intensely luminescent Ln(llI) complexes with 
dipicolinic acid are well documented in the literature, in general exhibiting approximately 
1:3 stoichiometry. Molecular recognition between EuBEA and diPCA was followed by 
luminescence spectroscopy. Intense europium emission was observed and sample dilution 
required in order to prevent detector saturation. No plateau was observed in the binding plot 
(Figure 3-12), in contrast to the well defined interaction between EuBEA and PCA (Figure 
3-8). 
It is possible that diPCA is able to extract the metal from the highly stable EuNAL chelate, 
(Log K 15). Formation constants for the interaction between Ln(III) and diPCA are 
repoited" (Log K 1 8.83; Log K2 15.98; Log K3 21.00). We conclude that the bis(ortho) 
positioning of the acid residues prevents the acid from fulfilling its terdentate binding 
potential and facilitates formation of multinuclear species in solution as observed with 
isophthalic acid. No further studies were undertaken with this acid. 
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Figure 3-12 Relative emission intensity versus mole ratio for titration of EUBEA (1.5x10 'M) 
with dipicolinic acid LHC (2.ex = 270 urn) 
3.3 Ternaiy Complex Formation - Electrospray Mass Spectrometry 
Additional evidence for mixed ligand complex formation between these simple aryl acid 
LHCs and the EuDTPA-AM 2 NAL species is provided by electrospray mass spectrometry. 
Peaks corresponding to sodium adducts of the anionic ternary species are detected in the 
positive ES-MS and the mixed ligand complex [EuBEA.PCA] is observed by negative ion 
mass spectrometry (Table 3-2). 
Acid Peak (m/z) Assignment 
BZA 7621764 [(EuBEA.BZA) + 2Na1 
784/786 [(EuBEA.BZA) - 	+ 3Na1 
906/908 [(EuBEA.BZA2)2 + 3Na] 
PTA 82/830 [(EuBEA.PTA)2  + 3Na1 
PCA 763/765 [(EuBEA.PCA) + 2Na1 
717/719 fEuBEA.PCAJ 
Tab1 3-2 ElQctrospray mass spectrometry of ternary luminescent complexes in aqueous solution 
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3.4 Ternary Complex Formation - 1H NMR Studies 
Additional evidence supporting mixed ligand complex formation in aqueous solution 
between EuBEA and PCA is obtained form 'H NMR studies performed on the analogous 
diamagnetic La(HI) system. The complex is formed in an NMR tube upon addition of one 
equivalent of deprotonated PCA (pD 7-8) to a preformed solution of LaBEA (pD 7-8) in 
D2OINaOD. 
Comparison of the ternary complex spectra, [LaBEA.PCA], with that of LaBEA at 
the corresponding pD shows significant sharpening of the resonances upon PCA recognition. 
The LaBEA regions of the spectra are shown below in Figure 3-9. The spectra are 
complicated due to the observation of geminal coupling between the methylene protons of 
the ligand diethylenetriamine backbone, as observed by correlation spectroscopy (COSY). 
The unresolved nature of the spectra is due to line broadening effects induced by the metal 
ion. The sharpening of the resonances upon addition of PCA is attributed to recognition of 
the LaNAL binding pocket causing a conformational locking effect. It has been shown that 
LnDTPA-AM2 complexes exist in solution as eight diasteriomeric pairs in fast exchange. 121, 
130, 134, 136 The rotational isomerism of the tricapped trigonal 'prismatic coordination 
polyhedron of LaBEA is restricted upon interaction with picolinic acid, and the resonances 
of the diethylenetriamine backbone become more clearly defined. This observation provides 
further evidence for molecular recognition between the NAL complex and LHC in aqueous 
solution. Further NMR investigations with into the ternary complex formation with 
Yb(Ill)BEA are underway, in collaboration with Vincent Jaques at the University of Liege in 
Belgium. 
These results indicate that DTPA-AM 2 ligands can be successfully employed as NALs in the 
controlled formation of mixed ligand luminescent species with a variety of simple aromatic 
carboxylic acid LHCs. Following the success of these initial investigations we were keen to 
evaluate the influence of the amide arms of the ligand on the binding interaction. A library 
of several DTPA-AM2 derivatives was prepared in order to introduce structural and 
electronic diversity to the LnNAL chelate binding pocket. Synthetic methods are discussed 
in Chapter 4. Molecular recognition between these chelates and the simple but effective 
LHC, picolimc acid, was investigated by several spectroscopic techniques. Combinatorial 
screening technologies were then employed in evaluating the binding interaction with a 
library of aromatic carboxylic acids designed to introduce molecular diversity and allow 
identification of potential LHC units. Results of the screening experiment are considered in 
Chapter 5 and observations made from further binding studies discussed in Chapter 6. 
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4 Comments on Synthetic Methods 
4.1 Ligand Synthesis 
Preparation of the DTPA-AM 2 derivatives was performed following the procedure developed 
by Konings et al." 7 ' 19 The DTPA-AM2 species was formed by reaction of the cyclic 
anhydride of DTPA with excess amine (Scheme 2-1). Acidification of the reaction mixture 
to pH -P2 following dilution with water initiated crystallisation/precipitation of the ligand. 
Below pH - 2 protonation of the amide nitrogen atoms occurs disrupting the H-bonding 
network (Figure 4-1) between the carboxylate functional groups and the tertiary amine N of 
the diethylenetriamine backbone facilitating dissolution of the ligand. 
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Figure 4-1 H-bonding network established upon second protonation event in 
DTPA-AM2 ligands 
Preparation of the higher alkyl and aryl DTPA-AM 2 ligands (cyHA, mcyHA, PYA and 
cyOA) was attempted in isopropanol due to the hydrophobicity of the amines employed. 
The reaction between the dianhydride and amine occurred forming the desired DTPA-AM 2 
product (NMR, MS) but problems were encountered in purification of the ligand due to the 
association between the excess amine and the carboxylate groups. Crystallisation could not 
be induced upon acidification with HC1. Trituration of the mixture with an organic solvent 119 
such as acetonitrile or acetone was required to precipitate the compound. Recrystallisation 
of the solid was attempted from water, water/acetone or water/ethanol mixtures but proved to 
be an inefficient method of removing the excess amine. It was found that these higher alkyl 
and aryl DTPA-AM2 ligands could be successfully formed in water, DMF or pyridine and 
isolated by aqueous acidic work up (2.3.2.13, DTPA-BTA). 
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Several attempts were made to prepare the pyridine derivative, DTPA-PYA (Chapter 2.3.2, 
Figure 4-2). This heterocyclic ligand was chosen to enable investigation of H-bonding 
effects on molecular recognition. 
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Figure 4-2 Pyridine DTPA-AM2 derivative, DTPA-PYA 
The reaction between 4-picolylamine and DTPA-dianhydride at 60°C in pyridine resulted in 
formation of penta-, tetra-, tris-, bis- and mono amide products (FAB-MS), none of which 
were isolated. At lower temperatures and lesser excess of amine the desired bis-amide 
product could be obtained (solvents attempted: propan-2-ol, water, pyridine, DMF). The 
acidic aqueous work-up followed in the synthesis of aliphatic and aromatic DTPA-AM 2 
species (Chapter 2) was unsuccessful in this case due to the presence of the heterocyclic N 
atom (J)Ka -5). Protonation of this residue is expected to occur prior to protonation of the 
second carboxylate (pH 4.6) increasing the solubility of the ligand in aqueous media. Any 
solid obtained from the reaction by trituration with an organic solvent was extremely 
hygroscopic. 131  Problems were also encountered in removal of the excess amine, which 
associated with the carboxylates forming RNIU 3 CO2-  salts. Removal of the excess amine 
could be achieved using an aldehyde scavenger resin 92,97 to form an imine supported on the 
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Figure 4-3 Use of a scavenger resin to remove excess amine from the reaction mixture 
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The principle was applied to the solution phase reaction, employing benzaldehyde as the 
scavenger (Figure 4-4) and extracting the imine into chloroform. No free amine 1H 
resonances were observed in the NMR spectrum of the product (Figure 4-5). 
HO2C__\/__\/__V_CO2H 
0 	IN IN IN 	0 	
L4 
HO2C 	 ,N—\ 	
HO2C 
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Py 	H 	 H 	Py H 	 H 	Py  
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)N 
Figure 4-4 Imine scavenging in the solution phase purification of DTPA-PYA 
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Figure 4-5 'H NMR spectrum of DTPA-PYA following treatment with beuzaldehyde scavenger 
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Whilst scavenging using an aldehyde reagent is an option with aromatic amines this is not 
the case when simple aliphatic primary amines are employed, due to the reduced stability of 
the product imine. Solid phase synthesis using inert resin supports was attempted offering a 
potential synthetic route to asymmetric DTPA-bis(amides) (Figure 4-6) (Scheme 2-3). Such 
methods are routinely applied in the generation of large compound libraries in drug 
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Figure 4-6 Schematic solid phase synthesis of asymmetric DTPA-AM2 ligands 
Conventional methods for attachment of metal (Ln 3  and radioisotope) DTPA chelates to 
biological molecules of interest proceeding via the dianhydride reagent are generally non-
specific and allow multiple labelling to occur. 683 
By forming asymmetric DTPA-bis(amide) ligands the potential to introduce such 
functional groups as amines, N-hydroxysuccinimide esters and isothiocyanates selectively to 
one arm of the ligand, specific functionalities within the biological molecule of interest can 
be targeted (e.g. -SH in cysteins, N=C=S + NH 2  of lysine etc) (Figure 4-7, Scheme 1-1). 
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Figure 4-7 Schematic labelling processes: L = label; P = protein; X= spacer unit 
The solid phase synthesis (Scheme 2-3, Figure 4-6) was initially performed using only one 
amine reagent in order to optimise reaction conditions. The amine (4-methylbenzylamifle) 
was loaded on to the resin using conventional solid phase methodology. 149  This was then 
reacted with an excess of DTPA-dianhydride in dry DMF forming the DTPA-mono(amide) 
on the solid support. Unreacted dianhydride was washed from the resin with DMF prior to 
addition of the second equivalent of amine. Careful rinsing of the resin was required 
following reaction of the amine to ensure removal of the excess reagent. This was achieved 
using EtOAc/AcOH to form the acetate salt of the amine. Any remaining acid was then 
removed as the ammonium salt upon washing with EtOAcINII 3. The resin was finally 
washed with DCM and MeOH to rinse off all excess reagents prior to cleavage of the 
product from the resin. Cleavage was performed using TFA (95): H20 (5) breaking the 
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secondary amide bond between the linker and product. NMR analysis (Figure 4-8) and 
LCMS confirmed the formation of DTPA-bis(tolylamide). 
LL 	 -1-M 
Figure 4-8 111  NMR spectrum of 1)TPA-BTA prepared using solid phase methodology 
Preparation of asymmetric DUPA-AM 2 ligands by this method was found to he unsuccessful. 
The major reaction product was the symmetrical amide formed during the first step of the 
reaction due to rapid coupling between the dianhydride and solid-supported amine. This 
rapid coupling was found to occur in both pyridine and 1)MF and in the presence of a large 
excess of DTPA-dianhydride reagent. The subsequent steps attempted with primary amines 
(1 -butylamine, cyclohexylamine, benzylamine and 4-picolylamine) simply resulted in 
symmetrical amide products (LCMS, NMR) with little or no evidence of reaction of the 
second amine added. 
This route offers potential but requires much further development. It may be possible to 
-  
devise a synthesis employing different resins and linkers 9297,149-151 to alter the reactivity of 
the solid supported resin. 
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4.2 Complex Preparation 
The methods employed in formation and isolation of the LnNAL chelates were developed 
due to inconsistent results obtained upon formation of the species in situ in the cuvette. The 
problems encountered were found to be a consequence of ionic strength of the solution - 
variable due to the method of formation. Ligand solutions (-S  0.01 M, pH 7-8) were prepared 
in standard volumetric flasks, into which the solid ligand was accurately weighed, 
deprotonated with NaOH, then diluted to volume with deionised water. The complex of 
interest was formed in the cuvette by combining ligand and aqueous rare earth salt solutions 
(-j 0.1 mM) in equimolar amounts. The pH of the final solution was then adjusted to pH 7 
with NaOH. In forming the chelate complex in this way the ionic strength of the solution is 
unknown and variations exist between samples. In addition, Na association with the ligand 
carboxylate groups forming the salt may prevent complete ligand-Ln(llI) coordination. The 
presence of Na in high concentrations was also found to have a bearing on ternary complex 
formation. Variations between the Ln(IH)NAL chelate species present in solution and 
changes in the hydration state can alter the extent to which the complex can interact with the 
introduced LHC binding unit. At higher Na concentration the presence of free Ln(IH) 
cations cannot be disregarded, interaction of which with the added LHC can lead to greater 
enhancement of the luminescence and differences in the peak ratios observed (592:616 mm). 
Such inconsistencies can be minimised by isolation and characterisation (MS. CHN, and 
NMR) of the chelate complexes prior to their use in photophysical studies. Complexes can 
be isolated by precipitation from a concentrated aqueous solution upon addition of an 
organic solvent. 
Initial attempts to isolate the Ln(III)NAL chelates gave mixed results. Deprotonation of the 
ligand with NaOH prior to combination with the metal salt in aqueous solution and 
subsequent adjustment of the p1-I to neutrality resulted in the formation of excess NaCl. This 
co-precipitated with the LnNAL species giving erroneous elemental analyses and 
unexpectedly large Na peaks in the FAB and ES-MS. The high ionic strength of solutions 
prepared with these chelates was found to be detrimental to the LHC binding interaction 
required to form the ternary complex. In addition association between the sodium ion and 
carboxylate functional groups of the NAL may prevent complete chelation of the metal, as 
discussed above, although NMR studies with diamagnetic yttrium and lanthanum discussed 
in Chapter 6 suggest that this is less problematic. 
Preparation of EuDTPA-bis(amide) chelates was also attempted using Eu 203 starting 
material" 9 thus eliminating the formation of inorganic salts of the counter ions encountered 
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in the previous preparations. The metal oxide and appropriate ligand were combined in 
water and refluxed for approximately 1 hour forming a colourless solution (pH 12). The 
volume of the mixture was reduced to 1-2 ml and addition of acetonitrile to the concentrated 
solution instantly afforded a colourless solid. This was collected by filtration, washed with 
ACN and diethyl ether then dried under vacuum. Mass spectrometry and elemental analysis 
revealed the compounds obtained in this way to have the expected composition. 
Luminescence spectroscopy showed characteristic red Eu(ffl) emission upon excitation at 
394 nm. Binding studies with picolinic acid showed some ternary complex formation in 
aqueous solution, but with very little Eu(HI) emission enhancement. This is attributed to the 
coordination of OH to the metal during complex preparation. Although the formation and 
co-precipitation ofNaCl is avoided, the coordination of OH is not, as shown by the equation 
for the reaction (Equation 4-1): 
Eu203 +2 H3DTPA-AM2 -> 2 EuDTPA-AM2 +3 OFf 	Equation 4-1 
The release of Off accompanying the formation of the chelate raises the solution pH. This 
free OH can compete with the bulk solvent H 20 for the ninth coordination site of the 
lanthanide .21, 152 This stronger binding interaction between the anionic hydroxide ligand and 
the metal (relative to neutral water) is more difficult to perturb, thus LHC binding is 
inhibited and the luminescence of any mixed ligand species is weak. When a more 
hydrophobic ligand such as DTPA-cyllA or DTPA-BBZA is employed, addition of base to 
the Eu203 ligand mixture is required to aid dissolution. The stable H-bonding network 
present in the solid ligand must be disrupted for solvation to occur as the influence of the 
metal oxide alone is insufficient. Addition of the base (aqueous TBAOIT) to the reaction 
accentuates the problems encountered due to hydroxide coordination. Using. TBAOH in 
place of NaOH in preparation of the complexes from the Ln(I1I) chloride salts facilitates 
removal of the counter-ion salts after precipitation of the chelate. The solubility of TBACI in 
acetonitrile allows the excess salt formed during the reaction to be removed by washing of 
the solid obtained. 
Exceeding pH 6.5 during preparation results in formation of species containing coordinated 
OH. Eu(ffl) has a pL value of about 6.5 in water and Eu(OH)3 is known to precipitate from 
solutions at high pH (>8).21. 
148 In some cases the pH reached was as high as 12 or 13 and a 
fine suspension was observed in the solution which was attributed to formation of insoluble 
metal hydroxide species. The DTPA-AM2 ligands coordinate the metal in an octadentate 
manner through the 3 carboxylates, 2 amide carbonyls and 3 diethylenetriamine nitrogen 
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atoms. A water molecule occupies the ninth coordination site of the metaL 117 At high pH 
this water can form a more strongly coordinating hydroxide, displacement of which by a 
competing ligand (LHC) is more difficult. Consequently, ternary complex formation 
becomes more difficult and the resultant species is less luminescent than the corresponding 
complex prepared at lower pH. 
The anionic complexes of [LnDTPA] 2  have been studied extensively as a result of their 
application in MR1108116  The crystal structure of the Nd(ffl) complex' 
13 and NMR 
relaxation studies (1120 exchange and 'O NMR spectroscopy) show that only one water 
molecule coordinates the metal in aqueous solution.' 08  Supporting evidence is provided by 
potentiometric titrations and studies of luminescence as a function of pH, in which it was 
established that formation of the 1:1 complex is complete by pH 3 and that the 
luminescence intensities and lifetimes are unchanged between pH 3 and pH 12. This is in 
contrast to the ligands EDTA, HEDTA and TTHA which each exhibit variation in the 
photophysical properties with pH, due to oligomer formation at high pH, confirmed by 
energy transfer studies in mixed Eu 3 /Tb3 systems. 152 
Similar studies performed with DTPA-bis(amide) ligands' 
17-128,130-137 reveal that they 
fulfil their octadentate binding potential with Ln(Ill) cations in aqueous solution, with only 
one water molecule coordinated. NMR relaxation experiments simply reveal that the water 
molecule is coordinated to the metal centre, and do not permit differentiation between OH 
and 1120. Similarly, lifetime measurements on the chelates in solution cannot distinguish 
between a coordinating OH ligand and a water molecule. Mass spectrometry does not detect 
the 01111120 and the difference in composition of only one proton cannot be established by 
elemental analysis. The situation is further complicated by the fact that Ln-OH formation is 
a process in equilibrium, the position of which, and hence the percentage of chelate in the 
OH form is unknown. 
All chelates used in the screening experiment (Chapter 5) and photophysical studies 
discussed in Chapter 6 were precipitated from water with acetonitrile at pH 5-6 following pH 
adjustment with TBAOH (40 % w/w 1120). The ligand was dissolved in the LnC1 3 solution 
prior to addition of base. The chelates were characterised in full by mass spectrometry (ES-
MS), NTvIR (Y3 and La3  diamagnetic analogues) and elemental analysis. The photophysical 
properties were studied by luminescence spectroscopy (under steady state and pulsed 
excitation). 
92 Comments on Synthetic Methods 
Results and Discussion 
Attempted formation of the diamagnetic lanthanum complexes with the more hydrophobic 
DTPA-AM2 ligands (cyHA, BTA, NBA) for NMIR analysis was in many cases unsuccessful 
due to their limited solubility in aqueous media. A colourless solid immediately precipitated 
upon combination of DTPA-cyllA and LaC1 3 in water. Similarly, DTPA-BTA resulted in 
formation of an insoluble colourless solid with La(M) that could not be analysed by NMR. 
The Y(lll)DTPA-AM2  analogues were prepared successfully and were soluble in 
concentrations suitable for study by NMR. It was hoped that some interaction between the 
protons of the amide arms and the aromatic LHC could be detected upon molecular 
recognition. With La(HI) some splitting and sharpening of the NAL resonances was 
observed, attributed to a conformational locking effect (Chapter 3) discussed in more detail 
in Chapter 6, but no such splitting/sharpening was seen with the 
y3+ complexes. 
In conclusion, the method of preparation of the Ln(ffl)DTPA-AM2 chelates has a large 
influence on the molecular recognition processes involved in ternary complex formation. 
The pH of the EUNAL solution must not exceed pH 5-6 prior to precipitation of the complex, 
minimising the extent of Eu-OH coordination. Tetrabutylammonium hydroxide solution can 
be employed to raise the pH of the solution thus avoiding the problems of NaCl co-
precipitation encountered when NaOH is used. 
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5 Combinatorial Screening 
5.1 The Experiment 
A novel approach to the development of highly luminescent mixed ligand chelates is to 
employ combinatorial screening technologies - well-established methods in modern drug 
discovery. 1 The process is shown schematically in Figure 5-1. Screening of diverse 
compound libraries enables identification of potential LIICs in a manner analogous to the 
initial discovery and target validation in pharmacophore identification. Performing 
spectroscopic studies in microplate format (96 well) allows the luminescence triggered upon 
recognition between a large number of LnNAL/LHC combinations to be studied in a short 
space of time. Potential light harvesting centres can be identified quickly, the effect of the 
NAL on the interaction evaluated, and structure/activity relationships determined. 
Figure 5-1 Schematic Representation of 1-11gb Throughput Screening as applied to the 
development of novel luminescent mixed ligand chelates 
A selection of DTPA-bis(amidc) derivatives were prepared in order to introduce a variety of 
structural and electronic properties to the LnNAL chelates. The amide nitrogen of the ligand 
does not participate in coordination to the metal, thus leaving the arms free to form a cavity 
occupied by one water molecule in the absence of a competing ligand. The NALs chosen for 
study by combinatorial screening methods are shown in Figure 5-2 below. 
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Figure 5-2 Structures of EuDTPA-bis(amide) derivatives screened for molecular recognition with 
aromatic carboxylic acids by combinatorial methods 
The effects of hydrophobicity, rigidity, steric hindrance and E-interactions on the formation 
of mixed ligand species were investigated by comparison of the luminescence observed upon 
molecular recognition between aryl acids and the chosen LnNAL chelates. Potential LHCs 
were chosen on the basis of the ternary complex model system discussed in Chapter 3. The 
"model" chelate, EuBEA, demonstrated recognition at a molecular level with the simple 
aromatic carboxylic acids shown in Figure 5-3. Picolinic acid is a better sensitiser of Ln(III) 
emission than either the bidentate phthalic acid or the weakly binding monodentate benzoate 
LHC. 
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Figure 5-3 Benzoic (BZA), phthalic (PTA) and picolinic (PCA) acids 
Aromatic acids bearing at least one carboxylate substituent covalently attached to the ring 
were selected to provide a representative set of the potential LHC compounds available 
within GlaxoWellcome's structural database. The chosen acids represent a wide range of 
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structural and electronic characteristics and were chosen to ascertain which features are 
important to the molecular recognition processes involved in the controlled formation of 
luminescent mixed ligand species. Structures of the acids screened in the three iterations of 
the assay and the experimental results obtained are shown as SMILES strings in Appendix 2. 
Due to the large volume of data generated only the more interesting observations are 
discussed. Data directly compared were obtained under the same experimental conditions on 
the same day. The excitation wavelength employed (275 +1- 10 nm) was selected using the 
fixed wavelength filter slides provided by Tecan. Consequently, variations in X,, and/or 
C ( of the acids are not accommodated for in the screen. The experiment was performed 
around neutral pH. 
The assay results are discussed in two sections, treating individually the selectivity 




Triplet state energies 
Triplet yield 
Molar absorptivity at the excitation wavelength 
Micelle formation 
5.2 LHC Induced Molecular Recognition 
5.2.1 Saturated Alkyl Substitution on the Phenyl LHC Unit 
We know from our preliminary experiments with EuBEA (Chapter 3) that benzoic acid binds 
the metal centre weakly, resulting in a 10-coordinate ternary species with 1:2 stoichiometry. 
The effect of substitution on this simple aromatic acid was investigated. Firstly we noticed 
that when an aliphatic "tail" is incorporated on to the LHC the luminescence of the mixed 
ligand species is greatly enhanced relative to the mixed ligand EuBEA:BZA complex. 
Compounds GR203309X, GR241592X, GR207127X and GW399139X (Figure 5-4) best 
illustrate this effect. 
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• 1/10 EuNBA 
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GR2C33CGX GR241532X GR207127X GW399139X GR36337X 
Acid 
Chart 5-1 Relative emission intensity (LI!0) upon interaction of acids GR203309X, GR241592X, 
GR207127X and GW399139X with the EuNALs 
With a straight chain alkyl substituent at the 4-position of the aromatic ring a dramatic 
improvement in the luminescence of the ternary complexes formed with our EuNALs is 
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observed. The relative emission intensities arising upon molecular recognition with the 
chelates are shown in Chart 5-1. 
Compound GR207 127X (4-hexylbenzoic acid) affords 15-fold enhancement of the parent 
EuNAL emission, as does acid GW399139X (4-heptylbenzoic acid), pictured above in 
Figure 54. The acid chromophore and binding unit are unchanged with respect to benzoic 
acid (Figure 5-3) as the effect of alkylation on the electronic properties of the system is 
negligible. We therefore attribute the marked improvement in activity observed with these 
acids to a "shielding" effect introduced by the aliphatic chain. The hydrophobic nature of 
the substituent group protects the cavity from attack by outer-sphere solvent molecules, 
which can quench Eu(ffl) luminescence by non-radiative energy transfer to the 0-H 
oscillators .44,4'  Further evidence in support of this is provided by the most effective of the 
acids illustrated here, GR24 1 592X, which results in a 60-fold increase in sensitised Eu(III) 
emission under the same experimental conditions. 
It is proposed that introduction of the cyclohexyl component to the aliphatic tail provides 
additional protection from the outer sphere solvent molecules due to the increased rigidity, 
hydrophobicity and steric bulk of the substituent. It is interesting to note that with only a 
cyclohexyl ring, acid GR203309X is much less efficient as a sensitiser for our EuNALs. We 
attribute this observation to two possible factors: 
The steric bulk of the cyclohexyl group, without the further alkyl substitution can 
readily undergo ring-flip isomerisation, clashing with the amide arms of the NAL. 
Consequently the strength of the binding interaction and the degree of orbital 
overlap is likely to be diminished with respect to the straight chain alkyl derivatives. 
Despite this impediment, acid GR203309X remains a much better LHC for our 
EuNALs than unsubstituted benzoic acid. 
The long chain substituent group at the 4-position on the cyclohexyl ring of acid 
GR241592X (twelve carbons in length) is likely to be quite surfactant-like in 
character, encouraging micelle formation with the effect of excluding outer sphere 
water molecules from the Eu(III) coordination environment. 
Another acid of this type exhibiting good potential as a sensitiser for our mixed ligand 
system is GR36337X (3-octylbenzoic acid, Figure 5-5). This acid bears an n-octyl 
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substituent in the 3-position. The relative emission increase observed upon molecular 
recognition with the EuNALs is of similar magnitude to the 4-substituted acids discussed 
above (-50-fold) - but slightly stronger than the hexyl and heptyl derivatives (J/I —30). 
G R36337X 
Figure 5-5 3-octylbenzoic acid 
The efficiency of this acid as a LHC for the EuNALs studied is again due to the presence of 
the aliphatic tail, providing an "umbrella" type effect, since the chromophore and binding 
unit are unchanged with respect to benzoic acid. 
The "umbrella" effect has been observed in other cases. The DELFIA immunoassay system, 
discussed in Chapter 1.1.4, also exploits a mixed ligand Eu(III) chelate. The enhancement 
solution contains a tris-n-octyl phosphine ligand (topo) in addition to the sensitising 3-
diketonate, the purpose of which is to form an "umbrella" around the complex excluding 
outer-sphere solvent molecules. 74 Previous research in the Pikramenou group into novel 
luminescent lanthanide assemblies has lead to the design of luminescent spheres, in which 
the steric bulk of the tetraphenylimidophosphine (tpip) antenna ligand (Figure 5-6) was 
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Figure 5-6 Antenna ligands tpip and mtpip. Outer sphere water molecules are excluded from 
the core upon increasing the steric bulk of the aromatic substituents. 
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Results and Discussion 
Another example of such a phenomenon is in the shielding of the triplet state of 
bromonaphthalene from the quenching effects of molecular oxygen by the protective 
hydrophobic cavity of eyelodcxtrin molecules. 
The effect of straight chain and cyclic aliphatic substituents is also observed with the 
picolinate (PCA) binding unit (Figure 5-7). tinder continuous excitation we observe PCA to 
form a highly luminescent ternary complex with EuIIEA in aqueous solution (Chapter 3), 
attributed to the strength of its bidcntatc binding interaction with the metal, and closely 
matched excited state energies facilitating efficient intramolecular energy transfer. 
GR202022X 
Figure 5-7 5-alkyl pyridine2-cartx)xylic acids 
Here it is noted that acid GR202022X gives rise to an intensely luminescent species, 
increasing the EuNAL emission 120-fold (Chart 5-2). In common with GR241592X this 
acid bears a substituted cyclohcxyl ring in the aliphatic tail group, acting as an efficient 
shield. The smaller n-butyl derivative (1iR34043X, whilst enhancing the emission 20-fold, 
OH 
U 1/10 EUBEA 
• 1/10 EuBUA 
01/10 EucyHA 
01/10 EumcyHA 
M 111 EuNBA 
U Wo EuBBZA 
U 1/10 EuBTA 
Chart 5-2 Relative Emission Intensities observed upon recognition between 
EuNALs and alkyl-substituted picolinic acids 
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Results and Discussion 
5.2.2 Unsaturated Substitution on the Phenyl LHC 
A logical progression from the saturated substituents is to investigate the influence of 
unsaturated alkyl substituents (Figure 5-8) upon a molecular recognition event. 
OH 	 OH 	
N
OH 








C] Vb EurryHA 
•VbEuNBA 
• Vb EuBBZA 
•(Ib EJJBTA 
Chart 5-3 Relative emission intensities observed upon interaction between the EuNAL5 and the 
acids bearing unsaturated substituent groups 
It is notable that only one of these acids (GR87165X) interacts with the EuNAL resulting in 
sensitised metal emission, as illustrated by Chart 5-3. 
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In contrast to the saturated substituents that have little effect on the electronic structure of the 
acids, the functional groups chosen can withdraw electron density from the aromatic ring. 
Whilst such an effect lends stability to the carboxylate anion relative to the protonated form, 
the extended conjugation reduces the energy of the aromatic system. The triplet-state 
therefore may be expected to lie at a lower energy than that of the parent acid. Only one of 
these acids results in any sensitised EuNAL luminescence. Compound GR87 1 65X bears one 
double bond in addition to the aromatic system and enhances the emission —15-fold. In this 
case, the electronic influence of the unsaturated substituent is likely to be responsible for an 
improved binding interaction with the metal relative to benzoic acid. The 15-fold increase is 
of similar magnitude to that observed with acids GR207127X and GW399139X (Figure 5-4) 
bearing straight chain alkyl substituents in the 4-position, in which electronic influences of 
the substituent are negligible. The other unsaturated acids tested exhibit extended 
conjugation, reducing the triplet state energy to a level too low for efficient intramolecular 
energy transfer to the metal. Here we have our first encounter with a nitrated aryl acid, 
GR58626X, and note that the Eu(III) emission is not enhanced with respect to the parent 
chelate. The powerfully electron withdrawing nitro substituent lowers the overall energy of 
the aromatic system. Low energy n7t*  transitions lower the sensitiser triplet state energy of 
the compound, rendering it inactive towards our EuNAL chelates. Competitive coordination 
by the nitro group is unlikely to occur in aqueous solution, thus the influence of excited state 
LMCT between the nitro functionality and Eu(III) on the system can be disregarded under 
these experimental conditions. 
5.2.3 Alkoxy-subsituted Benzoic Acids 
Introduction of an ether linkage between the aryl head group and the substituent allows the 
influence of a wide variety of substituent tails on the formation of mixed ligand complexes to 
be investigated. Several aromatic and aliphatic derivatives were studied and a striking array 
of activities observed. Firstly we will examine the straight and branched chain saturated 
derivatives of the generic structure shown in Figure 5-9. 
Acid n Chain 1110 EuNAL 
GR34543X 0 1 I 
GR30476X 3 4 2 
GR208752X 4 5 9 
GR30894X 5 6 12 
GR30893X 7 8 29 
AH20078XX 9 10 28 
GR33911X II 12 24 
GR65884X 13 14 28 
GR65815X 15 16 20 




R = -(CH2 )CH 3 
Figure 5-9 4-alkoxy-benzoic acids 
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in solution cannot be disregarded, which would lead to false signals, the result of scattering 
from colloidal particles. 
A variety of compounds bearing chains of 3-6 carbon atoms in length (Figure 5-10) were 
studied and a range of activities observed as expected. For example, acid GR155589X bears 
a primary alcohol functionality at the terminus of the substituent chain and does not form 
luminescent ternary species with the EuNALs studied here. We propose that this is the result 
of non-radiative energy transfer from the Eu(III) excited state to the higher vibrational 
overtones of the OH oscillator, depopulating the emissive state of the metal preventing 
observation of sensitised emission. Although not likely to penetrate the inner coordination 
sphere of the metal, the hydrophilicity of the substituent chains may encourage outer sphere 
water molecules to solvate the metal via hydrogen bonding interactions. Acids CC19740 and 
GR53056X provide evidence in support of this. Both bear at least one OH substituent in the 
"tail" group and neither form luminescent mixed ligand complexes with our EuNAL chelates 
in aqueous solution. 
In contrast, 4-hexyloxy-3,5-dimethylbenzoic acid, GW288377X, (Figure 5-10) 
improves the interaction relative to the mono-substituted acid due to the increased degree of 



















Figure 5-10 Alkoxy-substituted benzoic acids - the presence of the OH functionality in the tail 
group is detrimental to the luminescence of the ternary complex 
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0 	 0 
0H 	 OH 	 OH 
GR30476X 	 GW371223X 	 GR240724X 
Figure 5-11 4-alkoxybenzoic acids which weakly enhance the chelate emission 
In common with acid GR203309X (Figure 54) discussed in 5.2.1, the presence of a 
simple mono-substituted cyclohexyl group on the acid (GW371223X) does not enhance the 
sensitisation upon molecular recognition with the EuNALs, and the signal detected is similar 
to that observed with the straight chain n-butyl derivative GR30476X (Figure 5-11). 
With a branched chain substituent a range of activities is observed, the best of which is 
obtained with GR54392X (Figure 5-12). This acid bears a methylated alkyl chain and a 
cyclohexyl group, and is capable of excluding outer-sphere solvent molecules to the extent 
that the benzoate/EuNAL interaction enhances EuNBA luminescence almost 200-fold (Chart 
5-5). 
The analogous acid GR57352X (Figure 5-12), without the methyl group at the 2-position of 
the alkyl chain achieves less than half this effect. The selectivity is attributed to additional 
protection of the cavity provided by the methyl substituent. Similarly the isopentyl 
derivative, GR240724X (Figure 5-11) forms luminescent mixed ligand complexes, and is 
observed to be about twice as effective as the straight chain butyl compound, GR30476X. 
0 
0,10 
AOH 	 OA0H  
G R57352X 
Figure 5-12 4-alkoxybenzoic acids which greatly enhance the chelate emission 
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Chart 5-5 1110 observed upon interaction between alkoxy substituted aryl-acid LHCs and the EuNALs 
The influence of the alkoxy substituent position on the luminescence of the mixed ligand 
complex has also been considered. The relative emission intensity observed upon 
combination of the acid and the chelate is plotted below in Chart 5-6. Upon comparison of 
the meta and para substituted acids, the maximum emission intensity is achieved for an alkyl 
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Chart 5-6 Average EuNAL relative emission increase versus chain length: comparison between 
meta and para substitution 
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5.24 Aromatic Substituents on the Phenyl LHC Unit 
Another interesting class of acids bearing long chain substituents incorporates those with a 











a.  2)111 	 OH 
n = 2,4,5,6,8,9,10,12 
Figure 5-13 4-alkoylbenzoic acids bearing a substituted phenoxy tail group 
The average relative emission increase upon molecular recognition with the EuNALs is 
presented below in Chart 5-7. Firstly we note the decrease in EUNAL emission observed 
between a spacer chain length of two and six carbon atoms. With only an ethylene bridge 
between the two aromatic rings the energy absorbed by the second ic-electron system can be 
transferred to the Eu(IIl) metal centre to be re-emitted as characteristic red light. As the 
distance between the two absorbing units is increased the efficiency of intramolecular energy 
transfer to the metal is decreased, hence the smaller relative emission intensity observed for 









2 	4 	5 	6 	8 	9 	10 	12 
Spacer Chain Length -(CH2)n- 
Chart 5-7 The effect of spacer chain length on the emission intensity observed from 
EuNAL chelates upon molecular recognition with aryl acids bearing a second aromatic ring 
as part of the substituent chain 
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As the aliphatic chain between the aryl rings is extended, the lipophilicity of the IJIC is 
increased. We propose that the increasing relative emission intensities observed with the 
acids bearing a substituent chain of eight or more carbon atoms is due to the improved 
capacity of the LHC to act as a shield, protecting the metal centre from the quenching effects 
of outer sphere solvent molecules. The importance of the propyl group on the second 
aromatic ring is highlighted by the fact that acid GR84408X, without the additional alkyl 
substituent enhances the ELINAL luminescence by only 5-fold, in contrast to the 
approximately 30-fold increase observed with compound GR64693X (Figure 5-14). 
p iYOH 	 9 OH o o 	 o o 
GR84408X 	 GR64693X 
Figure 5-14 Additional shielding provided by the propyl substituent on the phenoxy ring is 
demonstrated by the increased activity of compound GR64693X over GR84408X 
The selectivity of molecular recognition with the EuNALs is illustrated below (Chart 5-8). 
All exhibit good general activity towards the chelates. It is interesting to note that these 
mono-substituted benzoic acids display a similar pattern of selectivity towards the EuNAL 
chelate cavity. More intensely luminescent species arc formed upon molecular recognition 
between the acids and the complexes exhibiting well-defined binding cavities (EuBBZA and 
EuNBA) as expected, an effect discussed in more detail in section 5.3.1 and Chapter 6. 
0/10 EuBEA 
D 1/10 EuBUA 
o I/to EucyHA 
o 1110 EumcyHA 
• No EuNBA 
• No EuBBZA 
M No EuBTA 
S 
GR64693X GR55424X GR55422X GR55423X GR61326X GR61985X GR61891X GR61984X 
Acid 
Chart 5-8 Mono-substituted benzoic acids (Figure 5-13, 14) interact swIl with the EuNALs to form 
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5.2.5 Multiple Substitution on the Phenyl LHC Unit 
Interpretation of the influence of multiple LHC substituents on molecular recognition is 
more complex than evaluation of the effects of mono-substitution. The characteristic Eu(ffl) 
emission triggered upon formation of the mixed ligand species is indicative of a molecular 
recognition event resulting in sensitised europium luminescence. A measure of the strength 
of any such interaction can be gained from the intensity of the light emitted and direct 
comparisons between EuNAL/LHC combinations can be made from the qualitative data 
obtained. Variation in absorbance characteristics of the acids upon substitution of the aryl 
ring is not accounted for under the experimental conditions since the excitation wavelength 
is constant at 275 ± 10 nm during the assay. Any subtle but characteristic shifts in the 




















X7 OH  
'IN  
GW271 929X 
Figure 5-15 Benzoic acids bearing multiple alkoxy substituents 
We have demonstrated that the presence of an alkyl chain mew orpara to the carboxylate is 
beneficial to the luminescence of the ternary complex (5.2 - 5.4) due to its capacity to act as 
a shield protecting the metal centre from the quenching effects of outer sphere solvent 
molecules. We have also shown that the electron donating effect of a simple methoxy 
substituent can destabilise an interaction between the EuNAL and the acid LHC. The 
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counter-influence of these effects can be evaluated upon considering the interaction between 
the EuNALs and the acids shown in Figure 5-15. 
From the assay data (Table 5-1) it is clear that none of these acids trigger the characteristic 
Eu(lll) emission indicative of ternary complex formation, in contrast to the mono-
alkoxybenzoic acids discussed in 5.2.1 and 5.2.3, which on average enhance the chelate 
luminescence by approximately 30-fold. This can be attributed to a shift in the absorption 
hand away from Xexc. 
Relative Emission Intensity (Yb) 
ACID EuBEA EuBUA EucyHA 	EumcyHA 	EuNBA EuBBZA EuBTA Mean 
EuNAL 
GW463080X 
2 3 2 	 4 	 3 3 2 3 
GW442734X 
2 2 2 	 4 	 3 2 2 2 
GW272478X 
2 2 2 	 3 	 3 2 2 2 
0W442732X 
2 2 2 	 3 	 3 2 2 2 
GW271 929X 
2 3 2 	 3 	 3 2 2 3 
Table 5-1 Relative emission intensity upon interaction between EuNALs and the aryl acids pictured 
in Figure 5-15. No significant enhancement of Eu(I1I) luminescence is observed. 
In contrast to the mono and di-methoxy substituted compounds (Figure 5-15) which do not 
sensitise our EuNALs under the experimental conditions, tn-substituted acids GW4 I 5699X 
and (iW369764X (Figure 5-16) show good potential as light harvesting units, enhancing the 
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v415699X GW369764X GR258179X GR258213X 
Acid 
Chart 5-9 The relative emission intensities observed upon recognition of the trisubstituted acids 
illustrated in Figure 5-16 
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GW369764X 	 Cl 
Figure 5-16 Tn-substituted benzoic acid LHCs resulting in enhanced Eu(II1) emission 
upon molecular recognition. 
Similarly, acids GR258179X and GR258213X (Figure 5-16) result in luminescent mixed 
ligand species with approximately 70 and 80-fold enhancement of europium emission 
respectively (Chart 5-9) for chelates EuNBA and EuBBZA. Interestingly, the best 
sensitisation is observed with EuBUA and EucyHA. The phenoxy ether substituents are not 
detrimental to the chelate emission under the experimental conditions. Energy transfer to the 
metal is feasible from the benzyi-ether substituent groups and their steric bulk provides a 
shield around the cavity. As expected, the presence of a fourth aromatic ring in GR258213X 
increases the relative emission intensity of the mixed ligand complex with respect to 
GR258179X. The molecule contains an extra antenna unit absorbing around 275 nm. 
Evidence supporting the importance of electron withdrawing groups on ternary complex 
formation is provided by acid GW369764X (Figure 5-16), which bears no other aromatic 
substituents on the benzene ring. The luminescence arising upon molecular recognition 
between this acid and the EuNALs is compared in Chart 5-10 below with the analogous alkyl 
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(GW207127X. GW399139X) and alkoxv (GW30894X, GW288377X) substituted LHCs 
discussed earlier. Structures are pictured in Figure 5-17. The LHC GW369764X bears no 
absorbing groups in addition to the benzoate chromophore, yet can result in sensitised 
Eu(I1I) luminescence. In contrast to the phenoxy substituents, which can absorb UV 
radiation, the halide is inductively electron withdrawing and cannot absorb the UV excitation 
energy (275 nm). The positive influence of the chloride substituent on sensitised Eu(HI) 






0 W EuBUA 
o 40 	 01/10 EucyHA 
'I) 
01/10 Eumcy}- 
30 •I/lo EuNBA 
U) 
0 W EuBBZ.1 
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-u 0 W EuBTA 
10 
GR2071 27X GW3991 39X GW453080X GW41 871 6X GR30894X GW288377X GW369764X 
Acid 
Chart 5-10 IlL-> observed for alkyl and alkoxy substituted benzoic acids. Comparison between 
mono- and multiple substituted acids (Figure 5-17) 
Acids AI-114879X and GR34041X (Figure 5-18), with a meta ben.zyl-ether or phenoxy 
substituent respectively, do not increase the EuNAL luminescence. These aromatic 
substituent groups withdraw electron density from the ring, such that the absorption 
maximum of the molecule is shifted off the excitation wavelength at 275 am. The resonance 
effect of such substituents may have been expected to strengthen the binding interaction 
between the metal and LHC' 47 at the under the neutral pH conditions of the experiment. It 
appears, however, that the substituent lowers the triplet energy to a level below that of the 
Eu(IH) 5D0 excited state. Incorporation of a methoxy group restores some of the electron 
density, raising the energy of the excited state to a level appropriate for sensitisation at the 
excitation wavelength allowing intramolecular energy transfer to the metal centre. 
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GW30894X 	 (fOH 
14- 
GW369764X 
Figure 5-17 Mono and multiple substituted benzoic acids showing some activity as 






Figure 5-18 3-benzyloxybenzoic acid AH14879X and 3-phenoxybenzoic acid GR34041X 















GR38662X 	 GR203875X 
Acid 
Results and Discussion 
5.2.6 Dicarboxylic Aromatic Acids 
It has been shown with isophthalic acid 147 that resonance electron withdrawing effects, 
arising from incorporation of a second carboxylate unit in the 3-position, result in a stronger 
interaction with the Eu(III) metal centre. The stoichiometry of the luminescent complex in 
aqueous solution is poorly defined since the formation of multinuclear species is possible 
(Chapter 3). Upon comparison of acids GR38662X and GR203875X (Figure 5-19), it is 
apparent that the incorporation of a second carboxylate group facilitates a 1-fold 
enhancement in emission over the ternary complex formed with the mono-substituted acid. 
0 	 0 	0 






Figure 5-19 4-butoxybenzoic acid (GR38662X) and 5-pentoxy- 1,3 -benzene- 
dicarboxylic acid (GR203875X) 
Steric constraints prevent the 1,3-dicarboxylic acid from fulfilling its bidentate binding 
potential and coordination is via a single carboxylate functionality. The stronger interaction 
with GR203875X may also be attributed to the resonance effect of the second carboxylate 
group. The emission intensity of the ternary complex, relative to the parent chelate, upon 








Chart 5-11 VIO upon interaction aromatic acids GR38662X and GR203875X (Figure 5-19) 
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5.2.7 Heterocyclic acids (I) - Picolinic Acid Derivatives 
As discussed in Chapter 3, pyridine-2-carboxylic acid was identified as a particularly good 
example of a simple LHC for our EuNALs. We were interested in investigating how the 
recognition between the EuNAL and the picolinate binding unit could be improved to give 
better sensitisation. The effects of substitution and extended conjugation on the interaction 
were studied. The influence of simple substituent groups on PCA was evaluated initially. 
The structures of some of the derivatives studied are shown below in Figure 5-20 and assay 
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CCI2 1405 AH8268 
Figure 5-20 substituted picolinic acids 
Relative Emission Intensity 
ACID EuBEA EuBUA EucyHA EumcyHA 	EuNBA 	EuBBZA EuBTA Mean 
EuNAL 
AH10633 4 4 3 4 	 6 5 3 4 
AH1052 7 9 5 7 	14 12 15 10 
AHI03I - 1 1 1 	- 1 - 1 
AH11453 - 1 1 1 	- 1 - 1 
CC110176 3 3 2 3 	7 6 3 4 
AH16943AA 2 2 2 3 	2 2 2 2 
GW369905 7 15 4 5 	14 14 - 10 
AH8268A 1 1 1 1 	 1 1 1 1 
GR202022X 96 84 87 102 	143 127 41 97 
GR34043X - 19 12 19 	- 28 - 20 
Table 5-2 Relative Emission Intensities observed upon combination of substituted picolinic acids 
and the EuNAL chelates in aqueous solution 
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Firstly, it is noted that compound AH10633, 4-methoxypyridine-2-carboxylic acid, affords a 
4-fold emission enhancement relative to the EuNALs studied. Whilst this increase is 
considerably less (20%) than that of the unsubstituted picolinic acid (under steady-state 
illumination, Chapter 3) it is nonetheless proof that an interaction is occurring. In contrast. 4-
methoxybenzoate (GR34543X) is not recognised by the chelate cavity. Here the activity can 
be attributed to the presence of the heteroatom, forming a five member chelate ring with the 
metal and the carboxylate anion. The increased electron density of the ring system due to the 
activating influence of the methoxy substituent destabilises the strength of the binding 
interaction with the metal centre relative to PCA, but the required intramolecular energy 
transfer is not prevented and sensitised Eu(III) emission is observed. This may also be due 
in part to increased basicity of the pyridine nitrogen atom. 
Similarly, acid A141052 (3-hydroxypicolinic acid) gives on average a 10-fold increase in 
emission relative to the EuNAL. With this acid two modes of binding are possible - via the 









Figure 5-21 (a)"Picolinate" and (b) "Salicylate' bidentate binding units 
The binding by "salicylic acids", with a phenol group ortho to the carboxylate, is discussed 
in Chapter 5-10. The sensitised Eu(III) luminescence observed with AH1052 is evidence 
that the presence of an activating group ortho to the binding unit does not greatly impede the 
molecular recognition required to form the ternary complex. 
With acid AHI031, 3-aminopicolinic acid, no sensitised metal luminescence is observed, 
despite the activating nature of the substituent -NH 2 group, increasing the basicity of the 
pyridine nitrogen atom. This inactivity is attributed to a combination of two factors. 
Depopulation of the 5D0 excited state by non-radiative energy transfer to higher vibrational 
overtones of the N-H oscillator is known to occur in many systems, quenching Eu(III) 
luminescence, in addition to this some amine may be protonated under the slightly acidic 
assay conditions. The group then becomes deactivating in character, withdrawing electron 
116 Combinatorial Screening 
ff 
Results and Discussion 
density from the aromatic system, and reducing the basicity of the pyridine nitrogen, in turn 
weakening its activity as a donor ligand to the EuNAL. Proposed binding interactions are 
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Figure 5-22 Possible bidentate binding modes in 3-aminopyridine-2-carboxylic acid: (a) via 
amine and carboxylate; (b) picolinate binding and (c) protonated amine group reducing basicity 
of pyridine N donor. 
Similarly, 4-chloropicolinate (AHI 1453) does not interact with the EuNALs. Unlike 
resonance electron withdrawing CO 2H substituents (c.f. isophthalic acid), the inductively 
electron withdrawing Cl atom does not stabilise the formation of the carboxylate anion, but 
lowers the energy of the it-system and triplet state, probably to a level below that of the 
Ln(III) excited state such that the efficiency of intramolecular energy transfer is diminished. 
In contrast to Al-Il 1453. compound CCI2 1405, pyridine-2,4-dicarboxylic acid, forms ternary 
luminescent species. We attribute this to the resonance electron withdrawing effect of the 
second carboxylate substituent, stabilising the binding interaction between the metal centre 
and the PCA binding unit (c.f. isophthalic and dipicolinic acid binding). Compound 
CC110176, pyridine-2,3-dicarboxylic acid, results in a 4-fold enhancement in EuNAL 
luminescence. Like AH1052, this acid exhibits two potential modes of binding- picolinate" 









Figure 5-23 (a) "picolinate" and (b) "phthalate' binding 
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Dipicolinic acid (pyridine-2,6-dicarboxylic acid) is well known as an excellent LHC for the 
trivalent lanthanide cations, but here we note with interest that when the acid bears a nitro-
substituent (AH16943AA) the chelate luminescence is barely doubled. This can be 
attributed to the powerful electron-withdrawing influence of the functional group, reducing 
the basicity of the pyridine N and lowering the triplet-state energy 
An interesting observation is that acid GR369905X (Figure 5-20) enhances the emission 
—10-fold, but AH8268 does not. These acids differ by both nature and position of the 
substituent on the pyridine ring. Acid A118268 bears a n-methoxy group on the benzyloxy 
substituent at the 3-position of the pyridine ring, whereas GR369905X bears an unsubstituted 
benzyloxy group at the 4-position. It is expected that the resonance electron releasing 
methoxy group, can raise the energy of the it-system altering the absorption spectrum of the 
ligand considerably, and lower the carboxylic acid PK a . A further factor is expected to arise 
from the relatively high triplet state energy of methoxybenzene, resulting in mismatched 
triplet excited states. The pyridine substituent position may also influence the extent of 
interaction/energy transfer. The most efficient LHCs of the substituted picolinic acids tested 
are those bearing alkyl substituents in the 4 or 5-positions discussed in section 5-2 (Figure 5-
24). 
Guux 	 o 
OH 	 OH 
N 
GR34043X  0 
Figure 5-24 Alkyl substituted picolinic acids GR202022X and GR34043X 
The presence of a sterically bulky alkyl substituent does not perturb the electronic structure 
of the acid significantly and the chromophore and binding units are essentially unchanged 
relative to PCA. The hydrophobic nature of the tail group prevents attack by quenching 
outer sphere water molecules to the extent that an increase of ---100-fold is observed over the 
parent chelate under the experimental conditions of the assay. It is also observed that when 
the alkyl substituent bears an additional carboxylate function (Figure 5-25) the relative 
emission increase (Chart 5-12) is reduced with respect to the mono-carboxylic acid LHCs. 
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This can be attributed to competitive coordination of the metal by the aliphatic carboxylate, 
which cannot facilitate energy transfer to the Eu(Ill) metal centre. 
0 
OH 	 OH 
GW309880X GR230760X 
Figure 5-25 Alkyl substituted picolinic acids bearing a second carboxylate functional group. 
Activity is reduced with respect to the simple alkyl substituted PCA, GR202022X. 
5.2.8 Heterocyclic Acids (II) - Quinolinic Acid Derivatives 
5.2.8.1 Substituted Quinoline-2-Carboxylic Acid LHC Units 
The influence of extended conjugation on the luminescence interaction between the 
heterocyclic acid LHCs and the EuNAL chelates in aqueous solution was also examined by 
combinatorial screening techniques. The absorption of the LHC around 270 nm can be 
varied, and the characteristics of the picolinic binding unit maintained by progressing to 
quinoline systems with two fused aryl rings. 
Quinoline-2-carboxylic acid, AH9727 (Figure 5-26) is observed to form a ternary 
complex with our EuNALs but the metal centred emission is only enhanced by 3-fold, 
comparable to the benzoic acid LFIC. 
A much greater increase may have been expected on account of the extended 
chromophoric unit; however it is likely that the absorptivity of the acid at 270 nm is 
diminished slightly due to a red-shift in the absorption maximum, The observed inactivity 
is attributed to insufficient interaction for intramolecular energy transfer to occur. This is 
believed to be the result of a repulsive interaction between the Eu(III) metal centre and the 
proton at the 8-position of the quinolinic acid preventing the acid from fulfilling its bidentate 
binding potential. 



















Results and Discussion 
o No EuBEA 
o No BJBUA 
o No E.icyHP 
DV1oEjmcyF-IA 
• No aJNBA 
o Vlo BJBBZA 
0 Vlo BJBTA 
Chart 5-12 Comparison of the relative emision intensity observed upon interaction 
between alkyl and alkyl-carboxylate substituted picolinic acids 
The effect of substitution at the 4-position was investigated to see if the presence of a 
hydrophobic tail unit would enhance the luminescence of the mixed ligand species. The 
electronic effects of the substituent groups were also considered. Firstly we will examine the 











Figure 5-26 4-Alkoxy-substituted quinoline-2-carboxylic acids 
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Relative Emission Intensity 
ACID EuBEA EuBUA EucyHA EumcyHA EuNBA 	EuBBZ.A EuBTA 
EuNAL 
AH9727 - 	 3 2 	3 	 - 	 4 	- 3 
AH9678 2 	- - 	 - 	 3 	3 	- 3 
AHI5690XX 5 	- - 	 - 	 6 	6 	- 6 
AH15692XX 12 	- - 	 - 	 13 	17 	- 14 
AH15757XX 7 	- - 	 - 	 8 	5 	- 7 
AH10301X 23 	23 12 	25 	60 	28 	18 27 
Table 5-3 1/10 upon combination of quinoline-2-carboxylic acids with EuNALs 
On average, a 3-fold increase in EuNAL emission is observed with the unsubstituted acid 
A1-19727 as discussed above. Upon addition of an alkoxy group at the 4-position the 
interaction is improved slightly. Acid AH9678 (4-methoxyquinoline-2-carboxylic acid) 
results in 2-3-fold enhancement of the EuNAL emission (c.f. benzoate) whereas AH 15690 
(4-ethoxyquinoline-2-carboxylic acid) gives a relative emission increase of 5-fold, and the 
propyl derivative A1-115692 enhances the luminescence - 13-fold. Compound AH15757, 4-
isopropyloxyquinoline-2-carboxylic acid, achieves - 7-fold enhancement of the metal 
centred luminescence, less than the straight chain propyl derivative, and likely to be a 
consequence of adverse steric interactions between the amide arms of the EuNAL and the 
acid LHC. The straight-chain n-butyl derivative, AHI03O1X, forms a mixed ligand chelate 
with the EuNALs almost twice as luminescent as those formed with AH 15692. The increase 
in emission intensity relative to the parent quinoline-2-carboxylic acid, AH9729, can be 
attributed to two factors: 
The substituents are electron donating in character, and can increase slightly the 
electronic density of the aryl ring. This in turn increases the basicity of the pyridine 
nitrogen atom, improving its capacity to act as a donor ligand to the Eu(IIJ) metal centre 
(section 5.2.7). 
The second factor is the hydrophobic shielding effect as observed with the benzoic and 
picolinic acid derivatives discussed earlier in section 5.2. 
When an electron withdrawing substituent is placed at the same position, the resultant mixed 
ligand species exhibits weak metal centred emission. Acids AH12533 and A1-{12590 (Figure 
5-27), which bear unsaturated alkoxy substituents demonstrate this effect (Table 5-4). At 
best, the alkene derivative, acid AH12533 enhances EuBEA luminescence - 6-fold, whereas 
the alkyne derivative, A1-112590, only achieves an average 3-fold emission increase. 
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Figure 5-27 Substituted quinoline-2-carboxylic acids AH12533 and AH12590. 
Relative Emission Intensity 
ACID EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 	MeanEuNAL 
AH12533 
AH12590 
6 	- 	 - 	 - 	 8 	7 	- 	 7 
3 	- 	 - 	 - 	 5 	3 	- 	 4 
Table 54 Relative emission intensity observed upon interaction between acids AH 12533 and 
AH12590 with the EuNAIs 
The electron withdrawing group will stabilise the formation of the carboxylate anion with 
respect to the protonated species, but since this also reduces the basicity of the pyridine 
nitrogen the binding interaction is weakened. 
Introduction of a polyether function to the 4-position (Figure 5-28) of these acids does not 
improve the interaction and the maximum increase observed upon molecular recognition is 
3-fold (Table 5-5). With an OH group incorporated into the substituent chain (AH10978X) 
the acid results in no increase in EuNAL emission, attributed to additional quenching by 
non-radiative energy transfer. 
Relative Emission Intensity 
ACID EuBEA EuBUA EucyHA EumcyHA EuNBA 	EuBBZA EuBTA 
ELINAL 
AH12589 2 2 1 3 	3 	3 2 2 
AH13391 4 3 2 5 	5 	5 3 4 
AH11274 6 5 5 8 	8 	7 7 7 
AH10978 1 - - - 	 2 	3 - 2 
GR254264X 3 3 3 3 	5 	3 2 3 
Table 5-5 Relative emission intensity observed upon interaction between the EuNALs and quinoline-
2-carboxylic acids (Figure 5-28) 
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Figure 5-28 Aromatic substituted quinoline2-carboxylic acids 
The assay results show that acids AH12695X and AH9676 (Figure 5-29) trigger Eu(IH) 
emission upon molecular recognition with a increase of-.20-fold (Chart 5-13). 
oc 
O~N 	OH 	 OH 	 N 	OH CI:N 
0 	 0 	 0 0 
AH12695X 	 AH9676 	 AH9721 
Figure 5-29 Substituted quinoline-2-carboxylic acids resulting in 20- 
fold enhancement of EuNAL emission (Chart 5-13) 
In contrast to the other acids of this type, the substituent in the 4-position is aromatic. This 
has the effect of increasing the efficiency of photon absorption. This alone is not sufficient, 
and a strong binding interaction is required, providing good orbital overlap between the 
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metal centre and the acid. The N-oxide compound, AH9721, has no effect on the lanthanide 
luminescence. The N lone pair is unable to chelate the metal since the electrons are involved 
in formation of the N-O bond; however coordination by the NO moiety is possible. The 
inactivity is attributed to electronic factors which can adversely influence the triplet state 
energy or weaken the interaction with the metal. Acid AH9676 bears a tolyl substituent 
















Chart 5-13 Relative emission intensity upon recognition between aryl-acids AH12695X 
AH9676 and AH9721 (Figure 5-29) and EuBEA, EUNBA and EuBBZA 
Acid AH10698V (Figure 5-30) appears to be active as a light-harvesting centre towards our 
EuNALs (Table 5-6), but as observed with many of the other compounds tested, this is the 
result of strong organic fluorescence, and not of sensitised Eu(HI) emission following a 







Figure 5-30 Aryl-acid AH10698V exhibiting intense organic fluorescence only 
Compounds AH10300, A1-110801 and AH9678 (Figure 5-31) all form weakly luminescent 
ternary complexes, enhancing the lanthanide emission 3 to 5-fold. The feature common to 
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these acids is the presence of electron donating methoxy substituent groups. Substitution of 
the second aromatic ring does not greatly influence the interaction of these quinoline-2-
carboxylic acids with the EuNALs (Table 5 -6). 
Figure 5-31 Quinoline-2-carboxylic acids - interaction with EuNALs is weak 
Acid AH10853 (4,8-dihydroxyquinoline-2-carboxylic acid) and GR92452 (8-
hydroxyquinoline-2-carboxylic acid) (Figure 5-32) were tested to ascertain the extent to 
which a more hydrophilic substituent group at the 8-position would influence the interaction. 
No sensitised Eu(ITI) luminescence was observed in either case (Table 5-6). We attribute 
this to the close proximity of the OH oscillator to the metal centre, which can result in non-
radiative energy transfer and depopulation of the Eu(II1) excited state. Alternatively, as 
Eu(JII) is coordinating mainly though the carboxylate unit, the 8-hydroxyquinoline moiety is 
free to lose energy by the internal hydrogen bond with and intervening water leading to 
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GR92452 	 AH10853 
Figure 5-32 7-hydroxyquinoline-2-carboxylic acids GR92452 and AH1O853 
Further insight into factors governing the activity of substituted quinoline-2-carboxylic acids 
may be gained upon consideration of compounds bearing alternative functional groups at the 
8-position. Amine substituents. like the hydroxide groups, are capable of depopulation of 
the Eu(ffl) excited state by non-radiative energy transfer. 
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- 	 Relative Emission Intensity 
ACID EuBEA EuBUA EucyHA 	EumcyHA EuNBA EuBBZA EuBTA 
EJL 
AHI0300 3 - 	 - 	 - 	 3 	4 	- 3 
AHI080I 5 - 	 - 	 - 	 4 	7 	- 5 
AH9678 2 - 	 - 	 - 	 3 	3 	- 3 
AHI 0698 57 - 	 - 	 - 	 35 	46 	- 46 
AH10853 1 - 	 - 	 - 	 1 	1 	- 1 
GR92452 1 - 	 - 	 - 	 1 	1 	- 1 
Table 5-6 Relative emission intensity observed upon interaction between substituted quinoline-2- 
carboxylic acids (Figure 5-30 - 32) and the EuNALs 
5.2.8.2 Substituted Hydroxyquinoline-3-Carboxylic Acid LHC Units 
One class of acids showing particularly good potential as LHCs for our EuNALs comprises 
of compounds based on 4-hydroxyquinoline-3-carboxylic acid. Here, the interaction is via 
the bidentate "salicylate" binding unit - with a phenol functionality ortho to the carboxylate. 
The structures of the 4-hydroxyquinoline-3-carboxylic acids tested during the assay 
experiment are shown below (Figure 5-33). 
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Figure 5-33 4-hydroxyqu inol ine-3 -carboxyl ic acids 
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0 I/Io EuBTA 
Chart 5-14 1110 observed upon recognition between substituted 4-hydroxyquinoline-3-carboxylic 
acids and EuDTPA-AM2 chelates 
From the luminescence observed upon the interaction between the EuNALs and acid 
GW30473X (on average -43-fold) we know that the binding interaction is strong and that 
orbital overlap is sufficient to facilitate energy transfer between the acid triplet state and the 
emissive level of the metal. 
Upon extension of the chromophorio unit by fusing a second aryl ring to the heterocyclic 
acid, we improve the light harvesting ability of the acid as illustrated by AH10225, which 
forms ternary luminescent complexes with all of the EuNAL chelates studied here, 
enhancing the characteristic red Eu(Ifl) emission by 50-fold under the experimental 
conditions of the assay. Similarly, acid GR25 8750 exhibits excellent sensitiser behaviour 
towards our EuNALs, resulting in mixed ligand species - 200-fold more emissive than the 
parent chelate. This dramatic improvement is owed to the presence of the strongly 
electronegative -OCF 3 substituent in the 6-position of the acid. The triplet energy is affected 
greatly to the extent that an excellent match is established with the 5D0 excited state of the 
Eu(Ill) ion. 
The binding interaction may also be strengthened by the presence of the tnfluoromethoxy 
substituent, since inductive withdrawal of electron density from the aromatic system is likely 
to lower the acid pK a. Such an influence is expected to drive the equilibrium towards 
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formation of the deprotonated species, under the neutral pH conditions of the assay, thus 
more acid is available to form the ternary complex. 
It is also interesting to note that when the acid bears two electrons donating methoxy 
substituents on the second aromatic ring (AHI 1368 and AF111688) that the interaction is 
diminished greatly. These groups have the opposite effect to the -OCF 3 substituent of 
GR258750 and increase the electron density of the system, raising the PK a of the acid and the 
phenol with respect to the unsubstituted acid A1110225. This is expected to weaken the 
interaction with the metal centre and reduce the efficiency of intramolecular energy transfer 
to the excited state of the europium ion. The electron donating influence of the n-butoxy 
substituent in the 8-position (G1266527) does not destabilise the interaction significantly. 
This acid is observed to bind the EuNAL resulting in a -150-fold increase in metal emission. 
The alkyl chain substituent is also likely to provide addition protection to the metal centre 
from any quenching by outer sphere solvent molecules as discussed in section 5.2.1. 
5.2.8.3 "Salicylic Acid" LHC Units 
It is important to note that salicylic acid (Figure 5-34) is not observed to increase the 
emission of the EuNAL chelates, and does not form luminescent mixed ligand lanthanide 





Figure 5-34 Salicylic acid, CC14008 
This is attributed to the high pKa value of the phenol hydroxide, pK a 13.4 for salicylic acid 
(CC14008, Figure 5-34). The oxygen atom remains protonated at the neutral pH of the 
chelate solution. Any interaction between the carboxylate anion and the metal centre does 
not result in sensitised Eu(III) luminescence, as the close proximity of the 0-H oscillator can 
effectively depopulate the excited state of the metal by non-radiative energy transfer. The 
inactivity of Eu(III) with salicylic acid derivatives may also be due to formation of charge 
transfer states with the phenolate anion (possibly deprotonated under the influence of the 
Eu 3 closeby. The commercial assay, EALL, (Chapter 1.3.3) utilises a salicylic acid 
derivative in formation of highly luminescent Th(III) ternary complexes. It should be noted 
however, that the ThDTPA-AM, chelates tested during the assay did not give rise to 
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sensitised emission with the salicylic acid derivatives. Preliminary research in the 
Pikramenou research group revealed the mechanism by which ternary complex formation 
occurs with charged LnNAL species ([LnDTPAJ 2 , [LnEDTA}) to differ from that by which 
molecular recognition occurs with the neutral chelates. 
Similarly, ortho-hydroxynaphthoic acids (Figure 5-35) do not result in enhanced Eu(IIl) 
emission under our assay conditions. A weak interaction (-2-3 fold increase) was observed 
between the EuNALs and the acids CCI17440 and GR68891X (Table 5-7) in contrast to the 














Figure 5-35 orzho-hydroxynaphthoic acids - no interacton is observed with the EuNALs (Table 5-7) 
Relative Emission Intensity 
ACID EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA EUNAL 
CC14008 1 1 1 	2 	1 	1 	1 1 
CC117440 3 4 4 	4 	3 	3 	3 3 
GR68891 1 4 4 	4 	5 	4 	- 4 
G1148915 1 - - 	 - 	 2 	1 	- 1 
GR207121 6 4 5 	5 	6 	5 	- 5 
Table 5-7 Relative emission intensity observed upon combination of ortho-hydroxynaphthoic acids 
with the EuNALs 
The small enhancement of Eu(III) emission observed with acid CCI 17440 can be attributed 
to the presence of a second hydroxide substituent increasing the electron density of the 
aromatic system. It is proposed that the presence of the activating substituent results in a 
slight increase of electron density located at the oxygen atom of the ortho hydroxide group. 
This in turn improves the ability of the oxygen to act as a donor ligand to the hard Eu(III) 
metal centre, strengthens the interaction and facilitates more efficient intramolecular energy 
transfer. 
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5.2.9 Naphthyndine Carboxylic Acids 
When a second heteroatom is introduced to the aromatic system using naphthyridine 
carboxylic acids we observe a dramatic change in the molecular recognition between the 
acids and our EuNAL chelates. The 4-hydroxyquinoline-3-carboxylic acid binding unit 
remains unchanged with respect to the acids discussed above, but the pattern of activity with 
the metal chelates is quite different (discussed in Chapter 5.3 below). 
Both acids AR 11967 and AR 12133 (Figure 5-3 6) exhibit excellent potential as light 
harvesting units on account of the well-matched triplet energy levels and strong binding 
interaction with the metal centre. 
OH 
H 	 r1LrOH 
AH11967 	 AH12133 
Figure 5-36 Naphthyridine carboxylic acids which show excellent LHC potential 
for the EuNALs and marked selectivity towards EUNBA and EuBTA 
0 I/to EuBEA 






Chart 5-15 Selectivity of interaction between EuNALs and naphthyridine acids 
AH11967 and A}112 133 (Figure 5-36) 
It is noted that a non-chelating substituent group ortho to the carboxylate unit inhibits the 
interaction between the EuNAL and simple naphthyridine acids, as observed with 
GR216655X and GR220880X (Figure 5-37). 
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OH N3 7)OH 
GR2 1 6655X 
	
GR220880X F 
Figure 5-37 Naphthyridine acids bearing non-chelating substituents ortho to 
the carboxvlate bindin2 unit 
Neither of these acids results in any increase in metal centred emission. Steric effects 
impede the interaction between the carboxylate and the EuNAL, preventing orbital overlap 
and energy transfer. As a result no sensitised Eu(Ifl) luminescence is observed. 
5.2. 10 Sulphur and Oxygen Heterocyclic Acid LHC Units 
An interesting range of activity is observed when we study the recognition between other 











Figure 5-38 Oxygen containing heterocyclic carboxylic acids 
We note that the mono-carboxylic acid GR50838A interacts weakly with EuNALs forming 
mixed ligand species only 5-times more luminescent than the parent chelate. This acid 
exhibits bidentate binding potential via the lone pairs of the dioxane oxygen, but in water 
this interaction is very weak, and expected to be insignificant. Acid GR69421X, like 
GR50838A, forms weakly emissive ternary species in solution, coordinating via the 
carboxylate. The furan heteroatom is unlikely to bind the metal in aqueous solution. The 
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Results and Discussion 
electron withdrawing amide group can stabilise the negative charge on the carboxylate under 
assay conditions driving the equilibrium towards formation of the mixed ligand complex. 
o (lb BJBEA 
o (lb BJBUA 
E3 (lb BicyHA 
o (lb BimcyHA 
• (lb BINBA 
o (lb EuBBZA 
o I/b BiBTA 
Chart 5-16 1/10 observed upon combination of sulphur and oxygen 
heterocyclic acid LHCs with the EuNALs 
In contrast, hetero-dicarboxylic acids (Figure 5-39) result in much more luminescent ternary 
complexes in solution (Chart 5-16). It is initially surprising that the thiophene derivative, 
GR5 1678X, forms more intensively emissive species with the EuNALs than the analogous 
furan compound, GR54219X. The relative emission intensities observed for EuNBA and 
EuBBZA with each acid are - 50 and 20-fold respectively. 
0 	 OH 
Q OH 





Figure 5-39 Acid GRS 1678X and GR542 1 9X - thiophene and furan dicarboxylic acids 
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Europium, a "hard" acid by definition, normally preferentially binds "hard" donor ligands 
such as 0, 0 and N over the softer elements like sulphur. We may have therefore expected 
GR69421X to be a better LHC towards out EuNALs than GR54219X. Dipicolinic acid 
(pyridine-2,6-dicarboxylic acid) is an efficient LHC for our LnNALs in aqueous solution 
forming highly luminescent mixed ligand complexes, but the stoichiometry of the interaction 
is poorly defined. The potentially terdentate acid is capable of bridging between metal 
centres forming multinuclear species as observed with isophthalic acid (Chapter 3). 
The key to the apparent anomaly observed here might lie in the comparative atomic radii of 
oxygen and sulphur. The larger element, sulphur, forms longer bonds to carbon then the 
smaller oxygen atom (1.856 A and 1.421 A respectively), therefore distorting the chelate 
bite-angle forcing a bidentate binding interaction. In contrast, the smaller oxygen atom of 
the furan-2,5-dicarboxylic acid analogue may facilitate a terdentate binding interaction with 
the metal. Should both the carboxylate groups coordinate the metal excited state LMCT 
states may be established. Thermal population of the low lying excited states from the 5D 1 
led depopulates the emissive stae and sensitised Eu(1II) emission is not detected. 
The differing interactions between these two acids and our EuNALs can perhaps be 
explained by the relative aromaticity of the chromophore upon consideration of the 5-
membered parent heterocyclic compounds thiophene and furan (Figure 5-40). Furan, with 
the harder oxygen heteroatom, is quite diene like in character, with the oxygen reluctant to 
surrender its electrons to the aromatic ring. In contrast, the softer sulphur heteroatom of 
thiophene is less electronegative and better able to donate its electrons to the conjugated 
aromatic system. 
00, OS1  
furan 	thiophene 
Figure 5-40 
Evidence in support of this is provided by the observation that several thiophene-2-
carboxylic acids (Figure 5-41) interact with the EuNALs giving rise to ternary luminescent 
complexes (Chart 5-17). In contrast, the analogous furan-2-carboxylic acids (Figure 5-42) 
do not result in sensitised Eu(flT) emission (Table 5-8). 
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Chart 5-17 Relative emission intensities observed upon interaction of the EUNAL 






















OH 0 OH 











Figure 5-41 Thiophene-2-carboxylic acids 
134 Combinatorial Screening 





CO )1-Y 	 Y) 00 
o 0 d\  --f 0 	 0 	 0 
AH22735X 	 OH 	 GR225877X 







CroN QY0H ) N)i OH 







Figure 542 Furan-2-carboxylic acids 
Relative Emission Intensity (1/lo) 
ACID EuBEA EuBUA EucyHA 	EumcyHA 	EuNBA EuBBZA EuBTA 
AH21917X 1 1 1 	 1 	 1 1 1 
AH22735X 1 1 1 	 1 	 1 1 1 
GR177051X 1 1 1 	 1 	 1 1 1 
GW471604X 2 2 2 	2 	2 2 1 
GR152169X 1 1 1 	 1 	 1 1 1 
GR225877X 1 1 1 	 1 	 1 1 1 
GR225874X 1 1 1 	 1 	 1 1 1 
GR51045X 1 1 1 	 1 	 1 1 1 
GR193373X 1 1 1 	 1 	 1 1 1 
GR196926X 1 1 1 	 1 	 1 1 1 
Table 5-8 I/Ia  upon combination of fiiran-2-carboxylic acids and EuNALs 
Several substituted indole-2-carboxylic acids (Figure 5-43, Appendix 2) were also tested by 
combinatorial screening methods, none of which exhibited any activity towards the EuNALs. 
Under the assay conditions the lone pair electrons of the nitrogen heteroatom is and 
delocalised in the ring, maintaining the aromatic character. Consequently, these acids are 
unable to chelate the metal and any interaction would be mono-dentate via the carboxylate 
alone. In addition to this, the NH oscillator is capable of depopulating the Eu(III) excited 
state by non-radiative energy transfer. Coordination by the acid in the 2-position would 
bring the N-H bond into close proximity with the metal centre facilitating thermal 
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depopulation of the emissive 5D0 state (see salicylic acid 5.2.8.3). The absence of sensitised 
Eu(m) emission can be attributed to PET (photoinduced electron transfer) from indole to 
Eu3t' 55 
C~N (0 H 
I ridole-2-carboxylic acid 
Figure 5-43 
5.2.11 Anthraquinone Carboxylic Acids 
A variety of anthraquinone acids were also studied as potential LHCs. At first glance it 
would appear that these acids exhibit great promise as light-harvesting centres for our 
EuNAL chelates in aqueous solution. However, closer examination of the results reveals that 
much of the light emitted arises from organic fluorescence, not from the metal centre 
following intramolecular energy transfer, attributed to mismatched triplet state energies. The 
delayed organic fluorescence may be E-type, due to thermally-assisted back intersystem 
crossing from the triplet to the singlet, or by P-type, upon recombination of two triplets to 
produce a singlet. 
Anthraquinone carboxylic acids have a PK a value of 	3.4 and as a result are fully 
deprotonated under experimental conditions with the DMSO/H 20 solvent mixture stabilising 
the charge formation. Upon excitation at 275 nm, compounds of this type are known to 
undergo photochemical transformations and are unlikely to exist in the keto-form. Differing 
results are obtained upon excitation at 340 nm, although in each case the signal detected was 
predominately due to organic acid fluorescence. This is largely due to differences in molar 
absorption coefflcients of the acids and is also attributable to instrumental factors. For each 
emission/excitation wavelength pair, the Tecan Ultra automatically selects the appropriate 
mirror type. For 275/6 12 nm this is a 50% mirror, allowing transmission of only half the 
light. At ?.ex = 340 nm a dichroic mirror is selected, allowing transmission of nearly 100% 
of the light, hence stronger signals are observed. 
In all but three cases the signal detected is due to long lived organic fluorescence 
arising from excitation of the anthraquinone acids at 275 nm (Table 5-9). The feature 
common to these active acids, AH7652, AI-17697 and AH7552 (Figure 5-44) is the presence 
of a second chromophore in addition to the anthraquinone moiety. 
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Results and Discussion 
Attached in the 8-position via an ether linkage, these substituents can alter the photophysical 
properties of the acids relative to the inactive parent acid and the saturated alkyl derivatives, 
from which only organic fluorescence is observed under the assay conditions. 
ACID R1 R2 
AH11654 -OCH(CH3 )2 -H 
AH14868XX -H -OCH(CH 3)2 
AH7167 -O(CH2 )30H -H 
AH7792Z -H -O(CH2)30H 
AH7650 -O(CH2 )2CH3 -H 
AH6730 -H -OCH 3 
AH7290A -O(CH2 )2NMe2 -H 
AH7414Z -O(CH 2 )2OMe -H 
AH7621Z -H -O(CH 2 )20H 
AH7651 -O(CH2 )20(CH 2)2OMe -H 
Figure 544 Substituted anthraquinone carboxylic acids 
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ACID R1 R2 R3 
AHI520IXX -OH -H -H 
AH6859 -OMe -H -H 
AH152O3XX -OCH(CH3)2 -H -H 
GW314581X -OEt -H -H 
VVZJ4bA -U(L112)2UM -Il -Il 
GW328088X -OCH2CH(CH3)2 -H -H 
GW312792X -O(CH2)3CH3 -H -H 
GW294322X -O(CH2)2NMe2 -H -H 
GW304858X -O(CH2)20(CH2)20H -H -H 
GW312329X -O(CH2)20(CH2)20Ac -H -H 
AHI5400XX -OCH(CH3)2 -Br -H 
GW314526X -Et -H -OMe 





Results and Discussion 
Emission Intensity (I) 
ACID Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
AH7652 310 1169 1891 1157 935 2010 2205 1256 
AH7697 50 140 179 149 112 253 293 227 
AH7552 59 513 749 416 406 1044 1367 638 
AH11654 194 365 797 291 1747 2320 1562 1392 
AH14868XX 502 843 863 663 1339 1404 1352 918 
AH7167 840 921 833 801 845 893 906 869 
AH7792Z 407 390 501 491 533 598 589 555 
AH7650 816 950 960 869 955 1064 1100 955 
AH6730 607 643 613 540 582 674 682 598 
AH7290A 106 134 136 129 109 130 136 172 
A117414Z 880 843 879 852 821 863 832 788 
AH7621Z 575 587 597 584 589 571 584 570 
AH7651 700 759 744 735 753 782 738 778 
Table 5-9 Emission intensity (1) recorded upon excitation of 1:1 anthraquinone carboxylic 
acid:EuNAL solutions at 275 run. 
It is a logical progression from these anthraquinone carboxylic acids to the cyclic y-lactone 
xanthone derivatives as represented by the generic structure shown in Figure 5-45. As 
observed with the anthraquinone compounds, organic fluorescence is strong under 
experimental conditions and we must not only examine the relative emission increase with 
respect to the EuNAL, but also the raw luminescence signal from the assay giving rise to the 
following observations. 
Figure 5-45 Generic structure of xanthone carboxylic acid derivatives 
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At first glance it appears that this group of acids exhibit great promise as light harvesting 
centres for our system. This is in fact misleading since each of the acids emits strong 
organic fluorescence still detected after a 20.ts time delay following the excitation flash 
(Chart 5-18). 
Only three of the acids of this type tested enhance the luminescence from the EuNAL chelate 
in aqueous solution, distinct from the background organic emission. These acids, 
GW3 12792X, GW3 12329X and GW3 14526X (Figure 5-46), in common with the substituted 
benzoic acids discussed earlier bear a saturated aliphatic tail group, beneficial to the 
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Chart 5-18 Emission intensity observed upon excitation of 1:1 solutions of EuNALILHC at 275 nm. 
Predominantly organic fluorescence is observed. 
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Figure 546 Xanthone carboxylic acids resulting in enhanced metal centred emission 
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It is uncertain at this stage whether the activity of these acids is due to an alteration in the 
triplet-state of the LHC allowing more efficient energy transfer to the metal centre, a 
hydrophobic shielding effect, or an increased binding interaction. 
The location of electron density on the oxygen atom, discussed above when considering the 
furan derivatives (5.2.10), is likely to affect the distribution of electronic density in these 
acids. The it-electron density of these xanthone carboxylic acids is quite delocalised over the 
system, analogous to benzophenone, and have triplet state energies of similar value. In 
contrast, in the analogous thiaxanthone compounds (Figure 5-47) the ic-electron density is 
delocalised over all three rings. This is an important consideration as it is noted that the 
thiaxanthone carboxylic acids are better sensitisers for our EuNALs than the harder oxygen 
counterparts. 
0 
I 	 OH 
0 
Figure 547 Thiaxanthone carboxylic acid 
In common with the xanthone acids shown in Figure 5-45, the thiaxanthone acids bearing 
alkoxy substituents in the 6, 7 or 8 (Figure 5-48) positions give rise to strong, long-lived 
organic fluorescence under experimental conditions. We do, however observe a significant 
degree of sensitised Eu(III) emission with acid GW323591X, in which the chelate 
luminescence is enhanced 140-fold for EuNBA and EuBBZA. This increase is double that 
observed with EucyFlA, EuBEA and EuBTA (--60-fold). EuBUA and EumcyHA emission 
is increased 100-fold. 
10000 
9000 	 Ji 
5000 DAcids 
' 7000 DEuBEA 
Sc  6000 
DEuBUA 







GW322018X 	GW322801 	GW323446X 	GW323591x 
Acid 
Chart 5-19 Relative Emission Intensity observed upon excitation of 1:1 solutions of 
EuNAL: LHC at 275 nm 
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Figure 5-48 Thioxanthone derivatives showing activity towards the EuDTPA-AM 2 chelates 
The background acid fluorescence at the detection wavelength is significantly less than that 
of many of the other acids of this type, reading 139 counts in comparison to an average of 
-1000 counts. 
We attribute the strong interaction of this acid with the EuNAL to the presence of the 
powerfully electron withdrawing -CF 3 substituent in the 9-position. This group efficiently 
removes electron density from the aromatic system, stabilising the formation of the 
carboxylate anion with respect to the protonated species. Not only does this strengthen the 
binding interaction with the metal centre, but by altering the triplet state seems to lead to an 
excellent match of excited state energy levels, increasing the efficiency of intramolecular 
energy transfer. The low intensity of organic fluorescence observed with these thiaxanthone 
derivatives in combination with the intense sensitised Eu(ITI) emission is evidence for 
efficient energy transfer between the LI-IC triplet-state and metal centre. Similarly, acid 
GW323446X, bearing a bromide substituent in the 7-position is active as an LHC but the 
relative emission intensity observed is much weaker than that of the trifluoromethane 
derivative GW323591X. The activity of GW323446X may also be due to an increased 
triplet yield due to the heavy atom effect with the bromide substituent. The good activity of 
compounds GW323801X and GW32301 8X can be attributed to the steric bulk of the alkyl 
substituents in the 9 and 6-positions respectively. As expected, the tertiary butyl derivative, 
GW323018X, interacts with the EuNALs to form ternary complexes more intensely 
luminescent than the -CH3 derivative, GW323801X. As previously observed, these LFICs 
demonstrate selectivity towards EuBBZA and EuNBA, the more rigid and hydrophobic 
EuNALs. 
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5.3 LnNAL Chelatë Induced Selectivity 
The aromatic carboxylic acids screened for their ability to form ternary luminescent 
complexes with EuDTPA-AM2 chelates in aqueous solution have thus far been considered 
only from the perspective of the LHC binding and chromophoric units. We now turn our 
attention to the influence of the amide arms of the NAL on molecular recognition. It is noted 
from the assay data presented in the preceding section that several of the acids display good 
general activity towards all the EuNALs under investigation, whereas others interact more 
selectively, influenced by characteristics of the DTPA-AM 2 binding cavity. 
5.3.1 EuNAL Molecular Recognition with Substituted Phenyl LHC Units 
A feature of the substituted phenyl LHC units which result in increased sensitised Eu(III) 
emission discussed in sections is their good general activity towards the EuNALs under 
investigation, as discussed in sections 5.2.1 - 5.2.5. Interestingly, a degree of selectivity is 
seen towards EuNAL chelates by several of these LHCs, some of which form more intensely 
luminescent ternary complexes with EuNBA and EuBBZA than with the straight chain and 
cyclic aliphatic EuDTPA-AM2 derivatives. It is proposed the rigidity of the amide residues 
of DTPA-NBA and DTPA-BBZA results in a binding cavity with better definition than those 
presented by EuNALs formed from the more flexible aliphatic NALs. The effect is 
illustrated well by the benzoic acid derivatives LHCs discussed in section 5.2.4. Chelates 
EuNBA and EuBBZA interact with these acids to form ternary luminescent complexes 
exhibiting at least twice the degree of sensitisation afforded by the model chelate, EuBEA 
(Chart 5-8). A striking observation is that although there is evidence for ternary complex 
formation with EuBTA with these LHCs, the luminescence arising from this interaction is 
comparatively weak (10-20 - fold). This remarkable difference is attributable to the 
influence of the tolyl groups on the NAL cavity. A stronger background signal is detected 
with EuBTA than from the other EuNALs, due to energy transfer from the tolyl rings of the 
NAL. The molar extinction coefficient of DTPA-BTA is expected to remain unchanged 
with respect to DTPA-BBZA, since the influence of the methyl substituents on the electronic 
structure of the aromatic ring is negligible. The increased background signal with EuBTA 
relative to the other EuNALs is attributed to a combination of two effects: 
Energy transfer to the metal from the aromatic amide arms 
Increased protection of the metal centre from quenching by outer sphere solvent 
molecules provided by the methyl groups. 
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Consequently, the relative emission increase observed upon molecular recognition is reduced 
with respect to the other EuNAL chelates. Energy transfer from the aromatic amide arms 
complicates determination of sensitisation by new LHCs. 
The selectivity towards EuBUA over EUBEA may be explained by consideration of the 
amide arm length. By increasing the aliphatic chain from the two-carbon ethyl to four-
carbon butyl we enhance the lipophilicity of the chelate, encouraging inclusion of the acid 
into the cavity. It is apparent that lipophilicity alone is not sufficient to drive the interaction, 
as EucyHA would also be expected to interact more strongly than the ethyl derivative 
EUBEA. This clearly is not the case, and is suspected to be due to steric crowding imparted 
on the cavity by cyclohexyl ring-flip isomerisation (Figure 5-49). Incorporation of a 
methylene spacer between the cyclic aliphatic group and the amide bond introduces an 
additional degree of rotational freedom to the chelate cavity and may account for the 






Figure 5-49 Schematic Representation of ring-flip isomerisation in EucyHA, which may serve 
to impede the molecular recognition between EuNAL and LHC 
5.3.2 EuNAL Molecular Recognition with Quinoline Carboxylic Acid LHC Units 
The selectivity of the hydroxyquinoline acid LHCs is best illustrated by Chart 5-14 (section 
5.2.8.2). It is apparent from the bar charts that 4-hydroxyquinoline-3-carboxylic acids 
(Figure 5-35) exhibit good general activity towards our EuNAL chelates. As with the 
substituted phenyl LHC units discussed above, the maximum emission increase is observed 
upon recognition with EuNBA, due to the more rigid and well-defined binding cavity of the 
complex. It is interesting to note that the simple chelate, EuBEA, with the shortest amide 
arms is also strongly active with these acids. One striking observation is that EucyHA and 
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EumcyHA result in mixed ligand luminescent complexes with almost half the relative 
emission intensity of EuNBA. We attribute this observation to ring-flip isomerisation within 
the cyclohexyl (Figure 549) and methylenecyclohexyl amide substituent arms of the NAL, 
which may serve to impede the acid recognition process. 
5.3.3 EuNAL Molecular Recognition with Naphthyridine Carboxylic Acid LHC Units 
With these LHCs (Section 5.2.9, Figure 5-36), the selectivity towards EuNBA is observed as 
expected (Chart 5-15). This is attributed as before to the rigid nature of the amide arms, 
unable to isomerise and therefore capable of forming a well-defined cavity for recognition by 
the LHC. The interaction with the smaller aliphatic EuNALs is weaker, as the arms of the 
NAL do not lend themselves to the formation of a pre-defined approach path for the acid 
LHC to the same extent as the norbomyl derivative does. 
The naphthyridine carboxylic acids (Figure 5-36) display a marked difference in 
activity, favouring EuBTA over EuBBZA under the experimental conditions. It was 
previously observed that the relative emission intensities recorded with the tolyl derivative 
are generally lower than those of the benzyl EuNAL, due to the stronger background chelate 
luminescence (Is)  detected from EuBTA. In this case we believe that the strength of the 
recognition with EuBTA is due to it-it electronic interactions between the acid chromophore 
and the tolyl arms of the NAL. The additional methyl substituents on the aromatic ring give 
the cavity some protection against quenching by outer sphere solvent molecules. The results 
from these assay experiments do not provide us with sufficient information to draw any firm 
conclusions as to what is governing this selectivity and further experiments under different 
conditions are required. The results of subsequent binding studies are discussed in Chapter 
6. 
5.3.4 EuNAL Molecular Recognition with Sulphur and Oxygen Heterocyclic 
Carboxylic Acid LHCs 
Many of the sulphur and oxygen containing heterocyclic carboxylic acid LHC units screened 
for their ability to form luminescent ternary complexes with our EuNAL chelates exhibit 
only organic fluorescence under the experimental conditions. It is noted that those enhancing 
the metal centred emission display some selectivity towards the more rigid chelates, EuNBA 
and EuBBZA, consistent with our previous observations. Results are presented and 
discussed in sections 5.2. 10 and 5.2.11. 
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5.4 Conclusions and Predictions 
In conclusion, by employing combinatorial screening techniques in the development of 
highly luminescent lanthanide chelates, we have demonstrated that selective molecular 
recognition may be achieved based on both the acid LHC and EuNAL chelate properties. By 
screening a large library of aromatic carboxylic acids versus a selection of EuDTPA-AM 2 
chelates in aqueous solution, chosen to represent a variety of different binding sites, some 
general structural and electronic trends have been identified. 
5.4.1 The Aromatic Acid LHC 
It has been shown that incorporating a hydrophobic aliphatic alkyl or alkoxy substituent to 
the simple acid LHC (benzoate or picolinate) can dramatically enhance the luminescence of 
the ternary complex formed upon molecular recognition. The presence of resonance electron 
withdrawing substituents often strengthened the binding interaction observed between the 
metal and the LHC, whereas electron donating groups such as -OMe, -OH and -N}1 2 
exhibited the opposite effect. By striking a balance between these two influences it is 
possible to manipulate the ground state energy of the IL-electronic systems of simple acids. 
The triplet state energy is in turn modified to afford a good match with the excited state of 
the metal centre, resulting in highly luminescent chelates in aqueous solution. 
It was noted that increasing the conjugation of the picolinic binding unit by progression to 
quinoline-2-carboxylic acids does not produce the expected increase in activity. Conversely 
the interaction is weakened relative to PCA and very little sensitised Eu(III) emission is 
observed. Interestingly, 4-hydroxyquinoline-3-carboxylic acids were shown to be 
consistently good light harvesters for our EuDTPA-AM 2 chelates. Considering these 
observations we wish to predict an ideal aromatic carboxylic acid LHC for optimum ternary 
complex luminescence upon interaction with the EuDTPA-AM 2 chelates (Figure 5-50). 
The binding unit should be based on the 4-hydroxypyridine-3-carboxylic acid 
moiety. Extension of the conjugation to the quinoline system will increase the molar 
absorptivity of the acid, in turn favouring the efficiency of energy transfer to the metal. The 
efficiency of energy transfer can be modified by subtle alterations to the triplet energy of the 
acid - achieved by incorporation of such inductively electron withdrawing substituents as 
-OCF3 and -CF 3 to achieve a good match of triplet LHC and Ln(III)*  excited states energies. 
Finally, attaching an alkyl or alkoxy hydrophobic chain to the acid chromophore/binding unit 
may reduce the quenching influence of outer sphere solvent molecules giving an overall 
increase in Eu(III) emission. 
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Figure 5-50 Predicted model of an aromatic acid LHC for efficient molecular 
recognition and optimum luminescence with EuDTPA-AM2 NAL chelates 
5.4.2 The EuNAL 
During the combinatorial screening experiment the more rigid and sterically bulky EuNALs 
emerged as better receptors for the aryl acid LHCs than their smaller, less rigid counterparts. 
Molecular recognition between the well-defined cavity of EuNBA and the LHCs consistently 
resulted in intensely luminescent ternary species in aqueous solution. Similarly, a strong 
interaction is observed between EuBBZA and many of the LHCs screened. At the 
wavelength employed (275 ± 10 nm) the benzyl rings of the NAL absorb some of the 
excitation flash. By shifting the excitation wavelength further into the red (- 30 nm) such 
absorption by the NAL can be avoided, thus minimising the background Eu(ffl) emission 
sensitised by excitation of the aromatic NAL. With the aromatic NALs BTA and BBZA it-
it interactions are possible and may enhance the efficiency of energy transfer from the LI-IC 
to the metal centre. In view of improvement in luminescence upon substitution of the LHC 
with an alkyl or alkoxy tail, it might be expected that addition of such substituents to the 
amide arms of the NAL should have a similar effect. The rigidity of the cavity must be 
maintained to provide a facile approach route for the LHC upon molecular recognition. 
Progression to a more rigid sterically bulky aliphatic DTPA-bis(amide) such as an 
adamantane derivative would also be expected to improve the interaction. Extending the 
cavity using biphenyl or fused aromatics such as anthracene, naphthalene or pyrene is 
possible, but enhances the problems of NAL absorption encountered with BBZA and BTA 
although the triplet states of anthracene and pyrene are known to be too low in energy to 
sensitise Eu(ffl) emission. The binding interactions between the acid LHCs identified here 
and the chelates are studied in more detail by luminescence spectroscopy under steady state 
and time resolved excitation and the results discussed in Chapter 6. 
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6 Binding Studies 
The specific molecular interactions leading to controlled self assembly of luminescent 
ternary complexes between LnDTPA-AM 2 chelates and aromatic carboxylic acid LHC units 
in aqueous solution were investigated using a variety of spectroscopic techniques. 
Electrospray mass spectrometry was employed in identification of ternary complexes 
formation. The strength of the binding interaction and intramolecular energy transfer 
processes were evaluated by luminescence spectroscopy under steady-state monochromatic 
excitation. Time-resolved emission spectroscopy, monitoring the luminescence decay at a 
fixed wavelength upon pulsed laser excitation was used to determine the hydration state of 
the metal and elucidate potential binding mechanisms. Ternary complex formation is also 
observed by 'H and ' 3C NMR spectroscopy. 
6.1 Aromatic Acid Recognition with EuBEA 
In Chapter 3, initial emission studies on the model mixed ligand system revealed the 
different modes of molecular recognition between EuBEA and the simple aromatic acid 
LHCs, PCA, PTA, BZA, IsoPTA and D1PCA. Binding of the EuNAL by the LHC is 
accompanied by increasing metal centred luminescence, as the strongly absorbing moiety 
chelates to the metal, allowing intramolecular energy transfer to occur. The observed 
emission intensity is a function of the efficiency of all the photophysical processes occurring 
within the system, including ligand absorption, intersystem crossing from S, to T,, 
intramolecular energy transfer to the metal emissive state, non-radiative depopulation, and 
radiative decay of the luminescent level. Equilibrium constants for formation of 1:1 ternary 
complexes between the EuNAL and LHC are obtained by fitting of the spectroscopic data to 
Equation 2-4 by the method on non-linear least squares analysis. The estimated equilibrium 
constants for the formation of ternary species in aqueous solution between EuBEA and 
simple aromatic acids BZA. PTA and PCA are given in Table 6-1. The emission spectra 
obtained upon titration of the EuNAL with the LHC under investigation are integrated (572 - 
640 nm) and the change, M = I-L), plotted versus the total acid concentration (molL'). 
Results are illustrated in Figure 6-1. 
EuBEA + Acid = [EuBEA.ACID] 
Acid K (M) Log K 	(±) 
PCA 8.8 x 104 4.95 0.14(3%) 
PTA 7.3x 104 4.86 	0.19(4%) 
BZA 3.9 x 10 4.60 0.02(0.6%) 
Table 6-1 Estimated formation constants for 1:1 EUBEA.LHC in aqueous solution at 0.15 MM 
(EuNAL chelate formed in solution in cuvette prior to titration with acid) 
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Figure 6-1 Plot of 1-10 versus [LHC] (mo1L') for the interaction between EuBEA (0.15mM aq) 
and benzoic, phthalic and picolinic acids in aqueous solution (pH 7-8). Binding constant curve fits 
are in solid lines. 
These results demonstrate that PCA is a better sensitiser than PTA or BZA. This can be 
attributed to three different factors. 
1) The recognition between PCA and EuBEA is stronger than that occurring between 
the chelate and the dicarboxylate PTA or monocarboxylate BZA, due to the better 
coordinating unit. Conformational analysis (Chem 3D) shows a planar conjugated system to 
exist between Eu(I11) and PCA (Figure 6-2). Similarly, BZA-Eu(I1I) binding results in a 
planar structural arrangement. Steric and electronic constraints prevent establishment of 
such a system with phthalate as the 7-membered chelate ring is likely to be puckered in its 
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Figure 6-2 Model PCA, BZA and PTA binding interactions with Eu(111) 
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Comparison of the molar absorptivity of the acids reveals that PCA (c = 3830 
M' cm') absorbs a slightly greater cross section of the excitation energy (Xex = 270 nm) than 
either PTA (c = 3200 M'cm) orBZA (c = 2930 M'cm') 
The intramolecular energy transfer between the triplet state of PCA and Eu(III) is 
more efficient due to the short distance between the chromophoric donor ligand and metal 
acceptor established upon nitrogen coordination (Eu-N 2.4 A). In contrast, the energy 
absorbed by the benzoate and phthalate antenna ligands must travel over three bonds, a total 
distance of greater than 5 A. 
Picolinic acid was therefore selected as a model LHC with which to study the 
influence of the amide arms on the LnDTPA-AM 2 binding cavity. 
An error involved in the experimental conditions is the formation of the EuNAL in solution. 
The chelate was formed in situ upon addition of one equivalent of the deprotonated NAL 
(H20INaOH) to aqueous EuCI 3 (2 ml, 0.15 mM) in the cuvette prior to titration with the acid 
of interest. Although the major species present in solution under these conditions is the 
EuNAL complex (Log K 15), Na also interacts with the ligand (as discussed in Chapter 4) 
and the ionic strength of the solution is not controlled. 
6.2 Factors Affecting Picolinic Acid LHC Recognition 
As discussed in Chapter 4, the preparative method employed in isolation of the EuNAL 
influences the ternary complex formation with PCA. It should be noted that the binding 
between picolinic acid and the EuNAL chelates isolated at pH 7 or greater, (and those from 
the Eu203 starting material) was much weaker than expected, on average resulting in a 5-6 
fold increase in emission intensity for both EuBEA and EucyHA. Emission spectra obtained 
upon excitation of equimolar EuNAL:PCA samples show the observed increase in sensitised 
Eu(III) luminescence (Figure 6-3). The characteristic absorption of PCA around 270 nm 
present in the excitation spectra (Figure 64) when emission is monitored at 616 nm provides 
unequivocal evidence for the intramolecular absorption energy transfer emission (AETE) 
mechanism. The comparatively inefficient intramolecular energy transfer is a consequence 
of the mode of LHC binding, influenced by the presence of hydroxide ions. 
Picolinic acid coordination is expected to occur via the carboxylate group only, with 
the nitrogen unable to participate in chelation. The luminescence lifetime measurements 
discussed below shed some light on the possible mechanism of interaction. 
149 Binding Studies 





550 	570 	590 	610 	630 	650 	670 	690 	710 
Wavelength (nm) 
Figure 6-3 Emission spectra obtained upon combination of EuBEA and EucyHA 
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Figure 64 Excitation spectra (no correction for lamp response) of EuBEA and 
EucyHA in aqueous solution (0.1 mM, pH 7) with I equivalent PCA (X em = 616 nm) 
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Luminescence lifetime data obtained upon pulsed laser excitation of the sample at 355 nm, 
as detailed in section 2.6.4, is fitted by the method of non-linear least squares curve fitting to 
a single or bi-exponential decay model (Equation 2-5), is given in Table 6-2. Molecular 
recognition between the EuNAL and picolinic acid is accompanied by an increase in the 
luminescence lifetime of the metal, evidence that high energy OH oscillators are displaced 
from the primary coordination sphere of the metal. For the chelate complexes prepared and 
isolated from solutions of EuCI 3 and the appropriate ligand in the presence of TBAOH (pH 
-7) an increase in lifetime of approximately 50 .ts is observed upon the LHC binding event. 
Examples of typical EuNAL and [EuNAL.PCA] luminescence decay curves and fits are 
illustrated in Figure 6-5. 
EuNAL + PCA (),ex = 355 nm) TbNAL + PCA (Aex = 355 nm) 
Chelate LHC t (ms) 	+1- Chelate LHC t (ms) 	+1- 
EuBEA - 0.574 	0.001 TbBEA - 1.710 	0.0024 
PCA 0.630 	0.001 1 PCA 1.698 	0.0025 
2 PCA 0.629 	0.000 2 PCA 1.689 	0.0020 
3 PCA 0.626 	0.000 3 PCA 1.684 	0.0026 
EuBUA - 0.578 	0.001 TbBUA - 1.699 	0.0021 
PCA 0.635 	0.001 1 PCA 1.689 	0.0018 
2 PCA 0.643 	0.001 2 PCA 1.679 	0.0017 
3 PCA 0.643 	0.001 3 PCA 1.671 	0.0018 
EuBBZA - 0.524 	0.001 TbBBZA - 1.588 	0.0022 
PCA 0.776 	0.015 1 PCA 1.611 	0.0028 
2 PCA 0.877 	0.025 2 PCA 1.587 	0.0036 
3 PCA 0.707 	0.356 3 PCA 1.564 	0.0024 
EucyHA - - 	- TbcyHA - 1.647 	0.0020 
PCA - 	- 1 PCA 1.627 	0.0020 
2 PCA - 	- 2 PCA 1.620 	0.0018 
3 PCA - 	- 3 PCA 1.610 	0.0024 
Table 6-2 Luminescence lifetimes for EuNAL and ThNAL ternary complexes formed upon molecular 
recognition with the PCA binding unit. 
The corresponding terbium chelates do not show a measurable increase in the 
luminescence lifetime upon picolinic acid recognition. This is a reflection of the relative 
quenching power of the OH oscillator towards Eu 3 ( 5 130 ) and Th3 ( 5 D4 ) respectively. The 
observed luminescence lifetime of the ThNAL species in aqueous solution measured upon 
excitation at 355 nm is circa 1.6 ms. This is significantly longer than that observed for the 
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EuNAL species, (0.5 ms), exhibiting the same coordination polyhedron. Picolinic acid 
binding, displacing the remaining H 20 from the coordination sphere, has a less significant 
bearing on the luminescent lifetime of the TbNAL.LHC ternary complex than that of the 
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Figure 6-5 Linear plot: Luminescence decay curves of EuBUA and [EuBUA.PCA] mixed ligand 
complexes in aqueous solution (0.01 M, ?.ex = 355 rim, Xem = 616 rim) 
It is clear from the above observations that PCA is forming ternary luminescent 
complexes in the presence of competing hydroxide ligands, however, the relative emission 
intensity is somewhat diminished. The consequences of 01-I coordination are evaluated in 
Chapter 6.2.1 below. 
6.2.1 Competing Coordination by Hydroxide Ligands 
Regardless of the mechanism of 01-I coordination to the EuNAL, whether by displacement of 
the neutral coordinating water molecule by the anionic hydroxide ligand or by proton 
transfer, the equilibrium is expected to lie to the side of the [EuNAL.O1-[] - species at high 
pH. 
NMR studies reported' 56  on GdDTPA-AM and GdDTPA-AM2 (Log K 1. 15) 
chelates describe an increase in the relaxation time of the protons of the coordinated water 
molecule in comparison with the anionic chelate [GdDTPA] 2  (Log Ko. 22).130 133 
Replacement of one ligand carboxylate group with an amide results in a decrease in the 
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exchange rate of the metal bound water molecule by a factor of approx. 4, attributed to the 
lower thermodynamic stability of the Gd(III) amide bond with respect to carboxylate 
coordination. In neutral DTPA-AM 2  species the longer amide Gd-O bond (2.444 A) (relative 
to the carboxylate Gd-O (2.40 A)) results in a less crowded inner coordination sphere than 
that of the analogous anionic DTPA complexes. It was shown that the dissociatively 
activated water exchange mechanism was favoured in complexes with a tight inner 
coordination sphere. Additionally it was proposed that the positively charged metal centre is 
more exposed to the solvent environment in the amide complexes than in the corresponding 
aminopolycarboxylate species. 
It is therefore reasonable to expect similar behavioural trend when a hydroxide 
ligand occupies the remaining binding site of the EuDTPA-AM2 chelates. The less shielded 
positive charge on the metal is likely to increase the strength of an electrostatic interaction 
with the anionic hydroxide ligand. The protonation constant of the water in an aqueous 
solution of the Eu(II1) ion 141  is 8.3 It is proposed that the PK a of the metal bound water in 
the EuDTPA-AM 2  complex is reduced with respect to the free aqueous ion, an important 
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Figure 6-6 EuNAL + PCA binding interactions in the presence of competing hydroxide ligands 
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Picolinic acid coordination, expected to occur via the bidentate binding unit (comprising the 
deprotonated carboxylic acid and the nitrogen heteroatom of the aryl ring) becomes 
increasingly difficult when a hydroxide ligand occupies the ninth coordination site of the 
EuNAL chelate. Three possible mechanisms of coordination are illustrated above (Figure 6-
6) and are discussed below. 
Mode (a) is the bidentate interaction forming a 5-membered chelate ring between the 
metal and the ligand heteroatom and carboxylate, expected to result in increasing metal 
centred emission. A lengthening of the observed luminescence lifetime 45 by approximately 
0.6 ms is predicted as the OH oscillators for one water molecule are displaced from the inner 
coordination sphere. In mode (b) a hydroxide ligand occupies the ninth coordination site of 
the metal. The PCA-Eu(III) interaction is not sufficiently strong to displace the OH ligand 
completely, and any sensitised emission observed is the result of energy transfer occurring 
via the coordinating monodentate carboxylate group only. The nitrogen heteroatom is not 
expected to bind the metal in this species, and no increase in the luminescence lifetime is to 
be expected since the number of OH oscillators in the inner sphere of the metal is unchanged 
with respect to the EuNAL species. In mode (c) the hydroxide ligand is not displaced from 
the metal centre, but acts as a bridge forming an H-bonding linkage between the negatively 
charged carboxylate and the partial positive charge on the coordinated OH. This binding 
interaction is expected to give rise to an increase in sensitised metal emission. Energy 
transfer is facilitated by the H-bonding network between the LHC and the EuNAL as the 
acid is not bound directly to the metal centre. A slight increase in luminescence lifetime is 
also to be expected. Interaction with the LHC may result in a change in the stretching 
frequency of the coordinated OH oscillator, thus slightly altering the observed lifetime. As 
the EuNALs studied exhibit an increased luminescence lifetime upon LHC recognition in 
aqueous solution, it is proposed that mode (c) is the mechanism by which PCA coordination 
occurs in the presence of competing hydroxide species. Improved sensitisation of Ln(III) 
luminescence is observed upon picolinic acid recognition with the chelates which were 
isolated from aqueous solution at pH 5-6 (avoiding OH coordination: Chapters 2, 4). 
Binding studies with analogous ThNAL chelates demonstrated controlled formation of 
mixed ligand luminescent complexes with PCA. Increasing sensitised terbium emission was 
observed upon excitation of the sample at kex = 270 nm but no change in luminescence 
lifetime detected upon molecular recognition. At 20 430 cm - 'the 5 D4 excited state of 
n(III) is much less susceptible to depopulation by non-radiative energy transfer to OH than 
the corresponding 5 D0 level of Eu(III) (17 250 cm'). Consequently, a reduction in the 
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stretching frequency of 0-H bond due to interaction with the carboxylate group (Figure 6-6 
(c)) will not give rise to a significant change in luminescence lifetime. Intramolecular 
energy transfer between the LHC and the metal is confirmed by the presence of the 
characteristic PCA absorption band in the excitation spectra (Appendix 3). 
6.3 Picolinic Acid Molecular Recognition with EuDTPA-AM2 Che!ates 
6.3.1 PCA Recognition: Luminescence Studies 
The PCA binding unit is observed to recognise the binding cavity of the EuNAL chelates. 
The effect of the amide arms on this molecular recognition was evaluated using EuNBA, 
EuBBZA and EuBUA, each forming 1:1 mixed ligand luminescent complexes with PCA 
(Figure 6-7). In agreement with results of the combinatorial screening experiment, EuNBA 
is observed to form a more intensely luminescent ternary complex with PCA than EuBUA or 
EuBBZA. 
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Figure 6-7 Relative emission intensity versus mole ratio [PCA]/[EuN AL] for formation of I: I 
mixed ligand complexes between EuNBA, EuBUA and EuBBZA (0.1 mM aq, pH 7, X ex 270 nm) 
Controlled assembly of the 1:1 mixed ligand species between EuNBA and PCA 
triggers a 30-fold increase in sensitised Eu(III) emission. in contrast, the analogous ternary 
species with EuBUA affords approximately 6-fold enhancement under similar experimental 
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conditions, and PCA recognition with the aromatic derivative, EuBBZA, yields a ternary 
complex with barely double the emission intensity of the EuNAL chelate upon excitation at 
270 nm. Emission spectra are shown in Figure 6-8. The linear plot of the change in 
emission intensity versus total acid concentration and theoretical curve fits for the binding 
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Figure 6-8 Emission Spectra of EuNBA, EuBUA and EuBBZA 1:1 mixed ligand complexes with 
PCA (0.1 mM aq, pH 7, X ex = 270 nm) 
Chelate Log KPCA Error ± 1110 
EuNBA 5.12 0.06 32 
EuBUA 5.43 0.07 6 
EuBBZA 5.18 0.06 2 
Table 6-3 EuNAL + PCA = [EuNAL.PCA] binding constants 
It is noted that despite the greatly improved luminescence observed upon 
PCAIEuNBA binding, the estimated formation constant for the interaction (Log KPCA) is of a 
similar order of magnitude (Table 6-3) to that of PCA recognition with EuBBZA and 
EuBUA. It is proposed that the strength of molecular recognition is principally governed by 
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the acid binding unit rather than by hydrophobic, electronic or steric effects imparted on the 
cavity by the amide arms of the NAL. In contrast, the efficiency of the energy transfer to the 
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Figure 6-9 Plot of emission intensity (I-I a) of the EuNALs versus PCA concentration (molL5 
upon molecular recognition between EuBUA, EuNBA and EuBBZA, (0.1 mM aq, pH 7) and PCA 
(X ex = 270nm) 
The flexible n-butyl arms of DTPA-BUA are expected to offer less protection to the 
metal from quenching effects of outer sphere water molecules than the bulky, rigid and 
hydrophobic DTPA-NBA ligand. It is possible that when PCA coordinates the Eu(III) metal 
centre in EuBIJA, the butyl arms are repelled from the LHC and facilitate approach of high 
energy OH oscillators. The steric bulk and hydrophobicity of the rigid norbomyl groups is 
capable of forming a protective shield around the binding cavity. Quenching effects of outer 
sphere water molecules are minimised and the efficiency of intramolecular energy transfer 
from the triplet state is maximised. The hydrophobic nature of the amide substituent groups 
is likely to favour exchange of the of the coordinated water molecule by a dissociative 
mechanism. Consequently, the rate of exchange between PCA and water in the binding 
cavity of EuNBA at equilibrium is expected to be slower than the corresponding rate in the 
acyclic EuBUA system and a better interaction between the nitrogen heteroatom of the 
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aromatic ring and the emissive metal centre of EuNBA can be established. In addition to the 
steric and hydrophobic interactions important in molecular recognition with the aliphatic 
derivatives, electronic effects are expected to be implicated in PCA molecular recognition 
with aromatic chelates such as EuBBZA. 
The relatively small increase in sensitised emission observed upon PCA!EuBBZA 
recognition is attributed to the residual absorbance of the DTPA-BBZA ligand. The 
aromatic arms of this ligand absorb UV radiation around 270 rim, the excitation wavelength 
employed in this study of PCA binding. Some of this energy is transferred to the metal 
centre resulting in stronger background EuNAL luminescence than observed from the 
aliphatic chelates under the same experimental conditions. Consequently, the relative 
emission intensity for the interaction is reduced with respect to the luminescence observed 
with the aliphatic systems. 
Coordination by the aromatic acid LHCs is required in order for intramolecular energy 
transfer to occur. The carboxylic acid must be deprotonated prior to combination with the 
EuNAL solution. Maximum emission intensity was observed upon addition of PCA solution 
at pH 7 (Figure 6-10) to EuBEA (0.1 mM aq, pH 7). At lower pH a greater proportion of the 
acid is protonated and unable to fulfil its LHC potential (pKa 5.4). At high pH hydroxide 
ions can compete for the remaining Eu(1II) coordination site reducing the overall observed 
emission intensity, as discussed in 6.2.1. 
EJBEA 
F'CA pH 4.5 
RA pH 7.1 
FnI 
	 RA pH 10.5 
Wavelength (nm) 
Figure 6-10 Eu(1l1) emission spectra upon addition of PCA (pH 4.5, pH 7 and p1-I 10.5) to EuBEA 
(pH 7, 0.1 mM aq) k ex 270 nm, corrected for PMT response 
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In contrast to the aliphatic DTPA-AM 2 chelates, in which coordination of the LHC is 
prerequisite for AETE, the aromatic derivative, EuBBZA, exhibits an increase in sensitised 
emission upon addition of toluene (1:1 v/v CH 3CN) to the aqueous chelate sample (Figure 6-
11). Characteristic UV absorbance around 270 nm is observed in the excitation spectrum 
(em = 616 nm) in addition to the residual absorbance of the benzyl arms of the NAL 
(Figure 6-12). Toluene bears no lanthanide binding unit and is unable to coordinate the 
metal centre. The increase in sensitised emission is attributed to it—it electronic interactions 
occurring between the EuNAL and the LHC. The published crystal structure of the 
diamagnetic analogue, [YBBZA.H 20].3H20 25 (Figure 6-13) shows a face-edge 
arrangement of the two aromatic rings of the benzyl arms in the solid state (centroid-centrid 
5.5 11 A; edge-centroid 4.365 A). It is proposed that toluene forms an inclusion type 
complex with EuBBZA in water, and that the observed AETE occurs by an intermolecular 
FRET mechanism between the aromatic moieties, followed by intramolecular energy transfer 
between DTPA-BBZA and the 5 D0  excited state of the Eu(III) ion. No sensitised emission is 
observed upon addition of toluene to the cyclic aliphatic derivatives, EucyHA or EumcyllA 
(Figure 6-14, 15), supporting the observation that the molecular recognition between toluene 
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Figure 6-11 Emission spectra of EUBBZA (0.1 mM aq) ± toluene (1:1 v/v CH3CN) (X ex 270 run) 
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Figure 6-12 Excitation spectra (X em 616 rim) of EuBBZA (0.1 mM aq) + toluene (1:1 v/v CH 3 CN) 
Figure 6-13 [YBBZAH 20] X-ray structure 26 (Chem 3D view) 
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Figure 6-14 Emission spectra (X ex 270 nm) of EumcyHA and 
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Figure 6-15 Excitation spectra (X em 616 nm) of EumcyHA and 
EucyHA (0.1 mM aq) + toluene (1:1 v/v CH 3CN) 
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To summarise, it is apparent that the model LHC, picolinic acid, is capable of selectively 
recognising the binding cavity of the EuNAL chelates in the controlled formation of ternary 
luminescent complexes in aqueous solution. The selectivity induced by the amide ligand is 
rationalised upon consideration of the properties of the arms. In conclusion, it is observed 
that increasing the steric bulk and rigidity of the DTPA-AM, employed as the NAL greatly 
benefits luminescent ternary complex formation with the simple aryl carboxylic acid. PCA, 
consistent with the results of the combinatorial screening experiment. 
6.3.2 PCA Recognition: NMR Studies 
Further to the preliminary studies described in Chapter 3, whereby the binding of PCA to the 
diamagnetic chelate, LaBEA, was observed by 'H NMR spectroscopy, an investigation was 
undertaken to establish the extent of the interaction between the acid and the amide arms of 
the binding cavity. 
[LnDTPA] 2 and LnDTPA-AM, species have been extensively studied by several 
research groups whose interest lies in development and characterisation of Gd(IIl) 
complexes for application in MR]. Although thermodynamically very stable (Log K - 15) 
the complexes are kinetically quite labile and exist as a series of interchanging conformers in 
aqueous solution. 121 130 134, 136, 156 Isomerism occurs by rearrangement of the coordination 
polyhedron, involving dissociation of the Ln-O and Ln-N bonds (\G 283 = 71 kJ/mol for 
La(III)DTPA-bis(n-propylamide. from ' 3C NMR). 134 The rate determining step in the 
dynamic isomerisation process was found to be inversion of the terminal diethylenetriamine 
nitrogen atoms (k 283 = 0.7 s5.  In contrast, carboxylate exchange is rapid on the NMR 
timescale, and values of G283 = < 43 kJ/mol and k 283  > 9.6 x 10 3 s' are reported.' 
14 
Consequently, the NMR spectra observed comprise the average of several signals for each 
distinct nucleus in fast exchange on an NMR timescale. 
Several NMR experiments were performed in an attempt to detect an interaction 
between the aliphatic protons of the amide arms and the aromatic PCA protons. One 
dimensional NMR ('I-I and 13C) for LaBUA and [LaBUA.PCA] are shown in Figures 6-16 - 
6-21. It is noted that the methylene and terminal -CH 3 protons of the n-butyl groups give rise 
to single resonances, which become multiple signals upon PCA binding (Expanded spectra 
shown in Figures 6-18 and 6-19). Similarly, a sharpening of the resonances of the 
diethylenetriamine backbone is observed, indicative of the interaction. The change in the 
spectra is attributed to a conformational locking effect, which restricts the rotational 
isomerisation process occurring more rapidly in the LaNAL species. The number of 
resonances observed in the ' 3C spectra increase accordingly. The rate of isomerisation is 
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reduced and the number of distinct nuclei detected at any given point in time increases as the 
diasteriomers become longer lived on the NMR timescale (The rate is expected to be less 
than < 0.7 s 1 , based on the literature values discussed above). 
Preliminary two dimensional NMR preliminary experiments (NOESY) failed to 
detect any through space interaction between the aromatic resonances of PCA and those of 
the aliphatic protons of the DTPA-AM 2 arms. Corresponding observations were made with 
LaBBZA (Appendix 4). The cyclic aliphatic derivatives LacyHA and LaNBA could not be 
studied due to their limited solubility. In an attempt to overcome these limitations the 
analogous Y(III) complexes were prepared. Although soluble at concentration suitable for 
NMR, these chelates did not exhibit any interaction with the added PCA ligand. It was 
suspected initially that the absence of an interaction was due to the small ionic radius of the 
Y(III) ion (0.93 A) in comparison to that of La" (1.06). Expansion of the Y(III) inner 
coordination sphere to accommodate 10 ligands is expected to be more difficult for the 
smaller ion. Upon reflection, it is noted that the ionic radius of Y(III) lies between that of 
Eu(III) and Th(III) (0.95 A and 0.92 A respectively) both of which exhibit molecular 
recognition with the PCA binding unit, detected by luminescence. It is more likely that the 
interaction is inhibited by hydroxide (or OD) coordination under the experimental conditions 
(pD - 7). The formation constants for Ln-OH species are given in Table 6-4. 







Table 6-4 Formation constants for Ln (OH) species (Lange's Handbook of Chemistry, 13th  Ed) 141 
It is noted that the stability constant for OH binding to yttrium (Log 5.0) is of similar 
magnitude to that of PCA recognition with EuDTPA-AM 2 species (Log 4.9). The binding 
constants for OH coordination to Eu(III) and Th(III) are also expected to be of this 
magnitude. The hydroxide ligand can therefore be expected to compete efficiently with 
PCA for the remaining coordination site of YNAL chelates, as discussed for Eu(III) and 
Th(III) in section 5.2.1. In contrast, the much lower hydroxide binding constant for La (Log 
3.3) explains why acid recognition is observed with this metal and not yttrium. No 
interaction was detected between PCA and the diamagnetic LuBUA derivative, attributed to 
both the small ionic size (0.85 A) and the high stability constant for hydroxide binding (Log 
6.6). 
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	Figure 6-17 'H NMR spectrum of[LaBUA.PCAJ ternary complex (400 MHz, D 20, pD 7-8) 
Results and Discussion 
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Figure 6-18 Expanded 'H NMR spectrum: LaBUA amide arm region (400 MI-li, D 20) 
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Figure 6-19 Expanded 'H NMR spectrum: [LaBUA.PCA] ternary complex, amide arm region 
(400 MHz, D,O) 
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6.4 Aromatic Acid Recognition with the EuNBA Binding Cavity 
Studies into the influence of the amide arms of the EuNAL on picolinic acid molecular 
recognition revealed that EuNBA consistently afforded more intensely luminescent ternary 
complexes than the other less rigid EuDTPA-AM 2 chelates. A case study was performed 
employing EuNBA as a model chelate, providing a well-defined cavity, with which to 
compare the interaction of aromatic carboxylic acids identified by combinatorial screening as 
potential LHC units. 
6.4.1 Simple Aromatic Acid Recognition 
Molecular recognition between the simple aromatic acid LHCs (benzoate, phthalate and 
picolinate) and EuNBA was investigated by steady-state and time-resolved luminescence 
spectroscopy. Consistent with initial observations made with EuBEA, PCA was observed to 
interact more strongly with EuNBA, forming a much more intensely luminescent mixed 
ligand chelate than that formed upon phthalate or benzoate recognition (Figure 6-22). In 
addition, it is noted that the binding constants (Table 6-5) for all three acids are greater than 
those observed for the corresponding molecular recognition with EuBEA. 
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Figure 6-22 Relative emission intensity versus mole ratio of [LHC}/[EuNBA] for PCA, PTA and 
BZA molecular recognition (0.1 mM aq, pH 7, X ex 270 nm) 
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Chelate Acid Log K 	Error (±) 1/10 
EuNBA PCA 5.12 	0.06 32 
EuNBA PTA 4.98 	0.08 2.5 
EuNBA BZA 4.38 	0.5 1.5 
Table 6-5 EuNBA+ LHC binding constants 
The equilibrium constant for the weak binding interaction between EuNBA and BZA, Log 
K1ZA, is 4.38 ± 0.5 (R = 0.995 17). Very little energy transfer is observed between the acid 
and the Eu(1ll) metal centre at 1: 1 stoichiometry. Benzoic acid is readily displaced upon 
addition of phthalic acid (Log 4.98 ± 0.08) to the solution sample. Similarly, the 
stronger binding between PCA and the EuNAL (Log KPCA = 5.12 ± 0.06) results in a further 
increase in sensitised emission. Spectra are illustrated in Figure 6-23 below. 
-EjjNBA 
1 eq BZA 
2eq BZA + leq PTA 
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Figure 6-23 Europium emission spectra of EuNBA (0.095 mM aq) upon combination with BZA. 
PTA and PCA. (pH 7-8) illustrating molecular recognition 
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Similar behaviour is observed for the aliphatic chelate EuBUA and the aromatic 
EuNAL species EuBBZA. Lifetime data for the EuBBZA and EuBUA solution samples are 
presented in Table 6-6. 
Chelate LHC t (ms) Error (±) 	% 
EuBUA - 0.83 0.005 	0.6% 
2eq PTA + leq PCA 1.076 0.005 	0.5% 
EuBBZA - 0.779 0.004 	0.5% 
I eq PTA 0.802 0.004 	0.5% 
I eq PTA + 3 eq PCA 1.325 0.01 	0.8% 
Table 6-6 EuNAL and ternary complex luminescence litetimes in aqueous solution 
(0.1 mM, pH 7, X ex = 532 nm) 
Luminescence lifetime measurements confirm the expected mechanism by which controlled 
assembly of the mixed ligand complexes between the EuNAL and PCA occur. Solution 
samples irradiated at 532 nm by a pulsed laser excitation source emitted characteristic 
Eu(III) luminescence at 616 nm, the decay of which was monitored. Under the experimental 
conditions, the EuNAL lifetime (- 0.8 ms) is increased substantially (= 0.6 ms for EuBBZA 
at saturation concentrations of LHC) upon displacement of the coordinating water in the 
presence of excess PCA. The observed lifetime of Eu(PCA) 3 in aqueous solution is 
approximately 0.2 - 0.3 ms, much shorter than that of the ternary complexes due to the 
adverse influence of quenching solvent OH oscillators. The measured EuNAL lifetime is 
longer than those reported in Table 6-2 due to the measures taken to avoid hydroxide 
coordination in preparation of the chelates. 
Electrospray mass spectrometry of emission samples provides supporting evidence for 
ternary complex formation (Table 6-7). The mixed ligand species are observed in both the 
positive and negative ionisation modes. Complexation by all three acids, BZA, PTA and 
PCA is detected simultaneously, confirmation of competitive binding and the similar 
magnitude of the equilibrium constants measured by luminescence spectroscopy. 
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Chelate ES +1- Acid Peak (miz) Assignment 
EuBUA + - 674/676 [EuBUA + Na] 
+ PCA 819/821 [EuBUA.PCA + 2Na 
+ PTA 884/886 [EuBUA.PTA + 3Naf 
+ BZA 896/898 [EuBUA.BZA+3H] - 
EUBUA - - 650/652 [EuBUA-H] 
- 817/819 [EuBUA+PTA] 
EuBBZA + - 742/744 [EuBBZA+ Na] 
+ PCA 887/889 [EuBBZA.PCA + 2Na] 
+ PTA 907/909 [EuBBZA.PTA+ Na+ 2H] 
EuBBZA - - 718/720 [EuBBZA-H] 
- PTA 885/887 [EuBBZA.PTA+H] 
Table 6-7 Electrospray mass spectrometry data for ternary complex formation in aqueous solution 
Several acids bearing the "picolinic" binding unit were identified as potential light-
harvesting centres by combinatorial screening under time-resolved conditions (Chapter 
5.2.7). The mode of interaction with the EuNAL chelates was studied in greater detail under 
steady-state monochromatic excitation. 
6.4.2 Substituted Picolinic Acid LHCs 
The influence of substituent effects on the binding interaction between the PCA unit and 
EuNALs was briefly investigated during the high throughput screening experiment. The 0-
CH 2Ph substitutcd picolinic acid GW369905X (Figure 6-25) facilitates a 5-6 fold 
enhancement of metal centred emission from each of EuNBA and EuBUA (Figure 6-24). 
The reduction in activity with respect to PCA is attributed to the electronic influence of the 
benzyl ether substituent. The resonance effects of the substituent para to the heteroatom 
must be taken into account when considering the pKa values for GW369905X (Table 6-8). 
With a PK a of 6.71 this compound is expected to be protonated to a greater extent than the 
parent PCA LHC at pH 7. Consequently, the initial interaction between the LFIC and 
EuNAL is expected to be weaker and the acid unlikely to fulfil its bidentate binding potential 
towards the Eu(III) metal centre. The efficiency of intramolecular AETE is reduced and the 
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resultant mixed ligand species is considerably less luminescent than the analogous 
[EuNAL.PCA] complex. In addition, adverse steric interactions between the amide arms and 
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Figure 6-24 Emission spectra for the 1:1 mixed ligand species formed upon 
combination of EUBUA and EuNBA with acid GW369905X (). ex 270 nrn) 











Table 6-8 pK values for substituted picolinic acids (calculated using pKadB4.() software) 
EuBUA was titrated with the alkyl substituted picolinic acid, GR34043X (Figure 6-25), and 
observed to form a 1:1 mixed ligand luminescent species, enhancing the metal emission 
approximately 10-fold. This increase is comparable to that observed with PCA under the 
same experimental conditions (0.1 mM aq, pH 6-7. A ex = 270 nm. 150 W Lamp). The 
binding constant for the interaction is in each case approximately Log K = 4.9. No 
detectable difference in the strength of binding interaction or efficiency of energy transfer is 
observed between these two acids with EuBUA under steady-state excitation. It is 
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conceivable that an improvement may be detected with the alkyl substituted acid under time-
resolved experimental conditions. The luminescence lifetime of EuBUA with GW369905X 







Figure 6-25 Substituted picolinic acids 
6.4.3 Thiophene and Furan Carboxylic Acids 
The thiophene and furan-2,5-carboxylic acids GR51678X and GR54219X (Figure 6-26) 
were combined with EuBUA in :1 stoichiometry. Some interesting differences are 
observed between the emission spectra of the solution samples (Figure 6-27). An increase in 
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Figure 6-26 Thiophene and furan-2,5- dicarboxylic acids 
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The thiophene derivative GR51678X is more active towards EuBUA than the 
analogous furan derivative GR542 1 9X. As discussed in Chapter 5.2.10, this is attributed to 
the relative aromaticity of the heterocyclic ring. The thiophene ring with the softer su;phur 
heteroatom is more aromatic in character than the furan ring with the harder oxygen 
heteroatom. The peak ratio 592:616 nm differs slightly between the furan and thiophene 
dicarboxylic acids, suggesting a change in the ligand environment with respect to the 
EuNAL chelate, though in both cases the relative intensity 592:616 is roughly equal. In 
contrast to the nitrogen heterocyclic acids, which act as bidentate binding units, these LI-ICs 
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Figure 6-27 Emission Spectra: EuBUA (0.05 mM aq, pH 7) + GR51678X and GR54219X (.ex = 300 mu) 
6.4.4 Quinoline-2-Carboxylic Acid LHCs 
The influence of extension of the chromophoric unit and further substitution of PCA (Figure 
6-28) was investigated using EuNBA and EuBUA as model EuNAL chelates. Interestingly, 
it is observed that these acids are poor sensitisers for Eu(III) ternary complex formation, in 
contrast to picolinic acid. Estimated pKa values (pKadB 4.0) are given in Table 6-9. 
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Figure 6-28 Quinoline-2-carboxylic acids 
Acid pK11 ± pK12 ± pK 3 ± 
A1-19727 5.34 0.40 1.20 0.30 - - 
A1-112695X 5.76 0.50 0.95 0.30 - - 
A1-19676X 6.62 0.50 1.05 0.30 - - 
GR92452X 9.98 0.10 4.91 0.40 1.32 0.30 
Table 6-9 pKa values for quinoline-2-carboxylic acids (Figure 6-28) calculated using pKadB 4.0 
Acid A1-19727, quinoline-2-carboxylic acid, is observed to result in a two-fold 
enhancement of Eu(III) emission in aqueous solution at neutral pH, forming a 1:1 mixed 
ligand species with EuBUA. The emission and excitation spectra for the system at 
equilibrium are obtained upon excitation at 270 nm and monitoring emission at 616 nm 
respectively are shown below in Figure 6-29 and 6-30. It is noted that the normally 
hypersensitive transition at 616 nm is less sensitive to A}-19727 binding than the 592 nm 
band, as observed for EuNBA/BZA recognition (Figure 6-3 I). AH9727 is a poor sensitiser 
for our EuNAL species, with very little energy transfer observed between the acid and the 
metal centre. 
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Figure 6-30 Excitation spectra of EuBUA (0.01 mM aq) + I eq AH9727 (?em = 616 nm) 
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Figure 6-31 Emission spectra of EuNBA (0.05 mM aq) + BZA (Xex = 270 nm) 
As pKa of acid AH9727 (pKai 5.34) is similar to that of the efficient LHC, PCA 
(pKa 5.40), the LHC is not expected to be significantly protonated under the experimental 
conditions. The inactivity of AH9727 cannot be directly attributed to the protonation state of 
the acid and additional factors must be considered. The inefficient interaction is therefore 
attributed to the hydrophobic nature of the H atom in the 8-position of the acid, impeding 
bidentate binding via the heteroatom and carboxylate. 
The light-harvesting abilities of a selection of the substituted quinoline-2-carboxylic acids 
(Figure 6-28) evaluated by high throughput screening were studied under steady-state 
excitation. Consistent with the results of time-resolved assay experiment (Chapter 5.2.8.1), 
these acids exhibit relatively poor sensitising properties towards the EuNAL chelates with 
respect to picolinate, attributed to mismatched triplet energy levels. 
The difference between the emission spectra obtained from 1:1 solution samples of 
EuNBA and acids A119676 and AF112695 (Figure 6-32) is attributed to the influence of the 
substituent in the 4-position. Whilst both LHCs are poor sensitisers for this system, only 
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facilitating approximately 4-fold enhancement of Eu(III) emission, it is noted that the mode 
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Figure 6-32 Emission spectra of EuNBA (0.05 mM aq) + substituted carboxylic acid LHC units 
AH12695 and AH9676 (X ex = 300 run) 
Acid Al-I 12695 bears an aromatic ether -OPh substituent. This group is electron 
withdrawing, reducing the coordinating ability of the nitrogen heteroatom (pK a 2 0.95) with 
respect to PCA (pK a 2 1.0). Consequently, the observed emission spectrum is similar to that 
observed upon benzoic acid interaction. In contrast, a better interaction is observed between 
AI-19676 and EuNBA. The -OCH 2Ph substituent exerts a lesser influence on the aromatic 
ring, and the nitrogen heteroatom (pK a2 1.05) is better able to chelate the metal centre in 
combination with the CO 2  group. In both cases, the weak intramolecular energy transfer 
observed is attributed to the weak binding interaction caused by the hydrophobic and steric 
influences of the proton in the 8-postion. Additional adverse stenc interactions are expected 
between the acid substituent and the norbornyl arms of the EuNAL chelate. 
Acid GR92452X (Figure 6-28), bearing a hydroxide substituent in the 8-position is 
inactive towards the EuNALs. No intramolecular energy transfer is observed between the 
ligand and the metal centre. It is expected that energy transfer to the luminescent state of the 
metal will be negated by non-radiative deactivation upon vibronic coupling with the high 
energy OH oscillator brought into close proximity with the metal centre upon carboxylate 
recognition. The inactivity of GR92452X may also be attributed to excited state 
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intramolecular proton transfer, established upon H-bonding interaction between the 
hydroxide and intervening water leading to depopulation of the acid excited state (as 
discussed in Chapter 5.2.8). 
As the quinoline-2-carboxylic acids were observed to be inefficient LHCs for the controlled 
assembly of ternary luminescent lanthariide complexes with our EuNALs, the influence of 
the chelate arms on the binding interaction was not investigated further. Instead, our 
attention turns to the "salicylate" binding unit and the acids identified by combinatorial 
screening (Chapters 5.2.8.2-3 and 5.2.9). 
6.5 Molecular Recognition between Good LHC Units and a Well 
Defined Binding Cavity 
6.5.1 The 4-Hydroxyquinoine-3-Carboxylic Acid LHC Unit 
The 4-hydroxyquinoline-3-carboxylic acid, AH10225, and naphthyridine acids AI-112133 
and AH 11967 were identified during the high throughput screening experiment as excellent 
candidate LHCs (5.2.8.2) for controlled formation of ternary luminescent complexes in 
aqueous solution by lanthanide molecular recognition. 
It was noted that the parent salicylic and o-hydroxynaphthoic acids do not bind the 
EuNALs to form ternary luminescent complexes (5.2.8.3), whereas their heterocyclic 
counterparts, in contrast are very efficient LHCs towards Eu(III). The structures and pK a 
values for a selection of the acids are given in Figure 6-33 and Table 6-10 respectively. 
Fig 6-33 Acid Tautomer pK11 pKai pK13 pK14 
1 Salicylic (SAL) - 13.70 3.01 - - 
2 1-hydroxy-2-naphthoic - 10.46 3.02 - - 
3 3-hydroxy-2-naphthoic - 13.29 3.02 - - 
4 GR340734X - 7.50 3.58 0.06 - 
5 AH10225 Keto - 3.57 0.80 - 
Enol 12.08 6.26 0.81 - 
6 GR258750X Keto - 2.72 0.11 - 
Enol 11.07 5.21 0.60 - 
7 AH11967 Keto - 5.08 1.71 -5.29 
Enol 8.05 4.44 0.41 -1.90 
8 AH12133 Keto - 3.07 0.97 -11.57 
Enol 7.32 4.00 0.46 - 
Table 6-10 Calculated pK values (pKadB 4.0) for 'salicylate" LHCs pictured in Figure 6-33 
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Figure 6-33 Structures of"salicylate" LHCs 
It is immediately apparent that the inactivity of salicylate and o-hydroxynaphthoic 
acids is a consequence of the high phenol PK a . Following the initial deprotonation event, a 
stable H-bonding network is established between the anionic carboxylate and the phenol 
group, disruption of which is energetically unfavourable. In addition to this, the high pKa is 
indicative of the electron richness of the phenolate, and hence the ease with which LMCT 
may occur. Commercial assay systems employing salicylate derivatives in detection of 
biological molecular recognition by Tb(III) luminescence operate at alkaline pH (EALL pH 
13, Chapter 1) ensuring a significant fraction of the acid exists in the deprotonated dianionic 
form (5-FAS: pKai 13.70, pKa2 2.68: pAS: PK a1 13.75, PKa2 3.58. pK 2.21). The 5-FAS 
ligand is unsuitable for use with Eu(III) due to LMCT. 
The model LHC, picolinic acid, is observed to bind the LnNAL chelates (Log K 5) 
in the presence of excess salicylic acid under neutral experimental conditions. Upon steady-
state excitation at 300 nm (Xax SAL) or 270 nm (L PCA) strong blue organic fluorescence 
is observed in the emission cell, the tail of which is seen in the Eu(I11) luminescence 
spectrum, despite the presence of a 550 nm cut-off filter (Figure 6-34, 35). The strength of 
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the organic fluorescence suggests that the acid does not coordinate the metal. Intersystem 
crossing to the triplet state, facilitated by the heavy atom effect upon mixing of the 
metallligand orbitals would result in a reduction in the intensity of fluorescence observed. 
The analogous terbium chelate exhibits similar behaviour to that of the Eu(IlI) complex, 
providing evidence that the inactivity of SAL towards LnDTPA-AM2 is not a consequence 
of mismatched triplet stale energies. In contrast to the TbDTPA-AM:!. covalently bound 
IThDTPA1 and ITbEDTA1 chelates interact with pAS or 5-FAS to form highly luminescent 
lanthanide ternary complexes employed in assay technologies. 
66-69 As discussed briefly in 
Chapter 5, our preliminary investigations have revealed differing mechanisms for ternary 
complex formation between such charged LnNAL species and the neutral LnDTPA-AM2 
chelates. 
Wavelength (nm) 
Figure 6-34 Emission specUa of EuBUA (0.1 mlvi aq) in the presence of excess SAL and I eq PCA 
(?ex720mn, 300 run) 
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Figure 6-35 Excitation spectra of EuBUA (01mM aq) in the presence of excess SAL and leq PCA (? m
616 nm) 
The influence of the heteroatom on molecular recognition is clear when the binding between 
acid GW304734X (Figure 6-33 (4)) and EuDTPA-AM2 chelates is considered. Emission 
and excitation spectra for 1:1 solution samples of EuBUA, EuNBA and EUBBZA (0.1 mM 
aq) upon excitation at 270 nm are shown below (Figure 6-36. 6-37). 
-EuBBZA 















Figure 6-37 Excitation spectra of 1:1 solution samples of EUNBA, EuBBZA and 
EUBUA (0.1 mM aq, pH 7) + GW304734X (?. em = 616 ran) 
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Figure 6-36 Emission spectra of I:! solution samples of EuBBZA, EuBUA and 
EuNBA (0.1 mM aq, pH 7) + GW304734X (X ex = 270 nm) 
The estimated equilibrium constants for the interaction between GW304734X and the 
EuNAL chelates are given in Table 6-11. It is observed that although the relative increase in 
sensitised luminescence (Figure 6-38) of EuBBZA is half that afforded by molecular 
recognition with the aliphatic chelates, (due to DTPA-BBZA residual absorbance) the 
binding constants for the interaction are of the same order of magnitude (average Log K 5.56 
± 5%), and show a significant improvement relative to PCA (Log Ka 4.9). 
Chelate LHC K ± Log K ± Error 1110 
EuBUA GW304734X 8.35E+05 5.71E+05 5.92 0.36 6% 14 
EuNBA 3.79E+05 1.85E+05 5.58 0.23 4% 14 
EuBBZA 1.49E+05 7.27E+04 5.17 0.23 4% 7 
Average GW304734X 4.54E+05 2.76E±05 5.56 0.28 5% 12 
Table 6-11 Estimated formation constants for EuNAL (0.1 mM aq, pH 7) + GR340734X 
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Figure 6-38 Relative emission versus mole ratio of [LHC]/[EuNAL] for GW304734X binding 
(0.1 mM aq, X ex 270 rim) 
The acid is expected to exist as the enol tautomer (Figure 6-33 (4)), with an 
estimated phenol pK a  of 3.58. Under the neutral conditions of the binding experiment in 
aqueous solution we can expect the hydroxide to be fully deprotonated. The hgand, bearing 
two anionic oxygen donors is ideally suited to Ln(IU) coordination. Upon molecular 
recognition a stable six membered chelate ring is established with almost planar geometry 
(torsion angles of Ca. i °  (Chem 3D)) facilitating efficient intramolecular energy transfer to 
the metal excited state. 
The light harvesting properties of the ligand can be improved by extending the 
chromophoric unit, as demonstrated by AH10225 (Figure 6-33 (5)) binding. With the 
absorption maximum around 300 nm, and the same binding unit as acid GW304734X 
discussed above, this acid interacts strongly with the EuNAL (Table 6-12) to form highly 
luminescent mixed ligand complexes in 1:1 stoichiometry (Figure 6-39). 
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Figure 6-39 Relative emission intensity versus mole ratio [AH10225]/[EuNAL} 
(0.05 mM aq, pH 7. X ex 300 rim) 
Chelate LHC K ± Log K ± Error 111 0 
EuNBA AH10225 	 2.55E+05 	6.74E+04 5.41 0.12 2% 100 
EuBBZA Ali 10225 	 2.01 E+05 	4.93E+04 5.30 0.11 2% 110 
EuBUA AH10225 	 1.82E+05 	7.81E+04 5.26 0.20 4% 80 
EuBTA A1110225 	 7.81E+04 	2.31E+04 4.89 0.13 3% 70 
Average AH10225 5.22 0.14 3% 90 
Table 6-12 Formation constants for 1:1 EuNAL + AH10225 complexation 
The relative emission increase observed for the interaction is on average 
approximately 100-fold. Interestingly, the LHC displays a degree of selectivity towards the 
more rigid EuNAL chelate (Figure 6-39), in common with PCA. The enhancement of 
Eu(III) emission observed for EuBBZA is almost double that of the other aromatic derivative 
studied, EuBTA, attributed to adverse steric interactions between the LHC and the methyl 
substituents in the 4-position of the aromatic amide arms. The estimated binding constant 
for EuBTA and AI-110225 is slightly smaller than the other EuNAL chelates studied here. 
Electronic effects cannot be disregarded when considering the efficiency of energy transfer 
from the LHC triplet state to the 5 D0  emissive level of Eu(HI). It is proposed that it—it 
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interactions between the arms of the aromatic DTPA-AM 2 and the acid may play a role in the 
pathway of energy transfer from the sensitising ligand to the metal. 
The lowest energy conformation of acid AH 10225 is expected to be the keto 
tautomer (Figure 6-40) with a carboxylate pK a  of 3.57. In the minor tautomeric species, the 
enol, the phenol pK a  is estimated at 6.26. The LHC is therefore expected to be completely 
deprotonated under the experimental conditions, presenting a dianionic bidentate binding 






Figure 640 Tautomeric structural forms of AH 10225 
The interaction is strong and energy transfer efficient, as the shortest intramolecular 
distance between the Eu(II1) metal centre and the sensitising ligand (Eu-O) is approximately 
3.3 A (Chem 3D). The stronger emission intensity observed from the [EuNBA.A1110225] 2 
species relative to the other EuNALs under the same experimental conditions is again 
attributed to the rigid, hydrophobic arms of the NAL protecting the antenna binding site from 
quenching effects of the solvent. Emission and excitation spectra are shown below in 
Figures 6-41 and 6-42 respectively. 
—BjNBA 
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Figure 641 Emission spectra of 1:1 solution samples of EuNBA, EuBBZA and EuBUA with 4- 
hydroxyquinoline-3-carboxylic acid LHC, AH10225 (0.05 mM aq, pH 7, X ex = 300 run) 
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Figure 6-42 Excitation spectra of 1:1 solutions of EuBBZA, EuBTA and EuNBA 
(0.05 mM) aq + AH10225 (X em = 616 nm) 
6.5.2 Substituted 4-Hydroxyq uinoline-3-Carboxylic Acid LHC Units 
The trifluoromethoxy derivative of AH10225. compound GR258750X (Figure 6-33 (6)) also 
exhibits promising light harvesting properties towards the EuNALs for ternary complex 
formation. The observed emission increase upon interaction with EuBUA under excitation 
at 300 nm (X max) is approximately 80-fold (Figure 6-43), and characteristic ligand 
absorbance bands are observed in the excitation spectrum confirming the intramolecular 
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Figure 643 Emission spectra of EuBUA (0.1 mM aq, pH 7) + GR258750X (Xex = 300 nm) 
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Formation constants (X ex 270 nm) are of similar magnitude to AH10225 for both 
EuNBA and EuBUA, as expected for coordination by the 4-hydroxyquinoline-3-carboxylic 
acid binding unit, fully deprotonated under the titration conditions. 
It can be concluded that the presence of strongly electron withdrawing —CF1 
substituent, reduces the resonance electron donating ability of the oxygen in the 6 position of 
the hydroxyquinoline carboxylic acid, and does not perturb the binding interaction with the 
EuNAL. The efficiency of intramolecular energy transfer between the LHC and EuBUA is 
of similar magnitude to that observed with the parent acid, AH10225, under steady-state 
excitation at 300 nm. In contrast, the substituted acids AH11688 and G1266527 (Figure 6-
44) do not recognise the EuNAL binding cavity. Strong blue organic fluorescence is detected 











In the enol tautomeric species the carboxylate and phenol pK a values are estimated at 
approximately 1 and 6 respectively, and the acids are expected to be fully deprotonated 
under experimental conditions. 
Comparison of the emission spectra (Figure 6-45) reveals the different interaction between 
each of these acids and EuNBA. Acid AH1 1688 binds the metal centre affording a small 
increase in sensitised Eu(III) luminescence with residual levels of organic fluorescence. The 
inefficiency of energy transfer is attributed to inappropriately matched excited state energy 
levels. Inductive electron donation from the methoxy substituents in the 6 and 7 positions 
raises the energy of the aromatic system. The emission spectrum of EuNBA + G1265527 
shows the strong organic background fluorescence almost obscuring the lanthanide emission 
bands. The alkoxy group in the 5-position is expected to impede the interaction between the 
phenolate and the metal centre, impeding the binding interaction. Consequently the 
efficiency of intersystem crossing is reduced and the singlet excited state of the LHC can 
decay radiatively. 
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Figure 645 Emission spectra of EuNBA (0.05 mM aq) + AHI 1688 and G1265527 (Xex = 300 run) 
6.5.3 Substituted Salicylic Acid LHCs 
The salicylic acid derivative, A1-190 18 (Figure 6-46), appeared to exhibit excellent potential 
as a light harvesting ligand when studied under the time-resolved conditions of the assay 
experiment. In contrast, no interaction is observed under steady-state excitation, as any 
characteristic red sensitised europium emission is obscured by intense organic fluorescence 
from the acid. This inactivity is attributed to the electron rich phenolate group which can 
easily establish LMCT states with the Eu(tII) centre. In contrast, acid GR94828 (Figure 6-
46) increases the emission intensity of the EuNAL (Figure 6-47). 
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Figure 646 Substituted salicylic acid LHC units 
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Figure 647Emission Spectra of EuNBA (0.05 mM aq, pH 7) + GR94828A (. ex = 270 nm) 
The stoichiometry of the ternary complex is poorly defined- illustrated by the emission 
spectra shown in Figure 647. and is attributed to the possibility of alternative coordination 
via the sulphonamide substituents. Under experimental conditions (pH 7) the phenol is 
substantially deprotonated (predicted pK a  8.0). This reduction in acid dissociation constant 
relative to the parent SAL is due to the presence of the electron withdrawing sulphonamide 
groups meta to the carboxylic acid unit (pKa 1.3). 
6.5.4 Molecular Recognition with EuBAA 
In light of the observations made regarding the steric bulk and rigidity of the NAL and the 
improved luminescence properties of the mixed ligand chelate in aqueous solution, it was 
decided to test the bulkier adamantyl DTPA-AM2 derivative. EUBAA (Figure 648). 
The chelate (0.05 mM aq. pH 7) was titrated with AH10225 (pH 7-8). Formation of the 1:1 
mixed ligand species resulted in a 500 fold increase in sensitised emission of the Eu(III) ion 
(Figure 6-49). Qualitatively, the experiments confirms the hypothesis that the rigidity and 
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hydrophobicity imparted on the EuNAL binding cavity by the DTPA-AM2 chelate arms is 
greatly beneficial to luminescence of the ternary complex formed upon molecular 
recognition with 4-hydroxyquinoline-3-carboxylic acid LHCs in aqueous solution. Emission 
plots for the interaction of AH 10225 with chelates EuNBA and EuBAA are shown below 
(Figure 6-49). Molecular recognition with the well defined binding cavity of EuBAA 
affords an increase in sensitised luminescence approximately five times that of the 
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Figure 649 Plot of relative emission intensity versus mole ratio for ternary complex formation 
with EuNBA and EUBAA chelates (0.05 mM aq) and AH10225 ()ex = 300 nm) 
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Acid AH10225 is an excellent light harvesting unit for Eu(III) under these conditions, 
forming stable mixed ligand, intensely luminescent complexes with the EuNALs in aqueous 
solution (Log K - 5.5). The presence of aromatic absorption bands in the excitation spectra 
corresponding to AH10225 absorbance provide unequivocal evidence that the increase in 
emission intensity is due to intramolecular energy transfer from the LHC chromophore. 
6.5.5 4-Hydroxynaphthyrid ine-3-Carboxyl ic Acid Recognition 
The naphthyridine derivatives AH12133 and AN! 1967 (Figure 6-50) were identified as 
potentially excellent sensitising ligands for ternary complex formation with Eu(llI) DTPA-
AM2 chelates during the high throughput screening experiment (Chapter 5.2.9). Further 
study into controlled formation of luminescent mixed ligand species with the EuNALs gave 
interesting results. The acids are predicted to adopt the keto tautomeric structure, of lower 
energy than the enol conformation, and to be fully deprotonated under experimental 
conditions (pKa values are given in Table 6-11). 
The acids were observed to interact with the metal centre substantially increasing 
EuNAL emission upon excitation of the chromophoric unit, exhibiting excellent potential as 
sensitising ligands for our ternary complex system. Emission plots for titration of EuBBZA, 
EuNBA and EUBUA with AH12133 (Figure 6-51) and EuNBA with AH1 1967 (Figure 6-52) 
plateau fairly sharply, indicative of a strong binding interaction. However, instead of 
forming 1:1 mixed ligand [EuNAL.LHC] complexes, analogous to AH10225 binding as 
expected, the stoichiometry appears to be 1:0.5. Several controlled experiments were 
performed in order to check this effect. The behaviour is wavelength independent, observed 
at A. ex 270 rim, 300 nm and 350 nm, and unlikely to arise from organic photophysical or 
photochemical processes occurring within the LHC. No signal degradation is observed 
under steady-state irradiation or pulsed-excitation during the experimental period. Dilution 
of the sample by a factor of two (0.1 mM - 0.05 mM) did not influence the results, 
confirmation that the behaviour is not the result of instrumental artefacts arising from sample 
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Figure 6-50 4-hydroxynaphthyridine-3-carboxylic acid LHC units 
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Figure 6-51 Plots of relative emission intensity versus mole ratio LHC :EuNAL for ternary 
complex formation between EuNALs (EuBUA, EuNBA and EUBBZA, 0.1 mM aq, pH 7) and 
AH12133 (.ex= 270nm) 
The interaction between EUNBA and AH1 1967 is clearly stronger than the corresponding 
recognition with AH 12133. as demonstrated by the sharp plateau in the emission plot (Figure 
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Figure 6-52 Plot of relative emission intensity versus mole ratio LFIC :EuNAL for the interaction between 
EuNBA (0.05mM aq, pH 7) and naphthyridine acid LHCs, AH12 133 and A1 -11 1967 (ex = 300 rim) 
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To the best of our knowledge little attention had been paid to the light harvesting 
properties of naphthyridine carboxylic acids towards Ln(III) cations. One paper reports the 
evaluation of 33 potential fluorogenic chelators for europium and terbium towards their 
application in enzymatic assays (EALL) at alkaline pH. One naphthyridine acid (Figure 6-
53) was identified as a good substrate molecule for alkaline phosphatase assays employing 
Eu(IH) or Th(ffl) metal lumophores. Characteristic sensitised Ln(III) emission was detected 
at 616 nm and observed to be stable over time in buffered solution at pH 9 in the presence of 
excess EDTA (1 mM in LHC; LHC:Ln:Buffer = 1:4:5). No further investigation into the 
mechanism of luminescent complex formation was reported. 
OH 0 7 L) 0H 
H3C 	N 
Figure 6-53 4-hydroxy-7-methyl- 1,8-naphthyridme-3-carboxylic acid 
Luminescence lifetimes of mixed ligand samples (Table 6-12) were measured 
upon excitation at 355 nm (single photon absorption) or 532 nm (expected to be a two-
photon excitation process). The emission detected at 616 nm arises from the sensitised 
Eu(III) lumophore and the measured lifetime is that of the metal centre. Agreement within 
experimental error is observed between the two studies. 
Chelate LHC r (ms) Error (±) % 
EuBAA t - 0.741 0.010 1.3 
AH10225 t 0.847 0.007 0.8 
AH11967 t 0.556 0.007 1.3 
AH12133t 0.567 0.002 0.4 
EuNBA* - 0.780 0.002 0.3 
Ali 11967* 0.560 0.001 0.2 
Table 6-13 Luminescence lifetimes for [EuNAL.LHC] mixed ligand samples ()ex = 	nm or *532 
nni, Xem = 616 run) 
The ternary complex formed between the effective sensitising ligand, AH10225,and 
the well defined binding cavity of EuBAA exhibits a longer luminescence lifetime that the 
parent chelate (\t 0.1 ms), confirmation that OH oscillators are displaced from the primary 
coordination sphere. In contrast, aqueous solution samples containing EuNAL and a 
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naphthyridme LHC, AH11967 or AH12133, exhibit a significant reduction in the observed 
luminescent lifetime relative to the parent chelate. 
It is possible that the rate of EuNAL isomerisation is reduced upon addition of the 
second component which may partially associate with the chelate to inhibit rearrangement of 
the coordination polyhedron. The measured decay constant comprises the average of terms 
for all the distinct Eu(ffl) environments present and interchanging on a timescale observable 
with the laser set-up employed. The kinetic lability of the thermodynamically very stable 
LnDTPA-AM2  complexes is well established, as discussed in section 6.3.2. Transient 
intermediate species that are short lived are not readily observed on the timescale of pulsed 
laser excitation, and single exponential decay curves are obtained. 
Lifetime measurements performed in H 20 and D20 provide a measure of the number 
of water molecules occupying coordination sites in the inner sphere of the metal complex. 
Corrections made to Equation 1-2 allow the influence of closely diffusing OH and proximal 
XH oscillators to be included in evaluation of the hydration state (q) (Equation 6-1). The 
parameter AE = 1.11 waters.ms, as determined by Horrocks et al 
.41 and 't 1 D20 are the 
reciprocal lifetimes (ms -' ) for the species under investigation in H 20 and D20 respectively, 
and kxH (ms') represents the contribution from other high energy X-H oscillators capable of 
depopulating the excited state by non-radiative energy transfer. 
q = AEU(t'H20 - T_ I D20 - kxH) 
	
kxH = a + PnOH  + )'flNH + 6O=CNH 	Equation 6-1 
The parameters nOH. nNH and flO=CNH  represent the number of alcoholic OH, secondary amine 
NH and amide NH where the carbonyl group coordinates the metal respectively, and a is the 
de-excitation rate constant for closely diffusing solvent molecules (a = 0.30 ms, 3 = 0.45 
y = 0.99 ms', 6 = 0.075 ms- '). For the DTPA-AM2 ligands employed in this study kxH 
adopts the value 0.0525 ms'. 
Chelate Solvent 'r 1 ± q (± 0.1) 
EUBUA H20 0.786 0.003 - 
D20 2.414 0.019 0.89 
EuNBA H20 0.780 0.002 - 
D20 2.297 0.005 0.88 
EuBBZA H20 0.956 0.011 - 
D20 2.480 0.031 0.65 
Table 6-14 Luminescence lifetimes measured in water and D 20 and estimated hydration states (q) for 
EuNALs(Xex532 nm, Xem=616run) 
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Interaction between the LHC and free Eu(ffi) was considered but can be disregarded, 
as the high thermodynamic stability of the EuNAL species (Log KGdL 15) prevents 
significant dissociation of the metal from the NAL chelate. Under the experimental 
conditions at pH 7, 0.05 mM, the stability constant for EuNAL formation is 1.37 x iø' (Log 
KML 13.14) (computed from literature values for protonation and formation constants for 
GdBEA)' 20 . The major species present in solution is the EuNAL chelate and the 
concentration of free Eu(ffl) estimated at around 2x 10 -9 M (- 0.004 % dissociated). At this 
concentration the level of free Eu(III) can be regarded as negligible. The possibility of non-
specific binding of dissociated Eu(III) with by LHC titrant can be disregarded due to the 
extremely low level of free Eu(ffl). The major species detected by electrospray MS analysis 
of the emission samples is the EuNAL, confirmation that the LHC is not extracting the metal 
from the aminopolycarboxylate complex. No peaks corresponding to Eu(LHC) n  species are 
observed. 
Luminescence quantum yields were evaluated relative to a [Ru(bipy) 3C12] standard (1 = 
0.028 in water)' 53  for the interaction between EuBAA and acids AH10225, AH12133 and 
AH 11967 (1:1 solutions) by the method of Haas and Stein. 158 
Chelate Acid Quantum Yield 




Table 6-15 Relative luminescence quantum yields for mixed ligand complexes formed between 
EUBAA and LHCs AH10225, AH12133 and AHI 1967 in aqueous solution. 
The results are representative of the interaction between the LHC and the metal in aqueous 
solution and demonstrate that energy transfer between the antenna ligand and the Eu(III) ion 
is relatively efficient. From the results (Table 6-15) it is obvious that the acids are excellent 
antenna and sensitiser ligands for Eu(III), but further investigation into ternary complex 
formation is clearly necessary. 
The observations regarding molecular recognition between the EuNALs and 4-
hydroxynaphthyridine-3-carboxylic acids suggest that a dinuclear inclusion type complex 
may be forming, with one naphthyridine LHC unit acting as a bridging ligand between two 
discrete EuNALs. This was initially thought to be unlikely as the bulk solvent water is a 
196 Binding Studies 
Results and Discussion 
much better ligand towards Eu(llI) than a neutral, heterocyclic nitrogen atom. Bipyridine 
compounds of Eu(llI) are generally unstable in aqueous solution, unless the chromophore is 
incorporated into a macrobicyclic cryptand structure, rendering dissociation of the metal 
entropically unfavourable. 
Coordination of the second nitrogen atom, normally unfavourable in water, in the 
absence of a second, anionic donor group, becomes more stable when shielded from the 
effects of outer sphere solvent molecules by the hydrophobic arms of the DTPA-AM 2 ligand. 
Whereas an increased lifetime could be expected for a dimeric [(EuNAL) 2LHC] species, it 
is not unreasonable to propose that charge transfer states are established upon heterocyclic 
nitrogen coordination, resulting in an increased rate of radiative decay and hence a shorter 
lifetime. The highly conjugated aromatic system may be responsible for establishing 
resonance structure between the two metal centres (cf isoPTA). 
6.6 Conclusions 
It can be concluded from these spectroscopic studies that aromatic carboxylic acid binding to 
LnDTPA-AM2  chelates can be modified by the structural and electronic properties of the 
NAL, as initially established during the high throughput screening of a diverse library of 
potential antenna ligands (Chapter 5). Molecular recognition can be controlled primarily by 
the choice of LHC binding unit, with additional selectivity imparted by careful NAL design. 
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7 Luminescent Heterobimetallic ID Coordination Polymers: 
Towards New Properties in the Solid State 
7.1 Luminescent Materials 
Novel functional materials with tuneable luminescent properties are continually in demand' 59 
to keep abreast with the technological advances in modern display and sensory equipment. 
Combinatorial approaches adopted in materials research (outlined in Chapter 1.4.4) have 
accelerated the discovery and optimisation of potentially viable luminescent systems. 
Lanthanide ions are routinely employed as dopants' 6°  in inert metal oxide lattices, and have 
been incorporated into zeolites and colloidal particles to produce luminescent nanomaterials. 
In contrast to the traditionally trial and error process by which many of today's commercially 
important luminescent materials evolved, it has been the goal of some researchers to 
introduce structural control at a molecular level in the design of organic-inorganic hybrid 
solids. 161  Whereas the photophysical properties of luminescent lanthanide complexes are 
often thoroughly investigated, much less attention has been paid to the behaviour of such 
species in the solid state. 
An unexpected, but nevertheless very interesting result was obtained whilst 
attempting to crystallise the luminescent ternary complexes formed upon molecular 
recognition between the EuNALs and the model LHC, PCA, and is discussed below. 
7.2 Structural Studies 
Large, well defined, hexagonal single crystals, exhibiting characteristic sensitised Eu(Ill) 
emission were grown from aqueous solutions of the EuNAL with a large excess of PCA in 
the presence of NaOH (pH 7-8). Further investigation demonstrated that mixing concentrated 
aqueous solutions of EuCl 3.6H20 with excess picolinic acid in the presence of NaOH (pH 7- 
8) lcad to precipitation of a microcrystalline solid, from solutions of which the large 
hexagonal crystals could be grown by vapour diffusion with acetone (Chapter 2). 
Analysis by X-ray diffraction revealed the crystals to have the formulation 
[EuNa(PCA)4H20]O.5nH20 with a high degree of structural organisation. The crystal 
structure (Figre 7-1) shows closely packed polymeric chains comprising of [Eu(PCA) 4] units 
liked together by bridging carboxylate oxygen ligands and the sodium counterions. Each 
europium is nine coordinate, encapsulated by four bidentate PCA units and one additional 
carboxylate unit bridging to the Na ion in what can loosely be described as a distorted 
monocapped square antiprismatic polyhedron. The distance between neighbouring Eu(llI) 
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ions of the [Eu(PCA)41 monomers is 6.3 A. within the limits of the range covered by Dexter 
type energy transfer. Interestingly, no quenching water molecules occupy the primary 
coordination sphere of the Eu(Ill) centre, despite the presence of H-bonding solvent between 
the chains. Each sodium ion with only three ligands is unexpectedly low in coordination 
number. One water molecule and two bridging carboxylate oxygen atoms bind the alkali 
metal ion. The one dimensional polymers are disposed along a 2 1 screw axis, with the Na 
adopting a zig-zag motif along the chain. Face-edge it interactions exist (5.1 A centroid-
centroid) between the pyridyl moieties of neighbouring PCA units contributing to the 
stability of the polymeric structure. 
Figure 7-1 Crystal structure of [EuNa(PCA) 4H20]0.5nH20 
Single crystals of the yttrium and gadolinium species were found to have the same 
unit cell as the Eu(I11) polymer. The X-ray powder diffraction patterns obtained trom 
microcrystalline samples of the Eu(III), Tb(III) and Gd(III) solids (Figure 7-2) matched that 
predicted from the Eu(Il1) single crystal structure. It can be concluded from this information 
that the single crystals obtained are representative of the bulk microcrystalline material. 
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Figure 7-2 Powder XRD patterns obtained from microcrystalline samples of Eu(LH), Gd(111) and 
Tb(HI) ID coordination polymers with PCA and sodium 
7.3 Luminescence Studies 
The single crystal exhibits characteristic strong red Eu(lll) emission (Figure 7-3) upon 
excitation in the UV and the visible region of the electromagnetic spectrum. Unlike solution 
samples of Eu(HI) and PCA, whose excitation profile match closely that of the ligand 
absorption spectrum, with a maximum around 270 nm, the crystal excitation spectrum 
exhibits a broad profile, shifted significantly into the red (Figure 7-4). This unexpected 
profile is indicative of a new interaction occurring in the single crystal, not present in 
solution. The interaction is believed to arise from the structural arrangement of the 
luminescent components in the solid state, with the new state responsible for energy 
transport to the metal ion. 
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Figure 7-3 Single crystal emission spectrum (corrected for PMT response) upon excitation at 360 nm 
Inset shows 616 nrn peak under high resolution (0.18 nm). 
Figure 7-4 Single crystal excitation spectrum, not corrected for lamp response (Xem = 616 rim) 
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The red shifted excitation profile could be attributed to the presence of charge transfer states, 
however this seems unlikely as such bands are known to quench Eu(Ill) emission and the 
solid exhibits a long luminescence lifetime (- 1.5 ms). 
We believe that this new state is arising from it interactions' 62 between the closely 
packed PCA units in the crystal lattice, responsible for ground state interactions enhanced 
upon irradiation with ultra violet or visible light, leading to new states from which energy 
transfer to the metal ion then occurs triggering characteristic lanthanide luminescence. 
When the crystals are washed with water or alcohol the polymeric structure is broken down 
and the excitation profile reverts back to that of the solution samples. Provisional absorption 
studies made on KBr disk samples of the single crystal and bulk solids have not detected the 
presence of any new bands arising from the structural organisation of the PCA units. Spectra 
exhibit only the UV absorbance around 270 nm attributed to the picolinate residues. 
74 Further Studies 
Initial investigations carried out in the Pikramenou research group' 63 into the influence of the 
counterion on the structural and photophysical properties of the polymeric species formed 
have revealed some interesting trends relating to the size and charge of the chosen cation. 
When the monovalent potassium ion is employed the crystalline one dimensional 
heterobimetallic coordination polymer obtained is similar to that of the sodium species, 
exhibiting an analogous red shifted broad excitation profile. This is again attributed to 
ground state interactions between the closely packed picolinate antennae groups, enhanced 
upon light excitation allowing new states to form, from which efficient energy transport to 
the metal centre can occur. In contrast, when EuCl 3 96H20 is combined with PCA in the 
presence of ammonium hydroxide, the NW counterion is not involved in formation of the 
polymeric structure,163' 164  and the excitation spectrum exhibits characteristic PCA 
absorbance around 270 nm. The mechanism by which energy transfer to the metal centre is 
facilitated clearly differs between these solids prepared in the presence of coordinating and 
non-coordinating counterions, suggesting that the alkali metals are of importance in 
influencing the energy transport mechanism within the crystal. 
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Figure 7-5 Simplified Chem 3D view of polymeric [EuNH4(PCA)4] 
[EuNa(PCA)4]O.5nH 2O 









Figure 7-6 Ortep view showing numbered atoms and table with selected bond lengths (A) for the 
[EuNa(PCA)4]nO.5nH20 coordination polymers 
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Detailed photophysical and structural studies are underway on the coordination solids 
obtained from trivalent lanthanide cations, the picolinic acid light harvesting ligand and 
alkali metal (Li, Na, K, and Cs) counterions. The [Eu(PCA) 4] crystalline polymer with Ca2 
has also been prepared and characterised giving the formulation [EuCa o.5(PCA)42H20]. 16 ' In 
contrast to the linear polymeric chains of the sodium and potassium polymers, the 
provisional structure of the calcium solid reveals a two dimensional coordination network, 
with carboxylate oxygen atoms bridging directly between Eu(ffi) nuclei in one direction, and 
via the Ca2 counterions in the other. Further photophysical studies are currently underway. 
One limiting factor in developing new lanthanide materials has been the inherently weak 
absorption coefficient of the ions. In solution this has been overcome by designing 
complexes with light harvesting ligands to act as antennae, populating the emissive states by 
energy transfer. Such complexes are routinely applied as luminescent sensors in solution 
(Chapter 1). 
Applying the approach commonly adopted in solution, using our simple model light 
harvesting ligand, picolinic acid (PCA) to overcome the weak absorptivity of the Ln(llI) 
cations, and its characteristic bidentate binding unit to impart control on the coordination 
environment of the metal centre, it is possible to design structurally organised, highly 
luminescent solids. It is foreseen that this strategy will allow development of novel 
luminescent materials with tuneable photophysical properties quite different from the 
corresponding solution phase species. Microstructural control can be achieved by careful 
selection of the metal counterion based on its size and charge. The photophysical attributes 
of the system may also be tailored by choosing suitable light harvesting ligands, analogous to 
the design now routinely implemented in the solution phase. Moreover, it is possible to 
modify the macroscopic properties of the coordination complex such that ligands whose 
absorption band is in the UV can be employed to sensitise Ln(Ill) luminescence upon 
excitation in the near U',' and visible region. 
204 Luminescent Coordination Polymers 
Conclusions and Future Work 
8 Conclusions and Future Work 
We have successfully demonstrated the controlled self-assembly of ternary luminescent 
lanthanide complexes in aqueous solution, achieved by molecular recognition. The 
octadentate DTPA-AM 2  ligands are ideal candidate NALs, forming a cavity for LHC binding 
upon chelation to the trivalent lanthanide cations. A stronger interaction is observed when a 
more hydrophobic/rigid DTPA-AM 2 ligand is employed, offering a well-defined path by 
which the LHC can approach the metal centre. Aromatic acid LHCs recognise the LnNAL 
binding pocket and exhibit a range of sensitising abilities related to their structural and 
electronic properties. 
Several aspects of the molecular recognition observed between the LnNALs and aromatic 
acid LHC units require further investigation. A detailed investigation into ternary complex 
formation with naphthyridine carboxylic acids is necessary in order to characterise the 
species forming in solution. 
Computational modelling of the system may provide insight into the steric factors 
introduced by the amide arms of the DTPA-AM 2 ligand and LHC substituent groups on the 
binding interaction. Such techniques may also allow prediction of suitable LHC moieties in 
development and optimisation of specific signalling systems. 
It was discovered that molecular recognition is perturbed in the presence of 
competing hydroxide ligands. NMR relaxivity studies with Gd(III)NAL species are 
expected to provide better insight into the displacement of water/hydroxide from the inner 
sphere of the metal upon LHC recognition. Potentiometric studies with the complexes may 
also allow the local pH at the metal bound water in the neutral chelates to be investigated. It 
is expected that the EuNALs are better acids than the free Eu 3 ion, and that the ninth 
coordination site is more exposed in the more bulky DTPA-AM 2 chelates. In addition, infra-
red spectroscopy may be employed in examination of the isomerisation kinetics, in 
combination with variable temperature NMR and luminescence studies. An investigation 
into the formation of ternary complexes with YbNALs by NMR is currently underway in 
collaboration with the University of Liege. 
The effect of ionic strength on the interaction, thus far not considered in any detail, 
will be further investigated. Signalling systems exhibiting sensitivity to Na and or Cl - ions 
are of immense value in the study of biological ion transport channels, often implicated in 
complex physiological disorders. 
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The extent to which it-it interactions influence molecular recognition between the LnNALs 
and the aromatic acid LHCs will be studied in more detail. We propose to develop the 
DTPA-AM2  ligands. Aromatic bis(amide) derivatives incorporating pyrene and anthracene 
residues exhibiting extended conjugation will be employed. Although not strictly "non-
absorbing ligands" the triplet excited states of these chromophores are known to be 
inappropriately matched for efficient population of the Ln(III) excited state. It is expected 
that the rigid arms of these ligands will present well-defined binding cavities for LHC 
recognition. We also expect to observe sensitised emission from non-coordinating aromatic 
moieties. Two-dimensional NMR (NOESY) will be exploited in the study of the 
interactions. 
Research in the Pikramenou group has shown the mechanism of ternary complex formation 
to differ considerably when charged LnNAL chelates are employed. We propose further 
investigation with the more biologically compatible neutral DTPA-AM 2 species, replacing 
the central NCH 2CO2H with NHCH20H. By incorporating non-coordinating residues (alkyl 
or halide for example) at this position, the influence of both charge and the binding pocket 
on molecular recognition can be evaluated. 
We will also exploit solid-phase and combinatorial methodology in development of 
asymmetric DTPA-bis(amide) derivatives (see Chapter 4) such that specific bioconjugation 
may be achieved. Methods for attaching the aromatic LHC to the biomolecule under 
investigation will also be considered such that targeted labelling will be possible. 
In conclusion, a molecular recognition system exhibiting great potential for application in 
new, homogeneous screening technologies has been developed by adopting a supramolecular 
approach to lanthanide coordination chemistry in aqueous solution. 
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Appendix I 
LC/MS Analytical Methods 
Mass Spectrometer Micromass series II MS 
ELSD 	 Sedere Sedex 55, 40°C, 
Temp 	 40°C 
Gas Flow 	 2.2 bar N2 
LC/Auto injector 	HP 1100 
Column 	 3.3 cm x 4.6 mm ID (3 tm particle size) ABZ+PLUS 
Flow Rate 	 3 ml/min  
Injection Volume 	5 p.L 
Temp 	 RT 
UV Detection Range 215 - 330 nm 
Solvents 	 A: 0.1% Formic Acid + 10 m Ammonium Acetate 
B: 95% Acetonitrile + 0.05% Formic Acid 
Gradient 	Time (mins) A % B % 
0.00 100 0 
0.70 100 0 
4.20 0 100 
5.30 0 100 
5.50 100 0 
Floinject ES/MS 
Mass Spectrometer 	Micromass LCTOF 
Electrospray + ye only (Z spray source) 
LC/Auto injector HPI 100 + Gilson 233x1 Autoinjector 
ELSD Polymer Labs PL-ELS 1000 
Temp 55°C 
Gas Flow 2.2 bar N 2 
Flow Rate 1 ml/min  
Injection Volume 5 .tL 
Temp RT 
Isocratic run 30 % A, 70 % B 
Solvents 0.1% Formic Acid + 10 mM Ammonium Acetate 
95% Acetonitrile + 0.05 % Formic Acid 
Appendix 1 
Reg No Smiles String 	 I Formula 	1 MW 
GR207962X COd cc(cccl C)C(=O)0 C91-11003 166.18 
GR21 2454X COO cc(cc(OC)ci C)C(0)0 Cl OH1 204 196.21 
CCI21 177 COd cc(OC)cc(cl )C(0)O C91-11004 182.18 
GR257381 X COO cc(C)c(OC)c(C)cl C(0)0 Cli H 1404 210.23 
AH6621 OC(=0)cl cc(0)cc(cl )C(0)0 C81-1605 182.13 
GR1 93563X COC(0)cl cc(OC)cc(cl )C(0)0 Cl OH1 005 210.19 
GF267447X COd cc(C#N)ccci C(=0)0 C91-17NO3 177.16 
GW431 055X COd cc(cccl C#N)C(=0)0 C91-17NO3 177.16 
GR25741 OX COC(=0)Odl ccccci C(=0)0 C91-1805 196.16 
GW503358X Cod cccccl COC(=0)c2ccccc2C(0)0 C161-11405 286.29 
GW31 8421 X COcicc(SC)cccl C(=0)0 C91-11 003S 198.24 
GR50343X OC(0)cl cccccl OP(0)(0)0 C71-1706P 218.10 
AH 1 4879XX OC(=0)dl cccc(OCc2ccccc2)cl Cl 4H 1203 228.25 
GR235591 X OC(0)ci ccc(N(0)0)c(OCc2ccccc2)cl C141-11 1 N05 273.25 
AH3827 CC(0)cl ccc(OCc2ccccc2)c(cl )C(=0)0 C161-11404 270.29 
GF267697X OC(0)cl ccc(C0c2cccc(0)c2C0)cc1 C1151-11205 272.26 
GR32 ii 4X OC(0)cl ccc(OCc2ccccc2)ccl 0 C141-111204 244.25 
AH1 4579XX OC(=0)cl ccc(N=Cc2cccs2)cdl Cl 2H9NO2S 231.28 
GW288607X COcl ccc(N=Cc2ccc(cc2)C(0)0)cdl OC Cl 6H1 5N04 285.30 
CC123883 CNC(=0)Ociccc(ccl)C(0)0 C9H9N04 195.18 
GR30858X CNC(=O)Ocl ccc(ccl 0C(=0)NC)C(=0)0 C1111-112N206 268.23 
CC13965 COO cc(N)c(ccl OC)C(=0)O C9H1 1 N04 197.19 
G1207347X Cod cc(C(=0)0)c(ccl OC)N(=O)0 C9H9N06 227.18 
GR38987X COO ccc(C(=0)0)c(Br)cl OC C9H9BrO4 261.07 
CC13923A O.[Na+].Ncl ccc(C(0)[0-])c(0)cl C7H6NO3-.Na+.2.0(H20) 211.15 
GR38954X COcicc(N)c(cciC)C(0)0 C91-11 1 NO3 181.19 
GR251 01 6X NO c(Br)c(0)c(ccl C#N)C(0)0 C8H5BrN203 257.05 
AH 1 4993XX OC(=0)cl ccc(OCCOCCOc2ccc(cc2)C(0)0)CC1 C1181-11807 346.34 
AH 1 4994XX OC(0)cl ccc(OCCOc2ccc(cc2)C(0)0)CC1 Cl 6H 1406 302.29 
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Reg No 	j Smiles String 	 I Formula I _MW 
GR84408X OC(0)cl ccc(OCCOc2ccccc2)Ccl C151-11404 258.28 
AH25091X OC(=0)cl ccc(OCCC)cci Cl OH 1003 178.19 
GR64693X CCCc1 cccccl OCCOc2ccc(cc2)C(0)0 C181-12004 300.36 
AH 1 6584XX OC(=0)cl ccc(Oc2cccc(OCC#C)c2)cCl C161-11204 268.27 
GR76119A CI.CN(C)CC#CCOC1CCC(CC1)C(0)0 C13H15NO3. HCI 269.73 
G1224436X OC(0)ci ccc(OC(F)(F)F)ccl C81-15F303 206.12 
GR34543 C0c1ccc(ccl)C(0)0 C8H803 152.15 
GR4031 4 Cod ccc(C(0)0)c2ccccdl 2 C121-11003 202.21 
GR62892 COO cccc2ccc(ccl 2)C(=0)0 C121-11003 202.21 
GF 1 33808X CCOC(0)Ocl c(OC)cc(ccl OC)C(0)0 C121-11407 270.24 
GR253989X COC(0)Oci cc(OC)c(C(0)0)c(ci )C(=0)OC Cl 2H 1208 284.23 
GR21 5101 X CCOC(0)ci c(OC)c(0)c(OC)ccl C(0)0 C121-11407 270.24 
GW322044X OC(0)cl cc(Br)c2000Cc2cl C9H7BrO4 259.06 
GR1 48285X CC(0)Ocl c(CI)cc(ccl CI)C(=0)0 C9H6C1204 249.05 
GR81 I 42X CC(0)Ocl cc(cc(CI)c1OC(0)C)C(0)0 C1  H9C106 272.64 
GR63007X CCCc1 c(Cl)c(OC)c(CI)c(0)dl C(0)0 Cli Hi 2C1204 279.12 
GW423740X CC(=CCc1 cc(ccci OC(=0)C)C(0)0)C C141-11604 248.28 
AH 1 4732XX COO ccc(Oc2cc(CCc2C(0)0)C(0)0)CC1 C151-11206 288.26 
GW291 81 9X Cci ccc(Oc2cc(ccc2C(0)0)C(0)0)Cdi Cl 5H 1205 272.26 
AH I 5398XX COO ccc(Oc2cc(C(=0)0)c(Br)cc2C(=0)0)CC1 Cl 5H ii Br06 367.16 
GW3 1 4444X CSc1 ccc(Oc2cc(ccc2C(0)0)C(0)0)CC1 C151-11205S 304.32 
GW385245X NC(=0)cl ccc(cdl Oc2ccc(C0)cC2)C(0)0 Cl 5H 11 N05 285.26 
AH 15251 XX OC(=0)cl ccc20c3ccccc30c2dl C131-1804 228.21 
AH4591 OC(=0)cl ccccdl Oc2ccccc2 C131-11003 214.22 
AH8259 OC(=0)cl ccc(Oc2ccc(cc2)C(0)0)Cdl C141-11005 258.23 
GR34041 X OC(0)cl cccc(Oc2ccccc2)dl C131-11003 214.22 
GR261 706X COC(0)ci cc(ccdl Oc2ccc(OC)cc2)N(0)0.00d1 Cl 5H 1 3N06/C14H1 1 N06 592.52 
ccc(Oc2ccc(dC2C(0)0)N(0)0)CC1 
GR26501 3X OC(=0)ci ccc(CI)ccl Oc2ccc(C#N )cc2 Cl 4H8C1NO3 273.68 
GR49081 X Ncl cc(cc(N)dl Oc2ccccc2)C(0)0 Ci 3H 1 2N203 244.25 
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GW3394 1 6X CC(=O)Ncl ccc(Oc2ccc(cc2)C(0)O)ccl Cl 5H 1 3N04 271.28 
GW404922A Cl.NC(=N)Ncl ccc(Oc2ccc(cc2)C(0)O)ccl Cl 4H 1 3N303. HCI 307.74 
GW409763X NC(S)Ncl ccc(Oc2cccc(c2)C(=O)O)ccl Cl 4H 1 2N203S 288.33 
AH1 1164 OC(0)ciccc(Cl)C(CI)C1 C71-140202 191.02 
GR214770X OC(=O)cl ccc(F)ccl CI C71-14CIF02 174.56 
CCI51 34 OC(=O)cl cc(CI)c(Oc2ccc(0)cc2)c(CI)C1 C131-180204 299.11 
G1149795A O.00(=O)ciccc(0)c(CI)cl C7H5C103. 0.5(H20) 181.58 
GR38988X OC(=O)ciccc(0)c(0)clCI C71-15CI04 188.57 
GR391 82X COd ccc(CI)ccl C(=O)O C8H7CI03 186.60 
GW328037X OC(0)cl cc(Cl)cc(S)cl 0 C71-15003S 204.63 
AH9074 OC(=O)cl cc(Br)cc(Br)cl C7H4Br2O2 279.92 
Gil 60046X OC(0)cl cc(Br)cccl 0 C7H5BrO3 217.02 
GF253708X OC(0)dl cc(Br)cccl CI C7H4BrCIO2 235.47 
GW328038X OC(=O)cl cc(Br)cc(S)cl 0 C7H5BrO3S 249.08 
AH1 1410 COCc1ccccclC(0)O C91-11003 166.18 
GI 1 66356X COC(=O)dl ccc(ccl )C(=0)O C9H804 180.16 
AH5737 OC(=O)cl cccc(C0)cl C81-1603 150.14 
GR239060X COC(=O)cl cccc(cl )C(=O)O C91-1804 180.16 
CCI1 659 OC(0)cl ccc(C#C)ccl C91-1602 146.15 
GR1 56438X OC(=O)cl ccc(CS)cdl C81-1802S 168.22 
GR58626X OC(0)c1 ccc(CCN(0)0)cd1 C91-17N04 193.16 
GR87165X OC(=O)ciccc(CC)ccl C91-1802 148.16 
AH 1 8307XX OC(=O)cl cc(cccl C(F)(F)F)C(F)(F)F C91-14F602 258.12 
GF234517X OC(=O)cl ccc(ccl F)C(F)(F)F C81-14F402 208.11 
GF233960X OC(=O)cl c(F)ccccl F C71-14F202 158.11 
G122041 OA O.00(=O)cl c(F)c(F)c(0)c(F)cl F C71-121=403.1-120 228.10 
GRI01 348X OC(0)cl cc(F)cccl Br C7H4BrFO2 219.01 
AH1 4771 AA OC(=O)cl ccc(ccl )c2ccc(C#C)cc2 C151-11002 222.25 
GF241 458X OC(0)cl cccccl c2ccccc2C(0)O C14H1 004 242.23 
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GR7 1 072X OC(=0)cl ccc(ccl )c2ccc(cc2)N(0)0 Ci 3H9N04 243.22 
GR93262X OC(=0)ci cccccl c2ccc(cc2)N(=0)=0 Ci 3H9N04 243.22 
GW31 5267X OC(=0)cl ccc-2c(cl )C(0)C(0)c3cccCC32 C151-1804 252.23 
GR59449X COcl ccc(ccl c2ccccc2)C(0)O C141-11203 228.25 
GR59450X CCOc1 ccc(ccl C(=0)0)c2ccccc2 C151-11403 242.28 
CCI1 7440 OC(0)cl cc(0)c2ccccc2ci 0 C1  H804 204.18 
GR68891 OC(0)cl cc2cccc(0)c2ccl 0 C111-1804 204.18 
G1148915 OC(=0)cl c(0)ccc2cccccl 2 C1  H803 188.19 
GR2071 21 OC(=0)cl cc2ccccc2cc1 0 Cli H803 188.19 
GR26081 0 OC(=0)cl cc2cc3ccccc3cc2cdi 0 C151-11003 238.25 
GR66288 OC(=O)cl ccc2ccccc2cl 0 C111-1803 188.19 
G1166629 OC(0)cl ccc2cc(0)ccc2ci C1  H803 188.19 
GR235507 OC(=0)cl ccc2ccc(0)cc2cl C111-1803 188.19 
GR38555 OC(=O)dlccc(0)c2ccCCCi2 C11H803 188.19 
GW296997 OC(=0)cl ccc2cccc(0)c2cl C111-1803 188.19 
CCI4008 OC(=0)cl cccccl 0 C71-1603 138.12 
GR244973 COcl ccc2cc(ccc2ci )C(0)0 C121-11003 202.21 
GR26071 9 COO ccc2ccccc2cl C(=0)0 C121-11003 202.21 
GW31 7730 COO cc2ccccc2ccl C(=0)0 C121-11003 202.21 
GW4 12437 COO c(ccc2cccccl 2)C(=O)0 C121-11003 202.21 
GW369998 COO Cc2(0C)cCCC2CCi C(=0)0 C131-11204 232.24 
GW41 6206 COO ccc2cc(0)c(cc2ci )C(0)0 C121-11004 218.21 
GW3 1 5253X OC(0)cl ccc2ccc3ccccc3c(0)c2di C161-11003 250.26 
AH 1 6806XX Cod cccc(ci )C(=0)c2ccc(cc2)C(0)0 C151-11204 256.26 
AH1 71 57XX CCCOC1 cccc(ci )C(=0)c2ccc(cc2)C(0)0 C171-11604 284.32 
GW31 2681 X COO ccc20c3cc(ccc3Cc2cl )C(=0)0 C151-11204 256.26 
AH4366 OC(=0)cl ccc(cdi )C(=0)c2ccccc2 C141-11003 226.23 
AH4367 OC(=0)ci ccccdi C(=0)c2ccccc2 C141-11003 226.23 
AH9991 Cci ccc(ccl Ci)C(=0)c2ccccc2C(0)0 Ci 5Hl 1 C103 274.71 
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AH9456 NO cccccl C(=0)c2ccccc2C(0)0 Cl 4H1 1 NO3 241.25 
AH771 6 0C(=0)cl cc(Cc2ccc(0)c(c2)C(=0)0)CCC1 0 Cl 5H 1206 288.26 
GR244 1 60X OC(=0)dl cccc(cl )C(=0)c2ccc(Cl)cc2 Cl 4H9C103 260.68 
GR301 70X COO ccc(C(=0)c2ddddd2C(=0)0)C(0)C1 C151-11205 272.26 
GW294785X COO ddd(Cd2cc(ccd2C(=0)0)C(=0)0)CC1 C161-11405 286.29 
GR232463X OC(=0)cl ccc2C(OC(0)c2cl )c3ccc(F)cc3 Cl 5H9F04 272.24 
GW31 2679X COcl ccc(cdl )C2OC(=0)c3ccc(dc23)C(=0)0 C161-11205 284.27 
AH 12195 CC(=0)cl cccc2cccc(C(0)0)dl 2 Cl 3H 1003 214.22 
GR30355X CC(=0)cl ccc(ccl )C(=0)0 C91-1803 164.16 
GR30686X OC(=0)cl ccc(cdl )C(=0)C(F)(F)F C91-15F303 218.13 
G1221 306X OC(0)cl ccccdl CCc2ccccc2 Cl 5H 1402 226.28 
GRI 97556X OC(0)dl ccc2CCc3cccc1 c32 C131-11002 198.22 
GR236886 CC(0)cl cccc2cc(0)c(cdl 2)C(=0)0 C131-11004 230.22 
GW432536 COd cc(ccdl C(=0)0)C(=0)C Cl OH1 004 194.19 
AH 1 4680XX Ccl cc(C)c(C(0)0)c(CC(C)(C)C(0)0)d1 C141-11804 250.30 
GR21 5350X OC(=0)CCc1 ccc(cdl )C(=0)O Cl OH1 004 194.19 
GW4 131 25X COC(=0)CC(Ccl ccc(cdl )C(=0)0)C(=0)OC(C)(C) C171-12206 322.36 
C 
GR203309X OC(=0)cl ccc(ccl )C2CCCCC2 C131-11602 204.27 
GR24 1 592X CCCCCCCCCCCCC1 CCC(CC 1 )c2ccc(cc2)C(0) C251-14002 372.60 
0 
GR2071 27X CCCCCCc1 ccc(ccl )C(=0)0 C131-11802 206.29 
GW3991 39X CCCCCCCcI CCC(CCI )C(=0)0 C141-12002 220.31 
GR34040X CC(C)(C)cl cc(cc(cl 0)C(C)(C)C)C(0)0 C151-12203 250.34 
GW323465X CC(0)cl cc(Cl)c(0)c(cl )C(=0)0 C9H7C104 214.61 
GR36337X CCCCCCCCc1cccc(cl)C(0)0 C151-12202 234.34 
GR87232X OC(0)cl cccc(CCCCc2ccc(0)cc2)dl C171-11803 270.33 
GW322742X CCCCC(=0)ciccc(0)c(cl)C(0)0 C121-11404 222.24 
CC18247 CC(C)(OC(=0)cl cccccl C(=0)0)C#C C131-11204 232.24 
GW470564X Ccl (COC(=0)c2ccccc2C(0)0)CCCC1 =0 C151-11605 276.29 
GRI 36744X OC(=0)cl cncccl C20CCO2 C91-19N04 195.18 
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GW398946X OC(0)cl ccc(ccl )C2OCCO2 Cl OH 1004 194.19 
GR258074X OC(=0)/C=C/cl cccccl C(=0)0 Cl 0H804 192.17 
GR30298X OC(=0)C(=Cciccc(ccl)C(0)0)0 C10H805 208.17 
GW294643X Cod cccccl C=CC(0)c2cc(ccc20)C(0)0 C171-11405 298.30 
GW295897X OC(0)cl cccccl C=CC(=0)c2ccccc2 C161-11203 252.27 
AH51 19 NC(0)Ccl cccccl C(=O)0 C91-19NO3 179.18 
GR1 46857A 0.[Na+].[0-]C(=O)dl cccccl CC(0)Nc2ccccc2 Cl 5H 1 2NO3-. Na+. 0.2(H20) 280.86 
GR1 08821 X OC(CN(0)0)cl ccc(cdl )C(=0)0 C91-19N05 211.18 
CC 121441 X OC(0)Ccl cccccl C(=0)0 C91-1804 180.16 
G1222965X OC(=0)Ccl cccc(0)cl C(=0)0 C91-1805 196.16 
GR85032X Cod cc(CC(0)0)c(ccl OC)C(0)0 C111-11206 240.22 
GW3 1 7925X OC(=0)Ccl ccc(cdl C(=O)0)N(0)0 C9H7N06 225.16 
GW423592X CCOC(=0)C(C(0)C)ci cc(cccl C(=0)O)N(=0)0 Cl 3H 1 3N07 295.25 
GR21 2558X OC(=0)Cci cccc(cl )C(=O)0 C91-1804 180.16 
GV98449X NC(C(=0)0)cl cccc(cl )C(=0)0 C91-19N04 195.18 
GR245353X OC(=0)C(CC#N )dl cccc2cccc(C(0)0)cl 2 Cl 5H 11 N04 269.26 
AH 13207 OC(=0)ci cccc2C(=0)N(Cc3ccccc3)C(=0)c2 1 Cl 6H1 1 N04 281.27 
GR53007X OC(0)cl ccc2C(0)N(OCc3ccccc3)C(0)c2dl Cl 6H1 I N05 297.27 
AH8335X OC(0)ci ccc(ccl )N2C(=0)c3ccccc3C2=0 Cl 5H9N04 267.24 
GR1 001 33X OC(=0)cl cc(CNC(=0)C(F)(F)F)cccl CI Ci OH7CIF3NO3 281.62 
GRI 11981X CC(C)(C)O 1- (=O)NCC1CCcC(Cl)C(=O)O Cl 3H17N04 251.29 
GR1 24650X CCOCCOc1 ccc(cdl C(=O)N)C(0)0 Cl 2H1 5N05 253.26 
GR236342X CCNC(=0)cicc(cccl0)C(0)0 C1OH11N04 209.20 
GR258909 CONC(0)ci cc(0)c(C(=O)0)c(0)cl C91-19N06 227.18 
GR265026X CC(0)NCc1 ccc(ccl )C(=O)0 Ci OH ii NO3 193.20 
GR43579X NCc1 cc(cc1 )C(=0)0 C8H9NO2 151.17 
GR51 409X NC(=N0)cl ccc(ccl )C(=0)0 C81-18N203 180.17 
GW273704X NC(cl ccc(cdi )C(=O)O)P(0)(0)0 C8H 1 ONO5P 231.15 
GW324992X OC(=0)cl cccc(CP(=0)(0)0)cl C81-1905P 216.13 
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CCI 19762 OC(=0)cl cc2ccccc2cc1 C(=0)N3CCOCC3 Ci 6H 1 5N04 285.30 
GR249776X OC(=O)ci cccccl C(=0)NCCc2ccccc2 Cl 6H 1 5NO3 269.30 
GR256398X C[C@H](NC(0)cl cccccl C(=0)0)c2ccccc2 Cl 6H 1 5NO3 269.30 
GR269435X CNC(C(0)0)ci ccc(CI)ccl C(0)0 Ci OH 1 OCINO4 243.65 
GR1 8O85iA [Ba+2].[0-]C(0)Ci CCCN(Cc2ccccc2C(=0)[0-])C1 C14H 1 5N04(2-). Ba(2+) 398.62 
GR88677X NC(0)CC[C@H](NC(=0)Ci ccccci C(=0)0)C(0) Ci 3H1 4N206 294.27 
0 
GW401 244X COC(=0)[C@H](Ccl ccc(ccl )C(=0)0)NC(0)c2ccc Ci 8H 1 6C1N05 361.79 
cc2CI 
GW406680X COC(=0)[C@H](Cci ccc(cc1 )C(=0)0)NC(0)OC(C Cl 6H21 N06 323.35 
)(C)C 
GW521 849X COC(=0)[C@H](Ccl ccc(cci )C(=0)0)NC(0)OCc2 Cl 9H1 9N06 357.37 
ccccc2 
AH 13312 OC(0)CC 1 =CCCc2cccc(C(0)0)cl 2 C131-11204 232.24 
AH14681 XX Ccl cc(C)c(C(0)0)c2CC(C)(C)C(0)C21 C141-11603 232.28 
GR1 30650X CC1 (C)CCc2cçc(cc2i )C(0)0 Ci 2H 1402 190.24 
GR9951 3X OC(0)ci ccc2CCC(0)c2cl Cl 0H803 176.17 
AH23294X OC(=0)cl ccc2CCC(CC#N)c2cl Cl 2H9NO2 199.21 
GR2I 2000X Cci cccc2C3C(C4C3C(0)c5c4cccc5C(0)0)C(0 C20H 1404 318.33 
)c2i 
GR1 16024X CCN(CC)C(0)[C@H]1 CC[C@H]2[C@@H] 3CCc4 C241-133NO3 383.54 
cc(ccc4[C@H]3CC[C@] 1  2C)C(=0)0 
GR58504X CC  (C)CCC(C)(C)c2cc(ccc21 )C(=0)0 C151-12002 232.33 
GW31 51 24X OC(=0)ci ccc2CCCCc2cl C111-11202 176.22 
GW442963X OC(=0)cl ccc2CCCC(0)c2cl C111-11003 190.20 
GW342768X COO cc2CCCCc2cc1 C(=0)0 C121-11403 206.24 
AH25327X OC(=0)ci ccc(OC(=0)CCC/CC\CC2C(CC(0)C2 C36H39N07 597.72 
N3CCOCC3)OCc4ccc(cc4)c5ccccc5)cc1 
AH25377X OC(=0)cl cccc(dl )C(=0)CC2C(CC(=0)C2N3CCO C31 H31 N06 513.60 
CC3)OCc4ccc(cc4)c5ccccc5 
GR60468X OC(0)dl cccc(CCCOC2C(CCC2N3CCCCC3)OCC C271-135N04 437.58 
4ccccc4)cl 
GR223597X CC 1 (C)CC(0)/C12C(\C 1 )/Nc3ccccc3NC2c4ccc(c C22H22N203 362.43 
c4)C(=0)0 
GW543499X CC1 (C)CC(=C(C(C2C(0)CC(C)(C)CC20)C3CCC( C241-12806 412.49 
cc3)C(0)0)C(0)C1 )0 
GR257678X CC1 OC(=0)c2c(0)c(C(0)0)c(0)cc2Cl C C121-11206 252.23 
GW65271 6X CC1 (C)Cc2nc(cc(CI)c2CO1 )C(=0)0 Cli Hi 2C1NO3 241.68 
GW292869X COd ccc(CC(C)(CCCC2NOC(C2)C3CCC(CC3)C(0 C251-128N205 436.51 
)0)C#N)cci OC 
GW3424 1 2X COd ccc(CC(C)(CCC2NOC(C2)C3CCC(CC3)C(0) C241-126N205 422.49 
0)C#N)ccl OC 
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GR2321 27X OC(0)cl ccc2OCCCC(NC(0)OCC3CCCCC3)C2C1 Cl 9H 1 9N05 341.37 
GW309937A CI.CN 1 CCc2cc(C(0)O)c(0)CC2C1 Cc3ccccc3Cl Cl 8H 1 8C1NO3. HCI 368.26 
GR54241 COd ccc(cdl CCCN(C)C)C(0)0 Cl 3H 1 9NO3 237.30 
GR64 1 38A l.COcl ccc(cdl CCC2CCCCN2C)C(0)O Cl 6H23NO3. HI 405.28 
GR81 562 CN(C)CCCc1 cc(ccdl N(C)C)C(0)0 C141-122N202 250.34 
GW424484X OC(=0)dlcccc(CC2NC(0)NC20)C1 Cl 1H10N204 234.21 
GW294777X COO ccc(cdl )C2COc3ccc(Cc3C20)C(0)0 C171-11405 298.30 
GW3 I 3525X OC(0)cl ccc20C(CCc2cl )c3ccccc3 C161-11403 254.29 
GW321 902X OC(=0)cl ccc2OCCCc2cl Cl OH1 003 178.19 
GR1 94866A 0[C@@H](CNC 1 CCC(CC1 )c2ccc(cc2)C(0)0)c3c C21 H24C1NO3. C2HF302 487.91 
ccc(CI)c3.00(0)C(F)(F)F 
GR65644X NO c(CI)cc(ccl CI)C(0)CNCCCCCCOCCCc2ccC(dd C24H32C12N204 483.44 
2)C(=0)0 
GW55381 OA CI.Ncl c(CI)cc(ccl CI)[C©@H](0)CNCCCCCCOCC C24H32C12N204. HCI 519.90 
Cc2ccc(cc2)C(0)0 
GW549758A CI.Ncl c(Cl)cc(ccl CI)[C@@H](0)CNCCCCCOCCC C23H30C12N204. HCI 505.87 
c2ccc(cc2)C(0)0 
GW550038A CI.Ncl c(Cl)cc(ccl CI)[C@@HJ(0)CNCCCCCCOCC C24H32C12N204. HCI 519.90 
Cc2cccc(c2)C(0)0 
GR70745X NO c(CI)cc(ccl CI)C(0)CNCCCCCCOCCCC2CflCC(C C231-131 C12N304 484.43 
2)C(=0)0 
GR69220X Nd c(CI)cc(ccl CI)C(0)CNCCCCCOCCCc2cCC(02) C21 H28Cl2N205 459.37 
C(=0)0 
AH1 1291 NS(0)(0)dl cc(ccdl C(=0)0)C(=0)0 C8H7NO6S 245.21 
GR94828A N.NS(0)(0)dl cc(C(0)0)c(0)c(dl )S(0)(0)N C7H8N207S2. H3N 313.31 
AHI 2740 COd cc(ccdl C(=0)0)S(0)(0)N C81-19N05S 231.23 
AH12757 NS(=0)(=0)dlccc(cdl)C(0)0 C71-17N04S 201.20 
GR1 99839X Ccl ccc(cdi )S(=0)(=0)Nc2ccccc2C(0)0 Cl 4H1 3N04S 291.33 
GR581 91 X OC(0)cl ccc(CCCNS(=O)(0)c2CCCCC2)O1 C14H1 5N05S 309.34 
GR87036X CCCN(CCC)S(0)(0)cl ccc(cdl )C(=0)0 Cl 3H 1 9N04S 285.37 
GW41 5452X OC(=0)cl cc(cccl 0)S(=0)(=0)N2CCCCC2 Cl 2H1 5N05S 285.32 
AH8294 CS(=0)(=0)ciccc(ccl)C(0)0 C81-1804S 200.22 
GR39220X OC(0)cl ccc(ccl )S(=0)c2ccc(cc2)C(0)0 Cl 4H 1 005S 290.30 
GI 101 694A [K+] .00(=0)cl ccc(cdl )S(=0)(0)[0-] C7H505S-. K+ 240.28 
GR50961A N.00(=0)ciccccdlS(0)(0)0 C7H605S. H3N 219.22 
GR147168X Ncldd(C(0)0)C(0)C(Cl)S(0)(0)0 C7H7NO6S 233.20 
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GR51 196X Ncicc(Cl)c(ccl C(=O)O)S((0)(0)O C71-16CIN05S 251.65 
GR1 17463X OC(=O)cl cccccl SCc2ccccc2 Cl 4H 1 202S 244.32 
GR208696X OCCScI cccccl C(0)O C91-11003S 198.24 
GR32768A [Na+].CSc1 cccccl C(0)[0-] C8H702S-. Na+ 190.20 
GW43231 3X CC(=0)NCSc1 cccccl C(=0)0 Cl OH 11 NO3S 225.27 
GR266494X CSc1 ccc(CI)c(cl )C(=0)0 C81-17002S 202.66 
GW298250X OC(=O)CCScicccC(C1 )C(=0)0 C1OH1004S 226.25 
GR1 2501 7X CC(C)(C)OC(0)NCCSC1 ccc(ccl )C(=0)0 C141-1 1 9N04S 297.38 
GW37001 8X OC(=0)cl cccccl SCC(=0)Nc2ccccc2 Cl 5H 1 3NO3S 287.34 
GW31 51 03X OC(0)cl ccc2c(CCCS2(0)0)cl Cl OH 1 004S 226.25 
GW321 966X OC(0)cl ccc2C(0)CCSc2c1 Cl 0H803S 208.24 
GF233961 X OC(0)cl cccccl Sc2ccccc2C#N Cl 4H9NO2S 255.30 
G1230797A [Na+].[0-]C(0)cl cccccl Sc2ccc(cc2)N(0)0 Cl 3H8N04S-. Na+ 297.27 
GRI 401 64X OC(0)cl cccccl Sc2ccc(CI)cc2 Cl 3H9C102S 264.73 
GW290604X OC(=0)ciccc2Sc3ccccc3SC2Cl Cl 3H802S2 260.34 
GW291 821 X OC(0)cl cccc(Sc2ccccc2C(0)0)c1 C141-11004S 274.30 
GW361 278X OC(0)cl ccc(C(0)0)c(Sc2ccccc2)cl C141-11004S 274.30 
GW336990X OC(0)cl ccc(C(=0)0)c(Sc2cccC3CCcCC23)C1 C181-11204S 324.36 
GW295365X CCc1 ccc(Sc2cc(ccc2C(0)O)C(0)O)CCI C161-11404S 302.35 
GW29291 1X OC(0)cl cc(cccl 0)S(=0)(=0)c2ccccc2 C131-11005S 278.29 
GW294867X Ccl ccc(ccl S(=O1(0)c2cCccc2)C(0)0 C141-11204S 276.31 
GW322405X Ccl ccc(ccl )S(=0)(=0)c2cc(ccc2C)C(0)0 C151-11404S 290.34 
GW31 5228X OC(=O)cl ccc20c3ccc(cc3Sc2cl )C(=0)O C1 41-1805S 288.28 
GW32 1601 X OC(0)cl ccc2-c3ccccc3S(0)(0)c2cl C1 31-1804S 260.27 
G1230786 OC(0)cl csccl Sc2ccc(CI)cc2 C1  H7C102S2 270.76 
GW295364 OC(=O)cl ccc(C(=0)0)c(Sc2ccsc2)C1 C1 21-1804S2 280.32 
AH7066 OC(0)ciccc2c(ci )C(=0)c3ccccc3S2(0)0 C14H805S 288.28 
GF23451 6X OC(=0)cl ccc2C(=O)c3ccccc3S(0)(0)C2C1 C1 41-1805S 288.28 
GF269343X OC(0)cl ccc2Cc3ccccc3S(0)(0)c2C1 C141-11004S 274.30 
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GW31 4651 X OC(=O)cl ccc2C(=O)c3cc(F)ccc3S(=O)(=O)C2C1 Cl 4H7F05S 306.27 
GW31 1 857X Ncl ccc2C(=O)d3ccc(Cd3S(0)(=O)C2d1 )C(=O)O CI 4H9N05S 303.30 
GW323587X CCc1 ccc2c(cl )C(0)c3ccc(cc3S2(0)0)C(0)O C161-11205S 316.34 
GW294790X OC(=O)cl ccc2Cc3cc(CI)ccc3Sc2Cl Cl 4H9C102S 276.74 
GW3221 1 8X OC(=O)dl ccc2Cc3ccccc3Sc2cl C141-11002S 242.30 
GW31 2723X OCCOc1 ccc2Cc3ccc(cc3S(=O)(0)C2C1 )C(=O)O C161-11406S 334.35 
GW432537X CCOc1 ccc2Cc3ccC(cc3S(0)(0)C2C1 )C(=O)O Cl 6H1 405S 318.35 
GW322502X OCCOc1 ccC2C(0)C3Ccc(CC3S(0)(0)C2C1 )C(=O C161-11207S 348.33 
)o 
GW31 2725X OC(0)cl ccc2Cc3ccc(0)CC3S(=O)(0)C2C1 Cl 4H 1 005S 290.30 
GW322531 X COcl ccc2C(0)c3ccc(CC3S(0)(0)C2C1 )C(=O)O C151-11006S 318.31 
GW31 4663X CCCOc1 ccc2c(cl )C(=O)c3ccc(cc3S2(0)0)C(0 C171-11406S 346.36 
GW323690X CCOc1 ccc2c(cl )C(=O)c3ccc(cc3S2(0)0)C(0) C161-11206S 332.33 
0 
GW323328X COcl cccc2C(=O)c3ccd(Cd3S(=O)(=O)C1 2)C(=O)O C151-11006S 318.31 
AH10503 OC(0)CCC(0)Nc1CcC(cdl)C(0)O C1  H9N05 235.20 
AH25564X CN(C(0)C)cl ccc(cdl )C(0)O C101-111NO3 193.20 
CCI71 55 CC(0)Ncl ccc(C(0)O)c(0)cl C9H9N04 195.18 
GR51 515 CC(=O)Ncl ccc(C(=O)O)c(ci )N(=O)=O C91-18N205 224.18 
GW363503A CN(C)CCO.CC(0)Nd1ccc(C(0)O)C(F)d1 C9H8FNO3. C41-111 NO 286.31 
GR253714X CC(0)Ncl c(CI)cc(cdl Cl)C(0)O C9H7C12NO3 248.07 
AH901 8 OC(=O)cl ccc(cdl O)N2C(=O)C=CC20 Cli H7N05 233.18 
AHI 2070 CC(0)Nc1 cc(CI)cccl C(=O)O C91-18CINO3 213.62 
G1123058 CC(0)Ncl cccccl C(=O)O C9H9NO3 179.18 
GR55509 CC(=O)Ncl cc2ccccc2ccl C(=O)O Cl 3H1 1 NO3 229.24 
GR50239 CC(0)Ncl ccd(C)cdl C(=O)O C101-111NO3 193.20 
GR871 21 OC(0)ci cccccl NC(=O)C(F)(F)F C9H6F3NO3 233.15 
AH2951 CN(C0)cl cccccl C(=O)O C91-19NO3 179.18 
GR1 99994 CC(0)N(CC(C)Ci)cl cccccl C(=O)O Cl 2H1 2C1NO3 253.69 
AH 12275 OC(=O)cl cccccl N2C(=O)CCC20 C1  H9N04 219.20 
GR1 73757 CC(C)(C)C(0)Ncl cccc(dl C(0)O)C(F)(F)F Cl 3H 1 4F3NO3 289.26 
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GR1 61201 X COC(=O)CNC(0)Nc1cCcCC1 C(=O)O Cli HI 2N205 252.23 
AH 12764 OC(=O)C(Ncl ccccci C(0)O)c2ccccc2 Cl 5H 1 3N04 271.28 
AH 1 7306AB [Na+].[O-]C(0)CNC1 cccccl C(0)[0-1 C9H7N04(2-). 2(Na+) 239.14 
GR1 611 86X CCOC(0)CNc1 cccccl C(0)O Cii Hi 3N04 223.23 
AH 1 5079XX Ccl ccc(N(CC#C)CC#C)C(C1 )C(0)O Cl 4H 1 3NO2 227.27 
GR351 1 7X OC(=O)ci ccc(NCC#CC2CCCCC2)CC1 Cl 6H1 3NO2 251.29 
AH21453 OC(=O)CCNc1 cccccl C(=O)O Cl OH1 I N04 209.20 
GRI 78029 OC(0)cl ccccci NCCC#N Ci OH1 0N202 190.20 
GR33748 CCNc1 cccccl C(=O)O C91-11 1 NO2 165.19 
Gil 52672 CC(0)Ncl ccc(N)c(cl )C(=O)O C91-11 0N203 194.19 
GR141 743 CC(0)Ncl cccc(cl )C(0)O C91-19NO3 179.18 
GR39406 CC(0)Ncl cc(N)cc(cl )C(=O)O C91-1 1 0N203 194.19 
GR214280 CC(=O)Nci cc(cccl C)C(=O)O Ci OH1 1 NO3 193.20 
GR226270 OC(=O)C(0)Ncl cccc(cl )C(=O)O C9H7N05 209.16 
GR78537 CC(C)CC(0)Nci cccc(cl )C(=O)O Ci 2H 1 5NO3 221.26 
GR1 89793 CC(0)Ncl ccc(ccl NC(0)C)C(0)O C111-112N204 236.23 
GR263804X CC(0)Nci cc(cccl C(C)(C)C)C(0)O Cl 3H 1 7NO3 235.29 
GW324674 CC(0)Nciccc(N(0)0)C(C1)C(0)O C9H8N205 224.18 
GW41 0247 CC(0)Ncl cccc(C(=O)O)cl N(=O)=O C91-18N205 224.18 
GR38461X CC(0)Ncicc(C(0)O)C(0)CC1O C91-19N05 211.18 
GW340239X CC(0)Nciccc(OCCC)c(C1 )C(=O)O C121-113N04 235.24 
GR73 169X OC(0)cl cccc(NC(0)CCc2ccc(0)cC2)Cl Cl 6H 1 5N04 285.30 
AH1 5491 XX OC(0)cl cccccl C(=O)Nc2ccccc2F Ci 4H1 OFNO3 259.24 
GR1 07832X OC(0)cl ccc(NC(0)c2ccccc2)ccl Ci 4H1 1 NO3 241.25 
GR231 878X OC(0)cl cccccl NC(=O)c2ccccc2 Cl 4H1 1 NO3 241.25 
GR1 37556X OC(0)cl cccc(NC(0)c2ccc(C#N)cC2)Cl Ci 5H1 0N203 266.26 
GF146238 OC(=O)cl cc(NCc2cc(0)ccc2O)cccl 0 C141-11 3N05 275.26 
GW295088 COcl ccc(0)c(CNC2CCC(0)C(C2)C(0)0)C1 Cl 5H 1 5N05 289.29 
GF267572X COci ccc(CNc2ccc(cc2)C(0)0)CC1 OC Cl 6H 1 7N04 287.32 
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GW3231 41 X OC(=O)cl ccc(NCC2cCC3OCCOC3C2)cC1 Cl 6H 1 5N04 285.30 
GF267575X CCOC(=O)Ncl ccc(cci )C(0)O Cl OH 11 N04 209.20 
GR7631 9X OC(=O)cl cccc(NC(0)0CC2CcCcc2)C1 Cl 5H1 3N04 271.28 
GR78359X OC(=O)cl cccccl NC(=O)OCc2ccccc2 Cl 5H 1 3N04 271.28 
Gil 70475X CN(C)cl ccc(NNc2cccCC2C(0)O)CC1 Ci 5H 1 5N302 269.31 
GW275669A [Na+].CN(C)ci ccc(NNc2ccc(cc2)C(0)[O-])CCi Cl 5H14N302-. Na+ 291.29 
GR205623X CN(C)N=NciccccClC(0)O C9H11N302 193.21 
GR53844X CN(C)CNc1 cccc(C)ci C(=O)O Cli H14N202 206.25 
GW298071 X OC(0)ci cccccl NC=CN(0)0 C9H8N204 208.18 
GI 1 99827X NC(S)Ncl ccc(cci )C(=O)O C8H8N202S 196.23 
GR1 41 837X NC(=S)Ncl cccc(ci )C(=O)O C8H8N202S 196.23 
GW323802A [Na+].[O-]C(=O)cl ccc(NCS(0)(0)[O-])ccl C8H7NO5S(2-). 2(Na+) 275.19 
GW329522X NC(N )NC(0)Nci ccc(C(0)O)c(CI)ci C91-19C1N403 256.65 
GR251 266A CNC(0)cl ccc(cci NC(N)N)C(0)O.00(0)C(F)( Ci OH1 2N403. C2HF302 350.26 
F)F 
GR26501 8A Cci ccc(ccl NC(=N)N)C(0)O.00(0)C(F)(F)F C9H1 1 N302. C2HF302 307.23 
GR25301 7X COci ccc(ccl NC(=N)N)C(0)O C91-111N303 209.21 
GW4251 83X Ccl ccc(cdi NC(=NC(0)OC(C)(C)C)NC(0)OC(C)( Ci 9H27N306 393.44 
C)C)C(0)O 
GR267248A NC(=N)Ncl cc(ccdl CNC(=O)C(F)(F)F)C(0)O.00( Cli Hi 1 F3N403. C2HF302 418.26 
=O)C(F)(F)F 
GW4251 81 X OC(0)ci ccc(CNC(0)C(F)(F)F)c(di )N(=O)=O Ci 0H7F3N205 292.17 
AH17295XX Ncic(cccclN(0)0)C(0)O C71-16N204 182.14 
AH26206X CN(C)cl CCC(CC1 N(=0)0)C(=O)O C91-11 0N204 210.19 
AH2056OXX NNciccc(cciN(0)0)C(0)O C71-17N304 197.15 
GR971 73X CC(C)(CN)CNci ccc(cci N(0)0)C(0)O C121-117N304 267.29 
AH21 291 X OC(0)cl cc(Br)cc(ci )N(=O)0 C7H4BrNO4 246.02 
GW471 254X CN1 CCN(CC1 )c2ccc(cc2C(0)O)N(0)0 Cl 2H 1 5N304 265.27 
AH1 7365XX NO cccc(N(0)0)ci C(=O)O C7H6N204 182.14 
G11 98830X OC(=O)cl ccc(ccl N(=O)=O)C(F)(F)F C8H4F3N04 235.12 
AH7669 OC(0)di cc(N=Nc2ccc(cc2)N(0)0)CCCi 0 C1 31-19N305 287.23 
G1221 325A OC(0)cl cc(N(=0)0)c(0)c(cl )N(=O)0.cl ccncc C7H4N207. C5H5N 307.22 
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GI95276X OC(=O)cl ccc(N(0)0)c(0)cl C7H5N05 183.12 
CC17978 Ncl ncnc(Nc2cc(ccc2CI)C(0)O)fll Cl 0H8C1N502 265.66 
GF267691 X OC(=O)cl cc(N(0)0)c(CI)CC1 CI C7H3C12N04 236.01 
Gil 47499A NO ccc(CI)c(cl )C(0)O.OS(0)(0)O C71-16CIN02. H204S 269.66 
AH21 350X OC(=O)cl ccc(Nc2ccccc2C(=O)O)ccl Cl 4H 11 N04 257.25 
GW32 1 669X OC(0)cl ccc(Nc2ccccC2)ccl Cl 3H1 1 NO2 213.24 
GW323630X COO ccc(Nc2ccc(cc2C(=O)O)C(=O)O)CC1 Cl 5H 1 3N05 287.28 
CCI1 914 OC(=O)cl ccc(ccl Nc2ccccc2)N(0)0 Cl 3H1 0N204 258.24 
GF1 46728X OC(0)cl ccccdl Nc2cccc(c2)C(F)(F)F Cl 4H1 0F3NO2 281.24 
GR86838X OC(0)cl cc(Nc2ccc(Nc3ccddd3)CC2)C(CCl Nc4ccc( C32H26N404 530.59 
Nc5ccccc5)cc4)C(=O)O 
AH5502 Ncicc(ccdlC(0)O)C(0)O C8H7N04 181.15 
GRI 41836 Ccl ccc(ccl N)C(=O)O C81-19NO2 151.17 
GR248323 COC(=O)cl ccc(ccl N)C(=O)O C91-19N04 195.18 
AH6472 Ncicc(cc(cl)C(0)O)C(0)O C81-17N04 181.15 
GR141 839 Ncl ccc(cdl N)C(=O)O C7H8N202 152.15 
GR31 162 Nd cccc(cl )C(=O)O C71-17NO2 137.14 
GR40490 Ncicc(N)cc(cl)C(0)O C71-18N202 152.15 
GR40028 Nciccc(ccl)C(0)O C7H7NO2 137.14 
G1149060 Ncl cccc(C(0)O)cl C(=O)O C8H7N04 181.15 
G1153357 Ccl c(N)ccccl C(=O)O C81-19NO2 151.17 
GV95604 Nciccc(C(=O)O)c(di)C(0)O C8H7N04 181.15 
G1119939X Ncicc(F)ccclC(0)O C71-16FN02 155.13 
G1147798 Ccl cc(ccdl N)C(=O)O C8H9NO2 151.17 
GR1 13723 Ccl cc(cc(C)cl N)C(=O)O C9H1 1 NO2 165.19 
G1150183 Ccl ccc(N)c(dl )C(=O)O C8H9NO2 151.17 
GR259835 Ccl cc(C)c(N)c(cl )C(0)O C91-11 1 NO2 165.19 
GR1 97159 Ccl cccc(C(0)O)cl N C81-19NO2 151.17 
GRI 18329 NO ccc(ccl C(=O)O)C(0)O C81-17N04 181.15 
G1151314 Ccicccc(N)dlC(0)O C81-19NO2 151.17 
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GR21 4686 Ccl ccc(C(0)0)c(N)c1 C8H9NO2 151.17 
GR891 64 Nd cccccl C(=0)0 C71-17NO2 137.14 
GR261 930 NO cc2ccccc2cc1 C(0)0 Cli H9NO2 187.20 
GR31787A Cl.NNciccc(cdl)C(0)0 C7H8N202. HCI 188.62 
CC18566 CS(0)(0)Nci cccccl C(0)0 C8H9NO4S 215.23 
GR32579 CS(=0)(=0)Ncl ccc(cci )C(=0)0 C8H9NO4S 215.23 
GW2861 26 CS(=0)(=0)Ndi ccc(C(=0)0)c(Cl)cl C81-18CIN04S 249.67 
GW422957 NS(=0)(0)NC1CCC(CCi)C(=0)0 C7H8N204S 216.22 
GR123674 CS(=0)(0)Ncicccc(c1)C(0)0 C8H9NO4S 215.23 
GR146669 CS(0)(0)Nc1 cc(ccci 0)C(=0)0 C8H9NO5S 231.23 
CC19041 CS(=0)(0)Nci ccc(C(0)0)c(0)cl C8H9N05S 231.23 
GW296344 COO cc(NS(0)(0)C)CcC1C(0)0 C9H1 1N05S 245.26 
GR1 54729 CS(0)(0)NdlddC(CC10)C(0)0 C8H9NO5S 231.23 
GR1 71932 OC(=0)ci ccc(NS(0)(0)C(F)(F)F)C(0)C1 C8H6F3NO5S 285.20 
AH1 3018 OC(=0)cl cc2ccccc2ol C91-1603 162.15 
GV1 40840X OC(0)cl cc2cc(ccc2ol )N(=0)0 C9H5N05 207.14 
GR207209X CCC(0)CCc1 c(oc2ccccdl 2)C(=0)0 C141-11604 248.28 
GR1 12257X OC(0)cl cc(0)c2ccoc2cl C91-1604 178.15 
GR2631 52X OC(0)cl cc2oc3ccccc3c2cci 0 C131-1804 228.21 
GR1 12259X COO cc(cc2occcl 2)C(=0)0 Cl 0H804 192.17 
GR1 85905X COci ccC2OCCC2C1 C(=0)0.COcl cc2ccoc2ccl C(=0 Cl 0H804/C1 0H804 384.35 
)0 
GR1 86845X Cci cccc2c(coci2)C(=0)0 Cl 0H803 176.17 
GR21 9630X OC(0)cl coc2cccc(0)c12 C91-1604 178.15 
GW541 786X Ccl oc2cc(ccc2dl C)C(=0)0 Cii H 1003 190.20 
GW560094X Cci doc2cc(cccl 2)C(=0)0 Ci 0H803 176.17 
GR53539X OC(0)cl ccc2oc(=0)oc2cl C81-1405 180.12 
AH 15201 XX OC(=0)cl ccc2c(0)c3cc(0)dcc3oc2dl C1 4H805 256.22 
AH6859 COcl ccc2oc3cc(ccc3c(0)c2d1 )C(0)0 Cl 5H 1005 270.24 
AH 1 5203XX CC(C)Ocl ccc2oc3cc(ccc3c(0)c2d1 )C(=0)0 C171-11405 298.30 
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GW31 4581 X CCOc1 ccc2oc3cc(ccc3c(0)C2C1 )C(=0)0 C161-11205 284.27 
GW294655X OCCOc1 ccc2oc3cc(ccc3c(0)C2Cl )C(=0)0 C161-11206 300.27 
GW328088X CC(0)COci ccc2oc3cc(cCC3c(0)C2C1 )C(=0)0 C171-11406 314.30 
GW31 2792X CCCCOc1 ccc2oc3cc(cCc3C(0)C2C1 )C(0)0 Cl 8H 1605 312.33 
GW294322X CN(C)CCOc1 ccc2oc3cc(ccc3C(0)C2C1 )C(=0)0 Cl 8H 1 7N05 327.34 
GW304858X OCCOCCOc1 ccc2oc3cc(ccc3c(0)C2Cl )C(=0)0 C181-11607 344.32 
GW3 1 2329X CC(=0)OCCOc1 ccc2oc3cc(ccc3c(0)c2Cl )C(=0) Ci 8H 1407 342.31 
0 
AH1 5400XX CC(C)Ocl ccc2oc3cc(C(=0)0)c(Br)cC3c(0)C2C1 Cl 7H1 3Br05 377.19 
GW31 4526X CCc1 cc(OC)c2oc3cc(ccC3C(=0)C2C1 )C(=0)0 C171-11405 298.30 
GW324336X COO cc(C)cc2c(0)c3ccc(cc30C1 2)C(=0)0 Cl 6H 1205 284.27 
AH5558 OC(0)cl ccc2oc3ccccc3c(=0)c2C1 C141-1804 240.22 
AH5950 OC(=0)ci ccc2c(0)c3ccccc3oc2ci C141-1804 240.22 
GW31 2371 X OC(=0)ci ccc2c(=0)c3cc(C0)CCC3OC2C1 C151-1805 268.23 
GW3 1 5227X Ccl ccc2oc3cc(ccc3c(0)c2d1 )C(=0)0 C151-11004 254.25 
GW3 1 2460X COW ccc2oc3cc(ccc3c(0)c2C1 )C(=0)0 C161-11205 284.27 
GW3 1 2437X CCCc1 ccc2oc3cc(ccc3c(0)C2C1 )C(=0)0 C171-11404 282.30 
GW31 2435X Ncl ccc2oc3cc(ccc3C(0)C2Ci )C(0)0 Cl 4H9N04 255.23 
GF267701 X CSc1 ccc2oc3cc(ccc3c(0)c2ci )C(=0)0 Ci 5H 1 004S 286.31 
GR1 89755X OC(0)cl ccc(C(0)0)c(cl )c2c3ccc(0)cc3oc4cc( C211-11207/C211-11207 752.65 
0)ccc24.00(0)cl cccc(C(0)0)di c2c3ccc(0)cc3o 
c4cc(0)ccc24 
IC161-11005 GW31 3003X OC(0)cl ccc2occ(c3ccc(0)cc3)C(0)c2Ci 28226 
GR256734X Ccl cc(0)c(C(0)0)c2oc(0)Cc(C)C1 2 C121-11005 234.21 
GW321 21 8X OC(0)ci ccc2oc3CCCCc3c(0)c2ci C141-11204 244.25 
AH6372 OC(0)cl ccc2c(=0)cc(oc2cl )c3ccccc3 C161-11004 266.26 
G1205545X Cci c(oc2c(cccc2cl =0)C(0)0)c3ccccc3 C171-11204 280.28 
GW31 2626X OC(0)cl ccc2oc(cc2ci )c3ccc(CI )cc3 C151-19003 272.69 
GR23057 ix OC(0)ci ccc(ol )c2cc3ccccc3oc20 C141-1805 256.22 
AH21 91 7X Ccl ccoci C(0)0 C61-1603 126.11 
AH22735X OC(=0)cicccol C51-1403 112.09 
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GR177051X OC(=0)ciccc(ol)N(0)0 C5H3N05 157.08 
GW471 604X OC(=O)cl ccc(CC#N)ol C7H5NO3 151.12 
GR1 521 69X OC(0)cl cc(Br)c(CI)ol C5H2BrCIO3 225.43 
GR225877X CC(=0)IC=C/ci ccc(ol )C(=0)0 C91-1804 180.16 
GR255442X COO c(0C)c(ocl C(0)0)C(0)0 C81-1807 216.15 
CCI21 80 CCOC(0)cl cocci C(=0)0 C81-1805 184.15 
GR121162X OC(=0)cicoc(Br)ci C5H3BrO3 190.98 
GW308403X OC(0)cl ccocl C(=O)c2ccccc2 C121-1804 216.20 
GR1 14265X C[C@H](Ccicccccl)[C@H](OC(=O)C)C(=C)CCC2C C211-12405 356.42 
cc(o2)C(0)O 
GR225874X CC  (C)COC(C)(CCc2ccC(o2)C(=O)0)OC1 C141-12005 268.31 
GR51 045X Ccl oc(ccl NC(=O)OCc2ccccc2)C(0)O Ci 4H 1 3N05 275.26 
GW52 ii 43X Cod cc(cc(OC)cl OCc2ccc(02)C(0)C(F)(F)F)C( Cl 6H 1 3F307 374.27 
0)0 
GR200308X CCI =C2CC(C)(C)CC2Cc3coc(C(=0)0)cl 3.CC 1 =C Cl 5H2005/C1 5H 1804/Cl 5H 788.94 
2CC(C)(C0)CC2Cc3coc(C(=0)0)ci 3.CC1 (C)CC2C 
(Cl )C(C)(0)c3c(occ3C2O)C(0)0 
GR321 31 X OC(0)cl coc2CCCC(0)cl 2 C91-1804 180.16 
AH2599 OC(=0)cl cc(Cl)cccl NCc2ccco2 Ci 2Hi OCINO3 251.67 
AH7307 OC(=0)cl cc(CI)ccdi NC(0)c2ccco2 Cl 2H8C1N04 265.66 
GR1 21 876X OC(0)cl ccc(NC(0)c2ccccc2)oi Cl 2H9N04 231.21 
GR1 93373X CC(=0)Ncl ccc(oi )C(=O)O C71-17N04 169.14 
GR196926X OC(0)ci ccc(NC(0)OCc2ccccc2)o1 Cl 3H1 1 N05 261.24 
GW426030X CC(C)(C)OC(0)Ncl ccc(o 1 )C(=0)0 Cl OH 1 3N05 227.22 
AH21 971 X CC(0)cl ccc(si )C(0)O C71-1603S 170.19 
GW648032X OCCciccc(sl)C(0)0 C71-1803S 172.20 
CCI1 710 OC(0)cl cccsl C51-1402S 128.15 
GR71 245X OC(0)cl ccc(CCOCCCCCCBr)sl Cl 3Hl 9BrO3S 335.26 
GR1 7391 4X Cci ccc(C)nl c2ccsc2C(=0)O Cli Hi 1 NO2S 221.28 
GR257498X CC(C)S(=0)(=0)ci csc(C(0)0)dl Cl C8H9CI04S2 268.74 
AH23040X OC(=0)ci ccscl C51-1402S 128.15 
GR36682X OC(=0)cicsc(ci)N(0)0 C51-13N04S 173.15 
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GR47574X OC(=O)ciccc(si)N(0)0 C5H3NO4S 173.15 
GR21 5566X COd c(CI)scci C(0)O C6H5C103S 192.62 
Gil 98860X OC(=O)cl cc2ccccc2sl C91-1602S 178.21 
GR74829X OC(=O)cl csc2cccccl 2 C91-1602S 178.21 
GW271 761 X COcl ccc2sc(C(0)O)C(OC(C)C)C2d1 C131-11404S 266.32 
GR232957X CC(0)cl sc2sc(C(0)O)c(C)C2c1 C C111-11003S2 254.33 
GW32221 6X OC(0)ci cc2c(=O)c3ccccc3Sc2sl Ci 2H603S2 262.31 
AH4822 OC(0)cl ccc(sl )C(0)c2ccccc2 C1 21-1803S 232.26 
GR207205X OC(ciccc(sl)C(0)O)c2CCCCC2 C121-11003S 234.28 
GF267466X Cci cc(C(0)c2ccc(S2)C(0)O)C(C)S1 C121-11003S2 266.34 
GW328094A Cl.Ccl ccc(cci )IC(=CICN2CCCC2)Ic3ccC(S3)C(-0) Ci 91-121 NO2S. HCI 363.91 
0 
GW4 1 8822A CI.Ccl ccc(ccl )IC(=C\CN2CCCC2)Ic3ccC(S3)C(0) Cl 9H2 1 NO2S. HCI 363.91 
0 
GW44891 1X Ccl ccc(cdl )C(=CCN2CCCC2)c3ccc(s3)C(=O)O Ci 9H21 NO2S 327.45 
Gil 98877X OC(0)ci ccc(sl )c2ccccn2 Cl OH7NO2S 205.24 
GR267007X OC(0)cl cc(nc2cccccl 2)c3cccs3 Cl 4H9NO2S 255.30 
GW340373X OC(0)cl ccc(si )c2ccccc2 C111-1802S 204.25 
GR256536X Cnl nc(ccic2ccc(s2)C(0)0)C(F)(F)F C10H7F3N202S 276.24 
GR1 921 53X COC(0)ci scccl c2ccc(o2)C(0)O C11 1-1805S 252.25 
GW321 1 93X OC(0)cl cc-2c(sl )C(=0)c3ccccc23 C1 21-1603S 230.24 
AH23064X CScl sc(C(=O)0)c(C)cl C(=O)C C91-11 003S2 230.31 
GW279435X CSci sc(C(0)0)C2CCCC(0)Ci 2 C101-11003S2 242.32 
GW279438X CS(0)(0)cl sc(C(0)O)c2CCCCc1 2 C101-11004S2 258.32 
GW279439X CSc1 sc(C(=O)0)c2CCCCc1 2 C101-11002S2 226.32 
GR1 27482A [Na+].CC(0)Nci sc(ccl C(=O)[0-])C(0)C C9H8NO4S-. Na+ 249.22 
GR262262X CCCN(CCC)C(0)cl c(C)c(scl NC(=O)C)C(=O)0 Cl 5H22N204S 326.42 
GR262264X CCCNC(0)cl c(C)c(scl NC(0)C)C(0)O Cl 2H 1 6N204S 284.34 
GR267264X CCCN(CCc1 cccccl )C(=0)c2c(C)c(sc2NC(0)C)C( C20H24N204S 388.49 
=0)0 
AH8425 COcl ccc2sc3ccc(cc3c(0)C2C1 )C(=0)0 C151-11004S 286.31 
GW3 14731 X COcl cccc2c(0)c3ccc(cc3scl 2)C(0)O C151-11004S 286.31 
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GW31 4830X COd ccc2sc3cc(ccc3d(=0)d2Cl )C(0)0 C151-11004S, 286.31 
GW320557X CCOc1 ccc2sc3cc(ccc3c(=O)C2Cl )C(=0)0 C161-11204S 300.34 
GW323721 X CCCOc1 ccc2sc3cc(ccc3c(0)C2d1 )C(0)0 C171-11404S 314.36 
GW31 4662X CCc1 cccc2c(0)c3ccc(cC3SCl 2)C(0)0 C161-11203S 284.34 
GW3I 4681 X CCc1 ccc2sc3cc(ccc3d(=0)C2Cl )C(=0)O C161-11203S 284.34 
GW31 4793X CC(C)cl ccc2sc3cc(ccc3c(=0)C2Cl )C(=0)O C171-11403S 298.36 
GW32201 8X CC(C)(C)cl ccc2sc3cc(ccC3C(0)C2C1 )C(=0)0 C181-11603S 312.39 
GW31 4751 X Ccl ccc2sc3cc(ccC3C(0)C2C1 )C(=0)0 C151-11003S 270.31 
GW31 51 58X OC(0)cl ccc2c(0)c3ccccc3SC2C1 C1 41-1803S 256.28 
GW322801 X Ccl cccc2c(=0)c3ccc(cc3sCl 2)C(=0)0 C151-11003S 270.31 
GW323040X Ccl cc(C)c2sc3cC(ccc3C(0)C2C1 )C(=0)0 C161-11203S 284.34 
GW321 891 X OC(0)cl ccc2c(=0)c3ccccc3s(=0)C2C1 C1 41-1804S 272.28 
GW323845X OC(0)cl ccc2c(0)c3cc(F)CCC3sC2C1 Cl 4H7F03S 274.27 
GW323446X OC(0)cl ccc2c(0)c3cc(Br)ccc3sC2Cl Cl 4H7BrO3S 335.18 
GW32359 lx OC(0)cl ccc2c(0)c3cccc(c3sC2d1 )C(F)(F)F Cl 5H7F303S 324.28 
GW3 1 5075X OC(0)cl ccc2c(0)c3cc(CI)CCC3SC2C1 Cl 4H7C103S 290.73 
GW322693X OC(=0)cl ccc2c(0)c3c(CI)ccC(CI)c3SC2C1 C1 41-160203S 325.17 
GW32 1 808X Ccl ccc(CI)c2c(=0)c3CCC(Cc3SCl 2)C(=0)0 Cl 5H9C103S 304.75 
GW322384X OC(0)cl ccc2c(0)c3sccc3sc2Cl Cl 2H603S2 262.31 
GW321 800A C$.CCN(CC)CCNc1 ccc(C)c2sc3cc(ccc3c(0)dl 2)C C21 H24N203S. HCI 420.96 
(=0)0 
GW322628X CSc1 ccc.2sc3cc(ccc3c(0)C2Ci )C(=0)0 C151-11003S2 302.37 
GW322988X CS(=0)cl ccc2sc3cc(ccc3c(=0)c2dl )C(=0)0 C151-11004S2 318.37 
AH1 5466AA OCC(0)COcl cccccl C(=0)0.C1 CCC(CC1 )NC2CC C101-11205. C1 21-123N 393.53 
CCC2 
AH2565 CC(C)(C)C(0)0c1 cccccl C(=0)0 C121-11404 222.24 
GW366246 CCCCCCCOc1 ccc(N)ccl C(=0)0 Cl 4H21 NO3 251.33 
CCI1 7196 Ccl (C)C2CCC 1 (CC2)C(0)Oc3ccccc3C(0)0 C171-12004 288.35 
AH20078XX CCCCCCCCCCOc1 ccc(ccl )C(0)0 C171-12603 278.40 
GR208554X CCCCCCCCCCCCCCCCCCOc1 ccc(ccl )C(=0)0 C251-14203 390.61 
GR2301 04X OC(0)cl ccc(OCCCCCCCCCCCCOC2CCC(CC2)C( C261-13406 442.56 
=0)0)ccl 
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GR30893X CCCCCCCCOc1cCc(cC1 )C(=0)0 C151-12203 250.34 
GR3391 ix CCCCCCCCCCCCOC1CCC(CC1)C(0)0 C191-13003 306.45 
GR62459X OC(0)ci ccc(OCCCCCCCCCOC2CCC(CC2)C(=0)0 C231-12806 400.48 
)ccl 
GR6581 5X CCCCCCCCCCCCCCCCOC1 ccc(cci )C(=0)0 C231-13803 362.56 
GR65884X CCCCCCCCCCCCCCOC1 ccc(cci )C(=0)0 C211-13403 334.50 
GW385846X OC(0)cl ccc(OCCCCCCCOC2CCC(cC2)C(0)0)CC C211-12406 372.42 
GR155589X OCCCCCCOc1ccc(cci)C(=0)0 C131-11804 238.29 
GR30894X CCCCCCOc1 ccc(ccl )C(0)0 C131-11803 222.29 
GR208752X CCCCCOc1 ccc(ccl )C(=0)0 C121-11603 208.26 
GW288377X CCCCCCOc1 c(C)cc(ccl C)C(=0)0 C151-12203 250.34 
GR34968X CCOCCCCCCOcIccc(ccl)C(0)0 C151-12204 266.34 
GR54392X CC(CCC1 C(C)CCCC1 (C)C)C0c2ccc(cc2)C(0)0 C211-13203 332.49 
GR57352X CC  CCCC(C)(C)C1 CCCCOc2ccc(cc2)C(0)0 C201-13003 318.46 
GW37 1 223X OC(0)cl ccc(OC2CCCCC2)cc1 C131-11603 220.27 
CC19740 OCC(0)COcl ccc(cci )C(0)0 Cl OH 1205 212.20 
GR240724X CC(C)CCOc1 ccc(ccl )C(=0)0 C121-11603 208.26 
GR30476X CCCCOc1 ccc(ccl )C(=O)0 Cli Hi 403 194.23 
GR53056X OC(COci ccc(ccl )C(=0)0)CC#N Cli Hi 1 N04 221.22 
GR1 36670X OC(0)ci cc(l)c(OC2CCCCC2)c(l )ci C131-1121203 470.05 
GR34039X OC(0)cl ccc(OC2CCCCC2)cci Cl 3H 1403 218.26 
AH24908A CCCC1 c(0)c(ccci OCCCCCCCCCOc2ccc(C(0)0) C271-13607 472.58 
c(0)c2)C(0)C 
GR49928X CCCc1 c(0)c(cccl OCCCCOc2ccc(C(0)0)c(0)C2) C221-12607 402.45 
C(=0)C 
AH25368X CCCCC(CCOc1 ccc(C(0)0)c(0)cl )Oc2ccc(C(0) C221-12607 402.45 
C)c(0)c2 
GR55422X CCCc1 ccccci OCCCCCOc2ccc(cc2)C(0)0 C211-12604 342.44 
GR55423X CCCc1 ccccci OCCCCCCOc2ccc(cc2)C(0)0 C221-12804 356.47 
GR61 326X CCCc1 cccccl OCCCCCCCCOc2ccc(cc2)C(0)0 C241-13204 384.52 
GR61 891 X CCCc1 ccccci OCCCCCCCCCCOc2ccc(cc2)C(0) C261-13604 412.57 
0 
GR61 984X CCCc1 ccccci OCCCCCCCCCCCCOc2ccc(cc2)C( C281-14004 440.63 
0)0 
GR61 985X CCCc1 ccccci OCCCCCCCCCOc2ccc(cc2 )C(=0)0 C251-13404 398.55 
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GR55424X CCCC1CCCCC1OCCCCOC2CCC(CC2)C(0)0 C20H2404 328.41 
AH51 57 CC(C)(C)NCC(0)C0c1 ccc(0)c(cl )C(=O)0 Ci 4H21 N05 283.33 
AH6770 COC(0)ci ccc(cci OC(=0)C)C(0)0 C111-11006 238.20 
AH9603 OCCOcicccc(ci)C(0)O C9H1004 182.18 
GW31 5367X OC(=0)cl cc(OCCOC2CcC(0)C(C2)C(0)0)CCC1 0 C161-11408 334.29 
GR2 I 9955X OCCOc1 cc(cc(0)ci C(0)0)C(0)0 Ci OH 1007 242.19 
GR1 20092X CC(C)(C)OC(0)COci ccc(N)c(cl )C(=0)0 Cl 3H 1 7N05 267.28 
GR75258X OC(=0)C(=C)Ocl cc(cccl 0)C(=0)0 Cl 0H806 224.17 
GF233967X CCOc1 ccc(ccl OCC)C(0)0 C111-11404 210.23 
GW64 1 533X OC(0)ci ccc2OCCOCCOc3ccc(cc3OCCOCCOC2 C221-124010 448.43 
ci )C(=0)0 
GW321 911 X OC(0)ci ccc20CCCOc2ci Cl OH1 004 194.19 
GW402775X CCCOc1 cc(cc(CCC)ci OCCC)C(0)0 C161-12404 280.37 
GR2581 79X CCOCCOc1 c(OCc2ccccc2)cc(cCi OCc3ccccc3)C( C251,12606 422.48 
0)0 
GR25821 3X OC(=0)ci cc(0Cc2CCCCC2)C(OCCOCC3CCCCC3)C(0 C301-12806 484.55 
Cc4ccccc4)cl 
GF267695X OC(0)cl ccc2OCCOc2cl C91-1804 180.16 
GW322088X Ccl cc20CCOc2ccl C(=0)0 Cl OH1 004 194.19 
GW3221 1 2X OC(0)ci cc20CCOc2ccl C(=0)0 Ci 0H806 224.17 
GW32231 6X COd cc(cc20CCOcl 2)C(=0)0 Cl OH1 005 210.19 
GW322086X CC  Oc2ccc(cc2OCi C)C(=0)0 C111-11204 208.22 
GR222247X COcl ccc(Nc2ccc3OCOc3c2)c(Cl )C(0)0 Cl 5H 1 3N05 287.28 
GR53849X CCI(C)Oc2cc(N)c(cc2Oi )C(0)0 Cl OH1 1 N04 209.20 
GR9931 2X Cc  ccc(C(=0)0)c2OC(C)(C)0C21 Cii H 1204 208.22 
GR57082X OC(0)cl ccc(OC2CCCCO2)cci C121-11404 222.24 
GW320929X OC(=0)ci cc(OC2CCCCO2)cc(OC3CCCC03)C1 C171-12206 322.36 
GW4 1211 3X OC[C@H] 1 0[C@@H](Oc2ccc(cc2)C(0)0)[C@H1( C131-11608 300.27 
0)[C@@H](0)[C@@H] 10 
GR21 5780X CN(C)C(0)cl c(0)cc(ccl OCCO)C(0)O Cl 2H 1 5N06 269.26 
GR21 9957X CNC(0)cl c(0)cc(ccl OCCO)C(0)0 Cli Hi 3N06 255.23 
GR21 9958X CNC(0)cl c(0)cc(cci OCCOCCO)C(0)0 Cl 3H 1 7N07 299.28 
GR21 61 MX CCCCOc1 cc(cc(OCCCC)cl C(0)N(C)C)C(0)0 Ci 8H27N05 337.42 
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GR21 61 86X CCCCOc1 cc(cc(0)cl C(0)N(C)C)C(0)0 Cl 4H1 9N05 281.31 
GR21 8004X CCCCOc1 cc(cc(OCCCC)Ci C(=0)NC)C(0)0 Cl 7H25N05 323.39 
GR21 8005X CCCCOc1 cc(cc(0)cl C(0)NC)C(0)0 Ci 3H1 7N05 267.28 
GR1 33748X CCCCOc1 cc(OCCCC)cc(cl )C(0)0 C151-12204 266.34 
GR82836X CC(C)CCOc1 cc(0CCC(C)C)cc(ci )C(0)0 C171-12604 294.39 
GR38662X CCCCOc1 cccc(cl )C(=0)0 Cii H 1403 194.23 
GW292734X OC(0)cl cccc(OCCCCCOC2CCCC(C2)C(0)0)C1 C191-12006 344.37 
GW322234X CCCCOc1 ccc(0)c(ci )C(0)0 Cli H 1404 210.23 
GR79956X CC(=C)COci cc(OCC(=C)C)cc(cl )C(=0)0 C151-11804 262.31 
GR203866X CCCCCCCCCCCCCCCCCCOC1CC(CC(C1 )C(=0)0) C261-14205 434.62 
C(=0)0 
GR203872X CCCCCCCCOc1 cc(cc(cl )C(=0)0)C(0)0 C161-12205 294.35 
GR203875X CCCCCOc1 cc(cc(cl )C(=0)0)C(0)O C131-11605 252.27 
GR204301 X CCCCCCCCCCOcI cccc(cl )C(=0)0 C171-12603 278.40 
GR65881X CCCCCCCCCCCCCCCCCCOC1CCCC(C1 )C(=0)0 C251-14203 390.61 
GR65883X CCCCCCCCCCCCCCCCOC1 cccc(ci )C(=0)0 C231-13803 362.56 
GR65885X CCCCCCCCCCCCCCOc1 cccc(cl )C(=0)0 C211-13403 334.50 
GR1 88442X CCCCCCOc1 cc(C(0)0)c(OCCCCCC)ccl C(=0)0 C201-13006 366.46 
GW322235X CCCCOc1 ccc(OC(0)C)c(cl )C(=0)0 C131-11605 252.27 
GW327773X OC(0)CCCCOc1 cccc(C(=0)0)cl C=0 C131-11406 266.25 
GW643493X CCCCCCOc1 c(C(0)0)c(C(0)0)C(OCCCCCC)C2 C241-13206 416.52 
ccccci 2 
GW643495X CCCCOC1 c(C(0)0)c(C(0)0)c(OCCCC)C2CCCCC1 C201-12406 360.41 
2 
GR21 5459A CC(C)CCCOc1 cc(NC(N)N)cc(cl )C(=0)0.00(0) C141-121 N303. C21-117302 393.37 
C(F)(F)F 
GW28081 4 Nd ccc(cdl OCCCCCC(0)0)C(0)0 Ci 3H 1 7N05 267.28 
GW290851 X Ncl ccc(cdl OCCCCC(=0)0)C(0)0 Cl 2H1 5N05 253.26 
GW290862X Nd ccc(cdl OCCCC(=0)0)C(0)0 Cli Hi 3N05 239.23 
GW3261 1 2X CCCCCC(0)Ocl ccc(CC(0)Nc2ccccc2)c(ci )C(= C21 H23N05 369.42 
0)0 
GW27 1 929X CCCCCCOc1 cc(cc(OC)ci OC)C(=0)0 C151-12205 282.34 
GW31 7768X COd cc(cc(OCCCCCCCCCCCCCCOC2CC(CC(OC)C C321-146010 590.72 
20C)C(=0)O)cl OC)C(0)0 
GW272447X COd cc(cc(OC)cl OCCCCCOc2c(OC)cc(cC2OC)C( C231-128010 464.47 
=0)0)C(0)O 
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GW3261 27X COd cc(cc(OC)cl OCCCCCCCCCCCCOc2c(OC)c C301-142010 562.66 
c(cc20C)C(0)O)C(0)0 
GW440381 X CCCCCCCCCCCCCCCCOC1 c(OC)cc(ccl OC)C(= C251-14205 422.61 
0)0 
GW41 871 6X CCCCCCOc1 c(OC)cc(cci OC)C(0)O C151-12205 282.34 
GW453080X CCCCCCOc1 ccc(ccl OC)C(=O)O C141-12004 252.31 
GW442734X COO cc(cc(OC)ci OCCCCCC)C(0)O C151-12005 280.32 
GW272478X Cod cc(cc(OC)cl OCCC2CCCC2)C(0)0 C161-12205 294.35 
GW442732X Cod cc(cc(OC)cl OCC2CCCCC2)C(0)O C161-12205 294.35 
GW4 1 5699X CCCCCCOc1 cc(cc(OCc2ccccc2)dl OC)C(0)0 C211-12605 358.44 
GW369764X CCCCCCOc1 c(Cl)cc(ccl OC)C(=O)O C141-119004 286.76 
GR50838A NCO ccccci .00(=0)dl cccc20C(C0Cc3ccccc3)C( C251-12406. C71-19N 527.62 
C0Cc4ccccc4)0c12 
GR5I 678X OC(0)cl sc(C(=0)0)c2OC(COCC3CCCCC3)C(COC C241-12208S 470.50 
c4ccccc4)Ocl 2 
GR5421 9X OC(0)ci oc(C(0)0)c2OC(C0Cc3CCCCC3)C(COC C241-12209 454.44 
c4ccccc4)Oci 2 
GR69421 X OC(0)ci oc(C(=0)NCc2ccccc2)C3OC4CNCC40C1 Cl 7H 1 6N206 344.33 
3 
GW3 1 7904X CC(C)N1 CC(C0c2CC(Cc3CCCCC23)C(0)0)OCI =0 Cl 8H I 9N05 329.36 
GW41 191 3X COd ccc(cdl OCC2CN(C(C)C)C(0)02)C(0)0 Ci 5H1 9NO6 309.32 
GW327989X CC(C)N 1 CC(C0c2ccc(cc2)C(0)0)OC1 =0 Cl 4H 1 7N05 279.30 
GW4I 4889X COO cc(OCC2CN(C(C)C)C(0)02)CCCI C(=O)O Cl 5H1 9N06 309.32 
AH 101 04A Cl.CN(C)CCN(C)dl ccc2C(0)c3ccc(cc3C(0)c2C1 C201-120N204. HCI 388.85 
)C(=O)O 
AH7702 OCCN(CCO)cl ccc2C(0)c3ccc(cc3C(0)c2C1 )C(= Ci 9H 1 7N06 355.35 
0)0 
AH7559 CN(C)C1CCC2C(0)c3cCC(CC3C(0)C2C1)C(0)O C17H13NO4 295.30 
AH1 001 1A CI.00CN1 CCN(CC1 )c2ccc3C(=0)c4ccc(cc4C(0) C21 H20N205. HCI 416.87 
c3c2)C(0)0 
AH7724Z CN(C)CCO.00(0)dl ccc2C(0)c3cc(ccc3C(0)c2 C201-1 1 7N04. C41-1 11 NO 424.50 
ci )N4CCCCC4 
GW575621X OCCNc1 c(ccc2C(0)c3ccccc3C(0)dl 2)C(=O)O Ci 7H1 3N05 311.30 
AH1 0424A CI.00(0)ci ccc2C(0)c3ccc(NCCN4CCOCC4)CC C21 H20N205. HCI 416.87 
3C(=0)c2cl 
AH7620Z CN(C)CCO.00(0)c1 ccc2C(0)c3cc(ccc3C(0)c2 Cl 9H1 5NO5. C41-11 1 NO 426.47 
ci )N4CCOCC4 
AH7699 CC1 CN(CC(C)O1 )c2ccc3C(0)c4ccc(CC4C(0)C3C C2 1 Hi 9N05 365.39 
2)C(=0)O 
AH5961 OC(=0)ciccc2C(0)c3ccCCc3C(0)C2C1 N(=O)=O Ci 5H7NO6 297.23 
AH61 02 NO c(ccc2C(=O)c3ccccc3C(0)d1 2)C(0)O Cl 5H9NO4 267.24 
AH7647 NO cc2C(0)c3ccccc3C(0)c2cC1 C(=O)O Cl 5H9N04 267.24 
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AH9531 CCOc1 ccc(Nc2c(ccc3C(=O)c ccccc4C(=0)c23)C(= C231-1 1 7N05 387.40 
O)O)ccl 
GR1 99045X OC(0)cl ccc2C(0)c3ccccc3C(=O)c2c1 Nc4ccc- C28H 1 7N04 431.45 
5c(Cc6ccccc65)c4 
AH5724 OC(=O)cl ccc2C(=O)c3ccccc3C(=O)c2C1 C151-1804 252.23 
GW29501 4X Ccl ccc2C(0)c3ccc(cc3C(0)C2C1 )C(0)O C161-11004 266.26 
GW31 5237X OC(0)cl ccc2C(0)c3cc(ccc3C(0)C2C1 )C(=O)0 C161,1806 296.24 
GW31 5238X OC(=O)cl ccc2C(=O)c3ccc(cc3C(=O)C2c1 )C(=O)O C161-1806 296.24 
AH6593 OC(0)cl cc2C(0)c3ccccc3C(0)c2CC1 C(=O)O C161-1806 296.24 
GW31 5239X Ccl cc2C(0)c3ccccc3C(0)C2CC1 C(=O)O Cl 6H 1004 266.26 
AH6247 OC(0)cl ccc2Cc3ccccc3C(0)c2cl C151-11003 238.25 
AH631 3 OC(=0)cl ccc2C(0)c3ccccc3Cc2cl C151-11003 238.25 
AH6072 OC(0)cl cccc2C(0)c3ccccc3C(0)cl 2 C151-1804 252.23 
AH6624 NC(0)cl cc2C(0)c3ccccc3C(0)c2ccl C(0)0 Cl 6H9N05 295.25 
AH70 I 3Z CN(C)CCO.00(0)cl ccc2C(0)c3ccc(F)cc3C(0) Cl 5H7F04. C4H 11 NO 359.36 
c2cl 
AH70I4Z CN(C)CCO.00(0)cl ccc2C(=O)c3cc(F)ccc3C(0) Cl 5H7F04. C41-111 NO 359.36 
c2cl 
AH61 98 OC(=O)cl ccc2C(0)c3ccccc3C(0)c2c1 Cl Cl 5H7C104 286.67 
AH6248 OC(0)cl ccc2C(0)c3c(CI)CCcC3C(0)C2C1 Cl 5H7C104 286.67 
AH7031Z CN(C)CCO.00(0)cl ccc2C(0)c3cccc(Cl)c3C(0 C151-17004. G41-111 NO 375.81 
)c2cl 
AH7029 OC(0)cl ccc2Cc3c(CI)cccc3C(0)C2C1 Cl 5H9C1O3 272.69 
AH6292 OC(=O)cl cc2C(=O)c3ccccc3C(0)c2Cc1 Cl Cl 5H7C1O4 286.67 
AH6570 OC(=O)cl ccc2C(0)c3ccc(Cl)cc3C(0)c2cl Cl 5H7C1O4 286.67 
AH7083Z CN(C)CCO.00(0)cl ccc2C(0)c3cc(Cl)ccc3C(O C151-17004. C41-111 NO 375.81 
)c2cl 
GR24051 7X OC(0)cl ccc2Cc3ccc(Cl)cc3C(0)c2cl Cl 5H9C1O3 272.69 
AH61 69K [K+].00(0)cl ccc2C(0)c3ccccc3C(0)C2C1 S(=O Cl 5H707S-. K+ 370.39 
)(=O)[O-] 
GW3 1521 7X OC(=O)cl ccc2C(0)c3cc(ccc3C(0)c2cl )S(=O)(= C1 51-1807S 332.29 
0)0 
AH1 1654 CC(C)Ocl ccc2C(0)c3ccc(cc3C(0)c2c1 )C(0)O C181-11405 310.31 
AH14868XX CC(C)Ocl ccc2C(=O)c3cc(ccc3C(0)c2cl )C(=O)O Cl 8H14O5 310.31 
AH71 67 OCCCOc1 ccc2C(0)c3ccc(cc3C(0)c2cl )C(0)O C181-11406 326.31 
AH7792Z CN(C)CCO.00CCOc1 ccc2C(=O)c3cc(ccc3C(0)c C181-11406. C41-11 1 NO 415.45 
2c1 )C(=O)O 
AH7650 CCCOc1 ccc2C(0)c3ccc(cc3C(0)c2c1 )C(0)O Cl 8H 1405 310.31 
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AH6730 COO ccc2C(0)c3Cc(ccC3C(0)C2C1 )C(0)O C161-11005 282.26 
AH7290A CI.CN(C)CCOC1CCC2C(=0)C3CCC(CC3C(=0)C2C1)C( C191-117N05. HCI 375.81 
=0)0 
AH7652 OC(=0)cl ccd2C(=0)c3CcC(OCCC4CCCCC4)CC3C(0 C231-11605 372.38 
)c2cl 
AH741 4Z COCCOc1 ccc2C(0)c3ccc(cc3C(0)C2C1 )C(0)0. C181-11406. C41-11 1 NO 415.45 
CN(C)CCO 
AH7621Z CN(C)CCO.00COc1 ccc2C(0)c3cc(ccc3C(0)C2C C171-11206. C41-11 1 NO 401.42 
1)C(=O)O 
AH7552 OC(0)cl ccc2C(0)c3ccc(OCCOC4CCCCC4)CC3C( C231-11606 388.38 
O)c2cl 
AH7651 COCCOCCOc1 ccc2C(0)c3CCC(cc3C(0)C2C1 )C( C201-11807 370.36 
=0)0 
AH7697 OC(0)cl CdC2C(0)C3CdC(0Cd4CCC04)CC3C(0)C C201-11206 348.32 
20 
AH6276 OC(0)cl cc(0)c2C(0)C3ccccC3C(0)C2C1 C151-1805 268.23 
GR8541 lx OC(0)cl cc(0)c2C(0)c3c(0)CCCC3C(0)C2C1 C151-1806 284.23 
AH6390 OC(=O)cl ccc2C(=O)c3c(0)ccc(0)c3C(0)C2C1 C151-1806 284.23 
GR65254X OC(0)cl ccc2C(0)c3c(0)cccc3C(0)C2C1 C151-1805 268.23 
AH6535 OC(=O)cl ccc2C(0)c3ccccc3C(0)c2C1 0 C151-1805 268.23 
AH67 12 OC(0)cl ccc2C(0)c3C(0)CC(0)CC3C(0)C2C1 C151-1806 284.23 
AH7646 OC(0)cl cc2C(0)c3ccccc3C(0)C2CC1 0 C151-1805 268.23 
GR257968X CCI (0)c2cccc(0)c2C(0)C3C(0)C(C(0)O)C(CC31) C171-11208 344.28 
C(=O)O 
AH6342 COO cc(cc2C(0)c3ccccc3C(0)C1 2)C(0)O C161-11005 282.26 
AH6572 COO cccc2C(=O)c3cc(ccc3C(0)d1 2)C(0)O C161-11005 282.26 
AH7 133 COO cccc2C(0)c3ccc(cc3C(0)d1 2)C(=O)O C161-11005 282.26 
GW32 11 08X COO c(ccc2C(0)c3dcccc3C(0)C1 2)C(0)O C161-11005 282.26 
1 kH6550 COO ccc(OC)c2C(0)C3CC(CCC3C(0)C1 2)C(0)O C171-11206 312.28 
GR242642X Cod cc(OC)c2C(0)c3cCc(cc3C(0)C2C1 )C(=O)O C171-11206 312.28 
AH6573 CCCOc1 cccc2C(0)c3cc(ccc3C(0)C1 2)C(0)O C181-11405 310.31 
AH671 4 CCOc1 cccc2C(=O)c3cc(ccc3C(=O)c1 2)C(=O)O Cl 7H 1205 296.28 
AH6759 OCCCOc1 c(ccc2C(0)c3ccccc3C(0)C1 2)C(=O)O C181-11406 326.31 
AH67 13 OC(=O)cl ccc2C(0)c3c(Oc4ccccc4)cccc3C(0)C2 C211-11205 344.33 
ci 
AH7696 COd ccccdl Oc2ccc3C(0)c4Ccc(Cc4C(0)C3C2)C( C221-11406 374.35 
=0)0 
AH773 1 OC(=O)cl ccc2C(=O)c3ccc(Oc4cCCCd4O)CC3C(0) C211-11206 360.33 
c2ci 
AH267 1 OC(0)ci cccc2C(0)c3ccccc3-c21 C141-1803 224.22 
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71 39602 OC(0)cl cccc2Cc3ccccc3-c21 C141-11002 210.24 
GW433974 OC1 c2ccccc2-c3cl cccc3C(=0)0 Cl 4H 1003 226.23 
GW321 876 OC(0)cl ccc-2c(cl )C(=0)c3cccc(C(=0)0)c32 C151-1805 268.23 
GR1 39604 Ccl ccc(C(=0)0)c-2c1 Cc3ccccc32 C151-11202 224.26 
GW321 338X Ccl c2C(0)c3ccccC3-C2CCC1 C(0)0 C151-11003 238.25 
GW34361 9X OC 1 c2cccc(c2-c3ccc(cc1 3)C(=0)0)C(F)(F)F Cl 5H9F303 294.23 
AH2672 OC(=0)cl ccc-2c(cl )C(=0)c3ccccc32 C141-1803 224.22 
GR85308 OC(0)cl ccc-2c(cl )C(=0)c3cc(ccc32)C(0)O C151-1805 268.23 
GW321553X OC(=0)ciccc- C211-11204 328.33 
2c(cl )C(=0)c3cc(ccc32)C(0)c4cccCc4 
GW368591 A NCCO.00(=0)cl ccc-2c(cl )C(=0)c3cc(Cc4ccc- C291-1 1606. 2(C2H7NO) 582.62 
5c(c4)C(=0)c6cc(ccc65)C(0)0)CCC32 
GR1 15690 OC(0)cl ccc-2c(Cc3cc(C0)ccc32)C1 C151-11003 238.25 
GRI 76137 OC(0)cl ccc-2c(Cc3ccccc32)cl C141-11002 210.24 
GW321 167 OC(0)cl ccc-2c(Cc3cc(ccc32)C(0)0)c1 C151-11004 254.25 
GW320968X OCI c2ccccc2-c3ccc(ccl 3)C(=0)0 Cl 4H 1003 226.23 
GW321 421 OC(0)cl ccc-2c(cl )C(=0)c3cc(C#N)ccc32 Cl 5H7NO3 249.23 
GW3 1 5288X OC(0)cl ccc-2c(cl )C(=0)c3cc(Br)ccc32 Cl 4H7Br03 303.11 
GW31 5296X OC(0)cl ccc-2c(cl )C(=0)c3cc(CI)ccc32 Cl 4H7C103 258.66 
GW28861 5 CCC(0)cl ccc-2c(cl )C(0)c3cc(ccc32)C(0)0 C171-11204 280.28 
GW321 424X CCC(=0)cl ccc-2c(Cc3cc(ccc32)C(0)0)C1 C171-11403 266.30 
GW321 634X CCCCc1 ccc-2c(cl )C(=0)c3cc(ccc32)C(0)0 C181-11603 280.33 
GW321 145 CC(0)ci ccc-2c(Cc3cc(ccC32)C(0)0)C1 C161-11203 252.27 
GW321 1 68X CC(0)cl ccc-2c(cl )C(0)c3cc(ccc32)C(0)0 C161-11004 266.26 
GW321 422X CCc1 ccc-2c(cl )C(=0)c3cc(ccc32)C(0)0 C161-11203 252.27 
GW322230X OC(=0)cl ccc-2c(cl )C(=0)c3cc(ccc32)c4nflfl[nH]4 Cl 5H8N403 292.26 
GW31 4379 CCCOc1 ccc-2c(cl )C(=O)c3cc(ccc32)C(0)0 C171-11404 282.30 
GW3 1 4406X CCCOc1 ccc-2c(Cc3cc(ccc32)C(0)0)C1 C171-11603 268.32 
GW32 1 354X COO ccc-2c(cl )C(=0)c3cc(ccc32)C(0)0 C151-11004 254.25 
GW32 1 243X CC(0)OC 1 c2ccccc2-c3ccc(cdl 3)C(0)0 C161-11204 268.27 
GW321 742X CCCCOC(0)cl ccc- C191-11605 324.34 
2c(cl )C(=0)c3cc(ccc32)C(0)0 
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GW321 779X CCC(C)OC(=0)cl ccc- C191-11605 324.34 
2c(cl )C(=0)c3cc(ccc32)C(=0)0 
GW321 755X CCccCC0c(=0)cl ccc- C211-12005 352.39 
2c(cl )C(=0)c3cc(ccc32)C(0)0 
GW41 0928X CC(C)OC(=0)cl ccc- C181-11405 310.31 
2c(cl )C(=0)c3cc(ccc32)C(0)0 
GW324540X CCCOC(=0)cl ccc-2c(cl )C(0)c3cc(ccc32)C(0)0 C181-11605 312.33 
GW3221 98X OC(0)cl CCC- Cl 5H7Br305S 539.00 
2c(cl )C(=0)c3cc(ccc32)S(0)(=0)C(Br)(Br)Br 
GW322492X CS(0)(0)cl ccc-2c(cl )C(=0)c3cc(ccc32)C(=0)0 C151-11005S 302.31 
GW320926X ONC1 c2ccccc2-c3ccc(ccl 3)C(0)0 Cl 4H9NO3 239.23 
GW321 470X ONC1 c2cc(ccc2-c3ccc(ccl 3)C(0)0)C(0)0 Cl 5H9N05 283.24 
GW321 607X CON=C 1 c2ccccc2-c3ccc(ccl 3)C(=0)0 Cl 5H 11 NO3 253.26 
GW323008X CCCOC(=0)cl ccc- Cl 8H 1 5N05 325.32 
2c(cl )C(=N0)c3cc(ccc32)C(0)0 
GR1 75627 OC(=0)cl cccc-2c1 Cc3ccccc32 C141-11002 210.24 
GR1 75628 OC(0)cl cccc2-c3ccccc3C(0)c21 C141-1803 224.22 
GR1 96922 NNC1 c2ccccc2-c3cccc(C(0)0)cl 3 Cl 4H 1 0N202 238.25 
GR256963 OC(0)cl ccc2C(0)c3ccccc3-c2cl C141-1803 224.22 
GW321 245X OC(=0)cl cc2C(0)c3ccccc3-c2ccl C(0)0 C151-1805 268.23 
GW321 91 2X OC(0)cl ccc-2c(cl )C(=0)c3ccc(cc32)C(0)0 C151-1805 268.23 
AH1 0033 COcl ccc(Nc2cc(CI)ccc2C(0)0)cnl Cl 3H1 1 C1N203 278.70 
GR237865X Ccl cc(Nc2ccccc2C(0)0)n(C)fll Cl 2H1 3N302 231.26 
AH I 5255XX CC(=0)Ncl ccc(cn 1 )C(0)0 C8H8N203 180.17 
GR68357X OC(0)cl cccncl Nc2cccc(c2)C(F)(F)F Cl 3H9F3N202 282.22 
GW320801 X OC(0)cl ccc(NC(N)c2ccccn2)ccl Cl 3H 11 N302 241.25 
GW385455A CI.00(0)cl ccc(NCc2nc3ccccc3[nH]2)ccl Cl 5H I 3N302. HCI 303.75 
AH1 1305 OC(0)cl cc(nc2cccccl 2)N3CCCCC3 Cl 5H1 6N202 256.31 
AH9723 CC(0)Ncl cc(nc2cccccl 2)C(=0)0 Cl 2H 1 0N203 230.23 
GW655414X CCn1 cc(N2CCN(CC2)C(S)N)c(0)C3C(F)CC(CC1 3) Cl 7H1 9FN403S 378.43 
C(=0)0 
GR1 0711 4X CCCCc1 nc2ccc(cc2nl Cc3ccc(cc3)C(0)c4ccccc4 C26H23N305/C26H23N305 914.98 
C(=0)0)N(=0)=0.CCCCc1 nc2cc(ccc2nl Cc3ccc(cc 
3)C(=0)ccccC(0)0)N(0)0 
GR1 38809X COd cc(cccl Cc2cn(C)c3ccc(NC(0)OC4CCCC4)C C24H26N205 422.49 
c23)C(0)0 
GW29581 7X CC(=0)cl ccc2NC(0)c3ccc(cc3Sc2dl )C(=0)0 Cl 6H1 1 NO4S 313.33 
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GW365467X OC(=0)cl ccc2Sc3ccccc3Nc2cl Cl 3H9NO2S 243.29 
GW31 1 376X NC1 =NN(CC1 )c2ccc(cc2)C(0)0 Cl OH1 1 N302 205.22 
GW397304X COC(=0)CC1 Nc2ccc(cc2CN(C)C1 =0)C(=0)0 C141-116N205 292.29 
GW584442X OC(=0)cl cc2NCCC(0)c2cc1 Cl Cl OH8CINO3 225.63 
GW635258X CC(C)(C)C(0)C(0c1 ccc(ccl )C(=0)0)C(0)Nc2cc C201-12 1 C1N205 404.85 
(N)ccc2CI 
GW635452X CC(C)(C)C(0)C(Ocl ccc(ccl )C(=0)0)C(0)Nc2cc C20H 1 9C12N05 424.28 
c(Cl)cc2CI 
GR269503X COC(=0)C1 =C0[C@H](0)[C@H]2[C@@H] 1 Cc3nc C22H20N207 424.41 
(cc4c5cc(0)ccc5fl([C@@H]2C)C34)C(=0)0 
GR223454A Cl.COcl ccc2C[C@H]3N(C)CC[C@]4([C@H]50C1 c C251-124N205. HCI 468.94 
24)[C@@]3(0)Cc6c5[nH]c7ccC(CC67)C(0)0 
GW5801 27X OC(=0)cl ccc(sl )C2N(CCc3c2[nH]c4ccccc34)C(0 C25H20N203S 428.51 
)IC=C/c5ccccc5 
GW6231 42A CC(0)0.00(0)c1 ccc(sl )C2NCCc3c2[nH]c4cccc Cl 6H 1 4N202S. C21-1402 358.42 
c34 
GW624854X NO c(sc2nc(c3ccccc3)c4CCCCc4C1 2)C(=0)0 Cl 8H 1 6N202S 324.40 
GW6631 1 8X CCc1 nc2sc(C(0)0)c(N )c2c3CCCCc1 3 Cl 4H 1 6N202S 276.36 
GW65261 lx OC(0)cl c(SCC2CCC(C#N)CC2)flC3CCCCC3C1 c4cc C22H 1 8N202S2 406.53 
cs4 
GR1 51827X CCCCc1 nn(CC)c(ICC(ICc2cccS2)\C(0)0)C1 Cc3c C25H28N204S 452.58 
cc(cc3)C(0)0 
GR1 52989X CCCCc1 n[nH]c(/C=C(/Cc2cccs2)\C(=0)0)C1 Cc3cc C231-124N204S 424.52 
c(cc3)C(=0)0 
AH 11426 OC(=0)cl cnnc2cccccl 2 C91-16N202 174.16 
GR37359X OC(0)dl ccc2cn[nH]c2cl C8H6N202 162.15 
GW32 1 066X OC(0)cl ccc2cnn(C(0)OCc3cCCCC3)C2C1 Cl 6H 1 2N204 296.29 
CC18732 OC(=0)cl ccc2nnn(0)c2cl C71-15N303 179.14 
GW31 2666X COO ccc(ccl )c2n[nH]c(0)c3Cdc(cc23)C(0)0 Cl 6H1 2N204 296.29 
G1.N1424662X COO ccc2c(C(0)0)c(nn2nl )c3ccc(F)cc3 Cl 4H1 0FN303 287.25 
AH8940 OC(=0)cl cc(C(=O)O)c(ccl C(=0)Nc2nnn[nH]2)C( Cl 2H8N1 006/Cl 2H8N1 006 776.52 
0)Nc3nnn[nH]3.00(0)Cl cc(C(0)Nc2nnn[nH]2)c( 
ccl C(=0)Nc3nnn[riH]3)C(0)0 
GR258784X OC(=0)cl cccccl Oc2ccc(cc2)c3nnn[nH]3 Cl 4H1 0N403 282.26 
GW322374X OC(0)cl ccc(ccl Sc2ccccc2)c3nnn[nH]3 Cl 4H 1 0N402S 298.33 
AH8076 COO ccc2Cc3[nH]c(C)c(C(0)0)c3-C2C1 Cl 4H1 3NO3 243.27 
GW31 5274X OC(=0)cl ccn-2c1 C(0)c3ccccc32 Cl 2H7NO3 213.20 
GW650524X Ccl [nH]c(C(0)0)c(C#N)Cl C(=0)c2ccccc2 C141-11 0N203 254.25 
GW650525X CCn1 c(C)c(C(0)c2ccccC2)C(C#N )cl C(=0)0 Cl 6H 1 4N203 282.30 
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AH9033 OC(=0)cl ccc2C(0)c3ccccc3-c4ncncl c24 Ci 6H8N203 276.25 
GW649399X OC(0)cl ccc2C(=0)c3ccccc3-c4n[flH]C1 c42 Cl 5H8N203 264.24 
AH9527 OC(=0)cl ccc2-c3ccccc3C(0)C4ccCC1 c42 C181-11003 274.28 
CC14563 OC(=0)cl ccnc(cl )n2nnc3ccccc23 C1 21-18N402 240.22 
GR1 54660A Cl.Ccl ccc(c(cl )C(0)0)n2ccc(0)cc2 Cl 3H 11 NO3. HCI 265.70 
GR1 77049X OC(0)cl ccc(ncl )n2cccc2 Cl 0H8N202 188.19 
GR21 9652X Cod ccc(ccl C(=0)0)n2nnnc2C. Cl OH1 0N403 234.22 
GR249207X Ccl c(cnnlc2ccccc2)C(=0)0 Cii H1ON2O2 202.22 
GR1 18330 OC(=0)ciccc2[nH]c(=0)oc(=0)c2Ci C9H5N05 207.14 
GW276690 Cci nc2ccc(cc2c(0)ol )C(=0)O C101-17NO4 205.17 
GR242234X Ccl nn(Cc2ccc(o2)C(0)0)c(C)ci Br Cli H 11 BrN2O3 299.13 
GW283348X CCn1 ncc2c(NCc3ccccc3)c(cncl 2)C(=0)0 C161-116N402 296.33 
GW3I 8076X CCn1 cc(C(=0)0)c(0)c2cc(odi 2)C(=0)0 C11 1-19N06 251.20 
GR37727X NO nc(CC(=0)0)c(oi )C(=0)0 C6H6N205 186.13 
GR53040X OC(0)cl cnc(Cc2ccccc2)ol Cli H9NO3 203.20 
AH7643 OC(=O)cicc(nol)c2ccccc2 C1OH7NO3 189.17 
AH9554 Cclonc(ciC(0)0)c2ccccc2 C11H9NO3 203.20 
GR1 52077X Cci nc(noi )c2ccc(c(C)c2)c3ccc(cc3)C(0)0 Ci 7H 1 4N203 294.31 
GM1 89907X Ccl noc(C)di C(=0)0 C61-17NO3 141.13 
GR39699X Ccicc(oni)C(0)0 C5H5NO3 127.10 
GR1 14312X 0C(0)cl noc2ccccci 2 C8H5NO3 163.13 
AH1 ii 95B Br.00(0)cl nc2ccccn2cl c3ccccc3 C141-11 0N202. HBr 319.16 
GR2391 06X Cci nc2cccc(C)n2ci C(=0)0 C1OH1 0N202 190.20 
GR1 06841 X OC(=0)ci ncn2cc(cccl 2)N(=0)=0 C8H5N304 207.15 
AH6081 A Cl.Nci ncnc2[nH]c(ncl 2)c3cccc(c3)C(=0)0 Cl 2H9N502. HCI 291.70 
GR240822X OC(=0)cl ncnc2[nH]cndl 2 C6H4N402 164.12 
GW32751 5X COO cc(ccci c2nc3cnccc3[nH]2)C(0)0 Ci 4H ii N303 269.26 
GW4 16086 COcl ccc(c2nc3cc(cnc3[nH]2)C(0)0)C(OC)d1 C151-113N304 299.29 
AH9652 OC(=0)cl nc[nH]di C(=0)0 C5H4N204 156.10 
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GR44240X Cn 1 c(S)ncci C(=0)0 C5H6N202S 158.18 
GR103163A Ci.00(=0)ciccc(OCCfl2CCflC2)CC1 C12H12N203. HCI 268.70 
GW327758A CI.00(0)ci ccc(IC=CICn2ccnc2)ccl Cl 3H I 2N202. HCI 264.71 
GW312641A Cl.00(=0)cicCC(Cfl2CCflC2)CC1 C11H1ON202. HCI 238.68 
Gil 38330X OC(0)ci cnc(S)ncl 0 C5H4N203S 172.16 
GW329078X OC(0)cl c(CI)ncncl CI C5H2C12N202 192.99 
GR240576X CCScI ncc(C(0)O)c(N)nl C7H9N302S 199.23 
GW315215 Cclncc(C(0)0)c(N)fll C6H7N302 153.14 
GW41 2098 Ccl ncc(C(0)0)c(NC(S)S)fll C7H7N302S2 229.28 
GR1 08394X CSc1 ncc(Br)c(nl )C(0)O C6H5BrN202S 249.09 
GR245706X OC(0)ci ncnc(0)cl Br C51-1313rN203 219.00 
GR1 17055X OC(0)cl ccnc(nl )c2ccccc2 C11 1-18N202 200.20 
AH7461 CCCcI cc(Nc2ccccc2C(=0)0)nC(N)fli C14HI 6N402 272.31 
GW341 377 Ccl cnc(N)ncl Nc2ccc(cc2)C(0)0 Cl 2H1 2N402 244.26 
GW3651 40 Ccl cc(Nc2ccc(cc2)C(0)0)flc(N)fl I Ci 2H 1 2N402 244.26 
GW3651 73 Cci nc(N)nc(Nc2ccc(Cc2)C(0)0)Ci C Cl 3Hl 4N402 258.28 
G1261653 OC(0)cl ccc(Nc2ncnc3ccccc23)cc1 0 Cl 5H ii N303 281.27 
GR242078X Nclncnc(N)C1NCc2CCCC(C2)C(0)0 C12H1 1N502 257.25 
GW308852X NO nc(N)c(c2ccc(Ci)cc2Cl)c(ni )C(=0)0 C1  H8C12N402 299.12 
GW30751 2X NO nc(N )c(CCCOc2ccc(CC2)C(0)0)C(0)[nH] 1 Cl 4Hl 6N404 304.31 
GW31 1 866X CC1(C)Nc2nc(N)[nH]c(=0)C2NC1CCc3cCC(cC3)C( C1 71-119N503 341.37 
=0)0 
GW31 9241X OC(=0)ci ccc(cci O)n2cc(C#N)c(0)[nH]C20 Ci 2H7N305 273.21 
GW448056X CC(0)cl cn(c2ccc(o2)C(0)0)c(0)[flH]dl =0 Cli H8N206 264.20 
GR258734A CCN(CC)CC.00(0)ci ccc2c(0)[nH]c(N )[nH]c2c C9H7N303. C6H 1 5N 306.37 
GR264071A Cnl c(=N)[nH]c2cc(ccc2cl =0)C(=0)0.00(0)C(F)( C1 01-19N303. C2HF302 333.23 
F)F 
GR263255X OC(=0)cl ccc2c(=0)[nH]c(0)[nH)c2cl C9H6N204 206.16 
GR43767X OC(0)ci ccc2nc(nH]c2dl C8H6N202 162.15 
GW472535X OC(0)cl ccc2c(0)ncnc2cl C9H6N203 190.16 
GW288946X Cn 1 c2cc(nn2c(=0)c3cc(N)ccdl 3)C(0)0 Ci 2H 1 0N403 258.24 
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GW324060X OC(0)cl cccc2nc3CCCn3C(0)c1 2 Cl 2H 1 0N203 230.23 
AH1 0315 NO c(nnnl Cc2ccccc2)C(0)O Cl OH1 0N402 218.22 
AH10461 Nd c(nnnl C2CCCCC2)C(0)O C9H1 4N402 210.24 
GR1 0571 6X Cnl ncc(nl )C(0)O C4H5N302 127.10 
GR21 21 22X OC(0)cl [nH]nndl Nc2ccccc2 C9H8N402 204.19 
AH22431 B [K+].Ccl cc(n[nH] 1 )C(=O)[O-] C5H5N202-. K+ 164.21 
GR109361X OC(=O)cln[nH]cclN(0)0 C4H3N304 157.09 
GR60436X CCCCCCCCCCCCCc1CC(fl[flH]1 )C(=O)O C171-130N202 294.44 
AH6087 Cnl ncc(C(0)O)dl N C51-17N302 141.13 
G1163641X OC(=O)cicn[nH]cl C4H4N202 112.09 
CCI1 53 OC(0)cl csnnl C3H2N202S 130.13 
GR1 28873 OC(0)cl nnscl CN=[N+][N-] C41-13N502S 185.17 
GR75538X OC(0)cl snncl c2ccccc2 C9H6N202S 206.22 
GR35345A [Na+].OclnsnclC(0)[O-] C3HN203S-. Na+ 168.11 
GR49747X CCScI snc(0)cl C(0)O C6H7NO3S2 205.26 
GR51 603A N.00(0)cl noncl 0 C3H2N204. 2(H3N) 164.12 
GR851 61 X OC(0)cl noncl OCc2ccc(CI)c(Cl)c2 Cl 0H6C12N204 289.08 
AH1 0536 OC(0)cl nc2ccccc2ncl 0 C91-16N203 190.16 
AH1 0767 OC(=0)cl cnc2ccccc2nl C9H6N202 174.16 
AH9356 OC(=0)cl nc2ccccc2ncl C(=0)0 Cl 0H6N204 218.17 
GW3I 6125 CCOC(0)ci nc2cc(ccc2ncl O)C(0)0 Cl 2H 1 0N205 262.22 
CCI1 0174 OC(0)cl nccncl C(0)0 C61-14N204 168.11 
GR263958X NC(0)cl nccncl C(0)0 C61-15N303 167.13 
GW433821A CI.00(0)cicncc(nl )c2ccc(F)cc2 C1  H7FN202. HCI 254.65 
CC110446 CC(=0)Nclncc(sl)C(0)0 C6H6N203S 186.19 
GR1 3821 8X OC(0)cl cccccl C(=0)Nc2nccs2 Cli H8N203S 248.26 
GW349042X OC(=0)cl ccc2ncsc2cl C8H5NO2S 179.20 
GR44479X Ccl nc(C)c(sl )C(=0)O C61-17NO2S 157.19 
GR66484X OC(=0)ci cscnl C41-13NO2S 129.14 
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GW449422A CICC(C)C(N)cl nc(csl )C(=O)O C8H 1 2N202S. HCI 236.72 
G120451 OX OC(=O)cl csc(nl )c2cccnc2 C9H6N202S 206.22 
GR239579X OC(0)cl csc(nl )c2ccc3nonc3c2 Cl 0H5N303S 247.23 
GW352006X OC(=O)cl csc(nl )c2sccc2Br C8H4BrNO2S2 290.16 
G1233445X OC(=O)cl csc(n 1 )C2COc3ccccc3O2 Cl 2H9N04S 263.27 
GR239577X Ccl nc(COc2ccc3noflc3C2)SC1 C(=O)O Cl 2H9N304S 291.29 
AH1 010 Nd cncccl C(0)O C61-16N202 138.13 
CC121414 OC(=O)ciccnccl C6H5NO2 123.11 
G1222692X Ccl cc(cc(Cl)n 1 )C(0)O C71-16CIN02 171.58 
GR84679X CN(C)CC#Cdlcc(cCfll)C(0)O Cli H12N202 204.23 
GR84985A Cl.CN(C)CCCc1 cc(ccnl )C(=O)O C 1 HI 6N202. 2(HCI) 281.18 
AH 10182 OC(=O)cI ccnccl C(0)c2ccccc2 Cl 3H9NO3 227.22 
GR203336X OC(=O)ci ccnc(cl )C(0)c2ccccc2 CI 3H9NO3 227.22 
AH20998XX COC(=O)cl ccn(0)ccl C(=O)O C8H7N05 197.15 
AH6595 OC(=O)cicccn(0)dI C6H5NO3 139.11 
AH2 1 933X OC(0)cl ccc(Cl)ncl C61-14CIN02 157.56 
GR1 54396X OC(0)cl cncc(Br)cl C6H4BrNO2 202.01 
GW408 1 46X OC(0)dl ccc(C#N)ncl C71-14N202 148.12 
AH6732 OC(=O)cicccnclSC2cccCC2 C12H9NO2S 231.28 
GR2081 33X OC(0)ci cccncl S C6H5NO2S 155.18 
AH 1031 Nd cccncl C(0)O C6H6N202 138.13 
AH1 6943AA OC(0)cl ccc(N(0)0)C(fll )C(0)O C71-14N206 212.12 
AH1 052 OC(0)ci nccccl 0 C6H5NO3 139.11 
CC121405 OC(=O)ciccnc(dl)C(0)0 C7H5N04 167.12 
AH1 1453 OC(0)cl cc(CI)ccnl C61-14CIN02 157.56 
CCI1 0176 OC(0)cl cccncl C(=0)0 C7H5N04 167.12 
AH1 0633 COd ccnc(cl )C(0)O C7H7NO3 153.14 
GW369905 OC(=O)cl cc(OCc2ccccc2)ccn 1 Cl 3H 11 NO3 229.24 
AH8268A Cl.COcl cccc(COc2cccnc2C(0)O)Cl Cl 4H 1 3N04. HCI 295.73 
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GR202022X CCCCC1 CCC(CC1 )c2ccc(nc2)C(=O)O Ci 6H23NO2 261.37 
GR34043X CCCCc1 ccc(ncl )C(0)O Cl OH1 3NO2 179.22 
GR247048X CCCCCc1 c(N)c(nc2cc(C)c(C)cci 2)C(=O)O C1 71-122N202 286.38 
GW309880X OC(=O)CCCCc1 ccnc(ci )C(=O)O Cii Hi 3N04 223.23 
GR230760X OC(=O)CcicccnclC(0)O C81-17N04 181.15 
GW299526X CCOC(0)Ccl nccccl C(=O)O C101-111N04 209.20 
AH1 0225 OC(=O)ci cnc2ccccc2cl 0 Ci 0H7NO3 189.17 
AH1 1688 COcl cc2ncc(C(=O)O)c(0)c2ccl OC Cl 2H1 1 N05 249.23 
GR258750 OC(=O)cl cnc2ccc(OC(F)(F)F)cc2cl 0 Cii H6F3N04 273.17 
AH 11368 COcl ccc(OC)c2c(0)c(cncl 2)C(=0)0 Cl 2H1 1 N05 249.23 
G1266527 CCCCOc1 cccc2c(0)c(cnci 2)C(=0)O Cl 4H 1 5N04 261.28 
AH1 1967 Ccl cc2c(0)c(cnc2c(C)n1 )C(0)O Cli Hi 0N203 218.21 
GR140330X CC(C)cl cc(C(=0)O)c2ccccn1 2 Cl 2H 1 3NO2 203.24 
GR2I 6655X Cci nc2ncccc2ccl C(=O)O C1 01-18N202 188.19 
GR220880X OC(0)dl cc2cnccc2ncl C(F)(F)F Ci 0H5F3N202 242.16 
GR232939X OC(0)cl cc2sccc2ncl C(F)(F)F C9H4F3NO2S 247.20 
AH1 053 OC(0)ci cccnci 0 C6H5NO3 139.11 
AH6596 OC(=0)cl cccndi Oc2ccccc2 Cl 2H9NO3 215.21 
AH 12133 CCOc1 ccc2c(0)c(cnc2n1 )C(=O)O Cii Hi 0N204 234.21 
AH 13394 OC(=O)cl cccndl OCCc2ccccc2 Cl 4H I 3NO3 243.27 
GW299375X CCCCOcI ccc(cnl )C(=O)O Cl OH 1 3NO3 195.22 
AH3663 OC(=O)COcl cncccl C(=O)O C8H7N05 197.15 
GR239599X CCOc1 cc(cncl C(=O)O)C(F)(F)F C9H8F3NO3 235.16 
AH1 1395 OC(=O)ci cc(0)nc2ccccc1 2 Cl 0H7NO3 189.17 
AH 1 3826XX OC(0)cl c2ccccc2nc3cccccl 3 Ci 4H9NO2 223.23 
GR54987X OC(0)dl cc(CI)nc2cccccl 2 Cl OH6CINO2 207.62 
GW471 O49X Ccl cc(C(0)O)c2ccc(C)c(Br)c2n1 Ci 2Hi OBrNO2 280.12 
GW320828X OC(0)dl ccc2[nH]c3ccccc3c(0)c2dl Cl 4H9NO3 239.23 
GW321 479X Cnl c2ccccc2c(0)c3ccc(cci 3)C(=O)0 Ci 5H ii NO3 253.26 
Appendix 2_SMILES 	 Page 32 	 Aryl acid SMILES structures 
Reg No Smiles String 	 I Formula 	[ MW 
GR1 01886 OC(=0)cl ccc2ric(CI)c(CI)nc2cl C9H4C12N202 243.05 
GR82448 OC(=O)cl ccc2nc(0)c(0)nc2cl C91-16N204 206.16 
GW294831 Ccl ccc2nc3ccc(cc3n(0)C2C1 )C(0)0 Cl 4H 1 0N203 254.25 
AH 12975 OC(=0)cl cccccl c2nc3ccc(CI)cc3[nH]2 Cl 4H9C1N202 272.69 
GW31 2607X OC(0)cl ccc2[nH]c(cc2cl )c3ccc(CI)cc3 Cl 5H 1 OCINO2 271.71 
AH 1 7009XX OC(0)cl cc(nc2cccccl 2)c3ccccc3 Cl 6H 11 NO2 249.27 
GW31 4282X OC(0)cl c(cnc2cccccl 2)c3cccpc3 Cl 6H 11 NO2 249.27 
GW355545X OC(0)cl cc(nc2cccccl 2)c3ccco3 Cl 4H9NO3 239.23 
AH3705A Cl.00(0)cl cncccl c2ccccc2 Cl 2H9NO2. HCI 235.67 
CCI1 0881 OC(=0)cl cccccl c2ccccn2 Cl 2H9NO2 199.21 
AH1 0300 COd ccc2nc(cc(OC)c2cl )C(=0)O Cl 2H 11 N04 233.23 
AH1 0801 COd ccc2c(OC)cc(nc2cl )C(=O)O Cl 2H1 I N04 233.23 
AH9678 COd cc(nc2cccccl 2)C(0)0 Cli H9NO3 203.20 
AH 10698 OC(0)cl cc(0)c2cc(0)ccc2n 1 Cl 0H7N04 205.17 
AH 10853 OC(0)cl cc(0)c2cccc(0)c2n 1 Cl 0H7N04 205.17 
GR92452 OC(=O)cl ccc2cccc(0)c2nl Cl 0H7NO3 189.17 
AH9727 OC(=O)cl ccc2ccccc2nl Cl 0H7NO2 173.17 
AH 12695 OC(=O)ci cc(Oc2ccccc2 )c3ccccc3n 1 Cl 6H 11 NO3 265.27 
AHI 3070 OC(=O)cl nc2ccccc2c(0)cl CC=C Cl 3H1 1 NO3 229.24 
AH9676 OC(=O)cl cc(OCc2ccccc2)c3ccccC3fll Cl 7H 1 3NO3 279.30 
AH9721 OC(=O)cl cc(OCc2ccccc2)c3ccccc3nl =0 Cl 7H 1 3N04 295.30 
AH1 0301 X CCCCOc1 cc(nc2cccccl2)C(0)0 Cl 4H1 5NO3 245.28 
AH 15692 CCCOc1 cc(nc2cccccl 2)C(=0)O Cl 3H1 3NO3 231.25 
AH1 2533 OC(0)cl cc(OCCC)c2ccccc2n1 Cl 3H1 1 NO3 229.24 
AH 12590 OC(=O)cl cc(OCC#C)c2ccccc2n I Cl 3H9NO3 227.22 
AH1 5690 CCOc1 cc(nc2cccccl 2)C(=O)0 Cl 2H1 1 NO3 217.23 
AH1 5757 CC(C)Ocl cc(nc2cccccl 2)C(=O)O Cl 3H1 3NO3 231.25 
AH1 0978 OCCOc1 cc(nc2cccccl 2)C(0)0 Cl 2H1 1 N04 233.23 
AHI 1275 OC(0)cl cc(OCCOC2CC(nd3CccCC23)C(0)0)G4CC C22H 1 6N206 404.38 
ccd4n 1 
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AH1 2589 COCCOc1 cc(nc2cccccl 2)C(=O)O C131-113N.04 247.25 
AH 11274 OC(=O)cl cc(OCCOCCBr)c2ccccc2n 1 CI 4H 1 4BrNO4 340.18 
AH1 3391 CC(=O)OCCOc1 cc(nc2cccccl 2)C(=O)O C14H1 3N05 275.26 
GR254264X OC(0)cl cc(OCCOCO)c2ccCCC2fl1 Ci 3H 11 N05 261.24 
AH1 0616T CN(C)CCO.00(0)ci cc(0)c2cc(ccc2nl )N(=O)0 Cl 0H6N205. C4H1 1 NO 323.31 
AH7490 OC(=O)cl cc2cc(ccc2[nH]1 )N(=O)0 C9H6N204 206.16 
AH1 851 5XX OC(0)cl cc2ccccc2c(Cl)ni Cl OH6CINO2 207.62 
AH22573X OC(=O)ci cc2c(Cl)cccc2[nH] 1 C91-16CIN02 195.61 
AH8588 OC(0)c1cc2ccccc2[flH]1 C9H7NO2 161.16 
AH8601 COO ccc2[nH]c(cc2cl )C(0)O Cl 0H9NO3 191.19 
GR32737X OC(=O)ciccc[nH]1 C5H5NO2 111.10 
AH23288X CCOC(0)cl c[nHjc2cc(ccci 2)C(=O)O Cl 2H 11 N04 233.23 
G1149558 OC(0)di c[nH]c2cccccl 2 C9H7NO2 161.16 
GR1 33921 Cci ccc2[nH]cc(C(0)O)c2ci Cl 0H9NO2 175.19 
GR134971 OC(=O)cicccc2cc[nH]c12 C9H7NO2 161.16 
GR65242X Cnl cc(C(0)O)c2cccccl 2 Ci 0H9NO2 175.19 
AH26099 OC(=O)ciccc2cc[nH]c2cl C9H7NO2 161.16 
GR1 16365X Cci [nH]c2cc(ccc2dl C)C(0)O Cli Hi 1 NO2 189.22 
GW541 785X Cci cc2ccc(cc2[nH]i )C(=O)O Ci 0H9NO2 175.19 
GR3I 004 OC(0)cl ccc2[nH]ccc2cl C91-17NO2 161.16 
GW278395 OC(=O)cl ccc2nHjc3ccc(cc3c2c1 )C(=O)O Ci 4H9N04 255.23 
GR1 10635X Cni cc(C(0)O)c2cC(CNS(0)(0)C)cCC1 2 Ci 2H14N204S 282.32 
GR1 16353X CCOC(=O)Cci c(C(=O)O)c2ccccc2ni C Ci 4Hi 5N04 261.28 
GR1 25882X COW c(C(=O)O)c2ccccc2nl C Ci 2H1 3NO3 219.24 
GW294490X CC(C)(C)OC(0)ni c(cc2cccccl 2)C(=O)O C14H1 5N04 261.28 
GW589997X Ccl c(C(0)O)c2cccc3CCn1c32 C12H1 1 NO2 201.23 
AH20902 NCCc1 c[nH]c2ccc(ccl 2)C(=O)O Cii Hi 2N202 204.23 
GR36456 CN(C)CCci c[nH]c2ccc(ccl 2)C(=O)O Ci 3H 1 6N202 232.29 
AH20984 NCCc1 c([nH]c2ccc(cci 2)C(=O)O)C(0)O Ci 2Hi 2N2O4 248.24 
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AH21 852 CC(=O)ci ccc2[nH]c(C(=O)O)c(CCN )c2ci Ci 3H 1 4N203 246.27 
GR25201 7 NCCc1 c([nH]c2ccccci2)C(=O)O C111-112N202 204.23 
GR58047 CN 1 CCOC(C1 )c2c[nH]c3ccc(cc23)C(=O)O Ci 4H 1 6N203 260.30 
GR44857A CLCN 1 CCC(CC1 )c2c[nH]c3ccc(cc23)C(0)O Cl 5H 1 6N202. HCI 292.77 
GR2071 54 COO ccc2[nH]C(C(0)O)C(CCNC(0)C)C2Ci Cl 4H i 6N204 276.30 
GR78684X COO ccc2[nH]c(C(0)O)C(CCC(0)O)C2C1 Ci 3H 1 3N05 263.25 
AH2426A CI.00(=O)cl c2CCCCc2nc3cccccl 3 Cl 4H 1 3NO2. HCI 263.73 
AH31 16 OC(=O)ci ccc2[nH]c3CCCCc3c2cl Ci 3H1 3NO2 215.25 
GW304734X OC(=O)ci cnc2CCCCc2cl 0 C101-111NO3 193.20 
GW661 447X OC(=O)dl cc2CCCCc2[nH]1 C91-1 ii NO2 165.19 
GR1 73175X CCOC(0)cl [nH]c(C)c(C(0)0)dl C Cl OH1 3N04 211.22 
GR254404X CC(0)cl c(C)[nH]c(C(0)O)cl C C91-1 ii NO3 181.19 
GW2751 05X CCOCc1 [nH]c(C(0)O)c(C)cl C(=O)C Cli Hi 5N04 225.25 
GW29961 OX CC(0)OCcl [nH]c(C(0)0)c(C)dl C(=0)C Cli Hi 3N05 239.23 
GW298781 X COCci [nH]c(C(0)O)c(C)cl C(=O)C Ci OH 1 3N04 211.22 
GW470761 X CC(0)OCCcI c(C)[nH]c(C(0)0)cl C Cli Hi 5N04 225.25 
GW369798X CCc1 [nH]c(C(0)0)c(C)ci C(0)0 C91-1 ii N04 197.19 
GW659802X CC(=0)cl [nH]c(C(0)0)c(C(0)O)cl C C91-19N05 211.18 
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GR207962X 1 1 43 95 81 93 185 102 110 171 
GR212454X 1 2 44 88 84 104 184 103 108 162 
CC121177 1 3 47 77 68 69 60 71 80 91 
GR257381X 1 4 41 77 73 90 85 76 99 138 
AH6621 1 5 44 71 63 57 56 64 74 81 
GR193563X 1 6 39 75 67 71 61 61 78 87 
GF267447X 1 7 50 77 67 62 62 72 80 87 
GW431055X 1 8 44 55 45 64 58 59 65 81 
GR257410X 2 1 39 66 64 60 61 63 78 84 
GW503358X 2 2 36 74 65 58 62 75 76 85 
GW318421X 2 3 41 78 67 61 60 74 78 84 
GR50343X 3 1 45 95 81 78 65 102 118 95 
AH14879XX 4 1 45 73 64 67 96 118 94 98 
GR235591X 4 2 33 65 63 58 52 56 71 75 
AH3827 5 1 35 159 136 104 166 286 228 211 
GF267697X 5 2 66 75 58 61 61 70 80 64 
GR32114X 5 3 47 69 60 63 61 71 72 65 
AH14579XX 6 1 41 68 59 58 55 60 72 79 
GW288607X 6 2 35 62 63 57 59 59 70 67 
CC 123883 7 1 50 79 64 66 62 69 73 92 
GR30858X 7 2 44 78 72 67 58 83 91 87 
CC13965 8 1 56 72 64 67 61 64 65 79 
G1207347X 8 2 48 73 61 62 54 58 69 80 
GR38987X 8 3 43 72 56 58 53 57 69 71 
CC13923A 9 1 49 69 60 63 58 70 77 70 
GR38954X 9 2 51 72 61 62 59 66 73 88 
GR251016X 9 3 45 67 59 67 61 67 75 66 
AH14993XX 10 1 51 192 176 99 161 269 223 210 
AH14994XX 10 2 44 63 57 61 73 88 83 93 
GR84408X 10 3 38 736 351 215 170 230 321 229 
AH25091X 10 4 44 73 59 59 63 68 66 87 
GR64693X 10 5 39 813 1525 1606 1647 2371 2095 1327 
AH16584)(X 10 6 47 329 158 344 399 618 338 326 
GR76119A 10 7 43 74 58 65 56 65 74 85 
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Compound - - Emission Intensity (616 nm +1- 10 nm)  
Reg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
G1224436X 11 1 48 76 63 61 81 78 77 95 
GR34543 11 2 9 8 13 15 10 15 13 - 
GR40314 11 3 11 8 18 15 22 37 18 
GR62892 11 4 544 524 - - - 486 651 - 
GF133808X 12 1 49 86 70 62 66 68 82 93 
GR253989X 12 2 37 74 72 65 68 67 85 90 
GR215101X 12 3 43 72 63 65 64 85 86 76 
GW322044X 13 1 32 72 60 53 69 68 71 80 
GR148285X 14 1 38 88 76 82 102 133 108 107 
GR81142X 14 2 40 72 53 64 53 64 71 83 
GR63007X 14 3 44 72 58 60 59 68 77 66 
GW423740X 15 1 42 87 86 75 118 112 100 108 
AH14732XX 16 1 38 49 44 43 65 56 57 75 
GW291819X 16 2 42 73 76 84 86 79 97 123 
AH15398XX 16 3 40 49 51 44 73 61 65 78 
GW314444X 16 4 36 50 52 54 52 56 53 68 
GW385245X 16 5 47 94 87 81 115 141 130 119 
AH15251XX 17 1 95 122 101 123 163 143 167 129 
AH4591 17 2 41 74 62 60 54 72 74 95 
AH8259 17 3 62 476 351 279 242 379 265 224 
GR34041X 17 4 46 71 60 55 59 60 68 82 
GR261706X 18 1 39 55 61 59 51 57 72 78 
GR265013X 18 2 41 83 88 75 109 132 116 120 
GR49081X 19 1 42 76 56 63 53 69 70 81 
GW339416X 19 2 39 65 60 58 64 66 66 79 
GW404922A 19 3 34 88 68 66 70 82 83 93 
GW409763X 19 4 36 67 58 50 62 65 61 73 
AH11164 20 1 42 - 71 65 98 - 85 - 
GR214770X 20 2 39 - 64 60 57 - 64 - 
CC15134 20 3 56 82 73 76 67 83 88 79 
G1149795A 20 4 43 67 60 60 54 64 72 68 
GR38988X 20 5 44 69 55 63 54 67 74 62 
GR39182X 20 6 49 70 61 61 55 60 72 82 
GW328037X 20 7 45 62 53 58 53 62 63 59 
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Compound - 	 Emission Intensit (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
AH9074 21 1 40 - 57 56 69 - 64 - 
G1160046X 21 2 49 73 66 66 62 67 81 67 
GF253708X 21 3 43 - 65 60 62 - 63 - 
GW328038X 21 4 45 93 88 79 118 132 140 125 
AH11410 22 1 44 75 64 58 59 71 74 88 
G1166356X 22 2 46 79 65 65 62 73 83 90 
AH5737 22 3 43 67 62 60 61 71 74 80 
GR239060X 22 4 40 69 76 69 69 71 85 84 
CC11659 22 5 54 - 88 66 85 - 96 - 
GR156438X 22 6 39 73 53 56 55 67 68 78 
GR58626X 23 1 45 67 55 60 47 63 69 68 
GR87165X 23 2 40 - 1174 695 709 - 938 - 
AH18307)(X 24 1 40 - 69 63 66 - 74 - 
GF234517X 24 2 41 - 69 66 70 - 84 - 
GF233960X 25 1 43 - 59 58 55 - 63 - 
G1220410A 25 2 45 68 60 62 55 68 72 62 
GR101348X 25 3 40 - 60 62 59 - 64 - 
AH14771AA 26 1 40 - 136 161 170 - 167 - 
GF241458X 26 2 49 89 72 69 73 84 101 99 
GR71072X 26 3 42 228 126 197 219 374 331 289 
GR93262X 26 4 56 74 61 71 61 76 74 83 
GW315267X 27 1 38 56 56 57 50 59 57 67 
GR59449X 28 1 42 85 61 69 78 81 93 95 
GR59450X 28 2 51 144 298 75 282 667 334 91 
CC117440 29 1 57 235 231 211 195 197 221 187 
GR68891 29 2 50 11 53 47 50 48 50 - 
G1148915 29 3 81 157 - - - 194 186 - 
GR207121 29 4 56 57 55 57 55 56 54 - 
GR260810 29 5 17 9 14 14 15 14 15 - 
GR66288 29 6 9 14 15 18 16 23 13 - 
G1166629 29 7 65 68 83 69 75 78 80 - 
GR235507 29 8 41 48 55 53 46 48 49 - 
GR38555 29 9 22 21 27 25 21 23 24 - 
GW296997 29 10 71 70 81 72 70 73 75 - 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
CC14008 29 11 69 92 82 85 79 89 99 90 
GR244973 29 12 11 15 25 16 30 26 26 - 
GR260719 29 13 11 9 13 13 11 12 15 - 
GW317730 29 14 19 21 28 23 26 25 27 - 
GW412437 29 15 - - - - - - - - 
GW369998 29 16 17 17 23 21 19 22 25 - 
GW416206 29 17 - - - - - - - - 
GW315253X 29 18 52 118 147 187 283 264 227 239 
AH16806XX 30 1 45 87 80 69 86 143 96 92 
AH17157XX 30 2 47 388 202 507 768 1755 1751 742 
GW312681X 30 3 50 102 194 149 201 140 213 204 
AH4366 31 1 38 173 169 120 196 370 291 206 
AH4367 31 2 41 76 64 61 59 69 74 86 
AH9991 31 3 42 90 80 87 129 147 115 120 
AH9456 31 4 46 70 62 56 60 69 71 73 
AH7716 32 1 49 97 99 111 151 135 125 149 
GR244160X 32 2 40 70 77 63 72 66 80 84 
GR3017OX 32 3 44 62 51 55 50 58 71 59 
GW294785X 32 4 38 75 74 89 98 92 102 133 
GR232463X 33 1 37 79 73 68 115 125 101 112 
GW312679X 33 2 43 73 100 140 197 280 131 213 
AH12195 34 1 47 180 134 118 139 159 289 153 
GR30355X 34 2 43 163 129 104 165 249 239 159 
GR30686X 34 3 47 70 56 61 53 60 76 81 
G1221306X 34 4 42 - 69 72 100 - 78 - 
GR197556X 34 5 44 - 90 82 91 - 85 - 
GR236886 35 1 629 606 552 589 623 680 589 489 
GW432536 35 2 - - - - - - - - 
AH1468OXX 36 1 42 71 64 60 56 67 74 81 
GR215350X 36 2 37 89 78 68 79 71 105 90 
GW413125X 36 3 43 76 86 100 116 108 114 136 
GR203309X 37 1 38 366 597 629 485 622 882 687 
GR241592X 37 2 41 4134 3020 4788 4666 4469 5374 4317 
GR207127X 37 3 39 979 1280 1541 1060 1309 1503 1118 
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IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GW399139X 37 4 45 1397 1809 870 939 1033 1249 804 
GR34040X 38 1 42 82 67 70 83 95 97 92 
GW323465X 38 2 48 68 61 65 66 70 76 64 
GR36337X 38 3 43 1149 1899 1302 2084 2457 3483 1401 
GR87232X 38 4 35 60 58 136 94 154 74 140 
GW322742X 38 5 1603 54 55 69 165 82 63 120 
CC 18247 39 1 51 72 61 60 57 62 76 83 
GW470564X 39 2 34 96 75 62 85 108 94 99 
GR136744X 40 1 37 71 56 64 56 67 61 83 
GW398946X 40 2 34 78 66 62 66 82 85 88 
GR258074X 41 1 43 58 62 58 53 55 67 73 
GR30298X 41 2 44 70 58 61 56 58 68 81 
GW294643X 42 1 72 77 53 78 63 71 90 85 
GW295897X 42 2 38 68 75 54 56 58 66 74 
AH5119 43 1 45 86 73 63 77 93 88 101 
GR146857A 43 2 40 72 53 61 49 70 73 86 
GR108821X 43 3 40 74 56 68 61 76 74 86 
CC121441X 44 1 47 91 75 64 67 82 99 95 
G1222965X 44 2 51 73 64 61 58 64 71 88 
GR85032X 44 3 40 71 53 61 50 62 71 78 
GW317925X 45 1 37 83 58 56 52 59 72 73 
GW423592X 45 2 34 54 57 48 54 53 59 68 
GR212558X 46 1 37 92 79 74 85 70 105 90 
GV98449X 46 2 40 74 70 64 65 60 86 84 
GR245353X 46 3 38 319 285 166 457 236 447 215 
AH13207 47 1 44 94 78 66 69 86 88 88 
GR53007X 47 2 42 137 105 94 99 159 160 115 
AH8335X 47 3 44 78 87 75 96 121 133 79 
GR100133X 48 1 41 72 56 59 54 69 74 82 
GR111981X 48 2 41 80 63 66 78 94 94 94 
GR124650X 49 1 37 80 79 85 74 103 113 118 
GR236342X 49 2 53 74 64 74 58 74 79 71 
GR258909 50 1 50 329 361 331 348 377 335 342 
GR265026X 50 2 41 74 77 63 73 67 91 95 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
Reg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GR43579X 50 3 41 - 61 60 64 - 65 - 
GR51409X 50 4 41 66 55 61 48 61 65 71 
GW273704X 51 1 38 72 75 67 70 64 108 92 
GW324992X 51 2 42 93 83 68 72 110 112 107 
CC119762 52 1 44 153 123 100 131 203 192 155 
GR249776X 53 1 36 70 65 62 62 64 79 83 
GR256398X 53 2 39 72 73 65 72 68 86 89 
GR269435X 53 3 37 65 61 59 53 56 71 76 
GR180851A 54 1 37 64 66 63 48 59 79 82 
GR88677X 54 2 42 73 56 63 55 69 77 86 
GW401244X 55 1 40 57 54 67 64 63 64 84 
GW406680X 55 2 38 62 54 73 78 74 80 96 
GW521849X 55 3 40 65 68 75 97 89 85 109 
AH13312 56 1 52 122 76 76 92 117 131 104 
AH14681XX 57 1 36 69 67 45 75 86 89 85 
GR130650X 57 2 36 154 145 227 270 395 288 326 
GR99513X 57 3 42 85 83 80 57 104 98 104 
AH23294X 57 4 49 78 76 94 114 96 93 95 
GR212000X 58 1 38 114 122 104 125 148 171 247 
GR116024X 59 1 36 905 1041 796 461 535 1063 583 
GR58504X 59 2 39 310 315 326 286 386 407 333 
GW315124X 59 3 42 67 68 71 109 88 89 110 
GW442963X 59 4 45 88 102 100 130 159 152 159 
GW342768X 59 5 38 59 57 70 72 62 67 94 
AH25327X 60 1 36 81 117 85 92 134 188 142 
AH25377X 60 2 35 108 90 57 88 120 114 121 
GR60468X 61 1 38 156 145 93 158 180 174 183 
GR223597X 62 1 38 74 66 78 82 73 80 110 
GW543499X 63 1 40 54 50 64 74 66 63 116 
GR257678X 64 1 49 70 61 66 61 68 75 61 
GW652716X 65 1 46 77 77 81 74 74 95 97 
GW292869X 66 1 39 160 172 244 426 384 403 326 
GW342412X 66 2 42 175 75 79 236 233 279 169 
GR232127X 67 1 38 744 323 578 446 482 506 608 
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Compound 	 - Emission Intensit (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GW309937A 68 1 42 68 67 75 79 73 83 97 
GR54241 69 1 43 76 63 64 54 68 78 84 
GR64138A 69 2 45 50 58 62 71 58 64 86 
GR81562 69 3 108 - 88 82 88 - 92 - 
GW424484X 70 1 40 83 71 61 63 83 84 98 
GW294777X 71 1 44 77 86 93 131 89 106 181 
GW313525X 71 2 43 325 310 195 395 432 419 317 
GW321902X 71 3 42 63 58 68 81 79 66 81 
GR194866A 72 1 33 77 78 98 99 75 108 156 
GR65644X 72 2 37 53 46 58 74 60 57 77 
GW553810A 72 3 37 96 60 77 111 152 167 102 
GW549758A 72 4 45 105 93 120 113 115 111 146 
GW550038A 72 5 45 195 212 218 179 188 262 205 
GR70745X 72 6 35 129 107 121 81 120 140 112 
GR69220X 72 7 39 88 90 117 136 107 109 119 
AH11291 73 1 58 158 124 103 108 178 160 131 
GR94828A 73 2 47 779 57 321 399 565 1029 331 
AH12740 73 3 45 91 76 67 67 97 105 90 
AH12757 73 4 43 83 68 65 64 83 96 88 
GR199839X 73 5 56 84 85 80 71 80 95 100 
GR58191X 74 1 37 58 54 75 64 64 60 82 
GR87036X 75 1 41 74 58 61 54 66 72 91 
GW415452X 75 2 46 74 60 68 71 81 80 67 
AH8294 76 1 44 77 67 60 62 76 94 87 
GR39220X 76 2 51 149 128 95 134 184 188 133 
G1101694A 76 3 45 75 63 66 57 64 74 91 
GR50961A 76 4 43 125 115 102 98 176 173 126 
GR147168X 77 1 1267 1308 1222 1240 1288 1252 1310 1253 
GR51196X 77 2 43 69 56 62 52 67 67 80 
GR117463X 78 1 38 67 57 61 64 64 69 75 
GR208696X 78 2 39 66 66 61 60 60 77 87 
GR32768A 78 3 45 72 58 62 53 57 72 81 
GW432313X 78 4 37 73 66 65 62 65 74 88 
GR266494X 79 1 - - - - - - - - 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GW298250X 79 2 38 66 64 58 57 67 69 78 
GR125017X 80 1 41 104 88 127 244 152 132 178 
GW370018X 80 2 35 66 62 59 64 64 65 78 
GW315103X 81 1 39 85 79 65 77 72 94 91 
GW321966X 81 2 74 96 103 120 155 213 177 264 
GF233961X 82 1 50 76 61 60 59 62 72 87 
G1230797A 82 2 43 69 57 60 52 53 64 78 
GR140164X 82 3 41 77 64 61 82 81 82 99 
GW290604X 83 1 1174 1119 1042 1008 2234 1924 1502 1486 
GW291821X 83 2 41 64 63 57 55 67 70 79 
GW361278X 83 3 44 63 67 63 73 60 65 87 
GW336990X 83 4 45 54 65 73 74 86 71 86 
GW295365X 83 5 50 85 86 100 202 101 114 136 
GW292911X 84 1 57 79 125 76 94 82 84 74 
GW294867X 84 2 39 98 95 159 277 207 193 254 
GW322405X 84 3 40 90 100 146 292 277 161 336 
GW315228X 85 1 219 235 282 299 219 305 241 .260 
GW321601X 86 1 51 189 159 132 206 243 282 213 
G1230786 87 1 47 72 57 58 63 78 73 88 
GW295364 87 2 84 106 110 103 99 109 111 121 
AH7066 88 1 39 68 60 61 55 65 69 107 
GF234516X 88 2 38 41 41 53 90 67 54 121 
GF269343X 88 3 38 62 67 75 90 109 86 90 
GW314651X 88 4 2037 57 61 70 141 127 75 120 
GW311857X 88 5 61 89 84 91 85 87 101 113 
GW323587X 88 6 35 1346 1650 1370 1996 2361 2952 1500 
GW294790X 88 7 76 477 1246 919 897 1425 1446 919 
GW322118X 88 8 39 180 221 245 351 439 271 343 
GW312723X 89 1 41 95 119 130 196 192 179 189 
GW432537X 89 2 67 117 191 142 166 166 224 189 
GW322502X 89 3 36 98 107 117 153 157 148 201 
GW312725X 89 4 37 51 65 73 88 72 91 111 
GW322531X 89 5 47 75 83 81 126 175 122 127 
GW314663X 89 6 71 551 998 1054 1504 1420 895 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
JReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GW323690X 89 7 195 482 532 461 619 643 743 624 
GW323328X 89 8 82 123 122 135 178 175 165 153 
AH10503 90 1 41 62 54 52 47 56 63 69 
AH25564X 90 2 49 74 55 59 52 57 68 85 
CC17155 90 3 58 83 71 76 68 78 89 81 
GR51 515 90 4 39 67 51 61 46 59 48 74 
GW363503A 90 5 37 81 75 58 66 86 86 82 
GR253714X 90 6 35 67 62 57 57 60 75 75 
AH9018 90 7 50 3067 2980 1504 2485 4646 5336 5486 
AH12070 91 1 106 138 119 129 132 144 134 142 
G1123058 91 2 147 168 - - - 178 201 - 
CR55509 91 3 27 22 27 29 38 33 30 - 
GR50239 91 4 18 15 18 21 16 20 17 - 
CR87121 91 5 79 128 - - - 114 129 - 
AH2951 91 6 48 86 68 61 63 75 79 88 
GR199994 91 7 40 69 64 61 62 62 76 87 
AH12275 91 8 66 100 87 84 83 94 97 104 
GR173757 91 9 80 124 103 104 103 111 105 113 
GR161201X 91 10 41 72 55 65 50 68 71 78 
AH12764 92 1 65 90 87 87 83 81 83 96 
AH17306AB 92 2 53 75 66 64 62 66 78 80 
GR161186X 92 3 51 73 66 68 59 69 72 83 
AH15O79XX 93 1 43 - 66 58 61 - 64 - 
GR35117X 93 2 38 - 61 61 70 - 61 - 
AH21453 93 3 60 83 69 69 68 72 90 98 
CR178029 93 4 122 156 - - - 150 171 - 
CR33748 93 5 43 525 823 590 1046 1075 1140 491 
G1152672 94 1 113 133 122 121 122 114 129 149 
CR141743 94 2 11 13 11 12 10 12 14 - 
GR39406 94 3 9 10 13 15 11 11 11 - 
CR214280 94 4 39 93 83 94 95 82 101 145 
GR226270 94 5 13 10 13 12 10 12 15 - 
GR78537 94 6 11 8 12 11 10 17 12 - 
GR189793 94 7 86 129 - - - 122 136 - 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GR263804X 94 8 42 58 60 68 58 60 75 94 
GW324674 94 9 12 10 11 14 11 11 12 - 
GW410247 94 10 - - - - - - - - 
GR38461X 94 11 46 72 63 64 70 79 82 72 
GW340239X 94 12 39 74 65 58 59 65 70 81 
GR73169X 94 13 46 72 58 62 53 67 82 66 
AH15491XX 95 1 45 73 63 57 53 68 79 82 
GR107832X 95 2 39 62 50 55 51 60 64 64 
GR231878X 95 3 40 57 52 54 64 67 69 57 
GR137556X 95 4 40 66 48 59 46 67 68 76 
GF146238 96 1 444 441 319 395 424 386 449 372 
GW295088 96 2 72 72 72 67 75 63 65 - 
GF267572X 96 3 56 72 63 63 62 62 72 80 
GW323141X 96 4 51 75 69 63 71 72 75 89 
GF267575X 97 1 98 102 93 101 98 94 106 110 
GR76319X 97 2 48 294 316 664 1223 1511 1246 1430 
GR78359X 97 3 83 115 101 101 107 117 114 121 
G1170475X 98 1 42 - 68 57 55 - 64 - 
GW275669A 98 2 43 - 62 53 54 - 61 - 
GR205623X 98 3 43 - 70 59 63 - 62 - 
GR53844X 99 1 43 - 68 62 63 - 66 - 
GW298071X 100 1 41 67 63 59 51 59 74 78 
G1199827X 101 1 44 65 54 56 49 57 62 75 
GR141837X 101 2 39 57 48 52 46 55 67 64 
GW323802A 101 3 41 75 73 59 63 67 72 82 
GW329522X 102 1 38 67 57 56 57 72 64 78 
GR251266A 103 1 99 94 119 100 83 101 126 143 
GR265018A 103 2 39 55 58 71 58 61 79 97 
GR253017X 103 3 39 68 66 59 61 62 82 87 
GW425183X 104 1 37 174 165 156 194 189 183 192 
GR267248A 105 1 42 55 60 74 60 63 74 100 
GW425181X 105 2 35 67 61 58 58 63 70 82 
AH17295)(X 106 1 42 66 60 54 53 57 68 71 
AH26206X 106 2 44 58 53 51 49 55 59 69 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
AH2056OXX 106 3 42 68 53 58 49 57 62 71 
GR97173X 106 4 39 61 50 55 48 57 57 63 
AH21291X 106 5 43 65 56 57 47 61 63 71 
GW471254X 106 6 40 72 63 61 56 64 70 80 
AH17365XX 107 1 45 66 55 57 49 58 64 77 
G1198830X 107 2 45 63 56 57 51 56 66 71 
AH7669 107 3 45 53 52 55 50 58 66 58 
G1221325A 107 4 50 62 55 57 56 63 69 64 
G195276X 107 5 38 65 53 59 54 61 70 59 
CC17978 108 1 43 - 63 61 81 - 63 - 
GF267691X 108 2 47 71 59 57 54 65 71 87 
G1147499A 108 3 47 - 68 66 69 - 68 - 
AH21350X 109 1 41 67 50 53 71 54 62 76 
GW321669X 109 2 51 - 66 62 64 - 71 - 
GW323630X 109 3 49 60 55 54 56 59 65 75 
CC11914 109 4 59 54 46 44 42 47 54 58 
GF146728X 109 5 45 - 65 60 59 - 66 - 
GR86838X 109 6 43 55 49 49 47 54 51 56 
AH5502 110 1 129 136 133 134 115 126 130 128 
GR141836 110 2 117 148 - - - 143 170 - 
GR248323 110 3 21 19 24 22 17 24 19 - 
AH6472 110 4 101 149 - - - 146 160 - 
GR141839 110 5 76 159 - - - 163 170 - 
GR31162 110 6 16 13 14 15 12 17 16 - 
GR40490 110 7 15 11 14 14 13 13 14 - 
GR40028 110 8 8 8 11 9 7 11 10 - 
G1149060 110 9 314 456 - - - 382 422 - 
G1153357 110 10 136 165 - - - 163 177 - 
GV95604 110 11 38 40 42 42 40 42 42 - 
G1119939X 110 12 49 - 67 64 69 - 68 - 
G1147798 110 13 78 112 - - - 112 126 - 
GR113723 110 14 79 113 - - - 104 125 - 
G1150183 110 15 103 137 - - - 131 149 - 
GR259835 110 16 15 13 14 15 11 16 13 - 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GR197159 110 17 106 145 - - - 133 141 - 
GR118329 110 18 119 171 - - - 154 194 - 
G1151314 110 19 102 143 - - - 138 157 - 
GR214686 110 20 13 10 15 12 11 16 16 - 
GR89164 110 21 101 143 - - - 129 153 - 
GR261930 110 22 53 64 60 67 59 60 61 - 
GR31787A 110 23 41 - 59 60 55 - 58 - 
CC18566 111 1 101 133 114 113 111 117 123 140 
GR32579 111 2 11 12 11 12 9 11 11 - 
GW286126 111 3 38 131 164 354 320 280 264 144 
GW422957 111 4 - - - - - - - - 
0R123674 111 5 87 130 - - - 122 149 - 
GR146669 111 6 89 122 - - - 119 136 - 
CC19041 111 7 60 90 75 77 76 74 78 96 
GW296344 111 8 8 8 12 12 9 16 9 - 
GR154729 111 9 90 127 - - - 113 146 - 
GR171932 111 10 94 118 - - - 114 125 - 
AH13018 112 1 39 164 149 106 106 217 225 124 
GV140840X 112 2 40 58 65 56 50 57 61 71 
GR207209X 112 3 36 155 175 135 325 253 268 245 
GR112257X 113 1 48 70 62 62 51 63 70 81 
GR263152X 113 2 258 260 314 275 262 255 262 285 
GR112259X 113 3 40 64 69 64 53 76 73 79 
GR185905X 113 4 46 83 86 82 71 107 111 103 
GR186845X 113 5 38 86 86 105 238 94 115 138 
GR219630X 113 6 39 61 65 55 50 57 66 70 
GW541786X 113 7 44 75 87 148 840 203 100 227 
GW560094X 113 8 43 75 79 95 222 114 106 99 
GR53539X 114 1 44 68 52 64 50 61 65 77 
AH15201XX 115 1 225 178 170 189 217 220 196 216 
AH6859 115 2 4042 4523 3997 4167 4159 4019 4224 3917 
AH15203XX 115 3 3941 4430 4596 4896 5629 5717 5908 5625 
GW314581X 115 4 4049 4225 4237 3997 4729 5774 5367 5189 
GW294655X 115 5 206 433 325 317 17 440 548 486 
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Compound - 	 Emission Intensity (616 nm +1- 10 nm)  
Reg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GW328088X 115 6 4021 3968 4006 3952 4153 3932 4224 4094 
GW312792X 115 7 208 4057 7914 5158 8084 9459 12074 5383 
GW294322X 115 8 2559 2508 2301 2488 2289 2322 2576 2602 
GW304858X 115 9 228 304 323 295 333 597 417 441 
GW312329X 115 10 182 1045 998 809 1024 1254 1559 1088 
AH15400)(X 115 11 4490 3712 4594 3752 4600 5074 5391 4697 
GW314526X 115 12 231 1176 1646 - 1615 2366 2512 1956 
GW324336X 115 13 230 234 372 242 266 221 368 310 
AH5558 116 1 42 94 79 62 86 119 107 93 
AH5950 116 2 37 158 197 158 180 321 355 278 
GW312371X 116 3 37 156 186 143 189 331 328 286 
GW315227X 116 4 141 211 366 282 399 189 643 499 
GW312460X 116 5 44 341 806 681 632 1138 1366 1083 
GW312437X 116 6 49 921 1026 938 2567 2690 1655 1593 
GW312435X 116 7 47 65 73 76 81 75 77 101 
GF267701X 116 8 1226 799 959 1021 1144 1242 1054 1117 
GR189755X 117 1 4826 5117 5043 4212 4353 4915 4022 4235 
GW313003X 117 2 36 55 48 52 51 66 61 55 
GR256734X 117 3 42 86 80 84 87 83 97 138 
GW321218X 118 1 41 130 142 116 196 231 221 177 
AH6372 119 1 47 228 210 152 136 1265 601 249 
G1205545X 119 2 46 76 60 55 55 61 72 80 
GW312626X 119 3 41 139 135 105 240 134 220 139 
GR230571X 119 4 108 163 170 170 185 171 190 222 
AH21917X 120 1 49 74 62 57 51 66 68 78 
AH22735X 120 2 40 72 58 55 55 65 74 87 
GR177051X 120 3 40 59 48 58 48 58 61 67 
GW471604X 120 4 50 101 101 111 98 132 139 125 
GR152169X 120 5 36 68 56 63 49 62 52 74 
GR225877X 121 1 41 74 76 69 65 66 88 90 
GR255442X 121 2 39 519 738 456 676 1162 1179 590 
CC12180 122 1 48 74 60 59 55 66 73 78 
GR121162X 122 2 42 72 56 63 57 63 70 77 
GW308403X 123 1 36 137 129 88 164 114 175 134 
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Compound  Emission Intensity ____  (616 nm +1- 10 nm)   
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GR114265X 124 1 39 149 164 143 114 175 202 149 
GR225874X 124 2 43 83 80 86 81 90 111 139 
GR51045X 125 1 43 64 48 59 61 64 62 81 
GW521143X 126 1 55 65 60 66 64 64 72 79 
GR200308X 127 1 32 118 148 121 183 205 194 162 
GR32131X 127 2 47 90 73 65 66 92 90 93 
AH2599 128 1 97 120 115 113 116 114 121 135 
AH7307 128 2 77 243 - - - 387 360 - 
GR121876X 129 1 42 70 59 60 55 68 69 70 
GR193373X 129 2 36 61 64 65 62 60 82 98 
GR196926X 129 3 40 63 66 74 73 62 76 102 
GW426030X 129 4 34 82 73 65 69 78 85 86 
AH21971X 130 1 40 235 326 240 314 565 565 292 
GW648032X 130 2 42 107 114 98 126 167 179 129 
CC11710 130 3 45 118 100 81 86 153 147 105 
GR71245X 130 4 36 589 510 1347 1294 1684 1378 1305 
GR173914X 131 1 47 77 67 71 75 87 85 87 
GR257498X 132 1 34 86 93 70 102 81 120 96 
AH23040X 133 1 45 72 60 56 56 63 70 72 
GR36682X 133 2 47 65 55 56 53 57 67 117 
GR47574X 133 3 43 68 56 65 49 62 70 80 
GR215566X 134 1 39 68 66 60 56 58 74 77 
G1198860X 135 1 44 179 151 109 149 291 265 164 
GR74829X 135 2 43 95 74 85 97 139 107 114 
GW271761X 135 3 41 71 75 62 68 81 83 87 
GR232957X 136 1 96 366 468 431 415 433 600 433 
GW322216X 136 2 111 487 440 200 373 1052 1267 440 
AH4822 137 1 35 255 370 234 189 530 552 283 
GR207205X 137 2 39 285 507 642 1081 1426 624 791 
GF267466X 137 3 48 104 108 161 373 486 221 245 
GW328094A 138 1 35 43 48 41 51 52 52 66 
GW418822A 138 2 37 45 45 59 58 55 61 83 
GW448911X 138 3 42 59 59 65 59 60 72 91 
G1198877X 139 1 49 152 144 105 112 202 217 140 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GR267007X 139 2 144 249 320 240 392 281 332 231 
GW340373X 139 3 33 69 64 59 60 61 67 77 
GR256536X 140 1 39 249 304 371 883 774 493 365 
GR192153X 141 1 43 93 111 98 122 118 142 137 
GW321193X 142 1 41 53 51 52 50 52 57 67 
AH23064X 143 1 45 67 55 60 62 58 68 73 
GW279435X 143 2 42 54 54 66 67 60 65 88 
GW279438X 144 1 42 68 79 89 85 98 107 107 
GW279439X 144 2 38 72 83 172 366 344 100 244 
GR127482A 145 1 45 70 55 64 60 68 70 82 
GR262262X 145 2 37 50 47 43 48 50 54 73 
GR262264X 145 3 39 44 50 56 53 53 61 78 
GR267264X 145 4 38 40 41 40 44 51 52 67 
AH8425 146 1 2762 3113 3111 3196 3310 3862 3281 3186 
GW314731X 146 2 2548 2241 1881 2001 2639 2593 2090 2189 
GW314830X 146 3 6721 5113 4012 - 5768 5319 5839 5210 
GW320557X 146 4 5393 5488 4477 4768 5348 5412 4734 5606 
GW323721X 146 5 5682 5843 4959 4362 5392 5961 5197 5334 
GW314662X 147 1 566 1219 2747 1890 3690 4083 3696 3619 
GW314681X 147 2 982 1361 1449 1840 3202 2410 2538 2367 
GW314793X 147 3 897 1047 1429 - 3234 1610 1960 2590 
GW322018X 147 4 874 2568 3333 2538 4222 5959 5215 2878 
GW314751X 147 5 860 1202 1326 1091 2476 1626 1421 2001 
GW315158X 147 6 408 800 890 - 1454 1211 1182 1028 
GW322801X 147 7 690 1133 1581 1473 3545 2590 2318 2900 
GW323040X 147 8 1655 2566 2697 2977 4423 4055 4088 3261 
GW321891X 147 9 48 57 54 70 62 60 65 84 
GW323845X 147 10 300 326 383 358 387 309 392 456 
GW323446X 147 11 284 501 729 541 1084 1043 983 970 
GW323591X 147 12 139 3679 5117 3832 5583 8644 9493 5617 
GW315075X 147 13 403 604 643 643 1076 947 793 941 
GW322693X 147 14 145 444 586 482 859 805 846 734 
GW321808X 147 15 504 916 934 775 2567 1837 1621 1358 
GW322384X 147 16 178 418 435 444 584 865 765 622 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
Reg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GW321800A 147 17 190 182 83 208 203 214 270 179 
GW322628X 147 18 2174 1915 1671 1538 1900 1788 1702 1837 
GW322988X 147 19 343 450 494 426 556 585 681 706 
AH15466AA 148 1 46 72 62 60 59 66 82 79 
AH2565 148 2 45 70 61 58 55 71 78 94 
GW366246 148 3 125 141 144 128 129 137 142 140 
CC117196 148 4 39 179 199 173 207 264 133 170 
AH20078XX 149 1 58 747 1438 1115 1957 2264 1917 1556 
GR208554X 149 2 41 1008 1030 1008 1041 1012 876 1034 
GR230104X 149 3 43 546 750 699 1035 808 1110 663 
GR30893X 149 4 45 1121 1366 2060 1648 2164 1529 1603 
GR33911X 149 5 41 625 828 1465 1894 1550 1688 1413 
GR62459X 149 6 60 4918 6321 5597 6617 6705 7165 5595 
GR65815X 149 7 42 966 851 1136 1596 764 1403 1040 
GR65884X 149 8 46 1114 1087 1886 2067 1750 1805 1152 
GW385846X 149 9 75 3774 4733 3810 4020 4779 6426 3709 
GR155589X 149 10 37 103 85 117 129 158 161 173 
GR30894X 149 11 43 569 638 793 692 668 680 670 
GR208752X 149 12 46 282 592 680 686 1308 872 994 
GW288377X 149 13 64 1638 3143 1240 1183 1645 2966 1286 
GR34968X 149 14 40 191 210 220 311 320 267 275 
GR54392X 149 15 56 4718 7088 9723 4899 5444 11384 4384 
GR57352X 149 16 58 1021 1290 1299 1320 3363 2179 1403 
GW371223X 149 17 44 71 67 100 270 112 84 108 
CC19740 149 18 49 81 61 64 62 70 79 86 
GR240724X 149 19 43 274 343 1071 926 1263 988 1093 
GR30476X 149 20 39 57 54 72 200 92 77 122 
GR53056X 149 21 41 66 53 70 53 60 58 81 
GR136670X 150 1 44 140 214 106 82 132 185 108 
GR34039X 150 2 46 98 70 102 189 191 115 143 
AH24908A 151 1 107 113 209 160 261 213 204 167 
GR49928X 151 2 104 91 145 119 216 167 151 154 
AH25368X 151 3 56 200 378 401 481 454 505 252 
GR55422X 151 4 58 938 1278 1062 1172 2305 1690 1355 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
Reg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GR55423X 151 5 51 773 1053 1017 1154 1774 1834 1078 
GR61326X 151 6 40 688 1566 2701 3061 2857 3376 1175 
GR61891X 151 7 148 734 1804 2766 3312 3242 3040 2006 
GR61984X 151 8 70 1158 2101 3745 4412 4210 4178 2915 
GR61985X 151 9 81 973 2048 2702 3150 3315 3171 1888 
GR55424X 151 10 51 1117 1231 1293 1211 1900 1882 1408 
AH5157 152 1 87 98 98 98 95 102 130 105 
AH6770 152 2 40 78 70 59 60 73 80 85 
AI-19603 152 3 42 71 65 57 53 71 69 78 
GW315367X 152 4 70 89 84 86 74 84 84 97 
GR219955X 152 5 46 83 78 91 88 81. 92 124 
GR120092X 152 6 39 58 57 64 50 62 65 74 
GR75258X 152 7 43 31687 25909 22016 21843 21961 26775 18051 
GF233967X 153 1 42 71 54 61 57 61 71 82 
GW641533X 153 2 43 67 63 69 73 67 79 89 
GW321911X 153 3 39 70 66 58 60 69 81 87 
GW402775X 153 4 39 195 202 167 239 228 236 201 
GR258179X 154 1 42 1193 5398 1395 1421 5128 6037 1730 
GR258213X 154 2 58 687 4385 1490 6215 4141 5093 2125 
GF267695X 155 1 41 48 53 62 62 60 56 63 
GW322088X 155 2 38 60 61 63 63 63 67 81 
GW322112X 155 3 38 83 92 83 92 110 123 114 
GW322316X 155 4 35 54 50 53 61 54 56 74 
GW322086X 155 5 34 71 61 54 69 63 67 82 
GR222247X 156 1 41 61 61 59 48 58 70 72 
GR53849X 156 2 47 74 55 68 56 65 71 82 
GR99312X 156 3 45 60 61 65 48 56 66 79 
GR57082X 157 1 35 61 52 64 66 67 62 87 
GW320929X 157 2 34 45 54 88 62 68 102 
GW412113X 157 3 46 57 55 68 63 60 99 214 
GR215780X 158 1 41 85 81 90 87 82 111 147 
GR219957X 158 2 47 90 94 98 94 85 108 135 
GR219958X 158 3 46 92 87 97 104 94 104 147 
GR216184X 158 4 42 301 260 256 350 521 470 622 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GR216186X 158 5 41 85 80 90 85 83 99 141 
GR218004X 158 6 43 91 113 107 210 218 172 262 
GR218005X 158 7 44 99 108 125 201 161 111 246 
GR133748X 159 1 - - - - - - - - 
GR82836X 159 2 45 1661 1864 1468 1261 1821 2826 1207 
GR38662X 159 3 40 48 53 74 181 117 60 134 
GW292734X 159 4 42 160 165 350 346 384 380 347 
GW322234X 159 5 87 100 104 107 105 97 108 131 
GR79956X 159 6 42 153 131 111 148 179 186 169 
GR203866X 159 7 41 468 1057 568 846 885 1156 587 
GR203872X 159 8 39 348 297 204 665 466 626 295 
GR203875X 159 9 40 216 208 245 594 442 458 278 
GR204301X 159 10 39 3060 4370 2459 3727 8871 7392 2975 
GR65881X 159 11 47 299 209 118 554 1679 1003 803 
GR65883X 159 12 44 343 639 1609 1171 1313 1201 986 
GR65885X 159 13 48 388 699 428 776 1074 1417 842 
GR188442X 160 1 46 103 118 107 141 141 130 .184 
GW322235X 160 2 36 58 57 60 67 63 66 85 
GW327773X 160 3 39 60 61 66 80 77 72 96 
GW643493X 160 4 149 442 592 382 454 704 772 516 
GW643495X 160 5 59 91 90 90 99 94 122 140 
GR215459A 161 1 39 104 111 113 120 97 162 168 
GW280814 161 2 37 62 63 55 53 57 71 78 
GW290851X 161 3 38 48 55 60 52 59 61 83 
GW290862X 161 4 42 44 54 60 55 54 62 85 
GW326112X 161 5 37 110 120 122 216 282 187 262 
GW271929X 162 1 38 111 164 137 202 173 159 189 
GW317768X 162 2 49 1464 2122 1515 1882 2923 2166 1079 
GW272447X 162 3 42 93 130 122 257 173 140 220 
GW326127X 162 4 43 242 548 387 592 556 579 355 
GW440381X 162 5 51 255 551 524 1328 673 407 428 
GW418716X 162 6 43 120 102 142 191 173 155 202 
GW453080X 162 7 44 114 134 162 226 177 176 199 
GW442734X 162 8 42 83 97 138 216 168 115 220 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
Reg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GW272478X 162 9 42 82 89 117 197 154 131 182 
GW442732X 162 10 46 100 99 127 203 144 137 187 
GW415699X 162 11 45 1145 4990 1790 3551 2612 3377 1422 
GW369764X 162 12 53 1380 2312 1370 3700 2027 2363 1485 
GR50838A 163 1 42 151 184 175 182 311 407 177 
GR51678X 163 2 44 1710 1833 1590 1674 2745 2683 1807 
GR54219X 164 1 34 510 530 425 664 1252 1238 860 
GR69421X 164 2 38 228 311 189 129 537 554 245 
GW317904X 165 1 38 83 95 223 233 140 187 
GW411913X 165 2 39 57 54 72 69 60 66 92 
GW327989X 165 3 41 77 86 102 123 155 112 114 
GW414889X 165 4 43 57 59 70 56 58 74 98 
AH10104A 166 1 38 60 48 46 53 61 61 79 
AH7702 166 2 35 48 43 46 38 39 45 51 
AH7559 166 3 38 54 50 49 39 46 50 53 
AHIOOIIA 166 4 39 47 44 39 51 50 52 59 
AH7724Z 166 5 33 41 46 43 35 42 49 47 
GW575621X 166 6 41 49 48 59 49 49 58 68 
AH10424A 166 7 39 40 41 34 50 49 46 50 
AH7620Z 166 8 37 52 45 50 39 46 56 63 
AH7699 166 9 36 50 52 46 40 49 52 58 
AH5961 167 1 39 62 54 49 49 55 60 129 
AH6102 167 2 94 119 109 108 104 96 123 117 
AH7647 167 3 37 52 47 49 38 40 53 58 
AH9531 168 1 43 48 46 32 43 50 43 53 
GR199045X 168 2 50 42 49 41 45 45 51 44 
AH5724 169 1 36 99 120 71 63 449 545 220 
GW295014X 169 2 37 124 150 123 277 343 410 289 
GW315237X 169 3 41 67 78 57 55 100 179 104 
GW315238X 169 4 34 50 74 - 91 89 105 100 
AH6593 169 5 38 103 129 90 78 161 170 124 
GW315239X 169 6 34 268 438 - 634 428 287 436 
AH6247 169 7 741 514 463 444 449 372 546 434 
AH6313 169 8 191 171 158 172 146 144 163 160 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
AH6072 169 9 164 199 358 272 294 318 353 348 
AH6624 169 10 30 54 58 48 40 59 60 130 
AH7013Z 169 11 40 56 52 54 39 46 60 74 
AH7014Z 169 12 35 50 50 52 38 48 62 67 
AH6198 170 1 38 63 57 62 47 55 61 109 
AH6248 170 2 34 203 193 161 213 630 684 356 
AH7031Z 170 3 39 58 58 60 44 51 69 90 
AH7029 170 4 871 526 515 489 532 421 611 520 
AH6292 170 5 33 51 48 46 45 58 61 164 
AH6570 170 6 43 214 274 143 130 409 479 265 
AH7083Z 170 7 37 77 76 61 52 70 80 87 
GR240517X 170 8 69 76 70 72 79 77 83 100 
AH6169K 171 1 39 61 53 56 45 54 62 59 
GW315217X 171 2 28 45 37 - 57 48 59 74 
AH11654 172 1 194 365 797 291 1747 2320 1562 1392 
AH14868XX 172 2 502 843 863 663 1339 1404 1352 918 
AH7167 172 3 840 921 833 801 845 893 906 869 
AH7792Z 172 4 407 390 501 491 533 598 589 555 
AH7650 172 5 816 950 960 869 955 1064 1100 955 
AH6730 172 6 607 643 613 540 582 674 682 598 
AH7290A 172 7 106 134 136 129 109 130 136 172 
AH7652 172 8 310 1169 1891 1157 935 2010 2205 1256 
AH7414Z 172 9 880 843 879 852 821 863 832 788 
AH7621Z 172 10 575 587 597 584 589 571 584 570 
AH7552 172 11 59 513 749 416 406 1044 1367 638 
AH7651 172 12 700 759 744 735 753 782 738 778 
AH7697 172 13 50 140 179 149 112 253 293 227 
AH6276 173 1 422 511 350 415 403 279 458 430 
GR85411X 173 2 341 326 341 373 339 344 303 289 
AH6390 173 3 1651 1693 1586 1647 1606 1225 1787 1458 
GR65254X 173 4 308 218 243 252 244 243 244 259 
AH6535 173 5 113 113 106 113 97 97 115 109 
AH6712 173 6 50 62 60 61 47 60 61 68 
AH7646 173 7 39 50 50 53 47 57 52 87 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBIJA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GR257968X 173 8 45 63 76 75 85 101 113 96 
AH6342 173 9 44 112 174 192 177 272 288 295 
AH6572 173 10 93 113 118 110 114 136 113 141 
AH7133 173 11 65 85 88 93 96' 114 144 169 
GW321108X 173 12 42 58 54 62 63 64 63 78 
AH6550 173 13 1134 1191 1300 1247 1307 1253 1401 1176 
GR242642X 173 14 49 71 68 73 71 74 81 103 
AH6573 173 15 190 225 218 198 175 187 217 221 
AH6714 173 16 117 125 117 140 116 132 129 131 
AH6759 173 17 52 75 65 70 56 67 71 80 
AH6713 174 1 39 60 56 59 44 62 73 71 
AH7696 174 2 47 180 244 153 130 284 315 187 
AH7731 174 3 38 35 42 26 51 50 47 50 
AH2671 175 1 43 70 63 56 	' 56 63 72 83 
GR139602 175 2 80 154 - - - 224 199 - 
GW433974 175 3 - - - - - - - - 
GW321876 175 4 65 71 80 82 82 73 79 91 
GR139604 175 5 38 74 84 98 72 112 111 124 
GW321338X 175 6 51 62 65 68 90 74 68 89 
GW343619X 175 7 37 333 837 1642 1967 2384 1376 1721 
AH2672 175 8 48 66 62 61 50 61 69 71 
GR85308 175 9 67 80 83 81 73 82 85 86 
GW321553X 175 10 175 203 221 225 411 266 248 321 
GW368591A 175 11 49 67 70 75 72 63 76 96 
GR115690 175 12 250 404 587 390 473 835 831 496 
GR176137 175 13 120 502 - - - 2330 1568 - 
GW321167 175 14 10 68 118 49 162 62 158 - 
GW320968X 175 15 33 75 82 - 184 121 122 115 
GW321421 175 16 127 131 143 - 172 144 144 162 
GW315288X 175 17 55 58 62 - 66 62 75 74 
GW315296X 175 18 80 81 91 - 140 100 104 110 
GW288615 175 19 114 230 311 219 605 782 670 499 
GW321424X 175 20 3792 599 1042 554 1013 1227 1348 1042 
GW321634X 175 21 142 140 316 349 225 139 207 250 
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Compound 	- Emission Intensit (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GW321 145 175 22 105 882 746 - 847 1234 1402 748 
GW321168X 175 23 227 165 189 - 223 243 190 227 
GW321422X 175 24 130 180 179 - 286 242 208 254 
GW322230X 175 25 61 82 75 73 70 72 82 78 
GW314379 176 1 180 185 293 302 182 246 203 194 
GW314406X 176 2 55 1522 1613 - 1397 2562 2917 1436 
GW321354X 176 3 66 56 72 74 67 57 72 75 
GW321243X 177 1 35 84 86 - 242 202 125 228 
0W321742X 177 2 101 109 121 113 116 103 117 122 
GW321779X 177 3 158 151 144 144 152 162 153 181 
GW321755X 177 4 145 159 160 171 171 159 167 184 
GW410928X 177 5 155 127 129 128 130 114 131 147 
GW324540X 177 6 193 447 431 430 623 541 543 316 
GW322198X 178 1 201 260 227 243 527 324 367 362 
GW322492X 178 2 96 220 224 183 228 401 310 245 
GW320926X 179 1 293 278 251 229 274 269 259 292 
GW321470X 179 2 110 114 96 104 108 114 101 118 
GW321607X 179 3 367 377 333 391 340 332 325 391 
GW323008X 179 4 109 127 118 125 133 141 133 140 
GR175627 180 1 46 - 311 347 899 - 397 - 
GR175628 180 2 98 137 - - - 140 150 - 
GR196922 180 3 19 17 20 19 18 20 23 - 
GR256963 180 4 11 10 9 17 9 14 13 - 
GW321245X 180 5 65 77 99 108 131 139 105 
GW321912X 180 6 39 107 95 160 321 272 208 292 
AH10033 181 1 46 62 58 57 54 63 61 64 
GR237865X 182 1 37 62 61 63 45 60 67 71 
AH15255XX 183 1 45 75 64 64 61 74 82 85 
GR68357X 184 1 40 - 89 78 76 - 103 - 
GW320801X 185 1 38 - 59 54 49 - 58 - 
GW385455A 185 2 36 60 54 50 55 58 62 76 
AH11305 186 1 118 - 116 110 132 - 109 - 
AH9723 186 2 46 238 279 149 234 497 493 248 
GW655414X 187 1 222 5321 6663 - 7226 7154 8208 5525 
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Compound Emission Intensit ____  (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GR107114X 188 1 40 69 55 63 53 64 74 81 
GR138809X 189 1 45 95 117 104 80 100 121 98 
GW295817X 190 1 37 69 71 113 90 138 121 160 
GW365467X 191 1 327 345 319 284 314 312 324 323 
GW311376X 192 1 43 - 61 55 57 - 61 - 
GW397304X 193 1 35 63 58 54 56 58 63 73 
GW584442X 194 1 878 830 837 880 844 849 860 843 
GW635258X 195 1 44 50 52 64 69 58 64 92 
GW635452X 195 2 42 233 255 248 237 307 327 244 
GR269503X 196 1 314 325 342 343 296 296 342 356 
GR223454A 197 1 38 59 62 65 67 76 78 87 
GW580127X 198 1 54 113 207 138 135 218 267 123 
GW623142A 198 2 42 56 61 66 64 60 72 87 
GW624854X 199 1 48 76 114 86 182 124 110 97 
GW663118X 199 2 38 49 44 - 70 63 63 95 
GW652611X 200 1 47 391 1091 609 777 1452 1487 640 
GR151827X 201 1 62 235 235 162 145 196 312 196 
GR152989X 201 2 48 309 775 513 460 1334 1040 409 
AH11426 202 1 45 - 63 60 53 - 61 - 
GR37359X 202 2 47 79 72 66 59 74 82 89 
GW321066X 203 1 71 257 250 288 543 542 547 655 
CC18732 204 1 46 71 60 59 56 58 71 78 
GW312666X 205 1 44 167 299 171 146 235 206 209 
GW424662X 206 1 216 332 269 296 296 379 340 329 
AH8940 207 1 42 86 95 60 62 102 109 92 
GR258784X 208 1 46 70 75 64 65 75 76 83 
GW322374X 208 2 33 71 60 54 64 64 68 77 
AH8076 209 1 48 64 53 52 52 61 63 68 
GW315274X 210 1 40 66 59 55 50 58 66 71 
GW650524X 211 1 44 54 59 69 70 60 73 88 
GW650525X 211 2 46 58 57 68 86 64 75 93 
AH9033 212 1 43 82 67 63 63 74 76 85 
GW649399X 212 2 2448 2037 2009 1654 1600 1460 1792 1908 
AH9527 212 3 13186 12768 - - - 10757 10238 - 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
CC14563 213 1 48 68 55 55 54 54 62 75 
GR154660A 214 1 45 77 62 77 64 88 92 81 
GR177049X 214 2 44 76 56 65 55 67 77 80 
GR219652X 215 1 41 69 69 60 58 57 77 86 
GR249207X 216 1 40 65 69 68 59 66 80 103 
GR118330 217 1 112 153 123 142 135 135 145 154 
GW276690 217 2 26 31 40 30 42 36 43 - 
GR242234X 218 1 39 76 79 69 71 67 93 88 
GW283348X 219 1 38 70 71 62 79 91 80 85 
GW318076X 220 1 60 1675 2369 - 2693 4301 4911 2316 
GR37727X 221 1 43 71 59 63 56 57 68 82 
GR53040X 222 1 39 72 52 59 49 66 74 79 
AH7643 223 1 45 83 78 67 67 92 94 89 
AH9554 223 2 41 66 53 58 54 62 66 66 
GR152077X 224 1 40 715 599 283 470 395 707 513 
GM189907X 225 1 46 74 58 60 56 60 67 85 
GR39699X 225 2 46 71 63 58 53 60 70 86 
GR114312X 226 1 39 67 53 61 48 62 51 77 
AH11195B 227 1 47 81 69 64 57 78 81 81 
GR239106X 227 2 37 67 70 60 57 67 79 84 
GR106841X 228 1 67 78 69 76 70 82 80 95 
AH6081A 229 1 122 177 168 188 189 222 207 207 
GR240822X 229 2 38 262 251 160 353 203 399 209 
GW327515X 230 1 100 209 253 205 279 308 367 276 
GW416086 230 2 40 82 69 73 69 75 79 95 
AH9652 231 1 44 124 105 83 91 163 162 107 
GR44240X 231 2 41 62 51 62 50 62 62 73 
GR103163A 232 1 41 71 52 63 49 68 50 80 
GW327758A 232 2 37 67 57 52 53 58 67 77 
GW312641A 232 3 40 66 66 56 63 63 76 85 
G1138330X 233 1 41 230 228 147 195 395 395 401 
GW329078X 233 2 40 - 66 64 62 - 70 - 
GR240576X 234 1 48 86 85 74 93 87 100 99 
GW315215 234 2 62 - 91 78 82 - 81 - 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GW412098 234 3 68 111 97 87 96 103 107 115 
GR108394X 235 1 44 72 58 68 59 71 78 75 
GR245706X 235 2 45 67 58 62 53 67 76 68 
GR117055X 236 1 39 - 94 85 92 - 110 - 
AH7461 237 1 86 125 - - - 126 145 - 
GW341377 237 2 12 11 9 13 10 12 8 - 
GW365140 237 3 13 8 12 12 11 14 14 - 
GW365173 237 4 10 8 10 11 10 14 12 - 
G1261653 237 5 47 68 60 61 54 64 80 60 
GR242078X 238 1 46 - 69 65 61 - 62 - 
GW308852X 239 1 72 - 86 76 82 - 79 - 
GW307512X 240 1 41 72 65 86 95 82 76 95 
GW311866X 241 1 38 51 64 69 74 63 85 110 
GW319241X 242 1 39 67 55 53 58 68 66 74 
GW448056X 243 1 45 81 83 84 83 91 103 114 
GR258734A 244 1 53 69 66 71 67 66 80 101 
GR264071A 244 2 59 80 84 95 81 85 101 119 
GR263255X 244 3 45 63 65 72 65 67 76 104 
GR43767X 245 1 41 93 69 73 67 90 78 91 
GW472535X 245 2 43 71 67 64 65 83 89 89 
GW288946X 246 1 7487 6701 6936 7347 6519 8116 7340 6621 
GW324060X 247 1 47 101 88 72 73 99 112 108 
AH10315 248 1 46 72 63 59 57 66 67 81 
AH10461 248 2 43 74 61 58 56 67 72 80 
GR105716X 249 1 40 72 51 67 50 63 71 80 
GR212122X 249 2 42 68 70 59 51 59 80 80 
AH22431B 250 1 46 76 63 58 55 65 83 107 
GR109361X 250 2 39 64 51 60 49 60 63 69 
GR60436X 250 3 37 137 108 118 123 190 114 162 
AH6087 251 1 50 71 61 56 55 62 67 77 
G1163641X 251 2 47 75 59 65 60 62 76 84 
CC1153 252 1 47 76 60 60 53 65 73 87 
GR128873 252 2 82 113 109 113 100 108 124 124 
GR75538X 253 1 40 64 53 61 48 63 68 70 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GR35345A 254 1 46 212 169 131 144 273 289 265 
GR49747X 255 1 65 83 72 75 73 80 87 75 
GR51603A 256 1 45 65 59 56 54 68 78 64 
GR85161X 256 2 43 69 58 61 52 68 70 83 
AH10536 257 1 216 444 - - - 749 757 - 
AH10767 257 2 99 254 - - - 469 356 - 
AH9356 257 3 42 285 275 146 199 498 573 254 
GW316125 257 4 106 129 114 127 118 153 136 135 
CC110174 258 1 49 249 229 140 168 375 411 192 
GR263958X 258 2 40 76 80 66 70 70 91 80 
GW433821A 259 1 39 - 142 106 133 - 210 - 
CC110446 260 1 45 71 58 60 53 70 78 80 
GR138218X 260 2 41 67 51 53 48 69 72 78 
GW349042X 261 1 35 110 107 76 86 143 152 104 
GR44479X 262 1 40 70 57 60 49 62 75 74 
GR66484X 262 2 43 76 57 66 54 70 76 82 
GW449422A 262 3 37 74 68 60 64 66 75 92 
G1204510X 263 1 43 88 64 65 59 75 90 76 
GR239579X 263 2 339 381 361 345 278 325 319 315 
GW352006X 263 3 34 66 69 60 102 124 87 105 
G1233445X 264 1 48 74 59 63 53 62 70 78 
GR239577X 265 1 38 64 67 60 56 62 71 79 
AH1010 266 1 38 - 60 56 58 - 59 - 
CC121414 266 2 41 - 60 56 52 - 55 - 
G1222692X 266 3 47 - 66 61 64 - 69 - 
GR84679X 267 1 46 - 67 66 62 - 72 - 
GR84985A 267 2 41 - 64 63 53 - 67 - 
AH10182 268 1 40 61 59 51 54 61 59 65 
GR203336X 268 2 39 64 68 60 53 55 76 74 
AH20998XX 269 1 45 71 62 62 54 64 71 78 
AH6595 269 2 44 84 79 63 62 88 88 84 
AH21933X 269 3 38 - 84 67 73 - 100 - 
GR154396X 269 4 44 - 61 60 59 - 64 - 
GW408146X 269 5 39 92 80 66 70 101 104 92 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
AH6732 270 1 41 66 58 57 65 66 72 1 84 GR208133X 270 2 34 75 75 63 73 72 86 92 AH1031 271 1 38 - 61 56 53 - 66 - 
AH16943AA 271 2 44 133 95 130 135 136 136 181 
AH1052 271 3 49 485 497 300 354 887 813 970 
CC121405 271 4 48 513 466 221 363 799 929 425 
AH11453 271 5 41 - 65 57 53 - 60 - 
CC110176 271 6 44 238 180 131 147 392 424 242 
AH10633 272 1 44 290 227 153 197 391 382 197 
GW369905 272 2 12 66 191 52 136 63 173 - 
AH8268A 272 3 43 77 68 67 59 73 100 72 
GR202022X 273 1 36 7197 6348 7418 8270 11143 12427 5451 
GR34043X 273 2 39 - 1189 699 1056 - 1867 - 
GR247048X 274 1 44 80 79 86 85 82 98 142 
GW309880X 274 2 39 266 267 206 334 595 410 304 
GR230760X 275 1 41 381 350 197 569 283 584 278 
GW299526X 275 2 36 69 68 63 63 59 83 79 
AH10225 276 1 47 2820 2843 1625 2219 4972 5053 5087 
AH11688 276 2 172 1145 - - - 2525 1233 - 
GR258750 276 3 11 1831 1946 1219 2096 1419 2323 - 
AH11368 276 4 130 167 119 119 123 114 173 103 
G1266527 276 5 32 1441 1477 988 1619 1138 1581 - 
AH11967 277 1 50 779 1606 1310 878 4075 2405 5299 
GR140330X 277 2 468 515 461 405 520 511 428 532 
GR216655X 277 3 43 - 90 79 90 - 126 - 
GR220880X 277 4 41 - 65 57 55 - 65 - 
GR232939X 278 1 40 98 103 99 100 121 141 164 
AH1053 279 1 49 767 700 342 490 1225 1207 1196 
AH6596 279 2 43 67 60 56 53 65 70 76 
AH12133 280 1 45 785 945 1392 1647 5235 1969 5210 
AH13394 280 2 42 359 273 215 264 544 525 278 
GW299375X 280 3 40 98 89 80 110 195 118 106 
AH3663 281 1 44 89 73 79 77 79 97 100 
GR239599X 281 2 42 85 84 73 101 81 113 96 
Appendix 2(a) 	 Emission Intensity 	 27 
Compound - 	 Emission Intensity (616 nm +1- 10 nm)  
Reg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
AH11395 282 1 54 143 56 104 135 228 184 179 
AH13826XX 282 2 54 - 79 72 66 - 73 - 
GR54987X 282 3 38 - 69 60 73 - 82 - 
GW471049X 282 4 43 - 91 76 112 - 135 - 
GW320828X 282 5 319 425 445 442 440 617 557 456 
GW321479X 282 6 1046 1043 1117 - 1349 1336 1188 1279 
GR101886 283 1 123 - 155 145 165 - 158 - 
GR82448 283 2 98 120 193 102 108 117 134 123 
GW294831 283 3 178 200 204 211 223 187 197 - 
AH12975 284 1 127 155 138 146 152 174 175 161 
GW312607X 284 2 63 86 125 113 232 203 163 215 
AH17009XX 285 1 41 - 111 110 283 - 167 - 
GW314282X 285 2 39 - 64 57 56 - 58 - 
GW355545X 285 3 699 745 709 735 679 770 768 684 
AH3705A 286 1 40 - 66 57 63 - 74 - 
CC110881 286 2 37 - 62 52 59 - 63 - 
AH10300 287 1 194 396 - - - 387 445 - 
AH10801 287 2 101 595 - - - 534 841 - 
AH9678 287 3 91 251 - - - 416 399 - 
AH10698 287 4 6890 7190 - - - 4464 5857 - 
AH10853 287 5 96 121 - - - 114 149 - 
GR92452 287 6 80 113 - - - 104 122 - 
AH9727 287 7 43 - 176 106 166 - 259 - 
AH12695 287 8 86 3900 - - - 2837 2250 - 
AH13070 287 9 42 69 72 64 60 76 79 70 
AH9676 287 10 80 7701 - - - 11749 11235 - 
AH9721 287 11 90 119 - - - 108 122 - 
AH10301X 288 1 40 1035 1216 656 1425 3332 1645 1402 
AH15692 288 2 77 1465 - - - 1699 2145 - 
AH12533 288 3 82 705 - - - 1069 869 - 
AH12590 288 4 85 400 - - - 587 429 
AH15690 288 5 84 676 - - - 770 711 - 
AH15757 288 6 87 886 - - - 953 666 - 
AH10978 288 7 82 181 - - - 307 317 - 
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Compound    Emission Intensity (616 nm +1- 10 nm)  
Reg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
AH11275 288 8 39 733 1222 1894 1855 2572 2763 1119 
AH12589 288 9 42 109 112 72 171 192 170 143 
AH11274 288 10 43 278 280 283 465 426 420 524 
AH13391 288 11 43 176 164 107 277 263 267 265 
GR254264X 288 12 38 212 225 216 245 366 342 277 
AH10616T 289 1 45 60 54 59 54 62 73 53 
AH7490 289 2 39 53 49 46 51 51 50 56 
AH18515XX 290 1 40 - 287 161 247 - 503 - 
AH22573X 290 2 52 69 62 64 129 80 73 86 
AH8588 290 3 47 74 69 68 76 71 78 77 
AH8601 290 4 269 280 347 315 336 304 302 287 
GR32737X 290 5 44 65 58 57 54 53 69 72 
AH23288X 291 1 41 49 48 61 71 58 59 72 
G1149558 291 2 85 130 - - - 118 119 - 
GR133921 291 3 88 125 - - - 117 137 - 
GR134971 291 4 146 182 - - - 197 218 - 
GR65242X 291 5 43 73 56 62 52 66 72 77 
AH26099 291 6 157 172 161 179 185 162 176 163 
GR116365X 291 7 243 353 399 371 261 299 251 274 
GW541785X 291 8 59 69 71 86 93 76 80 106 
GR31004 291 9 13 15 13 17 14 16 12 - 
GW278395 291 10 89 108 131 118 114 111 121 - 
GR110635X 292 1 40 66 51 63 50 65 70 72 
GR116353X 292 2 41 65 49 58 63 69 71 71 
GR125882X 292 3 40 71 53 64 63 68 70 78 
GW294490X 292 4 39 65 66 59 55 60 73 82 
GW589997X 293 1 38 49 52 63 61 50 63 79 
AH20902 294 1 84 114 103 98 98 99 108 122 
GR36456 294 2 19 20 20 21 16 20 21 - 
AH20984 294 3 86 118 - - - 113 138 - 
AH21852 294 4 85 130 - - - 118 139 - 
GR252017 294 5 22 22 26 27 28 29 25 - 
GR58047 294 6 45 73 58 65 56 65 77 85 
GR44857A 295 1 227 267 238 208 214 231 241 266 
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Compound    Emission Intensit (616 nm +1- 10 nm) 	_____  
IReg_No Cluster Rank Acids EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA 
GR207154 296 1 54 88 85 78 71 76 97 94 
GR78684X 296 2 269 275 248 269 270 262 246 273 
AH2426A 297 1 39 - 67 63 58 - 71 - 
AH3116 297 2 165 174 157 168 166 197 181 179 
GW304734X 297 3 49 683 689 383 585 1263 1161 1029 
GW661447X 297 4 61 77 72 - 92 80 94 95 
GR173175X 298 1 42 69 56 66 52 67 73 72 
GR254404X 298 2 39 63 63 54 56 62 68 79 
GW275105X 298 3 42 54 54 65 76 61 65 83 
GW299610X 298 4 37 79 70 86 100 88 88 127 
GW298781X 298 5 40 48 44 40 48 54 55 72 
GW470761X 298 6 40 48 45 56 51 48 56 65 
GW369798X 298 7 42 57 56 66 61 60 71 88 
GW659802X 298 8 39 45 40 - 56 46 62 64 
GR221928X 299 1 43 75 72 86 126 84 83 121 
GW470720X 300 1 56 58 59 93 86 66 69 92 
GW641296X 300 2 46 49 41 52 60 55 52 67 
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Comound  Relative Emission _Intensity _(IlI)_______  
Reg_No Cluster Rank EuBEA EUBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GR207962X 1 1 1 1 1 2 1 1 1 1 
GR212454X 1 2 1 1 1 2 1 1 1 1 
CC121177 1 3 1 1 1 1 1 1 1 1 
GR257381X 1 4 1 1 1 1 1 1 1 1 
AH6621 1 5 1 1 1 1 1 1 1 1 
GR193563X 1 6 1 1 1 1 1 1 1 1 
GF267447X 1 7 1 1 1 1 1 1 1 1 
GW431055X 1 8 1 1 1 1 1 1 1 1 
GR257410X 2 1 1 1 1 1 1 1 1 1 
GW503358X 2 2 1 1 1 1 1 1 1 1 
GW318421X 2 3 1 1 1 1 1 1 1 1 
GR50343X 3 1 1 2 1 1 2 2 1 1 
AH14879XX 4 1 1 1 1 2 2 1 1 1 
GR235591X 4 2 1 1 1 1 1 1 1 1 
AH3627 5 1 2 2 2 3 5 3 3 3 
GF267697X 5 2 1 1 1 1 1 1 1 1 
GR32114X 5 3 1 1 1 1 1 1 1 1 
AH14579XX 6 1 1 1 1 1 1 1 1 1 
GW288607X 6 2 1 1 1 1 1 1 1 1 
CC123883 7 1 1 1 1 1 1 1 1 1 
GR30858X 7 2 1 1 1 1 1 1 1 1 
CC 13965 8 1 1 1 1 1 1 1 1 1 
G1207347X 8 2 1 1 1 1 1 1 1 1 
GR38987X 8 3 1 1 1 1 1 1 1 1 
CC13923A 9 1 1 1 1 1 1 1 1 1 
GR38954X 9 2 1 1 1 1 1 1 1 1 
GR251016X 9 3 1 1 1 1 1 1 1 1 
AH14993XX 10 1 4 3 2 3 5 4 3 3 
AH14994XX 10 2 1 1 1 1 2 1 1 1 
GR84408X 10 3 12 6 4 4 4 5 3 5 
AH25091X 10 4 1 1 1 1 1 1 1 1 
GR64693X 10 5 18 29 30 29 42 36 17 29 
AH16584XX 10 6 5 3 6 8 10 5 4 6 
GR76119A 10 7 1 1 1 1 1 1 1 1 
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Comound    Relative Emission _Intensity _(lllo)______  
Reg_No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
G1224436X 11 1 1 - 1 1 2 1 1 1 1 
GR34543 11 2 1 1 1 1 1 1 - I 
GR40314 11 3 1 1 1 3 2 2 - 2 
GR62892 11 4 4 - - - 4 5 - 4 
GF133808X 12 1 1 1 1 1 1 1 1 1 
GR253989X 12 2 1 1 1 1 1 1 1 1 
GR215101X 12 3 1 1 1 1 1 1 1 1 
GW322044X 13 1 1 1 1 1 1 1 1 1 
GR148285X 14 1 1 1 1 2 2 2 1 2 
GR81142X 14 2 1 1 1 1 1 1 1 1 
GR63007X 14 3 1 1 1 1 1 1 1 1 
GW423740X 15 1 1 1 1 2 2 1 1 2 
AH14732XX 16 1 1 1 1 1 1 1 1 1 
GW291819X 16 2 1 1 1 1 1 1 1 1 
AH15398XX 16 3 1 1 1 1 1 1 1 1 
GW314444X 16 4 1 1 1 1 1 1 1 1 
GW385245X 16 5 1 2 1 2 2 2 2 2 
AH15251XX 17 1 2 2 2 3 2 2 2 2 
AH4591 17 2 1 1 1 1 1 1 1 1 
AH8259 17 3 7 6 5 5 6 4 3 5 
GR34041X 17 4 1 1 1 1 1 1 1 1 
GR261706X 18 1 1 1 1 1 1 1 1 1 
GR265013X 18 2 1 1 1 2 2 2 2 2 
GR49081X 19 1 1 1 1 1 1 1 1 1 
GW339416X 19 2 1 1 1 1 1 1 1 1 
GW404922A 19 3 1 1 1 1 1 1 1 1 
GW409763X 19 4 1 1 1 1 1 1 1 1 
AH11164 20 1 - 1 1 2 - 1 - 1 
GR214770X 20 2 - 1 1 1 - I - 1 
CC15134 20 3 1 1 1 1 1 1 1 1 
G1149795A 20 4 1 1 1 1 1 1 1 1 
GR38988X 20 5 1 1 1 1 1 1 1 1 
GR39182X 20 6 1 1 1 1 1 1 1 1 
GW328037X 20 7 1 1 1 1 1 1 1 1 
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Comound   Relative Emission _Intensity _(lIlo)_______  
Reg_No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
AH9074 21 1 - 1 1 1 - 1 - 1 
G1160046X 21 2 1 1 1 1 1 1 1 1 
GF253708X 21 3 - 1 1 1 - 1 - 1 
GW328038X 21 4 1 2 1 2 2 2 2 2 
AH11410 22 1 1 1 1 1 1 1 1 1 
G1166356X 22 2 1 1 1 1 1 1 1 1 
AH5737 22 3 1 1 1 1 1 1 1 1 
GR239060X 22 4 1 1 1 1 1 1 1 1 
CC11659 22 5 - 1 1 2 - 1 - 1 
GR156438X 22 6 1 1 1 1 1 1 1 1 
GR58626X 23 1 1 1 1 1 1 1 1 1 
GR87165X 23 2 - 19 12 13 - 14 - 15 
AH18307XX 24 1 - 1 1 1 - 1 - 1 
GF234517X 24 2 - 1 1 1 - I - I 
GF233960X 25 1 - 1 1 1 - I - I 
G1220410A 25 2 1 1 1 1 1 1 1 1 
GR101348X 25 3 - 1 1 1 - 1 - 1 
AH14771AA 26 1 - 2 3 3 - 3 - 3 
GF241458X 26 2 1 1 1 1 1 2 1 1 
GR71072X 26 3 3 2 3 4 6 5 4 4 
GR93262X 26 4 1 1 1 1 1 1 1 1 
GW315267X 27 1 1 1 1 1 1 1 1 1 
GR59449X 28 1 1 1 1 2 1 1 1 1 
GR59450X 28 2 2 6 1 6 11 5 1 4 
CC117440 29 1 3 .4 4 4 3 3 3 3 
GR68891 29 2 1 4 4 4 5 4 - 4 
G1148915 29 3 1 - - - 2 1 - 1 
GR207121 29 4 6 4 5 5 6 5 - 5 
GR260810 29 5 1 1 1 1 2 1 - I 
GR66288 29 6 1 1 2 2 2 1 - I 
G1166629 29 7 7 6 6 7 8 7 - 7 
GR235507 29 8 5 4 4 4 5 4 - 4 
GR38555 29 9 2 2 2 2 2 2 - 2 
GW296997 29 10 7 6 6 6 7 6 - 6 
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Comound  Relative Emission _Intensity _(lII o)______  
Reg_No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
CC14008 29 11 1 - 1 1 2 1 1 1 1 
GR244973 29 12 2 2 1 2 3 2 - 2 
GR260719 29 13 1 1 1 1 1 1 - 1 
GW317730 29 14 2 2 2 2 3 2 - 2 
GW412437 29 15 - - - - - - - #DIV/0! 
GW369998 29 16 2 2 2 2 2 2 - 2 
GW416206 29 17 - - - - - - - #DIV/0! 
GW315253X 29 18 2 3 3 5 4 4 3 3 
AH16806XX 30 1 1 1 1 2 2 1 1 1 
AH17157XX 30 2 6 3 9 14 28 25 10 14 
GW312681X 30 3 1 3 2 2 2 2 2 2 
AH4366 31 1 2 3 2 4 6 4 3 3 
AH4367 31 2 1 1 1 1 1 1 1 1 
AH9991 31 3 1 1 2 2 2 2 2 2 
AH9456 31 4 1 1 1 1 1 1 1 1 
AH7716 32 1 1 2 2 3 2 2 2 2 
GR244160X 32 2 1 1 1 1 1 1 1 1 
GR30I7OX 32 3 1 1 1 1 1 1 1 1 
GW294785X 32 4 1 1 1 1 1 1 1 1 
GR232463X 33 1 1 1 1 2 2 1 1 2 
GW312679X 33 2 1 1 2 2 4 1 2 2 
AH12195 34 1 3 2 2 3 3 4 2 3 
GR30355X 34 2 2 2 2 3 4 4 2 3 
GR30686X 34 3 1 1 1 1 1 1 1 1 
G1221306X 34 4 - 1 1 2 - 1 - 1 
GR197556X 34 5 - 1 1 2 - 1 - 1 
GR236886 35 1 9 10 10 12 11 9 8 10 
GW432536 35 2 - - - - - - - #DIV/0! 
AH14680XX 36 1 1 1 1 1 1 1 1 1 
GR215350X 36 2 1 1 1 1 1 1 1 1 
GW413125X 36 3 1 2 1 2 2 2 1 2 
GR203309X 37 1 5 8 7 6 8 9 5 7 
GR241 592X 37 2 55 40 56 58 57 55 32 50 
GR207127X 37 3 13 17 18 13 17 15 8 15 
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Comound -- 	 Relative Emission _Intensity_(Ill0)______  
Reg—No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GW399139X 37 4 25 32 13 16 19 18 9 19 
GR34040X 38 1 1 1 1 2 2 1 1 1 
GW323465X 38 2 1 1 1 1 1 1 1 1 
GR36337X 38 3 25 37 25 37 44 60 18 35 
GR87232X 38 4 1 1 2 2 3 1 2 2 
GW322742X 38 5 1 1 1 3 1 1 1 1 
CC18247 39 1 1 1 1 1 1 1 1 1 
GW470564X 39 2 1 1 1 1 2 1 1 1 
GR136744X 40 1 1 1 1 1 1 1 1 1 
GW398946X 40 2 1 1 1 1 1 1 1 1 
GR258074X 41 1 1 1 1 1 1 1 1 1 
GR30298X 41 2 1 1 1 1 1 1 1 1 
GW294643X 42 1 1 1 1 1 1 1 1 1 
GW295897X 42 2 1 1 1 1 1 1 1 1 
AH5119 43 1 1 1 1 1 1 1 1 1 
GR146857A 43 2 1 1 1 1 1 1 1 1 
GR108821X 43 3 1 1 1 1 1 1 1 1 
CC121441X 44 1 1 1 1 1 1 1 1 1 
G1222965X 44 2 1 1 1 1 1 1 1 1 
GR85032X 44 3 1 1 1 1 1 1 1 1 
GW317925X 45 1 1 1 1 1 1 1 1 1 
GW423592X 45 2 1 1 1 1 1 1 1 1 
GR212558X 46 1 1 1 1 1 2 1 1 1 
GV98449X 46 2 1 1 1 1 1 1 1 1 
GR245353X 46 3 5 4 3 4 8 6 3 5 
AH13207 47 1 1 1 1 1 1 1 1 1 
GR53007X 47 2 2 :2 2 2 3 2 1 2 
AH8335X 47 3 1 1 1 2 2 2 1 2 
GR100133X 48 1 1 1 1 1 1 1 1 1 
GR111981X 48 2 1 1 1 2 2 1 1 1 
GR124650X 49 1 1 1 1 2 2 2 1 2 
GR236342X 49 2 1 1 1 1 1 1 1 1 
GR258909 50 1 5 6 6 7 6 5 5 6 
GR265026X 50 2 1 1 1 1 1 1 1 1 
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Comound   Relative _Emission _Intensity _(lIla)______  
Reg_No Cluster Rank EuBEA EUBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GR43579X 50 3 - 1 1 1 - I - 1 
GR51409X 50 4 1 1 1 1 1 1 1 1 
GW273704X 51 1 1 1 1 1 1 2 1 1 
GW324992X 51 2 1 1 1 1 2 2 1 1 
CC119762 52 1 2 2 2 3 4 3 2 2 
GR249776X 53 1 1 1 1 1 1 1 1 1 
GR256398X 53 2 1 1 1 1 1 1 1 1 
GR269435X 53 3 1 1 1 1 1 1 1 1 
GR180851A 54 1 1 1 1 1 1 1 1 1 
GR88677X 54 2 1 1 1 1 1 1 1 1 
GW401244X 55 1 1 1 1 1 1 1 1 1 
GW406680X 55 2 1 1 1 1 1 1 1 1 
GW521849X 55 3 1 1 1 2 2 1 1 1 
AH13312 56 1 2 1 1 2 2 2 1 2 
AH14681XX 57 1 2 1 1 1 2 2 1 1 
GR130650X 57 2 3 3 4 6 7 4 4 4 
GR99513X 57 3 1 1 1 1 2 1 1 1 
AH23294X 57 4 2 1 2 2 2 2 1 2 
GR212000X 58 1 2 2 1 2 2 2 2 2 
GR116024X 59 1 15 18 13 11 10 16 7 13 
GR58504X 59 2 7 6 6 5 7 7 4 6 
GW315124X 59 3 1 1 1 2 1 1 1 1 
GW442963X 59 4 2 2 1 2 3 2 2 2 
GW342768X 59 5 1 1 1 1 1 1 1 1 
AH25327X 60 1 2 2 2 2 2 3 2 2 
AH25377X 60 2 2 2 1 2 2 2 2 2 
GR60468X 61 1 3 3 2 3 3 3 2 3 
GR223597X 62 1 1 1 1 1 1 1 1 1 
GW543499X 63 1 1 1 1 1 1 1 1 1 
GR257678X 64 1 1 1 1 1 1 1 1 1 
GW652716X 65 1 1 1 1 1 1 1 1 1 
GW292869X 66 1 3 3 4 7 7 6 4 5 
GW342412X 66 2 3 1 1 4 4 4 2 3 
GR232127X 67 1 10 4 7 6 6 5 5 6 
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Comound   Relative _Emission _Intensity _(Iil)_______  
Reg—No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GW309937A 68 1 1 1 1 1 1 1 1 1 
GR54241 69 1 1 1 1 1 1 1 1 1 
GR64138A 69 2 1 1 1 1 1 1 1 1 
GR81562 69 3 - 1 1 2 - I - 1 
GW424484X 70 1 1 1 1 1 1 1 1 1 
GW294777X 71 1 1 1 1 2 1 1 1 1 
GW313525X 71 2 5 5 3 7 7 6 4 5 
GW321902X 71 3 1 1 1 1 1 1 1 1 
GR194866A 72 1 1 1 1 1 1 1 1 1 
GR65644X 72 2 1 1 1 1 1 1 1 1 
GW553810A 72 3 2 1 1 2 3 2 1 2 
GW549758A 72 4 2 2 2 2 2 2 2 2 
GW550038A 72 5 4 4 3 3 3 4 2 3 
GR70745X 72 6 2 2 2 2 2 2 1 2 
GR69220X 72 7 2 2 2 2 2 2 2 2 
AH11291 73 1 2 2 2 2 3 2 2 2 
GR94828A 73 2 11 1 5 8 9 15 5 8 
AH12740 73 3 1 1 1 1 2 2 1 1 
AH12757 73 4 1 1 1 1 1 1 1 1 
GR199839X 73 5 1 1 1 1 1 1 1 1 
GR58191X 74 1 1 1 1 1 1 1 1 1 
GR87036X 75 1 1 1 1 1 1 1 1 1 
GW415452X 75 2 1 1 1 1 1 1 1 1 
AH8294 76 1 1 1 1 1 1 1 1 1 
GR39220X 76 2 2 2 2 3 3 3 2 2 
G1101694A 76 3 1 1 1 1 1 1 1 1 
GR50961A 76 4 2 2 2 2 3 2 2 2 
GR147168X 77 1 19 23 20 26 20 19 16 20 
GR51196X 77 2 1 1 1 1 1 1 1 1 
GR117463X 78 1 1 1 1 1 1 1 1 1 
GR208696X 78 2 1 1 1 1 1 1 1 1 
GR32768A 78 3 1 1 1 1 1 1 1 1 
GW432313X 78 4 1 1 1 1 1 1 1 1 
GR266494X 79 1 - - - - - - - #DIV/0' 
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Comound    Relative _Emission _Intensity _(I!I)______  
Reg_No Cluster Rank EuBEA EUBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GW298250X 79 2 1 1 1 1 1 1 1 1 
GR125017X 80 1 2 2 2 5 2 2 2 2 
GW370018X 80 2 1 1 1 1 1 1 1 1 
GW315103X 81 1 1 1 1 1 I 1 1 1 
GW321966X 81 2 2 2 2 3 4 3 3 3 
GF233961X 82 1 1 1 1 1 1 1 1 1 
G1230797A 82 2 1 1 1 1 1 1 I 1 
GR140164X 82 3 1 1 1 2 1 1 1 1 
GW290604X 83 1 17 16 17 32 41 21 19 23 
GW291821X 83 2 1 1 1 1 1 1 1 1 
GW361278X 83 3 1 1 1 1 1 1 1 1 
GW336990X 83 4 1 1 1 1 1 1 1 1 
GW295365X 83 5 1 1 1 2 1 1 1 1 
GW292911X 84 1 1 2 1 2 1 1 1 1 
GW294867X 84 2 1 1 2 3 3 2 2 2 
GW322405X 84 3 2 2 2 5 5 3 4 3 
GW315228X 85 1 4 4 5 5 4 3 3 4 
GW321601X 86 1 3 3 2 4 4 4 3 3 
G1230786 87 1 1 1 1 1 1 1 1 1 
GW295364 87 2 2 2 2 2 2 2 2 2 
AH7066 88 1 1 1 1 1 1 1 1 1 
GF234516X 88 2 1 1 1 2 1 1 2 1 
GF269343X 88 3 1 1 1 2 2 1 1 1 
GW314651X 88 4 1 1 1 2 2 1 1 1 
GW311857X 88 5 1 1 1 1 1 1 1 1 
GW323587X 88 6 24 29 23 34 39 47 18 31 
GW294790X 88 7 6 16 11 11 18 15 7 12 
GW322118X 88 8 3 4 4 6 7 4 4 5 
GW312723X 89 1 1 2 2 2 2 2 1 2 
GW432537X 89 2 2 3 2 3 3 3 2 3 
GW322502X 89 3 2 2 2 3 3 2 2 2 
GW312725X 89 4 1 1 1 1 1 1 1 1 
GW322531X 89 5 1 1 1 2 3 2 2 2 
GW314663X 89 6 11 20 - 18 31 22 12 19 
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Comound  Relative 	_Intensity _(I!I) -- _Emission 
Reg—No Cluster Rank EuBEA Et3UA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GW323690X 89 7 8 10 8 11 11 12 7 9 
GW323328X 89 8 2 2 2 3 3 3 2 2 
AH10503 90 1 1 1 1 1 1 1 1 1 
AH25564X 90 2 1 1 1 1 1 1 1 1 
CC17155 90 3 1 1 1 1 1 1 1 1 
GR51515 90 4 1 1 1 1 1 1 1 1 
GW363503A 90 5 1 1 1 1 1 1 1 1 
GR253714X 90 6 1 1 1 1 1 1 1 1 
AH9018 90 7 44 51 25 50 74 77 84 58 
AH12070 91 1 2 2 2 2 2 2 2 2 
G1123058 91 2 1 - - - 1 2 - 1 
GR55509 91 3 2 2 2 3 4 3 - 3 
GR50239 91 4 2 1 2 2 2 1 - 2 
GR87121 91 5 1 - - - 1 1 - I 
AH2951 91 6 1 1 1 1 1 1 1 1 
GR199994 91 7 1 1 1 1 1 1 1 1 
AH12275 91 8 1 1 1 2 1 1 1 1 
GR173757 91 9 2 2 2 2 2 2 1 2 
GR161201X 91 10 1 1 1 1 1 1 1 1 
AH12764 92 1 1 1 2 2 1 1 1 1 
AH17306AB 92 2 1 1 1 1 1 1 1 1 
GR161186X 92 3 1 1 1 1 1 1 1 1 
AH 1 5079XX 93 1 - 1 1 1 - I - 1 
GR35117X 93 2 - 1 1 1 - I - 1 
AH21453 93 3 1 1 1 1 1 1 1 1 
GR1 78029 93 4 1 - - - I I - 1 
GR33748 93 5 11 16 11 19 19 20 6 15 
G1152672 94 1 2 :2 2 2 2 2 2 2 
GR141743 94 2 1 1 1 1 1 1 - 1 
GR39406 94 3 1 1 1 1 1 1 - 1 
GR214280 94 4 1 1 1 1 1 1 1 1 
GR226270 94 5 1 1 1 1 1 1 - 1 
GR78537 94 6 1 1 1 1 1 1 - 1 
GR189793 94 7 1 - - - 1 1 - 1 
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Comound   Relative Emission _Intensity _(lIl a)_______  
Reg_No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZAj EuBTA Average EuNAL 
GR263804X 94 8 1 1 1 1 1 1 1 1 
GW324674 94 9 1 1 1 1 1 1 - 1 
GW410247 94 10 - - - - - - - #DIV/0! 
GR38461X 94 11 I 1 1 1 1 1 1 1 
GW340239X 94 12 1 1 1 1 1 1 1 1 
GR73169X 94 13 1 1 1 1 1 1 1 1 
AH15491)(X 95 1 1 1 1 1 1 1 1 1 
GR107832X 95 2 1 1 1 1 1 1 1 1 
GR231878X 95 3 1 1 1 1 1 1 1 1 
GR137556X 95 4 1 1 1 1 1 1 1 1 
GF146238 96 1 6 6 7 8 6 7 6 6 
GW295088 96 2 7 6 6 5 8 5 - 6 
GF267572X 96 3 1 1 1 1 1 1 1 1 
GW323141X 96 4 1 1 1 1 1 1 1 1 
GF267575X 97 1 1 2 2 2 2 2 1 2 
GR76319X 97 2 5 6 11 28 27 18 18 16 
GR78359X 97 3 2 2 2 2 2 2 2 2 
G1170475X 98 1 - 1 1 1 - 1 - 1 
GW275669A 98 2 - 1 1 1 - I - I 
GR205623X 98 3 - 1 1 1 - 1 - I 
GR53844X 99 1 - 1 1 1 - 1 - 1 
GW298071X 100 1 1 1 1 1 1 1 1 1 
G1199827X 101 1 1 1 1 1 1 1 1 1 
GR141837X 101 2 1 1 1 1 1 1 1 1 
GW323802A 101 3 1 1 1 1 1 1 1 1 
GW329522X 102 1 1 1 1 1 1 1 1 1 
GR251266A 103 1 2 2 2 1 2 2 2 2 
GR265018A 103 2 1 1 1 1 1 1 1 1 
GR253017X 103 3 1 1 1 1 1 1 1 1 
GW425183X 104 1 3 3 2 3 4 3 2 3 
GR267248A 105 1 1 1 1 1 1 1 1 1 
GW425181X 105 2 1 1 1 1 1 1 1 1 
AH17295)(X 106 1 1 1 1 1 1 1 1 1 
AH26206X 106 2 1 1 1 1 1 1 1 1 
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Comound - 	 Relative Emission _Intensity _(lII)______  
Reg—No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
AH20560)O( 106 3 1 1 1 1 1 1 1 1 
GR97173X 106 4 1 1 1 1 1 1 1 1 
AH21291X 106 5 1 1 1 1 1 1 1 1 
GW471254X 106 6 1 1 1 1 1 1 1 1 
AH17365XX 107 1 1 1 1 1 1 1 1 1 
G1198830X 107 2 1 1 1 1 1 1 1 1 
AH7669 107 3 1 1 1 1 1 1 1 1 
G1221325A 107 4 1 1 1 1 1 1 1 1 
G195276X 107 5 1 1 1 1 1 1 1 1 
CC17978 108 1 - 1 1 1 - 1 - I 
GF267691X 108 2 1 1 1 1 1 1 1 1 
G1147499A 108 3 - 1 1 1 - 1 - I 
AH21350X 109 1 1 1 1 1 1 1 1 1 
GW321669X 109 2 - 1 1 1 - I - 1 
GW323630X 109 3 1 1 1 1 1 1 1 1 
CC11914 109 4 1 1 1 1 1 1 1 1 
GF146728X 109 5 - 1 1 1 - 1 - 1 
GR86838X 109 6 1 1 1 1 1 1 1 1 
AH5502 110 1 2 2 2 2 2 2 2 2 
GR141836 110 2 1 - - - 1 1 - I 
GR248323 110 3 2 2 2 2 2 2 - 2 
AH6472 110 4 1 - - - 1 1 - 1 
GR141839 110 5 1 - - - I I - I 
GR31162 110 6 1 1 1 1 1 1 - 1 
GR40490 110 7 1 1 1 1 1 1 - I 
GR40028 110 8 1 1 1 1 1 1 - I 
G1149060 110 9 4 - - - 3 3 - 3 
G1153357 110 10 1 - - - 1 1 - 1 
GV95604 110 11 4 3 4 4 4 4 - 4 
G1119939X 110 12 - 1 1 1 - 1 - 1 
G1147798 110 13 1 - - - 1 1 - I 
GR113723 110 14 1 - - - 1 1 - 1 
G1150183 110 15 1 - - - 1 1 - 1 
GR259835 110 16 1 1 1 1 1 1 - I 
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Comound - 	 Relative Emission _Intensity _(l!l)______  
Reg_No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GR197159 110 17 1 - - - 1 1 - I 
GR118329 110 18 1 - - - 1 2 - I 
G1151314 110 19 1 - - - 1 1 - 1 
GR214686 110 20 1 1 1 1 1 1 - 1 
GR89164 110 21 1 - - - 1 1 - I 
GR261930 110 22 6 5 6 5 6 5 - 5 
GR31787A 110 23 - 1 1 1 - 1 - 1 
CC18566 111 1 2 2 2 2 2 2 2 2 
GR32579 111 2 1 1 1 1 1 1 - 1 
GW286126 111 3 2 3 6 5 6 4 2 4 
GW422957 111 4 - - - - - - - #DIV/0' 
GR123674 111 5 1 - - - 1 1 - 1 
GR146669 111 6 1 - - - 1 1 - 1 
CC19041 111 7 1 1 1 1 1 1 1 1 
GW296344 111 8 1 1 1 1 1 1 - 1 
GR154729 111 9 1 - - - 1 1 - 1 
GR171932 111 10 1 - - - 1 1 - I 
AH13018 112 1 2 2 2 2 3 3 2 2 
GV140840X 112 2 1 I 1 1 1 1 1 1 
GR207209X 112 3 2 2 2 4 3 3 2 3 
GR112257X 113 1 1 1 1 1 1 1 1 1 
GR263152X 113 2 5 6 4 4 5 4 3 4 
GR112259X 113 3 1 1 1 1 1 1 1 1 
GR185905X 113 4 1 2 1 2 2 2 1 2 
GR186845X 113 5 1 1 1 3 1 1 1 1 
GR219630X 113 6 1 1 1 1 1 1 1 1 
GW541786X 113 7 1 2 2 14 4 1 2 4 
GW560094X 113 8 1 1 1 4 2 2 1 2 
GR53539X 114 1 1 1 1 1 1 1 1 1 
AH15201XX 115 1 4 3 4 4 4 3 3 4 
AH6859 115 2 74 70 69 97 72 62 48 70 
AH15203XX 115 3 96 88 92 101 102 102 71 93 
GW314581X 115 4 74 76 68 82 96 85 62 77 
GW294655X 115 5 6 4 4 0 6 6 4 4 
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Comound  Relative 	_Intensity _(l/I) - _Emission 
Reg—No Cluster Rank EuBEA EuI3UA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GW328088X 115 6 70 72 67 72 66 67 49 66 
GW312792X 115 7 54 104 61 100 121 123 40 86 
GW294322X 115 8 46 41 37 39 43 37 29 39 
GW304858X 115 9 4 4 3 4 8 4 3 4 
GW312329X 115 10 14 13 10 13 16 16 8 13 
AH15400)(X 115 11 81 88 71 82 91 93 59 81 
GW314526X 115 12 24 34 - 28 48 39 26 33 
GW324336X 115 13 4 7 4 5 4 6 4 5 
AH5558 116 1 1 1 1 2 2 2 1 1 
AH5950 116 2 3 3 3 4 6 5 3 4 
GW312371X 116 3 2 2 2 2 4 3 2 3 
GW315227X 116 4 4 7 5 7 3 10 6 6 
GW312460X 116 5 5 11 8 8 15 14 8 10 
GW312437X 116 6 12 14 11 32 34 17 12 19 
GW312435X 116 7 1 1 1 1 1 1 1 1 
GF267701X 116 8 17 18 19 20 22 18 14 19 
GR189755X 117 1 80 79 73 82 81 56 54 72 
GW313003X 117 2 1 1 1 1 1 1 1 1 
GR256734X 117 3 1 1 1 1 1 1 1 1 
GW321218X 118 1 2 3 2 3 4 4 2 3 
AH6372 119 1 4 4 3 3 23 9 3 7 
G1205545X 119 2 1 1 1 1 1 1 1 1 
GW312626X 119 3 2 2 2 2 4 3 2 3 
GR230571X 119 4 2 2 2 2 2 2 2 2 
AH21917X 120 1 1 1 1 1 1 1 1 1 
AH22735X 120 2 1 1 1 1 1 1 1 1 
GR177051X 120 3 1 1 1 1 1 1 1 1 
GW471604X 120 4 2 2 2 2 2 2 1 2 
GR152169X 120 5 1 1 1 1 1 1 1 1 
GR225877X 121 1 1 1 1 1 1 1 1 1 
GR255442X 121 2 7 10 5 8 15 12 4 9 
CC12180 122 1 1 1 1 1 1 1 1 1 
GR121162X 122 2 1 1 1 1 1 1 1 1 
GW308403X 123 1 2 2 2 2 3 2 2 2 
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Comound   Relative _Emission _Intensity _(III)_______  
Reg_No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GR114265X 124 1 2 3 2 3 3 3 2 3 
GR225874X 124 2 1 1 1 1 1 1 1 1 
GR51045X 125 1 1 1 1 1 1 1 1 1 
GW521143X 126 1 1 1 1 1 1 1 1 1 
0R200308X 127 1 2 2 1 2 3 2 1 2 
GR32131X 127 2 1 1 1 1 2 1 1 1 
AH2599 128 1 2 2 2 2 2 2 2 2 
AH7307 128 2 2 - - - 3 3 - 3 
GR121876X 129 1 1 1 1 1 1 1 1 1 
GR193373X 129 2 1 1 1 1 1 1 1 1 
GR196926X 129 3 1 1 1 1 1 1 1 1 
GW426030X 129 4 1 1 1 1 1 1 1 1 
AH21971X 130 1 5 6 5 6 10 10 4 6 
GW648032X 130 2 2 2 1 2 3 3 1 2 
CC11710 130 3 2 2 1 2 3 2 1 2 
GR71245X 130 4 10 9 22 30 30 20 16 20 
GR173914X 131 1 1 1 1 2 1 1 1 1 
GR257498X 132 1 1 1 1 1 2 2 1 1 
AH23040X 133 1 1 1 1 1 1 1 1 1 
GR36682X 133 2 1 1 1 1 1 1 1 1 
GR47574X 133 3 1 1 1 1 1 1 1 1 
GR215566X 134 1 1 1 1 1 1 1 1 1 
G1198860X 135 1 3 3 2 3 5 4 2 3 
GR74829X 135 2 1 1 1 2 2 2 1 2 
GW271761X 135 3 1 1 1 1 1 1 1 1 
GR232957X 136 1 6 8 7 10 8 9 5 8 
GW322216X 136 2 7 7 4 6 17 18 5 9 
AH4822 137 1 4 6 4 4 9 8 3 6 
GR207205X 137 2 4 7 8 13 18 6 6 9 
GF267466X 137 3 1 2 3 7 9 3 3 4 
GW328094A 138 1 1 1 1 1 1 1 1 1 
GW418822A 138 2 1 1 1 1 1 1 1 1 
GW448911X 138 3 1 1 1 1 1 1 1 1 
G1198877X 139 1 2 2 2 2 4 3 2 2 
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Comound  Relative Emission _Intensity _(lIlo)______ - 
Reg_No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GR267007X 139 2 4 5 4 5 7 5 3 5 
GW340373X 139 3 1 1 1 1 1 1 1 1 
GR256536X 140 1 4 5 6 13 16 7 5 8 
GR192153X 141 1 1 1 1 2 2 1 1 1 
GW321193X 142 1 1 1 1 1 1 1 1 1 
AH23064X 143 1 1 1 1 1 1 1 1 1 
GW279435X 143 2 1 1 1 1 1 1 1 1 
GW279438X 144 1 1 1 1 1 2 2 1 1 
GW279439X 144 2 1 1 3 6 7 1 3 3 
GR127482A 145 1 1 1 1 1 1 1 1 1 
GR262262X 145 2 1 1 1 1 1 1 1 1 
GR262264X 145 3 1 1 1 1 1 1 1 1 
GR267264X 145 4 1 1 1 1 1 1 1 1 
AH8425 146 1 44 52 55 62 61 47 42 52 
GW314731X 146 2 39 34 34 46 43 33 26 36 
GW314830X 146 3 104 82 - 99 109 91 69 92 
GW320557X 146 4 96 80 81 92 90 75 67 83 
GW323721X 146 5 103 89 74 93 99 82 64 86 
GW314662X 147 1 21 49 32 64 68 59 43 48 
GW314681X 147 2 24 26 31 55 40 40 28 35 
GW314793X 147 3 21 29 - 56 33 31 34 34 
GW322018X 147 4 45 60 43 73 99 83 34 62 
GW314751X 147 5 21 24 18 43 27 23 24 26 
GW315158X 147 6 16 18 - 25 25 18 14 19 
GW322801X 147 7 20 28 25 61 43 37 35 36 
GW323040X 147 8 45 48 50 76 68 65 39 56 
GW321891X 147 9 1 1 1 1 1 1 1 1 
GW323845X 147 10 6 7 6 7 5 6 5 6 
GW323446X 147 11 9 13 9 19 17 16 12 13 
GW323591X 147 12 65 91 65 96 144 151 67 97 
GW315075X 147 13 11 11 11 19 16 13 11 13 
GW322693X 147 14 8 10 8 15 13 13 9 11 
GW321808X 147 15 16 17 13 44 31 26 16 23 
GW322384X 147 16 7 8 8 10 14 12 7 10 
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Comound  Relative 	_Intensity _(III) -- _Emission 
Reg_No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GW321800A 147 17 3 1 4 4 4 4 2 3 
GW322628X 147 18 34 30 26 33 30 27 22 29 
GW322988X 147 19 8 9 7 10 10 11 8 9 
AH15466AA 148 1 1 1 1 1 1 1 1 1 
AH2565 148 2 1 1 1 1 1 1 1 1 
GW366246 148 3 2 2 2 2 2 2 2 2 
CC117196 148 4 3 3 3 4 5 2 2 3 
AH20078XX 149 1 16 28 21 35 40 33 20 28 
GR208554X 149 2 13 14 12 13 13 9 8 12 
GR230104X 149 3 7 10 8 13 10 11 5 9 
GR30893X 149 4 24 26 39 29 39 26 20 29 
GR33911X 149 5 14 16 28 34 28 29 18 24 
GR62459X 149 6 107 1:22 106 118 120 124 71 109 
GR65815X 149 7 21 16 21 29 14 24 13 20 
GR65884X 149 8 24 21 36 37 31 31 15 28 
GW385846X 149 9 69 85 57 68 89 93 41 72 
GR155589X 149 10 2 1 2 3 3 2 2 2 
GR30894X 149 11 12 12 15 12 12 12 8 12 
GR208752X 149 12 4 8 8 8 17 9 7 9 
GW288377X 149 13 30 56 19 20 30 43 14 30 
GR34968X 149 14 4 4 4 6 6 5 3 5 
GR54392X 149 15 103 136 183 87 97 196 55 123 
GR57352X 149 16 22 25 25 24 60 38 18 30 
GW371223X 149 17 1 1 1 5 2 1 1 2 
CC19740 149 18 1 1 1 1 1 1 1 1 
GR240724X 149 19 4 5 13 11 16 10 8 10 
GR30476X 149 20 1 1 1 4 2 1 2 2 
GR53056X 149 21 1 1 1 1 1 1 1 1 
GR136670X 150 1 2 4 2 2 2 3 1 2 
GR34039X 150 2 1 1 2 4 3 2 2 2 
AH24908A 151 1 2 4 3 5 4 4 2 3 
GR49928X 151 2 2 3 2 4 3 3 2 3 
AH25368X 151 3 4 7 8 9 8 9 3 7 
GR55422X 151 4 20 25 20 21 41 29 17 25 
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Comound    Relative 	_Intensity _(lIla)______  _Emission 
Reg_No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GR55423X 151 5 17 20 19 21 32 32 14 22 
GR61326X 151 6 15 30 51 55 51 58 15 39 
GR61891X 151 7 16 35 52 59 58 52 25 43 
GR61984X 151 8 25 40 71 79 75 72 37 57 
GR61985X 151 9 21 39 51 56 59 55 24 44 
GR55424X 151 10 24 24 24 22 34 32 18 25 
AH5157 152 1 1 2 2 2 2 2 2 2 
AH6770 152 2 1 1 1 1 1 1 1 1 
AH9603 152 3 1 1 1 1 1 1 1 1 
GW315367X 152 4 2 2 1 1 1 1 1 1 
GR219955X 152 5 1 1 1 1 1 1 1 1 
GR120092X 152 6 1 1 1 1 1 1 1 1 
GR75258X 152 7 459 489 355 437 354 383 231 387 
GF233967X 153 1 1 1 1 1 1 1 1 1 
GW641533X 153 2 1 1 1 1 1 1 1 1 
GW321911X 153 3 1 1 1 1 1 1 1 1 
GW402775X 153 4 3 3 3 4 4 3 2 3 
GR258179X 154 1 16 71 16 18 66 62 13 37 
GR258213X 154 2 12 78 22 105 77 74 23 56 
GF267695X 155 1 1 1 1 1 1 1 1 1 
GW322088X 155 2 1 1 1 1 1 1 1 1 
GW322112X 155 3 1 2 1 2 2 2 1 2 
GW322316X 155 4 1 1 1 1 1 1 1 1 
GW322086X 155 5 1 1 1 1 1 1 1 1 
GR222247X 156 1 1 1 1 1 1 1 1 1 
GR53849X 156 2 1 1 1 1 1 1 1 1 
GR99312X 156 3 1 1 1 1 1 1 1 1 
GR57082X 157 1 1 1 1 1 1 1 1 1 
GW320929X 157 2 1 1 - 2 1 1 1 1 
GW412113X 157 3 1 1 1 1 1 1 2 1 
GR215780X 158 1 1 1 1 1 1 1 1 1 
GR219957X 158 2 1 1 1 1 1 1 1 1 
GR219958X 158 3 1 1 1 1 1 1 1 1 
GR216184X 158 4 4 3 3 4 7 5 5 4 
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Comound  Relative Emission 	_(I!I)_______  _Intensity 
Reg No Cluster Rank EuBEA EUBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GR216186X 158 5 1 1 1 1 1 1 1 1 
GR218004X 158 6 1 1 1 3 3 2 2 2 
GR218005X 158 7 1 1 1 2 2 1 2 2 
GR133748X 159 1 - - - - - - - - 
GR82836X 159 2 27 33 24 29 33 42 15 29 
GR38662X 159 3 1 1 1 3 2 1 2 2 
GW292734X 159 4 3 3 5 6 7 6 4 5 
GW322234X 159 5 2 2 2 2 2 2 2 2 
GR79956X 159 6 2 2 2 3 3 3 2 2 
GR203866X 159 7 6 14 7 10 11 12 4 9 
GR203872X 159 8 5 4 2 8 6 6 2 5 
GR203875X 159 9 3 3 3 7 6 5 2 4 
GR204301X 159 10 41 58 29 46 114 75 22 55 
GR65881X 159 11 7 4 2 10 30 17 10 11 
GR65883X 159 12 7 12 30 21 23 21 12 18 
GR65885X 159 13 8 13 8 14 19 24 11 14 
GR188442X 160 1 1 2 1 2 2 1 1 1 
GW322235X 160 2 1 1 1 1 1 1 1 1 
GW327773X 160 3 1 1 1 1 1 1 1 1 
GW643493X 160 4 8 11 6 8 13 11 6 9 
GW643495X 160 5 2 2 1 2 2 2 2 2 
GR215459A 161 1 1 1 1 1 1 2 1 1 
GW280814 161 2 1 1 1 1 1 1 1 1 
GW290851X 161 3 1 1 1 1 1 1 1 1 
GW290862X 161 4 1 1 1 1 1 1 1 1 
GW326112X 161 5 2 2 2 4 5 3 3 3 
GW271929X 162 1 2 3 2 3 3 2 2 3 
GW317768X 162 2 26 38 26 32 49 34 13 31 
GW272447X 162 3 2 2 2 4 3 2 2 3 
GW326127X 162 4 4 10 7 10 9 9 4 8 
GW440381X 162 5 5 10 8 23 12 6 5 10 
GW418716X 162 6 2 2 2 3 3 2 2 2 
GW453080X 162 7 2 2 2 4 3 3 2 3 
GW442734X 162 8 2 2 2 4 3 2 2 2 
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Comound  Relative Emission _Intensity _(IIl)_______ - 
Reg_No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GW272478X 162 9 1 2 2 3 3 2 2 2 
GW442732X 162 10 2 2 2 3 3 2 2 2 
GW415699X 162 11 21 89 27 60 48 49 16 44 
GW369764X 162 12 25 41 20 63 38 34 16 34 
GR50838A 163 1 3 4 3 3 6 7 2 4 
0R51678X 163 2 37 35 30 30 49 46 23 36 
GR54219X 164 1 11 10 8 12 22 21 11 14 
GR69421X 164 2 4 5 3 3 10 8 3 5 
GW317904X 165 1 2 2 - 4 5 2 2 3 
GW411913X 165 2 1 1 1 1 1 1 1 1 
GW327989X 165 3 1 2 2 2 3 2 1 2 
GW414889X 165 4 1 ii 1 1 1 1 1 1 
AH10104A 166 1 1 1 1 1 1 1 1 1 
AH7702 166 2 1 1 1 1 1 1 1 1 
AH7559 166 3 1 1 1 1 1 1 1 1 
AH10011A 166 4 1 1 1 1 1 1 1 1 
AH7724Z 166 5 1 1 1 1 1 1 1 1 
GW575621X 166 6 1 1 1 1 1 1 1 1 
AH10424A 166 7 1 1 1 1 1 1 1 1 
AH7620Z 166 8 1 1 1 1 1 1 1 1 
AH7699 166 9 1 1 1 1 1 1 1 1 
AH5961 167 1 1 1 1 1 1 1 2 1 
AH6102 167 2 2 2 2 2 2 2 1 2 
AH7647 167 3 1 1 1 1 1 1 1 1 
AH9531 168 1 1 1 1 1 1 1 1 1 
GR199045X 168 2 1 1 0 1 1 1 0 1 
AH5724 169 1 2 2 1 1 8 8 3 4 
GW295014X 169 2 2 2 1 3 4 4 2 3 
GW315237X 169 3 1 1 1 1 2 3 1 1 
GW315238X 169 4 1 2 - 2 2 2 1 1 
AH6593 169 5 2 2 2 2 3 3 2 2 
GW315239X 169 6 5 9 - 11 9 4 6 7 
AH6247 169 7 8 8 7 10 7 8 5 8 
AH6313 169 8 3 3 3 3 3 2 2 3 
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Comound - 	 Relative _Emission _Intensity _(l1l)______  
Reg—No Cluster Rank EuBEA EUBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
AH6072 169 9 3 6 5 6 5 5 5 5 
AH6624 169 10 1 1 1 1 1 1 2 1 
AH7013Z 169 11 1 1 1 1 1 1 1 1 
AH7014Z 169 12 1 1 1 1 1 1 1 1 
AH6198 170 1 1 1 1 1 1 1 1 1 
AH6248 170 2 3 3 3 5 11 10 4 6 
AH703IZ 170 3 1 1 1 1 1 1 1 1 
AH7029 170 4 9 9 8 12 8 9 6 9 
AH6292 170 5 1 1 1 1 1 1 2 1 
AH6570 170 6 4 5 2 3 7 7 3 4 
AH7083Z 170 7 1 1 1 1 1 1 1 1 
GR240517X 170 8 1 1 1 1 1 1 1 1 
AH6169K 171 1 1 1 1 1 1 1 1 1 
GW315217X 171 2 1 1 - 1 1 1 1 1 
AH11654 172 1 8 15 5 31 41 27 18 21 
AH14868XX 172 2 18 17 13 24 25 23 12 19 
AH7167 172 3 15 15 13 20 16 13 11 15 
AH7792Z 172 4 8 10 9 10 11 10 7 9 
AH7650 172 5 16 17 14 22 19 16 12 17 
AH6730 172 6 11 11 9 14 12 10 7 10 
AH7290A 172 7 2 2 2 3 2 2 2 2 
AH7652 172 8 19 33 19 22 36 32 16 25 
AH7414Z 172 9 14 15 14 19 15 12 10 14 
AH7621Z 172 10 10 10 10 14 10 9 7 10 
AH7552 172 11 8 13 7 9 19 20 8 12 
AH7651 172 12 12 13 12 18 14 11 10 13 
AH7697 172 13 2 3 2 3 5 4 3 3 
AH6276 173 1 8 6 7 9 5 7 5 7 
GR85411X 173 2 5 6 6 8 6 4 4 6 
AH6390 173 3 28 28 27 37 22 26 18 27 
GR65254X 173 4 5 5 5 4 4 4 3 4 
AH6535 173 5 2 2 2 2 2 2 1 2 
AH6712 173 6 1 1 1 1 1 1 1 1 
AH7646 173 7 1 1 1 1 1 1 1 1 
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Comound   Relative Emission _Intensity _(I!I)_______  
Reg_No Cluster Rank EuBEA EUBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GR257968X 173 8 1 1 1 1 1 1 1 1 
AH6342 173 9 2 3 3 4 5 4 4 4 
AH6572 173 10 2 2 2 3 2 2 2 2 
AH7133 173 11 1 2 2 2 2 2 2 2 
GW321108X 173 12 1 1 1 1 1 1 1 1 
AH6550 173 13 20 23 21 30 22 21 15 22 
GR242642X 173 14 1 1 1 1 1 1 1 1 
AH6573 173 15 4 4 3 4 3 3 3 3 
AH6714 173 16 2 2 2 3 2 2 2 2 
AH6759 173 17 1 1 1 1 1 1 1 1 
AH6713 174 1 1 1 1 1 1 1 1 1 
AH7696 174 2 3 4 3 3 5 5 2 4 
AH7731 174 3 1 1 0 1 1 1 1 1 
AH2671 175 1 1 1 1 1 1 1 1 1 
GR1 39602 175 2 1 - - - 2 2 - 2 
GW433974 175 3 - - - - - - * #DIV/0! 
GW321876 175 4 1 1 1 1 1 1 1 1 
GR139604 175 5 1 1 2 2 2 2 2 2 
GW321338X 175 6 1 1 1 2 1 1 1 1 
GW343619X 175 7 6 15 28 34 40 22 20 24 
AH2672 175 8 1 1 1 1 1 1 1 1 
GR85308 175 9 1 1 1 2 1 1 1 1 
GW321553X 175 10 4 4 4 7 4 4 4 4 
GW368591A 175 11 1 1 1 1 1 1 1 1 
GR115690 175 12 7 10 7 11 15 12 6 10 
GR176137 175 13 4 - - - 18 12 - 12 
GW321167 175 14 7 9 4 5 16 13 - 9 
GW320968X 175 15 2 2 - 3 2 2 2 2 
GW321421 175 16 3 3 - 3 3 2 2 3 
GW315288X 175 17 1 1 - 1 1 1 1 1 
GW315296X 175 18 2 2 - 2 2 2 1 2 
GW288615 175 19 4 6 3 10 14 10 5 8 
GW321424X 175 20 11 19 9 17 20 21 12 16 
GW321634X 175 21 2 6 6 4 2 3 3 4 
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Comound  Relative Emission _Intensity _(lIla)______ - 
Reg—No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GW321145 175 22 18 15 - 15 25 22 10 17 
GW321168X 175 23 3 4 - 4 5 3 3 4 
GW321422X 175 24 4 4 - 5 5 3 3 4 
GW322230X 175 25 1 1 1 1 1 1 1 1 
GW314379 176 1 3 5 5 4 3 3 2 4 
0W314406X 176 2 31 33 - 24 52 46 19 34 
GW321354X 176 3 1 1 1 1 1 1 1 1 
GW321243X 177 1 2 2 - 4 4 2 3 3 
W321742X 177 2 2 2 2 2 2 2 1 2 
GW321779X 177 3 3 3 2 3 3 2 2 3 
GW321755X 177 4 3 3 3 3 3 3 2 3 
GW410928X 177 5 2 2 2 2 2 2 2 2 
GW324540X 177 6 8 8 7 11 9 9 4 8 
GW322198X 178 1 5 4 4 9 5 6 4 5 
GW322492X 178 2 4 4 3 4 7 5 3 4 
GW320926X 179 1 5 4 4 5 4 4 3 4 
GW321470X 179 2 2 2 2 2 2 2 1 2 
GW321607X 179 3 7 6 7 6 6 5 5 6 
GW323008X 179 4 2 2 2 2 2 2 2 2 
GR175627 180 1 - 5 6 16 - 6 - 8 
GR175628 180 2 1 - - - 1 1 - 1 
GR196922 180 3 2 2 2 2 2 2 - 2 
GR256963 180 4 1 1 1 1 1 1 - 1 
GW321245X 180 5 2 2 - 2 3 2 1 2 
GW321912X 180 6 2 2 3 6 5 3 3 3 
AH10033 181 1 1 1 1 1 1 1 1 1 
GR237865X 182 1 1 1 1 1 1 1 1 1 
AH15255XX 183 1 1 1 1 1 1 1 1 1 
GR68357X 184 1 - 1 1 1 - 2 - 1 
GW320801X 185 1 - 1 1 1 - 1 - I 
GW385455A 185 2 1 1 1 1 1 1 1 1 
AH11305 186 1 - 2 2 2 - 2 - 2 
AH9723 186 2 3 5 3 4 8 7 3 5 
GW655414X 187 1 109 136 - 125 146 128 73 119 
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Comound  Relative Emission _Intensity _(liI) - 
Reg—No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GR107114X 188 1 1 1 1 1 1 1 1 1 
GR138809X 189 1 2 2 2 2 2 2 1 2 
GW295817X 190 1 1 1 1 1 2 1 1 1 
GW365467X 191 1 5 5 5 5 5 5 4 5 
GW311376X 192 1 - 1 1 1 - 1 - 1 
GW397304X 193 1 1 1 1 1 1 1 1 1 
GW584442X 194 1 15 15 13 14 16 12 9 14 
GW635258X 195 1 1 1 1 1 1 1 1 1 
GW635452X 195 2 4 5 4 4 6 5 3 4 
GR269503X 196 1 6 '5 5 5 5 5 4 5 
GR223454A 197 1 1 1 1 1 1 1 1 1 
GW580127X 198 1 2 4 2 2 4 4 1 3 
GW623142A 198 2 1 1 1 1 1 1 1 1 
GW624854X 199 1 1 2 1 3 2 2 1 2 
GW663118X 199 2 1 1 - 1 1 1 1 1 
GW652611X 200 1 7 19 9 13 27 22 7 15 
GR151827X 201 1 4 It 3 3 4 5 2 4 
GR152989X 201 2 7 15 10 8 24 18 5 12 
AH11426 202 1 - 1 1 1 - 1 - 1 
GR37359X 202 2 1 1 1 1 1 1 1 1 
GW321066X 203 1 5 At 5 9 9 9 8 7 
CC 18732 204 1 1 1 1 1 1 1 1 1 
GW312666X 205 1 2 It 2 2 3 2 2 2 
GW424662X 206 1 5 It 5 5 6 5 4 5 
AH8940 207 1 1 2 1 1 2 2 1 1 
GR258784X 208 1 1 1 1 1 1 1 1 1 
GW322374X 208 2 1 1 1 1 1 1 1 1 
AH8076 209 1 1 1 1 1 1 1 1 1 
GW315274X 210 1 1 ii 1 1 1 1 1 1 
GW650524X 211 1 1 1 1 1 1 1 1 1 
GW650525X 211 2 1 1 1 1 1 1 1 1 
AH9033 212 1 1 1 1 1 1 1 1 1 
GW649399X 212 2 37 36 25 27 27 26 21 28 
AH9527 212 3 101 -. - - 85 81 - 89 
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Comound  Relative Emission _Intensity _(Ill 0)_______  
Reg No Cluster Rank EuBEA EUBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
CC14563 213 1 1 1 1 1 1 1 1 1 
GR154660A 214 1 1 1 1 1 1 1 1 1 
GR177049X 214 2 1 1 1 1 1 1 1 1 
GR219652X 215 1 1 1 1 1 1 1 1 1 
GR249207X 216 1 1 1 1 1 1 1 1 1 
GR118330 217 1 2 2 2 3 2 2 2 2 
GW276690 217 2 3 3 3 3 4 4 - 3 
GR242234X 218 1 1 1 1 1 1 1 1 1 
GW283348X 219 1 1 1 1 2 1 1 1 1 
GW318076X 220 1 34 48 - 46 88 77 30 54 
GR37727X 221 1 1 1 1 1 1 1 1 1 
GR53040X 222 1 1 1 1 1 1 1 1 1 
AH7643 223 1 1 1 1 1 1 1 1 1 
AH9554 223 2 1 1 1 1 1 1 1 1 
GR152077X 224 1 10 11 5 9 6 10 7 8 
GM189907X 225 1 1 1 1 1 1 1 1 1 
GR39699X 225 2 1 1 1 1 1 1 1 1 
GR114312X 226 1 1 1 1 1 1 1 1 1 
AH11195B 227 1 1 1 1 1 1 1 1 1 
GR239106X 227 2 1 1 1 1 1 1 1 1 
GR106841X 228 1 1 1 1 1 1 1 1 1 
AH6081A 229 1 3 3 3 4 4 3 3 3 
GR240822X 229 2 4 4 3 3 7 6 3 4 
GW327515X 230 1 4 5 3 5 5 6 3 4 
GW416086 230 2 1 1 1 1 1 1 1 1 
AH9652 231 1 2 2 1 2 3 2 1 2 
GR44240X 231 2 1 1 1 1 1 1 1 1 
GR103163A 232 1 1 1 1 1 1 1 1 1 
GW327758A 232 2 1 1 1 1 1 1 1 1 
GW312641A 232 3 1 1 1 1 1 1 1 1 
G1138330X 233 1 3 4 2 4 6 6 6 5 
GW329078X 233 2 - 1 1 1 - 1 - 1 
GR240576X 234 1 1 1 1 1 2 1 1 1 
GW31 5215 234 2 - 1 1 1 - 1 - 1 
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Comound Relative Emission _Intensity _(lIla)______  
Reg—No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GW412098 234 3 2 2 2 2 2 1 1 2 
GR108394X 235 1 1 1 1 1 1 1 1 1 
GR245706X 235 2 1 1 1 1 1 1 1 1 
GR117055X 236 1 - 2 1 2 - 2 - 2 
AH7461 237 1 1 - - 1 1 - 1 
GW341377 237 2 1 1 1 1 1 1 - 1 
GW365140 237 3 1 1 1 1 1 1 - I 
GW365173 237 4 1 1 1 1 1 1 - I 
G1261653 237 5 1 1 1 1 1 1 1 1 
GR242078X 238 1 - 1 1 1 - 1 - 1 
GW308852X 239 1 - 1 1 1 - I - 1 
GW307512X 240 1 1 1 1 1 1 1 1 1 
GW311866X 241 1 1 1 1 1 1 1 1 1 
GW319241X 242 1 1 1 1 1 1 1 1 1 
GW448056X 243 1 1 I 1 1 2 1 1 1 
GR258734A 244 1 1 1 1 1 1 1 1 1 
GR264071A 244 2 1 2 1 1 2 1 1 1 
GR263255X 244 3 1 1 1 1 1 1 1 1 
GR43767X 245 1 1 1 1 1 1 1 1 1 
GW472535X 245 2 1 1 1 1 1 1 1 1 
GW288946X 246 1 105 108 127 135 121 102 85 112 
GW324060X 247 1 2 1 1 1 2 2 1 1 
AH10315 248 1 1 1 1 1 1 1 1 1 
AH10461 248 2 1 1 1 1 1 1 1 1 
GR105716X 249 1 1 1 1 1 1 1 1 1 
GR212122X 249 2 1 ii 1 1 1 1 1 1 
AH22431B 250 1 1 1 1 1 1 1 1 1 
GR109361X 250 2 1 1 1 1 1 1 1 1 
GR60436X 250 3 2 2 2 2 3 2 2 2 
AH6087 251 1 1 1 1 1 1 1 1 1 
G1163641X 251 2 1 1 1 1 1 1 1 1 
CC1153 252 1 1 1 1 1 1 1 1 1 
GR128873 252 2 2 2 2 2 2 2 2 2 
GR75538X 253 1 1 1 1 1 1 1 1 1 
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Comound   Relative 	_Intensity _(lIl a)_______  _Emission 
Reg—No Cluster Rank EuBEA EuUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GR35345A 254 1 3 3 2 3 4 4 4 3 
GR49747X 255 1 1 1 1 1 1 1 1 1 
GR51603A 256 1 1 1 1 1 1 1 1 1 
GR85161X 256 2 1 1 1 1 1 1 1 1 
AH10536 257 1 3 - - - 6 6 - 5 
AH10767 257 2 2 - - - 4 3 - 3 
AH9356 257 3 4 5 3 4 8 8 3 5 
GW316125 257 4 2 :2 2 2 2 2 2 2 
CC110174 258 1 4 4 2 3 7 6 2 4 
GR263958X 258 2 1 1 1 1 1 1 1 1 
GW433821A 259 1 - 2 2 2 - 3 - 2 
CC110446 260 1 1 1 1 1 1 1 1 1 
GR138218X 260 2 1 1 1 1 1 1 1 1 
GW349042X 261 1 2 2 1 1 2 2 1 2 
GR44479X 262 1 1 1 1 1 1 1 1 1 
GR66484X 262 2 1 1 1 1 1 1 1 1 
GW449422A 262 3 1 1 1 1 1 1 1 1 
G120451 OX 263 1 1 1 1 1 1 1 1 1 
GR239579X 263 2 6 6 6 5 5 4 4 5 
GW352006X 263 3 1 1 1 2 2 1 1 1 
G1233445X 264 1 1 1 1 1 1 1 1 1 
GR239577X 265 1 1 1 1 1 1 1 1 1 
AH1010 266 1 - 1 1 1 - 1 - 1 
CC121414 266 2 - I I I - 1 - 1 
G1222692X 266 3 - 1 1 1 - 1 - 1 
GR84679X 267 1 - 1 1 1 - I - 1 
GR84985A 267 2 - 1 1 1 - 1 - I 
AH10182 268 1 1 1 1 1 1 1 1 1 
GR203336X 268 2 1 1 1 1 1 1 1 1 
AH20998XX 269 1 1 ii 1 1 1 1 1 1 
AH6595 269 2 1 1 1 1 1 1 1 1 
AH21933X 269 3 - 1 1 1 - 2 - 1 
GR154396X 269 4 - 1 1 1 - 1 - 1 
GW408146X 269 5 1 1 1 1 2 1 1 1 
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Comound  Relative Emission _Intensity _(I/b)______  
Reg_No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
AH6732 270 1 1 1 1 1 1 1 1 1 
GR208133X 270 2 1 1 1 1 1 1 1 1 
AH1031 271 1 - 1 1 1 - I - 1 
AH16943AA 271 2 2 2 2 3 2 2 2 2 
AH1052 271 3 7 9 5 7 14 12 15 10 
CC121405 271 4 7 8 4 7 14 14 5 8 
AH11453 271 5 - 1 1 1 - 1 - I 
CC110176 271 6 3 3 2 3 7 6 3 4 
AH10633 272 1 4 4 3 4 6 5 3 4 
GW369905 272 2 7 15 4 5 14 14 - 10 
AH8268A 272 3 1 1 1 1 1 1 1 1 
GR202022X 273 1 96 84 87 102 143 127 41 97 
GR34043X 273 2 - 19 12 19 - 28 - 20 
GR247048X 274 1 1 1 1 1 1 1 1 1 
GW309880X 274 2 4 4 2 4 8 4 2 4 
GR230760X 275 1 6 5 3 5 11 8 4 6 
GW299526X 275 2 1 1 1 1 1 1 1 1 
AH10225 276 1 41 49 27 44 79 73 78 56 
AH11688 276 2 9 -. - - 20 10 - 13 
GR258750 276 3 183 150 102 118 210 194 - 159 
AH11368 276 4 2 2 2 2 2 3 2 2 
G1266527 276 5 144 114 82 95 162 132 - 121 
AH11967 277 1 11 28 22 18 65 35 82 37 
GR140330X 277 2 7 9 7 10 8 6 7 8 
GR216655X 277 3 - 1 1 2 - 2 - 2 
GR220880X 277 4 - 1 1 1 - 1 - 1 
GR232939X 278 1 1 1 1 1 2 1 1 1 
AH1053 279 1 11 12 6 10 19 17 18 13 
AH6596 279 2 1 1 1 1 1 1 1 1 
AH12133 280 1 11 16 23 33 83 29 80 39 
AH13394 280 2 5 5 4 5 9 8 4 5 
GW299375X 280 3 2 1 1 3 2 2 1 2 
AH3663 281 1 1 1 1 1 1 1 1 1 
GR239599X 281 2 1 1 1 1 2 2 1 1 
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Comound  Relative 	_Intensity _(Ill)_______  _Emission 
Rea No Cluster Rank EuBEA EuBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
AH11395 282 1 2 1 2 3 4 3 3 2 
AH13826XX 282 2 - 1 1 1 - 1 - 1 
GR54987X 282 3 - 1 1 1 - I - 1 
GW471049X 282 4 - -. - - - - - #DIV/0! 
GW320828X 282 5 6 7 8 8 10 8 6 7 
GW321479X 282 6 21 23 23 27 19 17 - 22 
GR101886 283 1 - 3 3 3 - 2 - 3 
GR82448 283 2 2 3 2 2 2 2 2 2 
GW294831 283 3 20 16 18 16 22 16 - 18 
AH12975 284 1 2 2 3 3 3 3 2 2 
GW312607X 284 2 1 2 2 3 4 2 3 3 
AH17009XX 285 1 - 2 2 5 - 3 - 3 
GW314282X 285 2 - 1 1 1 - 1 - 1 
GW355545X 285 3 11 11 13 12 12 11 8 11 
AH3705A 286 1 - I I I - 1 - 1 
CC110881 286 2 - 1 1 1 - 1 - 1 
AH10300 287 1 3 - - - 3 4 - 3 
AH10801 287 2 5 - - - 4 7 - 5 
AH9678 287 3 2 - - - 3 3 - 3 
AH10698 287 4 57 - - - 35 46 - 46 
AH10853 287 5 1 - - - I I - I 
GR92452 287 6 1 - - - 1 1 - I 
AH9727 287 7 - 3 2 3 - 4 - 3 
Al-112695 287 8 31 - - - 22 18 - 24 
AH13070 287 9 1 1 1 1 1 1 1 1 
AH9676 287 10 61 - - - 93 88 - 81 
AH9721 287 11 1 - - - 1 1 - I 
AH10301X 288 1 23 23 12 25 60 28 18 27 
AH15692 288 2 12 - - - 13 17 - 14 
AH12533 288 3 6 - - - 8 7 - 7 
AH12590 288 4 3 - - - 5 3 - 4 
AH15690 288 5 5 - - - 6 6 - 6 
AH15757 288 6 7 - - - 8 5 - 7 
AH10978 288 7 1 - - - 2 2 - 2 
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Comound  Relative Emission _Intensity _(lIlo) - 
Reg No Cluster Rank EuBEA EuBUA EucyHA Eumc yHA EuNBA EuBBZA EuBTA Average EuNAL 
AH11275 288 8 16 24 36 33 46 48 14 31 
AH12589 288 9 2 2 1 3 3 3 2 2 
AH11274 288 10 6 5 5 8 8 7 7 7 
AH13391 288 11 4 :3 2 5 5 5 3 4 
GR254264X 288 12 3 3 3 3 5 3 2 3 
AH10616T 289 1 1 1 1 1 1 1 1 1 
AH7490 289 2 1 1 1 1 1 1 1 1 
AH185I5XX 290 1 - 5 3 4 - 8 - 5 
AH22573X 290 2 1 1 1 2 1 1 1 1 
AH8588 290 3 1 1 1 1 1 1 1 1 
AH8601 290 4 4 6 5 6 5 4 4 5 
GR32737X 290 5 1 1 1 1 1 1 1 1 
AH23288X 291 1 1 1 1 1 1 1 1 1 
G1149558 291 2 1 - - 1 1 - 1 
GR133921 291 3 1 - - 1 1 - 1 
GR134971 291 4 1 - - 2 2 - 2 
GR65242X 291 5 1 1 1 1 1 1 1 1 
AH26099 291 6 2 3 3 4 3 3 2 3 
GR116365X 291 7 6 7 6 6 5 4 3 5 
GW541785X 291 8 1 1 1 2 1 1 1 1 
GR31004 291 9 2 1 1 1 1 1 - I 
GW278395 291 10 11 10 10 9 11 10 - 10 
GR110635X 292 1 1 1 1 1 1 1 1 1 
GR116353X 292 2 1 1 1 1 1 1 1 1 
GR125882X 292 3 1 1 1 1 1 1 1 1 
GW294490X 292 4 1 1 1 1 1 1 1 1 
GW589997X 293 1 1 1 1 1 1 1 1 1 
AH20902 294 1 2 2 2 2 2 2 2 2 
GR36456 294 2 2 2 2 2 2 2 - 2 
AH20984 294 3 1 - - - 1 1 - I 
AH21852 294 4 1 - - - 1 1 - 1 
GR252017 294 5 2 2 2 2 3 2 - 2 
GR58047 294 6 1 1 1 1 1 1 1 1 
GR44857A 295 1 4 4 3 4 4 3 3 4 
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Comound    Relative 	_Intensity _(lII)______ _Emission 
Reg_No Cluster Rank EuBEA EUBUA EucyHA EumcyHA EuNBA EuBBZA EuBTA Average EuNAL 
GR207154 296 1 1 1 1 1 1 1 1 1 
GR78684X 296 2 4 5 4 5 4 4 4 4 
AH2426A 297 1 - 1 1 1 - 1 - 1 
AH3116 297 2 3 3 3 4 4 3 2 3 
GW304734X 297 3 10 12 6 12 20 17 16 13 
GW661447X 297 4 2 1 - 2 2 1 1 1 
GR173175X 298 1 1 1 1 1 1 1 1 1 
GR254404X 298 2 1 1 1 1 1 1 1 1 
GW275105X 298 3 1 1 1 1 1 1 1 1 
GW299610X 298 4 1 1 1 1 1 1 1 1 
GW298781X 298 5 1 1 1 1 1 1 1 1 
GW470761X 298 6 1 1 1 1 1 1 1 1 
GW369798X 298 7 1 1 1 1 1 1 1 1 
GW659802X 298 8 1 1 - 1 1 1 1 1 
GR221928X 299 1 1 1 1 2 1 1 1 1 
GW470720X 300 1 1 1 1 1 1 1 1 1 
GW641296X 300 1 	2 1 	1 1 	1 1 	1 1 1 	 1 1 1 1 
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Figure 1 Emission spectrum (corrected for PMT response) of 
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Figure 2 Lifetime decay curves for ThBUA (0.1 mM a + PCA 
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Appendix 5 
Model for calculation of polyprotic acid speciation versus solution pH 





K 	 Ka3 
H2L 	 HL- - L3- 
Kai = [H2L]/[H3L]; Ka2 = [HL 2 ]/[H21-] Ka3 = [L 31/[HL21 
Protonation Constants: 
Protonation Ka pKa 
Event  
I 6.31E-04 3.2 
2 2.51E-05 4.6 
3 6.31E-10 9.2 
PH = -Log1oIH301 
1H301 = 10(-pH) 
Mass Balance Equation: 
[LIT = [113L] + IIH2L] + [HL 
2-]+ [L3 ] 
Species Fraction (a) 
a0 = [H3L]/{L}T; a 1 = [H2U]/[L]T ; ; a2 = [HL 2 ]/[L] 1 ; a3 = [L3 ]/[LIT 
a0 = [1130+ ] 3/([H30+1' + K.1[113 
0+]2±  Ka iKa2[H30] + Kai Ka2Ka3) 
a 1 = Kai[H30]2/([H30]3 + Kai [H3O]2 + K ai Ka2 [H30 4] + KaiKa2Ka3) 
a2 = Ka iKa2[H3011/({H30i 3 + Kai [H3Of + K a iKa2[H30] + Kai Ka2Ka3) 
a3  = Ka1Ka2Ka3/([H30]3 + KaI[H3O]2 + KalKa2[11301 + K aI Ka2Ka3 ) 
Conditional Stability Constants 
The conditional stability constant (K'ML) for an aminopolycarboxylate complex in 
aqueous solution at a fixed pH is calculated from the thermodynamic stability constant (KML) 
for the complex and the species fraction of the fully deprotonated ligand. For DTPA-BEA, 
the thermodynamic stability constant with Gd(III) is 2.19x10' 5 (L0gKGdL = 15.34). 
Appendix 5 
DTPA-BEA Protonation Profile 
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Figure 1 DTPA-BEA protonation equilibria: Species fraction versus pH 
£ a3 a2 a, a0 K'ML 
Log KML 
U 1.00E+00 9.99E-18 1.58E-08 6.31E-04 9.99E-01 2.19E-02 -1.66 
I 1.00E-01 9.94E-15 1.57E-06 627E-03 9.94E-01 2.17E+01 1.34 
2 1.00E-02 9.41E-12 1.49E-04 5.93E-02 9.41E-01 2.06E+04 4.31 
3 1.00E-03 6.07E-09 9.62E-03 3.83E-01 6.07E-01 1.33E+07 7.12 
4 I.00E-04 /.12E-06 1.78E-01 7.09E-0I /.12E-01 2.46E+09 9.39 
5 /.00E-05 4.49E-05 7.12E-01 2.83E-01 4.49E-03 9.83E+ /0 10.99 
6 1.00E-06 6.06E-04 9.61E-01 3.83E-02 6.06E-05 1.33E+12 12.12 
7 1.00E-07 6.25E-03 9.90E-01 3.94E-03 6.25E-07 1.37E+13 13.14 
8 1. OOE-08 5.93E-02 9.40E-01 3.74E-04 5.93E-09 1.30E+14 14.11 
9 1.OUE-09 3.87E-01 6.13E-01 2.44E-05 3.87E-1I 8.46E+14 14.93 
10 I.00E-I0 8.63E-01 I.37E-01 5.45E-07 8.63E-14 1.89E+15 15.28 
11 1.00E-// 9.84E-0I 1.56E-02 6.21E-09 9.84E-17 2.15E+15 15.33 
12 1.00E-12 9.98E-01 I 	1.58E-03 6.30E-1 I 9.98E-20 2.18E+15 15.34 
13 I.00E-13 I.00E+00 /.58E-04 6.31E-13 /.00E-22 2.19E+15 15.34 
14 1.00E-14 1.00E+00 I 	1.58E-05 6.31E-15 /.00E-25 2.19E+15 15.34 
Dissociation Equilibrium 
EuNAL = Eu + NAL (Eu = NAL = x) 	K' = 1/K 	
0-14 
 
[EuNAL] = [EuNAL] o - [Eu]; [EuNAL] = [EuNAL] o - x 
K' = x2/([EuNAL] o - x) 
x2 - K'[EuNAL]o + K'x = 0 (solved for x; [EuNAL] o and K 1 are constants to give the 
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Firbush Outdoor Centre, April 1998 and 1999 
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RSC "New Chemistry, New People" 
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USIC 98 
University of Strathclyde, Sept 1998 
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Glaxo Wellcome, Stevenage 
June 2000 	"New Chelators for the Development of Highly Luminescent Complexes for 
Biomolecule Labelling" 
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Biomolecules" 
University of Edinburgh 
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May 1999 "Ternary Luminescent Lanthanide Complexes: New Light Bulbs" 
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